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Abstract 
 
The genus Yersinia consists of a heterogeneous collection of organisms, comprising 
the highly pathogenic species Yersinia pestis, enteropathogens 
Yersinia pseudotuberculosis and Yersinia enterocolitica as well as environmental 
species. The evolutionary history of Y. pestis has been well documented, but 
information on the evolutionary relationship between the other Yersiniae is less 
characterized. Y. enterocolitica is a diverse species classed into six different biotypes 
(BT), but only a single genome sequence for high-pathogenic BT 1B was available at 
the start of the project. 
This project looked into the dynamics shaping the pathogenic lineages in Yersinia. 
For each of the Y. enterocolitica BTs, a reference genome was sequenced, 
annotated and analysed in detail. Analysis of biochemical characteristics was carried 
out using a phenotypic microarray. A further 98 Y. enterocolitica, 36 
Y. pseudotuberculosis/Y. pestis isolates and 81 environmental species were 
sequenced and analysed to investigate the evolutionary dynamics of the genus 
Yersinia.  
The Y. enterocolitica BTs form three distinct groups according to non-, low-, and 
high-pathogenic BT, each with a different set of accessory genes. The 
Y. enterocolitica core genome comprises ~3,300 CDSs. The non-pathogenic BT 
contains genes involved in environmental survival, whereas the high-pathogenic BT 
has a high-pathogenicity island and the unique Ysa type III secretion system. The 
low-pathogenic BTs share a second flagella cluster and an insect pathogenicity 
island. Apart from the virulence plasmid pYV, only 40 CDSs are shared in all 
pathogenic BTs including the adhesion invasion locus ail. The phenotypic microarray 
confirmed higher metabolic flexibility of the non-pathogenic BT, and decreased 
biochemical abilities in the low-pathogenic BTs, mirroring an increased number of 
pseudogenes. 
Looking at the whole genus, pathogenic lineages are visible at opposite ends of an 
evolutionary tree. Y. pestis has evolved out of Y. pseudotuberculosis, and both are 
distinct from Y. enterocolitica which developed out of the environmental Yersiniae. 
Fish pathogen Y. ruckeri forms a third independent pathogenic lineage. Despite the 
large evolutionary distance, comparing dynamics in Y. enterocolitica to Y. pestis it is 
clear that independent acquisition of the virulence plasmid and metabolic 
streamlining to specific hosts drove pathogen evolution. Whilst this has concurrently 
happened in Y. pestis, this development has been weighted differently in lineages of 
Y. enterocolitica leading to a high-pathogenic, human-adapted biotype and low-
pathogenic biotypes, which can be adapted to human or animal hosts. 
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1 Introduction 
1.1 The Genus Yersinia 
The heterogeneous genus Yersinia comprises three human-pathogenic species, 
Y. pestis, Y. pseudotuberculosis, and Y. enterocolitica, the fish-pathogen Y. ruckeri, 
and a number of environmental, seemingly non-pathogenic species (Carniel and 
Mollaret, 1990; Bottone, 1997; Bottone, 1999; Sulakvelidze, 2000; Wren, 2003). The 
Yersiniae belong to the family of Enterobacteriaceae, and are rod-shaped, facultative 
anaerobic bacteria (Carniel and Mollaret, 1990; Bottone, 1999; Wren, 2003). 
Historically, speciation in Yersinia is based on biochemical differences (Sulakvelidze, 
2000). A selection of biochemical tests for species designation is listed in Table 1.1.  
 
Table 1.1: Selection of biochemical characteristics of members of the genus Yersinia [adapted 
from Bottone, 1997; Sulakvelidze, 2000; Hurst, et al., 2011; Murros-Kontiainen, et al., 2010a,b]. 
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Y. aldovae + - - - - - - + + + + 
Y. aleksiciae - + + - - - + - - + + 
Y. bercovieri - - + - - + - - - + + 
Y. enterocolitica - v + - - + v - + v + 
 Y. entomophaga - - + + + + - ? - - + 
Y. frederiksenii + + + - - + + v + + + 
Y. intermedia + + + + + + + + - + + 
Y. kristensenii - + + - - - v - - + + 
Y. massiliensis - + + v - + + - + + + 
Y. mollaretii - + + - - + - - + + + 
Y. nurmii - - (+) - - + - + - - - 
Y. pekkanenii - - + - - - - - - + + 
Y. pestis v - - - v - - - - - - 
Y. pseudotuberculosis + - - - + - - - - + + 
Y. rohdei - + + + v + - - - + + 
Y. ruckeri - - - + - - - - - - - 
Y. similis + - - - - - - - - + + 
+ – positive; (+) – delayed positive; v – variable; - – negative; ? – information unavailable 
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There is no one typing scheme used for Yersinia, and the most commonly used key 
tests are presented (Bottone, 1997; Stock, Henrichfreise and Wiedemann, 2002). 
The description of further species generally relies on new tests being added, 
resulting in data that is then not available for all species. Differences in DNA-DNA 
hybridization values are used to furthermore classify the environmental Yersiniae 
(Bottone, 1997). Most recently differences in the 16S rDNA sequence have been 
employed alongside biochemical signatures and DNA-relatedness to define new 
species (Sprague and Neubauer, 2005; Hurst, et al., 2011).  
 
1.1.1 Yersinia pestis and Yersinia pseudotuberculosis  
Y. pestis is the causative agent of plague, the notorious Black Death of the middle 
ages, responsible for the death of millions of Europeans (Brubaker, 1991; Perry and 
Fetherston, 1997; Wren, 2003). The life cycle of Y. pestis is depicted in Figure 1.1A. 
Y. pestis is a host-dependent organism, and has limited abilities to survive outside 
either the flea vector or a warm-blooded host (Perry and Fetherston, 1997; Parkhill, 
et al., 2001a; Wren, 2003). In the flea vector, the bacteria block the foregut. The flea 
cannot feed on a new host, but in trying will regurgitate the bacteria directly under the 
skin and into the blood stream of the mammalian host (Wren, 2003). This mammalian 
host can be wild living rodents, such as rabbits or gerbils (Carniel and Mollaret, 
1990). This is called the sylvatic cycle, and the ability to hibernate and circulate in 
wild rodent populations precludes eradication. Y. pestis may cause disease in wild 
rodents as well, and its persistence might be explained either by hibernation in the 
ground of abandoned rodent burrows, which may subsequently become re-inhabited, 
or reduced virulence in rodents due to mutations (Carniel and Mollaret, 1990).  
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Figure 1.1: Life cycle of Y. pestis and worldwide distribution. A. Sylvatic and urban transmission 
routes of Y. pestis. B. Current endemic foci of plague [according to CDC, 2009]. 
 
In the urban cycle, humans are infected as accidental hosts of the flea. Once inside 
the human body, the bacteria will spread to the regional lymph nodes, either by 
surviving inside macrophages or through tissue infection (Wren, 2003). Once there, 
Y. pestis multiplies and gives rise to the classic symptoms of inflamed lymph nodes 
of primary bubonic plague (Carniel and Mollaret, 1990; Perry and Fetherston, 1997). 
The incubation time of infection is 2 to 6 days after the bite (CDC, 2005). Once the 
bacteria have entered the lymph nodes of the human host, they then progress to the 
lungs, liver and spleen (Carniel and Mollaret, 1990; Wren, 2003). The bacteria enter 
the blood stream causing septicaemia (Carniel and Mollaret, 1990). The flea feeding 
on an infected, bacteraemic individual closes the cycle from mammalian host back to 
the flea. A transmission from cats to humans via aerosols has been reported, but is 
very rare (CDC, 2009). In crossing sylvatic and urban cycles, rats play an important 
role as hosts to infected fleas and their proximity to towns and settlements (Carniel 
and Mollaret, 1990; Perry and Fetherston, 1997). 
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The terminal phase of Y. pestis is associated with lodging and multiplication of the 
bacteria in the lung (Carniel and Mollaret, 1990). Upon reaching this site of infection, 
secondary pneumonic plague ensues with a fatality rate of over 50% (Wren, 2003; 
CDC, 2005). Additionally at this stage, an arthropod host is redundant as 
transmission via aerosols to other humans is possible and highly effective (Carniel 
and Mollaret, 1990; Wren, 2003). Following this infection route, the bacteria can 
rapidly spread to the bloodstream, circumventing the need for prior establishment in 
lymph nodes, and death occurs within a few hours (Carniel and Mollaret, 1990). 
Today, Y. pestis is still present in sylvatic foci found in North and South America, 
sub-Saharan Africa, and Asia with a sufficient rodent population (Figure 1.1B; CDC, 
2005). It is still a relevant human disease with 1,000 to 2,000 cases a year worldwide 
(CDC, 2005), and multidrug resistant strains have been identified (Wren, 2003). It 
also poses a bioterrorism threat due to extremely efficient person-to-person spread, 
and delayed onset of symptoms enabling a geographic spread (Carniel and Mollaret, 
1990; CDC, 2005). The infective dose is also very low, at 10 cells or less (Brubaker, 
1991). 
Three classic biovars of Y. pestis have been associated with the three main 
pandemics (Achtman, et al., 1999; Wren, 2003).  Bacteria that gave rise to the 
Justinian plague are related to Biovar Antiqua, and those that gave rise to the Black 
Death in the Middle Age relate to biovar Mediaevalis. Modern plague is associated 
with biovar Orientalis (Achtman, et al., 1999). These are distinguished on the basis of 
glycerol fermentation and nitrate reduction. 
 
Y. pseudotuberculosis is closely related to Y. pestis (Chapter 1.3), but has very 
different ecology. It is found widely in animals and the environment. Humans are 
infected via the fecal-oral route following the ingestion of contaminated food sources 
(Carniel and Mollaret, 1990; Carniel, 2003; Wren, 2003). In animals, the bacteria 
invade the small intestine and spread from lymphatic vessels to distal lymph nodes 
and subsequently to liver and spleen (Carniel and Mollaret, 1990). At these sites, 
abscesses form, and the bacteria can enter the bloodstream with fatal outcome 
(Carniel and Mollaret, 1990). In human infections, the bacteria enter the small 
intestine as well, but disease is usually milder (Carniel and Mollaret, 1990). 
Y. pseudotuberculosis targets microfold cells (M cells) for invasion of the gut 
epithelium (Carniel and Mollaret, 1990; Wren, 2003). It then disseminates widely, and 
causes mesenteric lymphadenitis (Wren, 2003). Mild diarrhoea can be observed, but 
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abdominal pain is the most frequent and constant symptom (Carniel and Mollaret, 
1990). No further colonization of deeper tissues or secondary organs ensues though, 
and usually the disease is self-limiting (Carniel and Mollaret, 1990; Carniel, 2003). 
Seasonality of the disease is suspected, as the susceptible animal hosts appear to 
shift from being healthy carriers to infected hosts after exposure to stresses such as 
cold, humid weather and starvation periods (Carniel and Mollaret, 1990). 
In countries of the Far East, infection with Y. pseudotuberculosis occurs with 
additional systemic symptoms such as skin rashes and toxic shock syndrome, which 
is also known as Far East scarlet-like fever (Fukushima, et al., 2001; Eppinger, et al., 
2007). It has been proposed that the presentation of Y. pseudotuberculosis as Far 
East scarlet-like fever arises predominantly in isolates that carry the superantigen 
Yersinia pseudotuberculosis mitogen (YPM), which is absent in strains causing 
enteric disease (Fukushima, et al., 2001; Eppinger, et al., 2007). 
In Y. pseudotuberculosis, 21 different serogroups are known which are combined in 
six serotypes (Carniel and Mollaret, 1990). There is no correlation between serotype 
and disease severity, in contrast to Y. enterocolitica (Carniel and Mollaret, 1990). 
Y. pseudotuberculosis infections are less common than Y. enterocolitica infections 
(Carniel and Mollaret, 1990).  
 
1.1.2 Yersinia enterocolitica 
Similar to Y. pseudotuberculosis, Y. enterocolitica causes enteric disease. 
Y. enterocolitica infections are most commonly due to ingestion of contaminated food 
products although cases of infections through contaminated blood transfusion have 
been reported (Bottone, 1997). Survival and proliferation at refrigeration 
temperatures make it a significant food-borne pathogen (Bottone, 1997; Bottone, 
1999). Following ingestion, the bacteria colonize the gastrointestinal tract, specifically 
the terminal ileum and proximal colon, by attaching and invading M cells in the 
Peyer’s patches (Carniel and Mollaret, 1990; Bottone, 1997; Bottone, 1999). They 
then multiply and spread horizontally through the mucosal epithelium  (Bottone, 
1997). This manifests in inflammatory symptoms such as enteritis, enterocolitis, 
acute mesenteric lymphadenitis, and terminal ileitis, and is also associated with fever 
and diarrhoea, which can occasionally be bloody (Carniel and Mollaret, 1990; 
Bottone, 1997; Bottone, 1999). It is thought that serotype O:8 strains present with 
more aggressive disease than O:3 infections (Bottone, 1999). Often, the infection is 
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self-limiting, as these symptoms subside on their own account after 2 weeks in adults 
and longer periods in infants (Pepe and Miller, 1993; Bottone, 1997; Carniel, 2003).  
The bacteria are able to invade deeper tissue layers as well, and may enter the 
bloodstream with subsequent spread to liver, spleen, and mesenteric lymph nodes 
(Bottone, 1997; Bottone, 1999). Arthritis and erythema nodosum, an inflammation 
under the skin, have been described as the most common sequelae of 
Y. enterocolitica infections (Bottone, 1997; Bottone, 1999). 
 
The species Y. enterocolitica is very heterogeneous with respect to both biochemical 
differences and causing disease. Some strains are able to cause severe enteritis in 
humans, other strains are responsible for milder symptoms, whilst a third group of 
strains is not associated with any disease in humans (Carniel and Mollaret, 1990; 
Bottone, 1999; Sulakvelidze, 2000; Virdi and Sachdeva, 2005). Therefore, the 
species is differentiated into six different biotypes (BT) based on biochemical 
differences (Table 1.2; Wauters, Kandolo, and Janssen, 1987).  
 
Table 1.2: Biotyping scheme according to Wauters, Kandolo and Janssens (1987) and Bottone 
(1997). 
 Biotype BT 1A BT 1B BT 2 BT 3 BT 4 BT 5 
 Pathogenicity potential No High Low Low Low Low 
1 Salicin AP + - - - - - 
2 Pyrazinamidase activity + - - - - - 
3 Esculin hydrolysis +/- - - - - - 
4 Lipase activity + + - - - - 
5 Indole production + + v - - - 
6 Xylose AP + + + + - v 
7 Trehalose AP + + + + + - 
8 Sorbose AP + + + + + - 
9 Nitrate reduction + + + + + - 
10 Ornithine decarboxylase + + + + + + (+) 
11 Voges-Proskauer test + + + + + + (+) 
12 Inositol AP + + + + + + 
AP – acid production, + – positive, - – negative, v – variable, (+) – delayed positive. 
 
There are several reactions, which are unique to BT 1A, whereas there is only one 
reaction to distinguish BT 4 from BT 3, and one variable reaction to separate BT 2 
and BT 3. Generally, biotyping identification is based on the absence of utilization of 
a nutrient source compared to BT 1A rather than unique properties specific for each 
biotype. This results in a “step-wise” appearance of positive reactions. 
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In line with its heterogeneity there are also approximately 60 serogroups in 
Y. enterocolitica, but only certain bio-serotypes are frequently associated with human 
infections, which are BT 1B O:8, and O:21, BT 2 O:9, and O:5,27, BT 3 O:1,2,3, O:9, 
and O:5,27, BT 4 O:3, and BT 5 O:2,3 (Carniel and Mollaret, 1990; Bottone, 1997; 
Bottone, 1999; Sulakvelidze, 2000; Virdi and Sachdeva, 2005). In early studies, 
these bio-serotypes have been associated with invasion of epithelial cells, 
autoagglutination and conjunctivitis in guinea pigs (Pedersen, Winblad and Bitsch, 
1979; Schiemann and Devenish, 1982). BT 5 potentially presents an exception and 
does not invade epithelial cells (Pedersen, Winblad and Bitsch, 1979). It was also 
noted specifically that BT 1B O:8 and O:21 serotypes generate more severe disease 
in the guinea pig model (Schiemann and Devenish, 1982).  
In a mouse infection model, the biotypes also exhibit differences in disease severity. 
BT 1B is considered the high-pathogenic BT, as it kills mice in infection models, and 
BTs 2 – 5 are the low-pathogenic BTs that cause infection in mice but are not lethal. 
Because it does not cause disease in mice, BT 1A is designated the non-pathogenic 
BT (Wren, 2003). Recently, two subspecies have been proposed (Neubauer, et al., 
2000). Based on differences in the 16S rDNA sequence, it has been suggested to 
refer to the high-pathogenic BT 1B as Y. enterocolitica subsp. enterocolitica, and the 
non- and low-pathogenic BTs 1A, 2 – 5 as Y. enterocolitica subsp. palearctica 
(Neubauer, Hensel, Aleksic and Meyer, 2000; Neubauer, et al., 2000; Neubauer and 
Sprague, 2003). 
Y. enterocolitica is a ubiquitous organism, found in the environment as well as the 
gastrointestinal tract of animals (Bottone, 1999). Pigs are a common reservoir for 
nearly all Y. enterocolitica, and this is considered a major route of infections for 
humans although a clear link has not yet been discovered (Carniel and Mollaret, 
1990; Bottone, 1999; Neubauer and Sprague, 2003). The non-pathogenic BT 1A is 
also found in a range of environmental sources such as animals, food, and water, 
and is also isolated from faeces of healthy and sick humans  (Bottone, 1999; 
Tennant, Grant and Robins-Browne, 2003; Tennant, Skinner, Joe and Robins-
Browne, 2005). BT 5 is a rarely isolated biotype, and its main ecologic distribution is 
in hare and goats. It is therefore commonly referred to as the “hare-biotype”, and 
isolation from humans has never been reported (Swaminathan, Harmon and 
Mehlman, 1982; Carniel and Mollaret, 1990; Wuthe and Aleksic, 1997; Bartling, et al., 
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2004). In hares, infection can cause acute septicaemic disease leading to epidemic 
outbreaks (Bartling, et al., 2004). 
1.1.3 The special case of Yersinia ruckeri 
Amongst the Yersiniae, Y. ruckeri is a special case. Compared to other members of 
the genus, it is the most distantly related species, and it has been questioned 
whether it is indeed a member of the genus (Bottone, 1997; Sulakvelidze, 2000). 
Studies on DNA relatedness indicated distant relationships to both Serratia and 
Yersinia, and a designation into the genus Yersinia was based on similarity in 
biochemical reactions as well as the GC content (Sulakvelidze, 2000; Fernández, 
Méndez and Guijarro, 2007). 
Y. ruckeri causes redmouth disease in salmonid fish, especially in rainbow trout, 
which presents as acute or chronic septicaemia with internal and external 
haemorrhages (Tobback, et al., 2009). Y. ruckeri has also been implicated in fatal 
septicaemia in carp (Sulakvelidze, 2000; Fernández, Méndez and Guijarro, 2007). As 
such, it is considered an important economic factor in the fish industry (Tobback, et 
al., 2009; Ryckaert, et al., 2010). An effective vaccine is available, yet outbreaks 
under stress conditions can spread quickly from faeces of ill and carrier fish through 
water (Fernández, Méndez and Guijarro, 2007). Recently, new strains have been 
reported, which are unaffected by vaccination, possibly due to changes in surface 
antigens (Fernández, Méndez and Guijarro, 2007). 
Little is known about the molecular mechanisms of pathogenesis. Both abilities to 
form biofilms and to survive for prolonged time in aquatic, nutrient-restricted 
environments are thought to play a role, as well as an iron-acquisition system 
(Fernández, Méndez and Guijarro, 2007). A large plamid that is in common to 
American and French isolates has also been reported (Toranzo, Barja, Colwell and 
Hetrick, 1983; Guilvout, et al., 1988). This plasmid could be correlated with 
pathogenicity as the French isolates were from a redmouth disease outbreak, and 
because it is found in the most pathogenic serovars of Y. ruckeri, but a link with 
disease has not been established (Lesel, Lesel, Gavini and Vuillaume, 1983; Garcia, 
Dominguez, Larsen and Pedersen, 1988). Expression of virulence genes is 
potentially regulated by the amount of available iron and temperature changes, and a 
decrease in temperature from 28°C to 18°C might be crucial (Fernández, Méndez 
and Guijarro, 2007). It was shown that gills could be an important entry point for 
Y. ruckeri into the host (Tobback, et al., 2009). The bacteria attach to the gills, which 
carry a large number of blood vessels for respiration. This opens up a direct route for 
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dissemination through the host via the blood stream (Tobback, et al., 2009). 
Y. ruckeri can also persist in macrophages, similar to the human pathogenic Yersinia, 
as means of protected environment and immune evasion (Ryckaert, et al., 2010). 
Y. ruckeri is a very homogeneous, clonal species, in contrast to the human 
pathogens Y. enterocolitica and Y. pseudotuberculosis, which are both considered 
heterogeneous  (Sulakvelidze, 2000). It can be differentiated into different bio-
serotypes, with the most virulent strains found in biotype 1 O:1 (Fernández, Méndez 
and Guijarro, 2007). 
 
1.1.4 Environmental Yersiniae 
Environmental species of the genus Yersinia are found in various environments, such 
as water and aquatic ecosystems, sewage, wild and domestic animals as well as 
foods (Sulakvelidze, 2000). They have not been associated with human infections, 
although some species have been isolated from sick and healthy individuals 
(Sulakvelidze, 2000). The environmental Yersiniae are also collectively referred to as 
‘Y. enterocolitica-like’ species, as they were speciated from Y. enterocolitica 
(Sulakvelidze, 2000). They do present individual species although the extent of their 
distinction may be underestimated (Sulakvelidze, 2000). 14 species have been 
described. Of these, eight species could be considered classical, established 
lineages speciated from Y. enterocolitica between 1978 and 1995 (Sulakvelidze, 
2000). The other six species have been portrayed from 2005 onwards and are 
therefore less well characterized (Sprague and Neubauer, 2005; Murros-Kontiainen, 
et al., 2010a,b; Hurst, et al., 2011; Merhej, et al., 2008; Sprague, Scholz, Amann and 
Busse, 2008).  
The eight species classically recognized as Y. enterocolitica-like species are 
Y. aldovae, Y. bercovieri, Y. frederiksenii, Y. intermedia, Y. kristensenii, Y. mollaretii, 
Y. rohdei, and Y. ruckeri (Chapter 1.1.3). In contrast to other environmental species, 
little is known about Y. aldovae. 
Y. frederiksenii is a heterogeneous species consisting of four genomospecies. These 
show differences in DNA-hybridization, 16S rDNA sequence comparison and when 
comparing the electrophoretic properties of specific enzymes (Sulakvelidze, 2000; 
Virdi and Sachdeva, 2005). As they do not differ on the biochemical level, these 
genomospecies can currently not be distinguished (Sulakvelidze, 2000). 
The naming of Y. intermedia arises from the fact that it shows common biochemical 
properties with both Y. enterocolitica and Y. pseudotuberculosis, and therefore was 
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thought to be ‘midway’ between the two (Sulakvelidze, 2000). Several different 
biotypes have been described based on differential utilization of Simmons citrate and 
fermentation of different sugars (Martin, Leclercq, Savin, and Carniel, 2009). 
Y. kristensenii was originally designated for trehalose-positive, sucrose-negative 
strains. This comprised a heterogeneous collection, with some isolates showing a 
closer genotypic similarity to Y. mollaretii  (Sulakvelidze, 2000). These were later 
speciated into Y. aleksiciae (Sprague and Neubauer, 2005). 
Y. mollaretii and Y. bercovieri were originally grouped as biotype 3A and 3B of 
Y. enterocolitica. They were then separated from that species based on differences 
in ecology, DNA hybridization, and antigen patterns (Sulakvelidze, 2000). 
Y. bercovieri is known to be genetically heterogeneous based on experiments 
distinguishing several ribotyping and pulse-field gel electrophoresis patterns 
(Sulakvelidze, 2000). 
Y. rohdei is a homogeneous group of organisms thought to be most closely related to 
Y. frederiksenii (Sulakvelidze, 2000). 
 
Recently described species are Y. aleksiciae, Y. entomophaga, Y. massiliensis, 
Y. nurmii, Y. pekkanenii, and Y. similis. Similarly to the classical environmental 
species, these have been isolated from various sources including water, symptomatic 
and asymptomatic humans, food products and animals such as reindeer and pigs. 
Y. aleksiciae was speciated as atypical isolates from Y. kristensenii (Sprague and 
Neubauer, 2005). They differ from Y. kristensenii in 16S rDNA sequence and lysine-
decarboxylase phenotype. 
Both Y. nurmii (Murros-Kontiainen, et al., 2010a) and Y. entomophaga (Hurst, et al., 
2011) are newly described species in which the closest relative appears to be 
Y. ruckeri. This is interesting as Y. ruckeri is thought to be the most distant member 
of the genus (Bottone, 1997; Sulakvelidze, 2000). Y. entomophaga was isolated from 
a diseased insect larva (Hurst, et al., 2011), and Y. nurmii was isolated from meat 
(Murros-Kontiainen, et al., 2010a). It is unknown how these two species relate to 
each other. Out of 19 biochemical tests with results available for both species, they 
differ in raffinose and melibiose utilization. Cellobiose and lactose give weak positive 
reactions for Y. nurmii, whereas Y. entomophaga is clearly positive (Hurst, et al., 
2011; Murros-Kontiainen, et al., 2010a). 
Y. massiliensis was initially isolated from water (Merhej, et al., 2008), but can be 
found in food sources as well (Souza, Falcão, and Falcão, 2011). The species is 
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thought to be closely related to Y. bercovieri, Y. mollaretii, and Y. frederiksenii and 
can be distinguished from these in indole, inositol, rhamnose, and citrate utilization 
patterns (Merhej, et al., 2008; Souza, Falcão, and Falcão, 2011). 
Based on commercially available biochemical tests, Y. pekkanenii cannot be 
distinguished from Y. pseudotuberculosis (Murros-Kontiainen, et al., 2010b). It was 
shown though that classical virulence determinants are absent, and that these 
environmental isolates form a unique cluster related to Y. mollaretii and Y. aldovae 
(Murros-Kontiainen, et al., 2010b). 
Y. similis isolates were also originally attributed to Y. pseudotuberculosis but 
phenotypic characterization as well as 16S rDNA analysis and DNA-DNA 
hybridization suggested a separate species (Sprague, Scholz, Amann and Busse, 
2008). 
 
1.2 Pathogenicity in the genus Yersinia 
1.2.1 Relationship of pathogenic Yersiniae 
The pathogenic Yersiniae have a number of characteristics that are thought to be 
involved in pathogenicity and virulence. Despite the difference in the diseases 
caused by Y. pestis, Y. pseudotuberculosis, and Y. enterocolitica some of these 
genes and islands are shared in all pathogenic Yersiniae (Revell and Miller 2001; 
Carniel, 2002). There is a common theme in the infections caused by pathogenic 
Yersiniae, in that iron overload of the host can increase pathogenicity, and there is 
marked tropism in all three species for lymphatic tissues: Y. pestis targets the lymph 
nodes, Y. pseudotuberculosis the lymphatic chain, and Y. enterocolitica infects the 
Peyer’s patches and lymphoid follicles (Carniel and Mollaret, 1990; Carniel, 2003). 
It is thought that Y. pestis expresses antiphagocytic, invasive, and toxic activities to 
cause an acute infection and effective transmission because it is less adapted to 
environmental survival than the enteropathogenic Y. enterocolitica and 
Y. pseudotuberculosis, which favour a chronic infection by production of adhesins 
and invasins (Brubaker, 1991).  
A considerable number of genes and regions have been implicated with a role in 
pathogenesis in Yersinia, yet not all of them present essential genes in the infection 
process. It is also becoming clear that some pathogenicity markers or islands that 
were thought to provide survival advantages under host infection conditions are in 
fact also present in environmental isolates and non-pathogenic BT 1A strains (Grant, 
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Bennet-Wood and Robins-Browne, 1998; Chen, et al., 2010). Some genes identified 
on the basis of essentiality in infection are housekeeping genes rather than specific 
virulence factors, therefore only genes involved in specific steps of the infection 
process are reviewed here. 
 
1.2.2 Plasmid-encoded basis for pathogenicity 
1.2.2.1 Shared virulence plasmid pYV 
The Yersinia virulence plasmid, pYV, is common to all pathogenic Yersinia, and 
varies in size between 40 to 48 kDa (Portnoy, Moseley and Falkow, 1981), equivalent 
to 60 to 70 kb. Hybridization experiments have indicated gene content variations 
suggesting the pYV plasmids are a "closely related family" of plasmids (Portnoy, 
Moseley and Falkow, 1981). In Y. enterocolitica, pYV is only present in high- and 
low-pathogenic strains, never in BT 1A (Carniel, 2002; Wren, 2003). It is also found 
in Y. pseudotuberculosis and Y. pestis; in the latter, it is called pCD1 for calcium 
dependency as expression of proteins encoded for on the plasmid is triggered under 
low-calcium conditions (Carniel, 2002; Chain, et al., 2004).  
Portnoy, Moseley and Falkow (1981) were among the first to link pathogenicity to the 
presence of pYV and showed that strains cured of the plasmid had reduced lethality 
in gerbils. The lethal dose of plasmid-cured strains was higher than 106 organisms 
compared to plasmid-bearing strains with a lethal dose of 103 organisms. Using the 
Sereny test it has been shown that infection of guinea pig conjunctiva is dependent 
on the presence of pYV, as cured strains did not cause an infection (Heesemann, et 
al., 1983). The lack of pYV in BT 1A is the main reason why it is considered to be 
non-pathogenic (Carniel, 2002).  
 
The pYV encodes a type III secretion system (T3SS) secreting Yersinia outer 
proteins (Yops) at 37°C in low calcium conditions (Cornelis, 2002; Carniel, 2002). 
The functionality of this replicon is conserved in all pYVs, although the overall 
organization may vary (Carniel, 2002). This system as been extensively studied as a 
model system for type 3 secretion in the past (Portnoy and Falkow, 1981; Portnoy, et 
al., 1984; Cornelis, et al., 1987; Cornelis, et al., 1998). 
 
The concerted action of Yops leads to prevention of phagocytosis and resistance to 
the immune response through three steps of adhesion to host cells, injection of 
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effectors using the T3SS, and modulation of target cell function (Cornelis, 2002; 
Carniel, 2002). The chromosomally encoded invasin Inv (1.2.3.1) and plasmid 
encoded YadA both mediate adhesion (Carniel, 2002). YadA is an outer membrane 
adhesin only expressed in enteropathogenic Yersiniae due to a frameshift mutation in 
Y. pestis (Brubaker, 1991; Cornelis, 1994). It is known to be involved in 
autoagglutination and erythrocyte agglutination as well as collagen and fibronectin 
binding (Brubaker, 1991; Cornelis, 1994). Contact with the host cell activates 
expression of structural and effector proteins of the T3SS, which is known as contact-
dependent secretion (Carniel, 2002; Cornelis, 2002). The apparatus genes are 
encoded by the ysc (Yersinia secretion) injectisome, whose 27 proteins make up the 
channel structure and protruding needle (Cornelis, 2002). The Yop effector proteins 
(YopEHMPT and YpkA) are then transported from the bacterial cell through the 
needle and injected straight into the target host cell where they have an effect on 
cellular pathways (Carniel, 2002). YopEHT and YpkA act on the cytoskeleton of the 
host cell and thus prevent phagocytosis (Cornelis, 1994; Carniel, 2002; Cornelis, 
2002). YopP and YopH down-regulate the immune response by inhibition of 
transcription activators resulting in decreased secretion of signal molecules (Carniel, 
2002; Cornelis, 2002). This also promotes intracellular survival of Yersinia inside 
macrophages (Cornelis, 2002). The exact nature of action for YopM is not known, but 
putatively involves influence on gene transcription (Cornelis, 2002). 
 
1.2.2.2 Plasmids specific to Y. pestis: pPCP and pMT 
Apart from the virulence plasmid pYV, Y. pestis has two additional unique plasmids 
that are implicated in pathogenicity; pPCP and pMT (Brubaker, 1991; Wren, 2003).  
The plasmid pPCP has a size of ~10 kb and can be referred to as pPla for 
plasminogen activator, pPst for pesticin, or pPCP1 for pesticin-coagulase-
plasminogen activator (Brubaker, 1991; Perry and Fetherston, 1997; Wren, 2003). 
Pesticin has a limited range of activity, and is restricted to acting on atypical 
Escherichia coli, Y. pseudotuberculosis serogroup 1A and 1B, and Y. enterocolitica 
serogroup O:8 (Brubaker, 1991). An essential role in disease has not been 
established and pesticin might be more important in competing with other bacteria in 
the same niche (Brubaker, 1991; Carniel, 2002). The plasminogen activator has 
fibrinolytic activity, and can coagulate rabbit plasma (Brubaker, 1991). This protein is 
involved in dissemination of Y. pestis in the infected host (Brubaker, 1991; Achtman, 
et al., 1999; Carniel, 2002). 
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The pMT plasmid encodes the murine toxin Ymt and has a size of 96 kb. It is also 
known as pTox or pFra, because it encodes the fraction 1 capsule-like antigen 
(Brubaker, 1991; Carniel, 2002; Wren, 2003). 
The fraction 1 capsule protein is an outer membrane protein that has been postulated 
to be involved in resistance to macrophage uptake during the initial stage of infection 
(Brubaker, 1991). As it presents an outwardly displayed antigen, it might be important 
in the interaction between the bacterium and host cells, especially of the immune 
response, and has been the target for vaccine development against plague (Carniel, 
2002; Eppinger, et al., 2010). Capsule-deficient Y. pestis biovar Angola was shown to 
lack lethality in the guinea pig model after subcutaneous infection, and was also less 
virulent in the subcutaneous mouse model but not in the aerosol model (Eppinger, et 
al., 2010). The exotoxin Ymt is responsible for the death of infected mice possibly 
due to blocking host cell receptors in the terminal, septicaemic stage of disease 
resulting in hypotension and vascular collapse (Brubaker, 1991; Hinnebusch, et al., 
2002). Ymt might be more essential for colonization of the flea (Parkhill, et al., 2001a; 
Hinnebusch, et al., 2002). It was shown that Ymt acts as an intracellular 
phospholipase that is involved in neutralizing agents in the flea midgut, which might 
otherwise lead to cell lysis (Hinnebusch, et al., 2002; Carniel, 2002). Through being 
able to persist and proliferate in the flea midgut, Y. pestis can then spread and block 
the proventriculus for effective transmission (Hinnebusch, et al., 2002). Without the 
protection through Ymt, the bacteria cannot establish colonization of the flea and are 
cleared (Hinnebusch, et al., 2002). 
 
A chimeric plasmid consisting of one pMT copy and two tandemly repeated copies of 
pPCP called pMT-PCP has been reported in Y. pestis strain Angola (Eppinger, et al., 
2010). It is thought that the presence of an  insertion sequence (IS) element enabled 
the co-integration of the plasmids via recombination (Eppinger, et al., 2010). The 
effect of this is unclear, but there are potentially dosage-related effects, as the 
chimeric plasmid is present in higher copy numbers than other plasmids (Eppinger, et 
al., 2010). There are three copies of the genes encoding the plasminogen activator. 
Conversely, the genes encoding the capsular antigen are absent on the chimeric 
plasmid, and it has been shown that this affects virulence following subcutaneous 
infection in the mouse model but not the aerosol route (Eppinger, et al., 2010). A 
chimeric plasmid might be an advantage in vertical plasmid progression and might 
ensure maintenance of all plasmid-encoded virulence factors (Eppinger, et al., 2010). 
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1.2.2.3 Plasmids specific to Y. pseudotuberculosis: pVM82 and pIB 
Both pVM82 and pIB have been isolated from strains of Y. pseudotuberculosis that 
have been implicated in Far East scarlet-like fever (Carniel, 2002; Eppinger, et al., 
2007). A region on pVM82 has been linked to immunosuppression and ability to 
resist phagocytosis (Eppinger, et al., 2007). Both plasmids carry genes encoding a 
pilus similar to the pilin gene cluster found on the Yersinia adhesion pathogenicity 
island (YAPI) although of different evolutionary origin (Eppinger, et al., 2007). This 
three-fold presence of pilin gene clusters might explain the host immune response 
associated with Far East scarlet-like fever (Eppinger, et al., 2007). 
Further plasmid-encoded genes that might potentially be involved in pathogenicity 
include a type 4 secretion system and a putative phytotoxin on pVM82, and a 
plasmid-transfer system on pIB (Eppinger, et al., 2007). 
 
1.2.3 Chromosomal markers of pathogenicity 
Whilst the virulence plasmid shared in the pathogenic Yersiniae undoubtedly plays a 
major role in infection, studies have shown that its loss in Y. enterocolitica does not 
completely abolish virulence, indicating the presence of essential chromosomally 
encoded virulence factors (Revell and Miller, 2001). 
1.2.3.1 Invasion and adhesion proteins: Inv and Ail 
Both Inv and Ail have been described as important proteins for promoting the 
invasion of host cells (Miller and Falkow, 1988; Miller, Farmer, Hill and Falkow, 
1989). The invasin protein Inv can confer an invasive phenotype on E. coli cells if 
cloned from the high-pathogenic Y. enterocolitica BT 1B (Miller and Falkow, 1988). 
Invasin mutants were also shown to be defective in colonization and dissemination in 
a mouse infection model (Pepe and Miller, 1993; Revell and Miller, 2001). The 
attachment and invasion locus ail was found to change invasive behaviour, but it 
appeared to be dependent on the cell type used suggesting a different mode of 
action of the two invasins (Miller and Falkow, 1988). Ail was shown to be involved not 
only in invasion, but also in adhesion to cells and in serum resistance (Pierson and 
Falkow, 1993). It is thought that Inv and Ail act in concert, with Inv important for 
priming of bacteria at lower temperatures, and Ail being responsible for acting once 
the infection process has started inside the host (Pepe and Miller, 1993). 
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Homologs of the invasin gene inv have been described in all Yersinia sp., but 
functionality has only been demonstrated in enteropathogenic Yersiniae (Miller and 
Falkow, 1988; Miller, Farmer, Hill and Falkow, 1989; Pierson and Falkow, 1990; 
Grant, Bennet-Wood and Robins-Browne, 1998). It is thought to be cryptic in 
Y. pestis due to disruption (Brubaker, 1991; Revell and Miller, 2001). Functionality in 
BT 1A could not be established, as it is neither expressed in the non-pathogenic BT, 
nor does it confer an invasive phenotype on E. coli, although no inactivating 
mutations were detected (Pierson and Falkow, 1990). The global regulator, rovA 
regulates the expression of invasion, and modulates the ability to infect and colonize 
deeper tissue layers in the mouse infection model (Revell and Miller, 2001). 
Distribution of the attachment and invasion locus protein Ail is very specific to 
pathogenic isolates, namely Y. pseudotuberculosis, Y. pestis and the 
Y. enterocolitica biotypes 1B, and 2 – 5 (Miller, Farmer, Hill and Falkow, 1989; Revell 
and Miller, 2001). Artificial overexpression of Ail in non-pathogenic BTs of 
Y. enterocolitica leads to transcription and localization to the cell surface, but fails to 
induce invasive behaviour, possibly due to differences in the cell surface structure of 
high- and non-pathogenic BTs (Pierson and Falkow, 1993). 
 
1.2.3.2 Yersinia Adhesion Pathogenicity Island (YAPI) 
The Yersinia adhesion pathogenicity island YAPI shows varied distribution amongst 
Y. pseudotuberculosis and Y. enterocolitica BT 1B strains. In Y. pseudotuberculosis it 
has been found in the strain causing Far East scarlet-like fever and a serotype I 
strain (Eppinger, et al., 2007). Only two BT 1B strains of Y. enterocolitica have been 
described containing YAPI suggesting independent acquisition events of this mobile 
genetic element (Thomson, et al., 2006). 
The conserved part of YAPI encodes a polycistronic pilin cluster that is involved in 
adhesion of bacteria to the respiratory epithelium in a mouse infection model (Collyn, 
et al., 2004; Eppinger, et al., 2007). The variable part of YAPI in 
Y. pseudotuberculosis contains metabolic genes, a restriction-modification system, IS 
elements and phage genes, which do not appear to contribute to pathogenicity 
(Collyn, et al., 2004). In Y. enterocolitica, the island is smaller than in 
Y. pseudotuberculosis, and apart from the shared pilin cluster encodes for a possible 
hemolysin, toxin/antitoxin system, and an arsenic resistance operon (Thomson, et al., 
2006).  
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It is thought that YAPI might have derived from the Salmonella Typhi island SPI-7 
due to extensive homology and is also found in other Enterobacteriaceae, such as 
Photorhabdus luminescens (Collyn, et al., 2004; Thomson, et al., 2006; Eppinger, et 
al., 2007). 
 
1.2.3.3 High-pathogenicity island (HPI) - Pigmentation / hemin storage locus 
The high-pathogenicity island (HPI) has been described in isolates of 
Y. enterocolitica, Y. pseudotuberculosis, and Y. pestis (Carniel, Guilvout and 
Prentice, 1996; Carniel, 2002). In Y. enterocolitica, it is only present in the high-
pathogenic BT 1B. Its presence is variable in Y. pseudotuberculosis isolates (Carniel, 
Guilvout and Prentice, 1996; Bach, et al., 1999) and was notably absent in the 
representative Y. pseudotuberculosis clone held responsible for Far East scarlet-like 
fever (Eppinger, et al., 2007). The HPI has been shown to play a major role in 
systemic dissemination during infection (Eppinger, et al., 2007).  
There are variations in gene content, and the HPI could be considered as two joined 
segments (Bach, et al., 1999; Carniel, 2002). The total island in Y. pestis occupies 
~100 kb and is referred to as pigmentation or hemin storage locus (hms / pgm; 
Carniel, Guilvout and Prentice, 1996). This locus has been described in Y. pestis as 
the ability to absorb exogenous hemin and form pigmented colonies (Brubaker, 1991; 
Carniel, Guilvout and Prentice, 1996). hms encodes an acquisition and storage 
system for the essential nutrient iron, which is limited in the host (Brubaker, 1991; 
Carniel, 2002). Also located on the pigmentation locus are fyuA-psn, which encodes 
the double protein FyuA acting as the siderophore yersiniabactin and bacteriocin 
pesticin, and irp1-5, iron-regulated high-molecular-weight proteins of which protein 2 
appears to have special importance (Carniel, Guilvout and Prentice, 1996; Bach, et 
al., 1999). In experimental studies, pigmentation mutants were shown to have a 
marked decrease in virulence (Brubaker, 1991; Carniel, Guilvout and Prentice, 1996). 
The locus is required in flea colonization as well, as it blocks the flea’s midgut leading 
to regurgitation of Y. pestis upon feeding on a host and thus ensuring efficient 
transmission (Parkhill, et al., 2001a). 
The HPI is significantly shorter in Y. enterocolitica BT 1B than in Y. pestis, and only 
stretches over 45 kb (Carniel, Guilvout and Prentice, 1996). The only genes 
conserved with the Y. pestis locus are the genes involved in iron capture: fyuA and 
irp1-5 (Carniel, Guilvout and Prentice, 1996; Bach, et al., 1999). Instead of the 
pigmentation locus, the rest of the HPI is occupied by IS and repeat elements in 
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Y. enterocolitica BT 1B (Carniel, Guilvout and Prentice, 1996). It is thought that this 
absence of iron-chelating proteins in the low-pathogenic Y. enterocolitica BTs 2 – 5 
contributes to their lowered virulence potential and less invasive disease outcome 
(Carniel, Guilvout and Prentice, 1996).  
The HPI in Y. pseudotuberculosis has the same genetic content as Y. pestis, and 
differs only in the terminal sites (Bach, et al., 1999). The presence of repeats and 
functional integrases in Y. pseudotuberculosis and Y. pestis leads to frequent 
deletion of the HPI, whereas due to a mutated integrase the region is highly stable in 
Y. enterocolitica (Bach, et al., 1999). Deletions of the HPI in Y. enterocolitica are 
possible but infrequent and comprise a much larger genomic region, with additional 
loss of phenotypes such as motility and growth defects (Bach, et al., 1999). The HPI 
has been described in other Enterobacteriaceae as well, including Klebsiella, 
Citrobacter, and E. coli, supporting the mobile nature of this locus (Bach, et al., 1999; 
Carniel, 2002). 
 
1.2.3.4 Yersinia pseudotuberculosis superantigen YPM 
The Y. pseudotuberculosis-derived mitogen (YPM) is a superantigenic exotoxin that 
has been linked with Y. pseudotuberculosis infections presenting as Far East scarlet-
like fever (Eppinger, et al., 2007). Similar to superantigens found in Gram-positive 
bacteria such as Staphylococci or Streptococci, the Y. pseudotuberculosis 
superantigen can activate the host immune system in an excessive, uncontrolled 
manner. The similar clinical manifestation of Far East scarlet-like fever and scarlet 
fever caused by Streptococcus pyogenes is probably due to an analogous action of 
the superantigens (Eppinger, et al., 2007). YPM can present in three different 
variants encoded by ypmA, ypmB, and ypmC. Whilst ypmB and ypmC have been 
correlated with environmental and animal isolates, ypmA is established in clinical 
isolates (Eppinger, et al., 2007). It has been suggested that the last common 
ancestor of Y. pseudotuberculosis bore an ancestral ypm gene, which subsequently 
diverged and has been lost in individual lineages of Y. pseudotuberculosis as it is 
contained in an unstable locus in the genome (Ch’ng, et al., 2011). It has been 
suggested that YPM+ HPI- strains cause Far East scarlet fever, whereas YPM- HPI+ 
strains are linked with enteric disease (Fukushima, et al., 2001; Ch’ng, et al., 2011; 
Eppinger, et al., 2007). 
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1.2.3.5 Ysa type 3 secretion system 
Y. enterocolitica BT 1B strains possess a second T3SS called the Ysa T3SS for 
Yersinia secretion apparatus that is absent from non- and low-pathogenic BTs and 
other Yersinia species and that is thought to be involved in virulence (Haller, Carlson, 
Pederson and Pierson, 2000; Foultier, et al., 2002). At least eight Yersinia secreted 
proteins, Ysps, depend on secretion by the Ysa T3SS (Haller, Carlson, Pederson and 
Pierson, 2000). It was shown that secretion by this system is activated at 28°C and 
high salt conditions, and that this secretion is independent from the plasmid-encoded 
Yop secretion that is triggered at 37°C and low calcium conditions (Haller, Carlson, 
Pederson and Pierson, 2000). This has prompted speculation that the physiological 
role of this system is early on in the infection process and helps to prime the bacterial 
cells (Haller, Carlson, Pederson and Pierson, 2000; Foultier, et al., 2002). A study 
was undertaken to determine the relatedness of this new, chromosomal T3SS to the 
established plasmid-encoded T3SS (Foultier, et al., 2002). It was shown that the two 
systems are very distinct, with the Ysa T3SS closely related to the Shigella Mix/Spa-
type system and the Salmonella SPI-1 T3SS, and the Yop T3SS related to the Psc 
T3SS in Pseudomonas aeruginosa and Bsc in Bordetella (Foultier, et al., 2002). It 
appears that there is a third, different T3SS present in Y. pseudotuberculosis and 
Y. pestis that is similar to the Salmonella SPI-2 T3SS, but so far no in-depth study 
into this system has been undertaken (Foultier, et al., 2002). 
 
1.2.3.6 Further chromosomally encoded virulence factors 
Other genes or operons have been implicated in a role in disease (Revell and Miller, 
2001). Amongst these is yst encoding the heat-stable enterotoxin. It is thought that its 
action induces diarrhoea, specifically in infants, similar to the heat-stable toxin of 
E. coli (Cornelis, 1994; Revell and Miller, 2001). Some non-pathogenic BT 1A strain 
may have homologous sequences to yst as indicated by hybridization experiments 
(Grant, Bennet-Wood and Robins-Browne, 1998), but their expression and 
functionality need further study. 
The myf operon encodes fimbriae similar to pili of E. coli, one of them being the pH6 
antigen (Cornelis, 1994; Revell and Miller, 2001). The operon is present in all of the 
pathogenic Yersiniae, and mediates binding to host cells (Revell and Miller, 2001). 
Similarly to yst, myf-homologous sequences might be present in the non-pathogenic 
BT (Grant, Bennet-Wood and Robins-Browne, 1998). 
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Using in vivo expression technology, IVET (Mahan, Slauch and Mekalanos, 1993), a 
number of genes were identified that are expressed under stress conditions but not 
under laboratory conditions. This led to the characterization of host responsive 
elements, hre (Young and Miller, 1997), regulator of systemic colonization RscR 
(Nelson, Young and Miller, 2001), and systemic invasion factors, sif, all of which have 
been attributed an undefined function in the mechanism of disease (Revell and Miller, 
2001). 
 
It is possible that a combination of different virulence factors is required for full 
infectivity and that the different factors contribute to various stages of disease, as 
individual mutants usually fail to completely attenuate the strain (Revell and Miller, 
2001).  
 
1.3 Evolution of the genus Yersinia 
1.3.1 Differentiation and speciation in Yersinia 
Correct identification of pathogenic Yersiniae is crucial for disease management. In 
the past, phenotypic tests and serotyping have been used, with the limitations of 
strains presenting with atypical biotyping reactions and with serotyping only possible 
at reference laboratories (Virdi and Sachdeva, 2005). Early on, autoagglutination, 
calcium dependency, uptake of crystal violet and Congo red, as well as serum 
resistance have been used as indirect indicators of virulence (Pedersen, Winblad and 
Bitsch, 1979; Schiemann and Devenisch, 1982; Robins-Browne, et al., 1989). 
Drawbacks of these techniques are atypical and contradictory results for a number of 
isolates (Robins-Browne, et al. 1989). Commercially available phenotypic tests were 
also lacking some of those sugars and tests that more reliably differentiate Yersiniae, 
leading to decreased sensitivity with respect to identification of environmental 
species (Neubauer, et al., 1998).  
These disadvantages prompted investigation into the use of DNA hybridization using 
probes for potential virulence genes for the detection of pathogenic isolates (Robins-
Browne, et al., 1989). Probes for the invasin Inv derived from Y. pseudotuberculosis 
only detected Y. pseudotuberculosis and Y. pestis isolates, but probing with 
Y. enterocolitica Inv gave positive results in environmental as well as pathogenic 
species of Yersinia (Robins-Browne, et al., 1989). In contrast, probes for Ail proved 
to be highly specific, and depending on design to include adjacent DNA regions can 
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either detect Y. enterocolitica BT 1B or all pathogenic Y. enterocolitica biotypes 
(Robins-Browne, et al., 1989). Probes designed for detection of the virulence plasmid 
pYV detected plasmid-bearing strain of Y. pseudotuberculosis, Y. pestis, and 
Y. enterocolitica (Robins-Browne, et al., 1989), but it has to be considered that the 
plasmid can be easily lost in laboratory culture and thus could have an influence on 
virulence assessment of isolates. The detection of virulence-associated genes was 
further developed into assays using polymerase chain reaction (PCR) to amplify 
parts of the virulence plasmid or chromosomal fragments including inv, ail, or the 
enterotoxin yst (e.g. Nakajima, et al., 1992; Ibrahim, Liesack and Stackebrandt, 
1992). 
New methods such as multilocus enzyme electrophoresis (MLEE), restriction 
endonuclease analysis of chromosomal and plasmid DNA (REAC, REAP), ribotyping, 
pulse-field gel electrophoresis (PFGE), and typing based on variable number of 
tandem repeats (VNTR) have been applied to study heterogeneity of Y. enterocolitica 
and ‘Y. enterocolitica-like’ species (reviewed in Virdi and Sachdeva, 2005; Souza, 
Pitondo-Silva, Falcão and Falcão, 2010). It was found that Y. enterocolitica has three 
consistent lineages of high-, low-, and non-pathogenic biotypes (Virdi and Sachdeva, 
2005). For some methods, limited data is available on the environmental species, 
precluding any deduction of the evolutionary relationship of Y. enterocolitica and the 
environmental species (Virdi and Sachdeva, 2005). Further more, these methods are 
more suitable for short-term study of isolates during an epidemic outbreak, but are 
less appropriate to determine the historic evolutionary relationships between the 
Yersinia species (Kotetishvili, et al., 2005). Nucleotide analysis of 16S rDNA gene or 
housekeeping genes in multi-locus sequence typing (MLST) is considered a more 
unbiased approach for speciation (Kotetishvili, et al., 2005; Souza, Pitondo-Silva, 
Falcão and Falcão, 2010). 
 
1.3.2 16S rDNA analysis and MLST scheme 
Initial phylogenetic studies in the genus Yersinia focussed on the 16S rDNA gene 
(Ibrahim, et al., 1993). The 16S rDNA gene is present in all bacteria and thus used as 
a gold standard to establish the relationship between different genera (Janda and 
Abbott, 2007). For Yersinia, five different lineages were identified (Ibrahim, et al., 
1993; Ibrahim, et al., 1997). Y. enterocolitica forms a heterogeneous cluster with the 
possibility of splitting them into two distinct subclusters of American and European 
isolates. Y. pseudotuberculosis and Y. pestis together with Y. frederiksenii form a 
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separate cluster. Y. rohdei and Y. ruckeri each form independent clusters, and the 
environmental species Y. mollaretii, Y. intermedia, Y. bercovieri, Y. kristensenii, and 
Y. aldovae form another heterogeneous cluster (Ibrahim, et al., 1993; Ibrahim, et al., 
1997). Later, a sixth lineage was discovered which includes atypical Yersinia 
isolates, which have a different 16S signature (Ibrahim, et al., 1997). Biochemically, 
these belong to Y. frederiksenii and have been designated as genomospecies 2 
(Ibrahim, et al., 1997). Generally, the sequence similarities vary between 96.9 – 
99.8%. This is considered too high to infer evolutionary relationships between 
different Yersinia lineages and a distinction between species is less reliable (Ibrahim, 
et al., 1993; Janda and Abbott, 2007). To improve speciation, 16S rDNA analysis in 
conjunction with DNA hybridization and biochemical characteristics was suggested 
(Ibrahim, et al., 1993; Neubauer, Hensel, Aleksic and Meyer, 2000). 
Upon reconstruction of a phylogenetic tree based on 16S rDNA sequences only, it 
was found that Y. ruckeri does not present an outlier as opposed to relationships 
based on other housekeeping genes (Ibrahim, et al., 1993; Ibrahim, et al., 1997; 
Souza, Pitondo-Silva, Falcão and Falcão, 2010). This might be due to an exchange 
of 16S rDNA sequences as has been noted in other bacteria before (Asai, 
Zaporojets, Squires and Squires, 1999; Schouls, Schot and Jacobs, 2003; Souza, 
Pitondo-Silva, Falcão and Falcão, 2010), and this recombinatorial potential might 
preclude this gene from use in establishing evolutionary connections. 
 
Recent exploration of use of the 16S rDNA sequence has lead to the proposition that 
Y. enterocolitica should be grouped into two subspecies (Neubauer, Hensel, Aleksic 
and Meyer, 2000; Neubauer, et al., 2000). DNA hybridization experiments indicate 
that there are possibly three groups within Y. enterocolitica corresponding to high-
pathogenic ‘New-World’ strain, low-pathogenic ‘Old-World’ strains, and non-
pathogenic ‘Old-World’ strains (Neubauer, et al., 2000). Studies on the 16S rDNA 
gene have found regions to distinguish between ‘American’ BT 1B strains and 
‘European’ BT 1A, 2 – 5 strains (Ibrahim, et al., 1993; Ibrahim, et al., 1997; 
Neubauer, Hensel, Aleksic and Meyer, 2000; Kotetishvili, et al., 2005). The 
comparison of 1367 bases of the 16S genes showed a difference in 12 nucleotides 
between isolates from America and Europe, which forms the grounds for establishing 
two subspecies: the ‘New World’ BT 1B designated as Y. enterocolitica subsp. 
enterocolitica and the ‘Old World’ BTs 1A, 2 – 5 belonging to Y. enterocolitica subsp. 
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palearctica (Neubauer, Hensel, Aleksic and Meyer, 2000; Neubauer, et al., 2000; 
Neubauer and Sprague, 2003).  
 
An MLST scheme has been attempted using the 16S rDNA sequence as well as the 
four housekeeping genes glnA, gyrB, recA, and hsp60 (Kotetishvili, et al., 2005). 
Only the 11 classically described Yersinia species were included, as the new species 
were proposed after publishing of the scheme. Y. pseudotuberculosis and Y. pestis 
proved inseparable by the gene fragments investigated, indicating their close genetic 
relationship that has been noted before (Achtman, et al., 1999; Kotetishvili, et al., 
2005). It was found that Y. aldovae, Y. bercovieri, Y. intermedia, Y. rohdei, and 
Y. ruckeri as well as Y. pestis and Y. pseudotuberculosis are homogeneous species, 
whereas the other four species Y. enterocolitica, Y. kristensenii, Y. frederiksenii, and 
Y. mollaretii are heterogeneous (Kotetishvili, et al., 2005). The 16S rDNA sequences 
had less discriminatory power than the proposed MLST scheme, and the biochemical 
species definition was more in agreement with the MLST scheme than 16S rDNA 
gene (Kotetishvili, et al., 2005), which could indicate recombination amongst 16S 
genes and thus masking of the evolutionary signal. Some strains were found to be 
distinct from their respective species based both on MLST and 16S rDNA analysis, 
and would warrant further investigation as potentially new species within the genus 
Yersinia (Kotetishvili, et al., 2005). Y. frederiksenii is known to be a heterogeneous 
species and the atypical isolates might be related to the newly proposed 
Y. massiliensis (Merhej, et al., 2008; Souza, Falcão, and Falcão, 2011). Atypical 
Y. kristensenii were later speciated into Y. aleksiciae (Sprague and Neubauer, 2005). 
 
1.3.3 Current model of evolution 
The current model for evolution of the genus Yersinia is presented in Figure 1.2 
(Carniel, 2002; Carniel, 2003; Wren, 2003). 
It is thought that the pathogenic Yersiniae have evolved from the environmental 
species following the acquisition of the virulence plasmid pYV (Carniel, 2002; Wren, 
2003). Y. enterocolitica and Y. pseudotuberculosis then developed independently. 
This split is thought to have occurred 42 – 187 million years ago, similar to the 
distance of 140 million years for the last common ancestor of Escherichia coli and 
Salmonella enterica (Achtman, et al., 1999). Y. enterocolitica is signified by the 
acquisition of the heat-stable toxin Yst. It then splits into three different lineages of 
non-, high-, and low-pathogenic isolates. The non-pathogenic BT 1A loses pYV to 
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once again become a predominantly environmental lineage. The New World, high-
pathogenic BT acquired several pathogenicity islands, including HPI, as well as 
unique type 2 and 3 secretion systems, explaining the increase in virulence potential. 
The low-pathogenic lineage includes BTs 2 – 5. 
 
 
Figure 1.2: Evolution of the genus Yersinia [adapted from Carniel, 2002; Wren, 2003]. 
 
Y. pseudotuberculosis also acquired pathogenicity islands. Similar to Y. enterocolitica 
BT 1B, it obtained the HPI, but it also has the hemin storage locus, and the insect 
toxin encoded on the tcPAI. A subset of Y. pseudotuberculosis then evolves the 
ability of biofilm formation, and the acquisition of the plasmids pPCP and pMT gives 
rise to the Y. pestis lineages. The last common ancestor of Y. pseudotuberculosis 
and Y. pestis is thought to have existed 0.4 – 1.9 million years ago (Achtman, et al., 
1999). The evolution of the Y. pestis biovars is thought to have occurred within the 
last 1,500 to 20,000 years, through a number of bottlenecks (Achtman, et al., 1999).  
 
For the evolution of Y. pestis three principles have been identified: add DNA, stir and 
reduce (Parkhill, et al., 2001a; Wren, 2003; Chain, et al., 2004). The acquisition of 
large genomic islands, such as the hemin storage locus, and additional plasmids 
pPCP/pPla and pMT/pFra has enabled the colonization of new niches (Wren, 2003). 
It is thought that the acquisition of the plasmid pMT occurred first, possibly donated 
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by Salmonella, which was important for colonization of and transmission via fleas 
(Achtman, et al., 1999; Carniel, 2003). Both chromosomal and plasmid factors are 
required for full virulence potential, acting together to enable Y. pestis to colonize the 
flea and be transmitted by it, and are also needed to avoid the mammalian immune 
system, and to disseminate in the mammalian host (Carniel, 2003; Wren, 2003). 
Compared to Y. pseudotuberculosis, the Y. pestis genome shows an increase in the 
number of insertion sequence (IS) elements that are present (Parkhill, et al., 2001a; 
Deng, et al., 2002; Wren, 2003; Chain, et al., 2004; Eppinger, et al., 2007; Eppinger, 
et al., 2010). IS elements are DNA sections encoding a transposase flanked by 
perfect inverted repeats. The transposase can mediate the transposition of the 
element to a different genomic location. Recombination between IS elements have 
led to wide-ranged genome rearrangements in Y. pestis, which are still ongoing in 
culture in vivo (Parkhill, et al., 2001a; Deng, et al., 2002; Chain, et al., 2004; 
Eppinger, et al., 2010). IS elements have inserted into the coding sequences of other 
genes, thus disrupting the expression of functional proteins and promoting isolate-
specific polymorphisms (Parkhill, et al., 2001a; Chain, et al., 2004; Eppinger, et al., 
2010). 
The loss of function plays a major part in the evolution of Y. pestis, and may be even 
more important than gene acquisition (Chain, et al., 2004). Some of the genomic 
islands identified in Y. pestis have orthologs in Y. pseudotuberculosis and thus 
precede the split of these two lineages, but there is evidence of gene decay in 
Y. pestis (Parkhill, et al., 2001a; Chain, et al., 2004). For instance, some proteins 
encoded in the toxin complex pathogenicity island (tcPAI) responsible for insect 
toxicity have been inactivated in Y. pestis (Parkhill, et al., 2001a). Instead of killing 
the flea, it might be more important for Y. pestis to establish persistence for 
transmission (Achtman, et al., 1999; Parkhill, et al., 2001a; Wren, 2003). Later 
studies however showed that the insecticidal toxins are not mutated in other Y. pestis 
biovars, leaving in question the exact role of functionality or non-functionality of the 
tcPAI in survival in the flea (Chain, et al., 2004). In comparing Y. pestis and 
Y. pseudotuberculosis it was found that up to 13% of the Y. pestis genome is 
inactivated (Chain, et al., 2004). These genes account for a number of functions 
relating to environmental and enteric survival that have become redundant in a host-
adapted life-style and include metabolic pathways, motility and lipopolysaccharides 
(Brubaker, 1991; Achtman, et al., 1999; Parkhill, et al., 2001a; Chain, et al., 2004). 
This way, Y. pestis has now restricted itself to be reliant on the host for the provision 
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of nutrients (Brubaker, 1991; Achtman, et al., 1999). It is also evident that 
Y. pseudotuberculosis possessed a number of colonization and virulence factors that 
primed Y. pestis in establishing its pathogenic potential (Parkhill, et al., 2001a). 
 
Recently the grouping scheme for Y. pestis has been revised based on genetic 
relatedness rather than biochemical differences (Achtman, et al., 2004; Morelli, et al., 
2010). The high diversity of strains can be a sign of geographical source, indicating 
Y. pestis originated in Asia (Achtman, et al., 2004; Morelli, et al., 2010). From 
Y. pseudotuberculosis, the evolutionary route develops into a branch 0, from which 
biovar Pestoides (0.PE) branches off about 2,600 years ago (Morelli, et al., 2010), 
confirming the ancestral status of the Pestoides group (Eppinger, et al., 2010). After 
further evolution along branch 0, there is a split into branch 1 and branch 2 about 700 
years ago (Achtman, et al., 2004; Morelli, et al., 2010). Branch 1 contains isolates of 
the most recent pandemic sweep of plague, and covers isolates of biovar designation 
Antiqua and Orientalis, hence 1.ANT and 1.ORI. It could be shown that this clone 
arose >200 years ago, and it subsequently spread out of China and around the world 
distributed by plague ships (Morelli, et al., 2010). Single introductory events into 
North America and Madagascar lead to local clonal evolution (Morelli, et al., 2010). 
Branch 2 of the phylogenetic tree in Y. pestis is evolutionary older than branch 1 
(>500 years ago) and is associated with biovars Medievalis and Antiqua (2.MED, 
2.ANT; Achtman, et al., 2004; Morelli, et al., 2010). The distribution of clones and 
their accumulating genomic differences implies that Y. pestis was spread along the 
silk trade route in medieval times (Morelli, et al., 2010). Isolates of biovar Antiqua are 
found in both branches 1 and 2, indicating that the genomic differences do not relate 
to phenotypic differences, and that the phenotype possibly arises from independent 
mutations (Achtman, et al., 2004). 
 
1.4 Next-generation sequencing techniques 
Recent advances in our knowledge of Yersinia evolution such as tracing plague 
along the silk trade route (Morelli, et al., 2010) are due to rapid advances in whole 
genome sequencing capacities. Sequencing of bacterial genomes provides a 
powerful tool to investigate the complete genetic makeup of a strain and allows for 
identification of regions unique to particular organisms by comparison of strains 
against each other. Until recently, sequencing was carried out using automated 
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Sanger or chain-termination sequencing (Mardis, 2008a; Ansorge, 2009; Metzker, 
2010). As this technique is costly, it was only applied to high-interest representative 
species of model organisms and pathogens, available at larger genome sequencing 
centres such as the Wellcome Trust Sanger Institute (WTSI) (Hall, 2007; Mardis, 
2008a).  
Next-generation sequencing techniques have been available since 2004 (Mardis, 
2008a), and have found widespread applications. The term next-generation 
sequencing is generally used to describe techniques that allow for massive parallel 
sequencing approaches and circumvent the need for cloning in Escherichia coli. This 
gives the opportunity to sequence larger strain collections in shorter periods of time 
compared to traditional Sanger sequencing (Mardis, 2008a; Ansorge, 2009; Metzker, 
2010). The different techniques have different strengths and weaknesses, making 
them more suitable for some scientific questions than others. In the following, the 
main sequencing techniques used in this study will be described and compared. 
 
1.4.1 Capillary sequencing 
The traditional sequencing technique is based on the chain termination method 
published by Sanger, Nicklen and Coulson (1977). DNA is isolated and fragmented 
into pieces of known size (Figure 1.3). These fragments are then cloned into a 
plasmid containing universal sequencing primers, thus creating a library of fragments 
(Mardis, 2008b; Shendure and Ji, 2008). The library is used to transform the vector 
into E. coli, using the bacterial host for amplification of the vector. Individual clones 
that have arisen from a single transformation event are then picked and the DNA is 
isolated for sequencing. The sequencing reaction occurs in several cycles by 
supplying it with two types of nucleotides: normal deoxynucleotides (dNTPs) that can 
be incorporated into the growing chain as usual, and di-deoxynucleotides (ddNTPs) 
which have a modified 3’ end (Sanger, 1988). The integration of a ddNTP leads to 
the termination of the chain, as another base cannot be added due to the blocked 3’ 
end, hence this method is known as chain-termination sequencing. Additionally, the 
ddNTPs are labelled with different fluorophores corresponding to the different bases. 
As the incorporation of ddNTPs is competitive with the dNTPs, the resulting chains 
are of different lengths with the terminal base marked by the fluorescence-labelled 
ddNTP (Shendure and Ji, 2008).  
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Figure 1.3: Workflow of capillary, pyro- and Illumina sequencing [adapted from Shendure and 
Ji, 2008; Ansorge, 2009; Meztker, 2010]. 
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For visualization of the different chains, separation is carried out in a gel 
electrophoresis step. In early sequencing, this meant running long gels and 
photographing them (Sanger, Nicklen and Coulson, 1977). Smaller fragments run 
faster than longer fragments, and the progression through the gel is proportional to 
the length of the molecule. A read-out of the 5’ to 3’ sequence is possible starting 
from the bottom upward. In more recent times polymer-coated capillaries are used 
which allow the elution of the chains according to length with high-resolution (Hall, 
2007; Shendure and Ji, 2008). The chains are excited with a laser and the 
fluorophore that terminated the chain can be read out.  
Capillary electrophoresis allows for parallelization of 96 or 384 independent 
capillaries. This limitation is the main drawback of Sanger sequencing, as only a 
specific number of sequencing reactions can be observed in parallel (Hall, 2007; 
Shendure and Ji, 2008; Ansorge, 2009). 
 
1.4.2 454 Pyrosequencing 
Pyrosequencing was the first commercially available platform introduced in 2004 
(Margulies, et al., 2005; Mardis, 2008a). The associated platform is the 454 FLX 
(Titanium) produced by Roche. 
DNA is isolated and fragmented, similar to the traditional sequencing technique 
(Figure 1.3). Instead of cloning and transformation into E. coli though, the DNA is 
ligated to specific adapters. These adapters have complimentary sequences located 
on the surface of agarose beads, so that the adapter-ligated DNA fragments can 
attach to the beads (Metzker, 2010). A 1:1 ratio of fragments to beads ensures that 
only one DNA fragment is attached per bead (Margulies, et al., 2005; Mardis, 2008b). 
The beads are then added to a water:oil mixture containing PCR reagents. Vigorous 
vortexing results in small micelles, which are beads in an aqueous phase containing 
PCR reagents and which are surrounded by oil. Universal primer binding sites 
incorporated in the adapter sequences allow for clonal amplification in vitro of the 
attached fragments resulting in approximately one million copies per bead (Mardis, 
2008b; Metzker, 2010). This has been termed emulsion PCR (Margulies, et al., 
2005). By this means a single-stranded fragment library is created (Mardis, 2008b). 
In the next step, the beads are added to a flow-cell. This is a picotiter plate consisting 
of several hundred thousand fibres per plate. The dimensions of the fibre only allow 
for one bead to be associated with a well in each fibre, thus immobilizing the 
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fragments on the plate in a specific position for monitoring of sequencing progress 
(Margulies, et al., 2005; Mardis, 2008a; Shendure and Ji, 2008; Ansorge, 2009). 
The underlying principle for pyrosequencing is that the incorporation of dNTP 
releases pyrophosphate. This in turn produces energy, which can be used to break 
down luciferin, resulting in light emittance (Ansorge, 2009). The primer sequence is 
located within the adapter, and the first four bases that are sequenced correspond to 
the end of the adapter. As the adapter sequence is fixed, these four bases are 
always the same and are used for calibration of the detector for signal strength 
(Mardis, 2008a). Each nucleotide is added separately, and the number of nucleotides 
incorporated is proportional to the emitted light (Mardis, 2008a,b; Shendure and Ji, 
2008). This poses a problem in regions where there are multiples of the same 
nucleotide, called homopolymeric runs (Mardis, 2008a; Ansorge, 2009). The detector 
can be saturated, and a differentiation between signal intensities is complicated. An 
additional or missing nucleotide within a coding sequence will show up as a 
frameshift in the sequence, implying that the gene would not be encoding a functional 
protein. This insertion/deletion error is the main inaccuracy in pyrosequencing 
(Mardis, 2008a; Metzker, 2010). Substitution errors in which the wrong base is 
incorporated are rare as nucleotides are added individually (Mardis, 2008a,b). 
Pyrosequencing produces 250 bp reads on average, although they can be longer 
(Metzker, 2010).  
 
A way of improving assemblies and counteracting the assembly of a large number of 
small contigs is paired-end sequencing. The initial fragmentation into ~3 kb 
molecules remains unchanged, but before the addition of adapters additional steps 
are introduced (Figure 1.4).  
The ends of the fragments are biotinylated so that circularization is possible. Through 
this circularization the ends of the 3 kb fragment come in close proximity to each 
other and are linked by the biotinylated fragment. The circularized molecules are 
fragmented into a few hundred base pairs and fragments with the linker can be 
identified using streptavidin. The adapters are then ligated to the ends of the 
fragments and are subject to emulsion PCR (454 Life Sciences, 2008). 
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Figure 1.4: Preparation of paired-end fragments for pyrosequencing [taken from 454 Life 
Sciences, 2008]. 
 
This results in paired sequencing reads for which the distance, typically 3 kb, 
between them is known. This is particularly useful in genomes that have a high 
number of repeat units such as IS elements (Pop and Salzberg, 2008). A typical IS 
element including transposase and repeat sequences is about 1,200 bp long. The 
short reads produced by pyrosequencing are unable to bridge this length with reads 
with unique end sequence, and the multiple copies of repeat sequences thus make it 
difficult to find the exact location in the genome. Using the information that mate-pairs 
are 3 kb apart, contigs can be linked across the IS element simply because the read-
pairs can be located on either side of it (Pop and Salzberg, 2008). 
 
1.4.3 Illumina sequencing 
Illumina produces the Illumina / Solexa genome analyser. 
Illumina or Solexa sequencing also starts with DNA isolation, fragmentation and 
ligation to adapters (Figure 1.3) (Mardis, 2008a). Instead of attachment to beads, the 
DNA fragments are immobilized on a glass slide in Illumina sequencing, which at the 
same time acts as the place where sequencing and detection takes place (Mardis, 
2008b). The glass slide is covered to a high density with adapters and adapter-
homologous fragments (Mardis, 2008a; Ansorge, 2009). Once the fragments have 
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been immobilized, PCR reagents are added for amplification. The DNA fragments will 
bend over to form a bridge, across which PCR can take place (Shendure and Ji, 
2008; Ansorge, 2009). The bridge PCR products are then denatured into single-
stranded format so that a new round of amplification can take place. Over time a 
cluster of amplified DNA fragments has grown, which is called a “polony” for a 
polymerase-triggered, spatially clustered colony (Ansorge, 2009).  
The sequencing reaction uses reversible termination technology. ddNTPs are added 
that contain a reversible block at the 3’end of the base and a fluorophore (Metzker, 
2010). All four nucleotides are added at the same time, but only one can be 
incorporated as the 3’end is blocked from further extension (Mardis, 2008b). Each 
polony spot is then measured for fluorescence before the fluorophore and the 3’block 
are removed thus enabling the addition of a new nucleotide (Mardis, 2008a; 
Shendure and Ji, 2008; Ansorge, 2009; Metzker, 2010). This technology eliminates 
the chance of wrong multiple calling in homopolymeric runs as each nucleotide is 
added singularly. Conversely, the most common error observed is substitution when 
a nucleotide other than the correct one is incorporated by mistake (Shendure and Ji, 
2008; Metzker, 2010). 
Illumina sequencing produces very short read lengths, currently between 36 and 54 
bp are common, but up to 100bp reads or longer are possible (Metzker, 2010). 
 
Paired-end technology has also been adapted for Illumina sequencing, with 
distances typically 200 – 300 bp. The process is slightly different as the fragments 
used for inserts are much shorter (Figure 1.5).  
Different adapters with individual primers are attached to either side of the 
fragmented molecule. Polony formation then enriches both sequences, but supply of 
only one primer in the first sequencing reaction will lead to sequence readout for one 
end of the molecule. In a separate sequencing reaction with the second primer the 
paired-end is read out. The spatial clustering allows sequences to be linked as pairs. 
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Figure 1.5: Paired-end fragment preparation in Illumina sequencing [taken from Illumina, 2011]. 
Adapter (A1 and A2) with sequencing primer sites (SP1 and SP2) are ligated onto DNA fragments. 
Template clusters are formed on the flow cell by bridge amplification and then sequenced by synthesis 
from the paired primers sequentially. 
 
The paired-end technology as described for pyrosequencing – using larger fragment 
inserts, biotinylation, and subsequent fragmentation – is also possible with Illumina 
sequencing, but is termed “mate-pair sequencing”. It uses a preparation protocol 
similar to that used for pyrosequencing. 
 
Usually the glass slide used for Illumina sequencing contains 8 lanes (Mardis, 
2008a). Each lane may contain a single DNA species, but it is also possible to 
sequence up to 12 different species per lane. This process is called multiplexing and 
involves adding different sequence tags to the adapters (Figure 1.6).  
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Figure 1.6: Multiplex preparation of DNA fragments for Illumina sequencing [taken from 
Illumina, 2011]. 
 
Each DNA species is treated separately with ligation of adapters for paired-end reads 
and a specific sequence tag of six bases. The different sequences are then mixed 
and applied to the lane. Sequencing takes place in three separate steps. The first 
and third reads supply the paired-end sequences, whilst the second read covers the 
index sequence. Computational methods then allow for identification of the index 
sequence and sorting. This increases the number of samples per slide from 8 to 96, 
but will decrease the coverage for each of the species, as physically less DNA is 
present. Because fragment density and thus coverage for each genome is very high 
in Illumina sequencing, this has minor influence on quality of sequence produced.  
 
1.4.4 Comparison of capillary, pryo- and Illumina sequencing and applications 
The different technologies described have advantages and disadvantages and are 
compared in Table 1.3. 
The biggest contributor to the need for development of next-generation technology 
was the time factor. The use of capillary separation presents the most advanced 
technology that is possible in Sanger sequencing, and does not allow for any more 
parallelization than the maximum of 384 samples (Shendure and Ji, 2008; Ansorge, 
2009). 
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Table 1.3: Comparison of sequencing technologies [adapted from Mardis, 2008a,b; Margulies, 
et al., 2005; Shendure and Ji, 2008; Metzker, 2010]. 
 Sequencing technology 
 Sanger 454 Illumina 
> time factor 96 / 384 reads Massive parallel 
sequencing array 
Several 100,000 reads 
Massive parallel 
sequencing array 
Tens of millions of reads 
> time factor 
> cloning bias 
Vector-based cloning 
libraries 
E. coli amplification 
In vitro fragment library & 
amplification 
In vitro fragment library & 
amplification 
> read length ~1,000 bp ~ 250 bp 36 – 54 bp 
> base accurarcy Very high Indel error in 
homopolymeric runs 
Substitution errors 
> error rate 0.001% 
1 error in 100,000 bp 
0.6% 
6 errors in 1,000 bp 
0.1% 
1 error in 1,000 bp 
> time factor Run time  1-2 h Run time 12 h Run time: SE*: 2 days 
                PE: 4 days 
> reagent cost Reagent volume µl Reagent volume pl Reagent volume pl 
> cost per Mb+ $ 500 $ 85 $ 6 
* SE – single-end read, 36 bp, PE – paired-end read, 36 bp; + data from Shendure and Ji, 2008; Mardis, 2008a. 
 
Library preparation, transformation and amplification in E. coli and the number of 
reads that can be analysed present the rate-limiting steps. Furthermore, there may 
be cloning bias as not all DNA is readily accepted and amplified in E. coli (Hall, 2007; 
Metzker, 2010). This adds to the comparably high reagent costs and thus the overall 
cost per megabase. 
The next-generation sequencing technologies all share an array approach, allowing 
massive parallelization of reads (Shendure and Ji, 2008). This reduces the time 
needed to cover the whole genome of an organism. Library preparation time is 
reduced as well, as the preparation and amplification takes place in vitro. This 
circumvents the cloning bias given in E. coli, and is also quicker (Shendure and Ji, 
2008; Metzker, 2010).  
The overall time for a sequencing run is comparable with Sanger sequencing, but 
gives a higher coverage, that is each base is sequenced and recorded 20 – 60X, as 
opposed to usually 2X in Sanger sequencing. The offset is that the new sequencing 
technologies give shorter sequence reads and have a higher error rate than Sanger 
sequencing (Mardis, 2008b; Shendure and Ji, 2008). Sanger sequencing gives reads 
of up to 1,000 bp, whereas pyrosequencing currently gives on average 250 bp. 
Ultrashort reads are produced by Illumina sequencing. It should be noted that the 
read lengths of the next-generation technologies are still under development and are 
increasing frequently (Shendure and Ji, 2008; Metzker, 2010) so the length limit is 
not known yet. There have also been studies suggesting that information given by 
paired-end and mate-pair sequencing might be more important than increasing read 
36 
length (Chaisson, Brinza and Pevzner, 2009). Even in very fragmented assemblies 
most genes will fall within a single contig and not be split in two different ones. That 
way discovery and annotation should be possible (Chaisson, Brinza and Pevzner, 
2009). 
The main errors in pyrosequencing are insertion/deletions (indels) in homopolymeric 
runs, as mentioned before. Substitution errors are rare as each base is supplied 
individually. For Illumina sequencing, the opposite is true. Substitution errors are the 
most common error, as all ddNTPs are competing with each other for incorporation 
into the growing chain. The reversible termination on the other hand precludes 
mistakes in homopolymeric runs (Shendure and Ji, 2008). 
Using an array approach with hundreds of thousands or more parallel reads also 
allows for a reduced reagent volume, which significantly lowers the cost of 
sequencing (Shendure and Ji, 2008). 
 
The application for which the sequence information will be used very much 
determines the sequencing technology that will be most appropriate to use (Hall, 
2007; Mardis, 2008b). 
Higher costs of Sanger sequencing precludes it from being used in large-scale 
studies, but for the determination of exact sequence it is still considered gold 
standard (Hall, 2007; Ansorge, 2009). Given the longer reads, pyrosequencing is 
used in de novo sequencing and assembly, where an appropriate reference genome 
is not present. Illumina sequencing is used in re-sequencing, when an alignment 
against a reference is produced and single nucleotide polymorphisms (SNPs) can be 
determined (Hall, 2007; Mardis, 2008a; Metzker, 2010). 
 
Next generation sequencing technologies have opened up new fields of applications 
of sequencing data (Mardis, 2008a; Metzker, 2010). A major field is population 
studies. It is now possible to sequence more strains of single species or even smaller 
distinctions such as subspecies or multi-locus sequence types. In this way it is 
possible to determine the normal range of variation within populations and distinguish 
it from variations that reflect specific adaptations for example in clinical isolates 
(Fraser-Liggett, 2005; Hall, 2007; Mardis, 2008a). Population studies also aid in 
mutation discovery, again possibly reflecting adaptational change (Mardis, 2008b; 
Shendure and Ji, 2008). 
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The possibility of sequencing of more representatives of species also helps 
identification of accessory genes and establishes the core genome of a species. 
Accessory genes can be unique phages as well as regions acquired by horizontal 
gene transfer, such as the exchange of antibiotic resistance markers and other so-
called “virulence genes” (Hall, 2007; Mardis, 2008a,b). The accessory genes can 
make up a considerable part of the total genome of a strain, and can vary between 
strains of a species. Considering this variability in possible genome content supports 
sequencing of more than one representative for each species to establish the 
species’ core and the overall variety within a species described by the pangenome 
(Fraser-Liggett, 2005; Hall, 2007). Comparison of the accessory genomes between 
different eco- and biotypes of a species may also discover mechanisms behind 
adaptation to specific niches (Fraser-Liggett, 2005). 
 
1.5 Aim of this project 
1.5.1 The Yersinia Paradox 
Yersinia is considered a paradoxical organism, as Y. pestis and 
Y. pseudotuberculosis are nearly identical with respect to genomic content, yet cause 
very different disease. On the other hand, Y. pseudotuberculosis and 
Y. enterocolitica are very distantly related, but cause the same disease outcome. 
From the current hypothesis for the evolution of the genus, there is another paradox: 
Y. pseudotuberculosis, Y. pestis, and Y. enterocolitica are thought to share a 
common pathogenic precursor that evolved out of the environmental Yersiniae. Yet, 
at the same time, Y. enterocolitica and the environmental Yersiniae are thought to be 
closely related, since they were originally part of the heterogeneous group of 
‘enterocolitica’ and are still referred to as ‘Y. enterocolitica-like’ species.  
 
1.5.2 Aims of the study 
Studies on the pathogenicity of strains of various biotypes of Y. enterocolitica have 
been undertaken in the past, generally using either random mutagenesis, 
hybridization techniques or insertional inactivation of genes that were shown to be 
involved in virulence in Y. pseudotuberculosis or Y. pestis. Although major genetic 
components were discovered with these methods in a wide range of bacteria, the 
disadvantages of these approaches are that only a limited number of genes are 
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observed – either the ones targeted for identification or those that give strong 
response signals under selective conditions. Hybridization approaches might also be 
complicated due to sequence divergence thus leading to false negative results. Also 
in many instances, single strains of that species or biotype are selected and used in 
these studies to represent all members of that species or biotype, and most often the 
high-pathogenic members are selected. In the case of Yersinia, Y. enterocolitica BT 
1B has been used extensively as a model for Yersinia pathogenesis. 
Little information is currently available on the Y. enterocolitica biotypes, although it is 
apparent that there is additional coding capacity within the BTs (Howard, et al., 
2006). Only one representative strain for the high-pathogenic BT 1B has been 
sequenced and analysed in comparison with Y. pestis and Y. pseudotuberculosis 
(Thomson, et al., 2006). This comparison showed that about 68% of the genes are 
conserved between the three pathogenic species. This is much higher than the 
20.8% of genes that are shared between all of the Y. enterocolitica biotypes as 
determined by microarray (Howard, et al., 2006), highlighting the sequence diversity 
inherent in Y. enterocolitica and also underlining the limitations of comparative 
genomic hybridization studies (Thomson, et al., 2006). 
This project therefore set out to sequence representative strains for each of the 
biotypes and comparatively analyse the genomic content. As biochemical traits form 
an important part of differentiating the Y. enterocolitica biotypes, a phenotypic 
assessment of the representatively sequenced strains was undertaken. 
 
The aims of the projects are: 
1) To establish the genetic makeup of each of the biotypes of Y. enterocolitica 
and to define the unique sets of genes for each biotype 
2) To characterize what is shared in pathogenic biotypes that is important for 
mechanism of disease 
3) To determine the metabolic capacities of each of the biotype 
4) To link phenotypic and genotypic traits for improved annotation and 
characterization of the Y. enterocolitica biotypes 
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2 Materials and Methods 
2.1 Bacterial Strains 
2.1.1 Reference Genomes 
The reference strains were selected based on the prevalence of the different bio-
serotypes of Y. enterocolitica isolated from cattle, pigs, and sheep throughout the UK 
between 1999 and 2000 during a randomised national survey of food pathogens in 
livestock sent for slaughter (McNally, et al., 2004) and in addition human isolates 
identified during the Intestinal Infectious Disease study (Tompkins, et al., 1999) 
carried out over the same time period. BT5 is not prevalent in the UK and poses no 
health concern. Thus, the reference strain was obtained from Germany from the 
laboratory of Dr. Thilo M Fuchs. The UK strain collection was extensively 
characterized genotypically (Howard, et al., 2006; Thomson, et al., 2006) and 
phenotypically (McNally, et al., 2006) and the strains listed below were chosen as 
representative strains for each prevalent bio-serotype. 
 
Table 2.1: List of reference strains sequenced in this project. 
Strain Biotype Serotype Plasmids Source 
YE53/03 1A O:5 pYV- Human faecal isolate  
YE8081* 1B O:8 pYV+ Clinical isolate 
YE212/02 2 O:9 pYV+ Pig abattoir isolate 
YE56/03 3 O:9 pYV+ Human faecal isolate 
YE149/02 3 O:5,27 pYV+ Sheep abattoir isolate  
YE12/03 4 O:3 pYV+ Human faecal isolate  
YE3094/96 5 O:2a,2b,3 pYV+ Animal isolate 
*: Reference strain, sequenced previously [Thomson, et al., 2006] 
 
2.1.2 Worldwide Collections 
The study of the genus Yersinia and a broader characterization of the species 
Y. enterocolitica were carried out on a worldwide collection of different species and 
strains from collaborating laboratories. The strains are listed in Table 9.1 (p. 204) and 
9.2 (p206) in the appendix. 
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2.1.3 Additional strains 
Some strains examined, which are not part of the sequencing collections, are listed in 
Table 2.2. 
 
Table 2.2: Additional strains. 
Strain  Biotype Serotype Source country Lab 
YE2103 1B O:19 Human control UK McNally 
NZ6 1B nd Human New Zealand DuFour 
YE21402 3 O:9 Pig UK McNally 
 
 
2.2 Sequencing, Assembly and Annotation 
2.2.1 Sequencing Technologies 
DNA extraction and genome sequencing was carried out at the Wellcome Trust 
Sanger Institute (WTSI), Cambridge.  
Sequencing for the reference genomes was carried out to improved high-quality draft 
genome standard (Chain, et al., 2009). The strains were sequenced using three 
different types of sequencing technologies. Capillary sequencing (ABI), also known 
as traditional Sanger sequencing, was used for 2X coverage, and produced long 
high-quality reads. Pyrosequencing (454/Roche GS20/FLX) and Illumina (Illumina 
GAII Analyser) technologies produce shorter reads, and thus reach higher coverage, 
in excess of 30- and 60-fold coverage respectively. PCR fragments were designed to 
span gaps and close them. This process was computerized by using algorithmic 
based automatic contiguation of assembled shotgun sequence (ABACAS; Assefa, et 
al., 2009; http://abacas.sourceforge.net). De-novo assemblies were produced using 
the Velvet assembler (Zerbino and Birney, 2008; 
http://www.ebi.ac.uk/~zerbino/velvet) and the GS De Novo assembly software 
(Roche, 2011). The final assembly was corrected with iCORN (Otto, Sanders, 
Berriman and Newbold, 2010). 
Pseudogenes containing stop codons or frameshifts were checked manually for 
sequence quality, and if necessary further sequencing of that region in question was 
carried out.  
 
Sequence for the worldwide collection was generated using the Illumina sequencing 
platform (GAII instruments) with indexed Illumina runs of 12 samples per lane of 
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sequencing, standard 200-300bp fragments and 76 cycles of sequencing. The 12 IP 
strains were sequenced separately at the Institute Pasteur using single-end Illumina 
reads. 
The genome coverage is a measure of how many times a base is sequenced on 
average by different reads, and is therefore an indication of sequence quality in next-
generation sequencing technologies. The coverage can be calculated from the 
average read length (here 76 bp), the number of reads, and the average genome 
size (5 Mbp) using the following formula: 
 𝑒𝑥𝑝𝑒𝑐𝑡𝑒𝑑  𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒 = 𝑎𝑣𝑒𝑟𝑎𝑔𝑒  𝑟𝑒𝑎𝑑  𝑙𝑒𝑛𝑔𝑡ℎ ∗   𝑛𝑢𝑚𝑏𝑒𝑟  𝑜𝑓  𝑟𝑒𝑎𝑑𝑠𝑎𝑣𝑒𝑟𝑎𝑔𝑒  𝑔𝑒𝑛𝑜𝑚𝑒  𝑠𝑖𝑧𝑒  
 
The resulting coverage for Y. enterocolitica strains is plotted in Figure 2.1. The 12 
strains obtained from E. Carniel at the Institute Pasteur were not included in this 
calculation, as they were sequenced separately. 
The average coverage is higher than 20X in the strain collection. Variation arises 
from the number of reads obtained in a sequencing run. 
 
 
Figure 2.1: Example of coverage of Y. enterocolitica strains sequenced as part of the 
worldwide strain collection. Coverage of strains varies between strains and different runs due to 
experimental error and DNA quality, but has a minimum of 20X for each strain. 
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Data for the worldwide collection was assembled using Velvet de novo assembly for 
the environmental samples and assembly against reference BT 1B strain 8081 for 
Y. enterocolitica isolates.  
 
2.2.2 Annotation and Sequence Analysis  
The reference genomes for each of the biotypes were annotated and analysed in 
detail. Algorithms used for gene prediction and characterization of CDSs are given in 
Table 2.3. Glimmer 3 was used for prediction of coding sequences (CDS; Salzberg, 
Delcher, Kasif and White, 1998; Delcher, Bratke, Powers and Salzberg, 2007), and 
searches for motifs (Nielsen, Engelbrecht, Brunak and von Heijne, 1997; Brendtsen, 
Nielsen, von Heijne and Brunak, 2004; Krogh, Larsson, von Heijne and 
Sonnhammer, 2001; Finn, et al., 2010; Sigrist, et al., 2002; Hulo, et al., 2006) were 
employed to characterize potential proteins as detailed in chapter 3.  
 
Table 2.3: Function and basis of the algorithms used for gene prediction and characterization. 
Algorithm Function Basis 
Glimmer 3 Model for prediction of coding sequences 
(CDSs) 
DNA sequence contains 6 reading frames, 
probability calculation and modelling of 
most likely open reading frame 
TMHMM Prediction of transmembrane domains Transmembrane domains will contain 
hydrophobic amino acids for integration 
into the lipid bilayer 
SignalP Prediction of signal domains Proteins transported to the cell membrane 
contain signals for trafficking and direction 
HTH Prediction of helix-turn-helix motifs (DNA 
binding proteins) 
Probability calculation that a short given 
stretch of amino acids has the properties to 
form a tertiary structure in the form of two 
linked helices  
Pfam Prediction of protein families and domains Indication for protein functionality by 
domain comparison with well-studied, 
functionally assigned examples 
Prosite Prediction of protein families and domains Indication for protein functionality by 
domain comparison with well-studied, 
functionally assigned examples 
 
Comparisons between BT 1B strain 8081 and the newly sequenced BT reference 
genomes were done using the Artemis Comparison Tool (ACT; Carver, et al., 2005). 
Regions differing from BT 1B received manual annotation in Artemis (Berriman and 
Rutherford, 2003). Annotation was based on basic local alignment search tool 
(BLAST) searches (Altschul, et al., 1990) as well as information gained from motif 
searches. 
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Between different sequence versions, the annotation was transferred using an in-
house perl script. This script will perform a blast search with the old FASTA file and 
compare it to the new FASTA file. Matches within CDSs are transferred into a new 
annotation file, which can be read into the new FASTA file using Artemis. The 
annotation transfer can be combined with the Glimmer 3 prediction, so that CDSs are 
highlighted, which have not yet received annotation. 
 
Homologous genes are called orthologous if they have been present in the last 
common ancestor before speciation. They are propagated vertically via inheritance 
from mother to daughter cells. The differences observed relate to the evolutionary 
distance during evolution. As orthologous genes have been present in the ancestor, 
their genomic context is conserved between different isolates. In contrast, paralogs 
arise following duplication of genes, and therefore have a different genomic context 
and differ with respect to distribution in isolate. One common family of paralogs are 
insertion sequence (IS) elements, and copy number can vary between isolates. 
To identify orthologs between the different reference genomes, another in-house perl 
script was applied. The script performs a homology search of CDSs with 40% 
homology over 80% of the length of the CDS (Figure 2.2). CDSs are compared 
pairwise, that is only those are retained as orthologs in which a search of genome 1 
against genome 2 yields an ortholog and in which the reciprocal search of genome 2 
against genome 1 yields the same ortholog.  
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Figure 2.2: Identification of orthologs and paralogs. A. Reciprocal identification of blue CDSs as 
orthologs. Pink CDSs are not reciprocally identified, CDS 1-2 and CDS 2-2 are orthologs, and CDS 1-
3 is a paralog to CDS 2-2. B. Genome example. Most genes are orthologous in both genomes, except 
an additional copy of IS1667 inserted in the top genome. This copy is paralogous to IS1667 found in 
the bottom genome, but is potentially misidentified in the reciprocal FASTA search. 
 
The results are comprised in a format readable in Artemis. The identified orthologs 
need to be checked manually, as pseudogenes might be below the 80% length cut-
off, and as IS elements may have been identified wrongly as having orthologs. For 
this, the orthologs of different combinations of reference genomes were firstly 
combined in a single annotation file. Then, an in-house perl script was employed to 
look at genomes in 3-way comparisons (Figure 2.3). 
 
true orthologs paralogs 
orthologs IS1667 - paralog 
A 
B 
genome 1 
genome 2 
CDS 1-1 CDS 1-2 CDS 1-3 
CDS 2-1 CDS 2-2 
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Figure 2.3: Example of a 3-way comparison for identification of orthologous gene sets. Genes 
present in genomes 1, 2, and 3 are blue. Genes unique to each genome are red. Genes orthologous 
in genome 1 and 2 are orange in both genomes. Genes orthologous in genome 2 and 3 are green and 
orange, respectively. Genes shared in genomes 1 and 3 would be green, but are not contained within 
this comparison. 
 
For each 3-way comparison, CDSs are sorted in four categories and colour-
highlighted accordingly: CDSs which are unique to each of the three genomes are 
highlighted in red, CDSs which are shared in all three genomes are highlighted blue, 
and CDSs which are shared between only two of the three genomes are highlighted 
either green or orange. The colouring of CDSs according to the four groups allows for 
quick identification of those CDSs that have not been coded correctly. For instance, if 
a red CDS occurs within a region conserved in all three genomes, this can easily be 
identified and resolved. 
 
The perl script used for identification and colouring of orthologs was then modified to 
allocate groups instead of colours to specific gene sets (see Appendix 9.5, p. 214). 
This was done to identify CDSs belonging to the backbone, as well as CDSs that 
might be shared only within subsets or specific lineages of Y. enterocolitica BTs. 
Sandra Reuter carried out this modification, whereas the Pathogen Genomics group 
at the Wellcome Trust Sanger Institute provided the other in-house perl scripts. 
The information on orthologs was also used to generate circular diagrams, either 
using the DNA plotter option in Artemis, or an in-house PERL script for high-
resolution pictures. 
genome 
1 
genome 
2 
genome 
3 
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Gene and protein alignments were generated using ClustalW2 (Larkin, et al., 2007) 
in the Seaview software (Galtier, Gouy, and Gautier, 1996; Gouy, Guindon, and 
Gascel, 2010). 
 
2.3 Plasmid profiling 
To establish a plasmid profile selected strains, the method of Kado and Liu (1981) 
was used. 
2.3.1 Reagents 
E buffer 
40 mM Tris Base (4.85g in 1 l, 121.14 g/mol; Fisher Scientific) 
2 mM Na2EDTA (0.744 g in 1 l, 372.24 g/mol; Sigma) 
Tris base and Na2EDTA were dissolved in 1 l of distilled water. The pH was then 
adjusted to 7.9 using glacial acetic acid. 
Lysis buffer 
0.6055 g Tris Base were dissolved in 40 ml distilled water. 30 ml of 10% SDS 
(Sigma) were added. Using 8 g in 100 ml distilled water, a 2M solution of NaOH 
(Fisher Scientific) was made up. To raise the pH, 3.2 ml 2M NaOH were added to the 
Tris base/SDS solution, and the total volume was adjusted to 100 ml. 
 
2.3.2 Protocol 
A 5 ml overnight culture in Luria-Bertani (LB) broth (Fisher Scientific) was set up for 
strains to be examined. Y. enterocolitica was grown at 25 °C, Salmonella was grown 
at 37 °C. 
2 ml of the overnight culture was pelleted for 5 minutes at 4,000 rpm at room 
temperature using a bench-top centrifuge (Hettich Mikro 2000). The pellet was 
resuspended in 150 µl E buffer. 300 µl lysis buffer were added and gently mixed to 
observe clearing indicating lysis. The sample was then heated for 60 minutes at 55°C 
using a heat block. After this incubation, 600 µl of phenol-chloroform (1:1 ratio 
saturated with Tris; Sigma) were added and gently mixed. To separate the layers, 
samples were centrifuged for 30 minutes at 14,000 rpm at room temperature in a 
bench-top centrifuge. From the upper watery layer, 35 to 45 µl of sample was 
removed and added to 5 µl of loading dye (Promega). For the markers, Salmonella 
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strains SL1344 and PT4 as well as Y. enterocolitica strains 5303 and 21202 
extractions were mixed in 1:1 ratio. 
Visualization was carried out on 0.7%-agarose gels with E buffer containing 10 mg/ml 
ethidium bromide. Gels were run for one hour at 30V, then a further four hours and 
30 minutes at 45 V for best separation. 
 
2.4 Phenotypic Microarray  
2.4.1 Experimental setup 
The phenotypic microarray experiment was carried out with the help of Theresa 
Feltwell (WTSI). Bacterial strains were cultured on LB agar plates at 25°C prior to 
starting the experiment. Inoculation and preparation of the 96-well plates used for 
phenotypic characterization was carried out as described by the manufacturer (Biolog 
Inc., Hayward, U.S.A.). PM1, 2A (carbon), PM3B (nitrogen), and PM4A (phosphorus, 
sulphur), PM9 and PM10 were chosen.  
The workflow is depicted in Figure 2.4.  
 
 
Figure 2.4: Preparation of fluids for phenotypic microarray. 
 
In detail, the inoculation fluids IF-0 for PM 1 – 4 and IF-10 for PM 9 and 10 were split 
into sterile flasks containing 50 ml each, and sterile water and tetrazolium dye A mix 
150$ml$IF)0$$
+$1.8$ml$dye$$
+$23.2$ml$dH2O$
150$ml$IF)10$$
+$1.5$ml$dye$
+$23.5$ml$dH2O$
60$ml$$
+$2.5$μl$L)cys9ne$
22$ml$
$
PM$1$+$PM$2A$
25$ml$$
+$1.25$μl$L)cys9ne$
$
PM$9$+$PM$10$
38$ml$$
+$280$μl$sodium$
pyruvate$
$
PM$3B$+$PM$4A$$
125$μl$cell$
suspension$85%$T$cell$
suspension$
10$ml$cell$
suspension$
50$ml$ 25$ml$
48 
for Gram negative bacteria was added. Additionally, to each IF-0 flask L-cystine, the 
homodimer of L-cysteine, (12.5 µM) was added because Yersinia needs a reduced 
from of sulphur for growth. The cell suspension for each strain was prepared by 
running a sterile swab over the agar plate and transferring the bacteria into a sterile 
tube containing IF-0. A uniform suspension was created until a turbidity of 42% 
transmittance (T) ± 2% in the Biolog turbidimeter was reached. 10 ml of this 42% % T 
cell suspension was then added to 50 ml of IF-0 + dye A to yield a final cell density of 
85% T. 125 µl of the 85% T cell suspension was then transferred to a flask containing 
25 ml IF-10 + dye A. This suspension was then used to inoculate PM9 and 10, using 
a volume of 100 µl/well. 22 ml of the 85% T cell suspension in IF-0 + dye was used to 
inoculate PM 1 and PM 2A with 100 µl/well. To the rest of the 85% T cell suspension 
280 µl of 2M sodium pyruvate was added, and PM 3B and PM 4A were inoculated 
with 100 µl/well. The plates were then placed in the OmniLog incubator/reader, and 
incubated for 48h, taking readings every 15 min. The experiment was carried out in 
triplicate for phenotypic characterization at 28°C and 37°C. 
 
2.4.2 Analysis 
Evaluation of phenotypic microarray (PM) data has not been standardized. The 
software that comes with the OmniLog instrument offers a number of variables that 
can be automatically calculated from the kinetic plots, such as maximum height, 
average height, area under the curve, and slope. It is also possible to manually select 
wells that visually stand out. 
An example of the current data set is given in Figure 2.5, showing the kinetic plots for 
the non-pathogenic BT 1A and the high-pathogenic BT 1B. Higher metabolic activity 
in BT 1A is seen in green, higher activity of BT 1B in red, and the overlapping areas 
of the curves are shown in yellow. 
One challenge with PM data is to determine a valid point to call metabolism versus 
non-metabolism of nutrient sources. Considering for instance A08, A09, and E01: is 
there utilization in these wells, or is the activity so low as to be considered 
background variation?  
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Figure 2.5: Example for utilization of carbon sources in BT 1A and BT 1B. A01 is the negative 
control. Overlapping curves are shown in yellow, BT 1A is shown in green, BT 1B is shown in red. 
Highlighted are wells described in the text. 
 
The curves also show very different shapes. Some curves rise steadily right from the 
start such as A06. Other curves show a sigmoidal progression imitating Michaelis-
Menten enzyme kinetics, where the curve rises quickly and then levels off as if there 
is a maximum turnover of this nutrient with a rate-limiting protein present, such as a 
transporter or a down-stream enzyme involved with conversion of the nutrient (B07, 
C01). Other curves resemble diauxic growth curves (A03, B02). How do you 
compare these curves and are the differences seen relevant or significant? One 
method would be to use the area under the curve, but there can be curves such as in 
A02, B03, and C04 with slightly different progression yet same area under the curve. 
One strain metabolises the nutrient earlier, the other strain utilizes it to a higher 
degree. Another method would be to look at the endpoint of the measurements. C02 
shows a curve that shows no utilization in the strains for most of the measurements 
and only gives a signal in the last hours. Is this to be treated the same as other 
curves that show a steady utilization over extended periods of time? Comparison with 
E08 shows that both curves have the same endpoint, but their progression is entirely 
different. Also interesting to keep in mind is F03: Is there utilization in BT 1A as the 
neg.%
control%
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signal activity is detected very late, or is there no activity as the signal is not very 
strong? 
 
We chose to adopt an approach by Homann, Cai, Becker and Lindquist (2008) and 
modified it to be able to apply statistical tests. This was done in collaboration with 
Lars Barquist (WTSI) who wrote the scripts to process the data and perform the 
calculations as well as produce heatmaps.  
The data was exported from the Biolog File Manager, and further analysis was 
conducted in R. For each replicate, the average height and maximum height over 
48h and the average height over 2h was extracted. The background control was then 
subtracted for each PM plate. The signal value was calculated using the following 
formula: 
 𝑠𝑖𝑔𝑛𝑎𝑙  𝑣𝑎𝑙𝑢𝑒 = !"#$!%#  !"#$%&  !"#$  !"#!!"#$!%!  !"#$%&  !"#$  !"#! − 𝑎𝑣𝑒𝑟𝑎𝑔𝑒  𝑠𝑖𝑔𝑛𝑎𝑙  𝑜𝑣𝑒𝑟  𝑓𝑖𝑟𝑠𝑡  2ℎ   
 
This was done to firstly correct the average height for later data points, to take the 
progression of the curve into account and to reduce any background signals. A single 
number can therefore reflect the time course of metabolism. 
Each plate showed a clear bimodal distribution of signal values. To call wells in which 
metabolic activity was taking place, normal distributions were fitted to the two peaks 
("off" and "on") of the bimodal distribution. From this the log-odds score for each data 
point could be calculated, showing how likely each well was to have been produced 
by the "on" distribution. A conservative cut-off of four times more likely was used for 
further analysis. To examine differential metabolism between strains, the limma 
R/Bioconductor package was used (Smyth, 2004). All strains were compared to BT 
1B strain 8081, and the Benjamini-Hochberg corrected p-values were used to 
determine statistical significance of differences controlling for a false discovery rate of 
5%. 
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2.5 Phylogenetic Analyses 
2.5.1 Phylogenetic reconstruction of Y. enterocolitica: whole genome 
alignment 
The phylogeny of Y. enterocolitica was reconstructed using an approach from Harris, 
et al. (2010). Dr Simon R. Harris (WTSI) provided the necessary scripts. Sandra 
Reuter and Dr Thomas R. Connor (WTSI) both carried out parts of the workflow. 
The genome sequence of BT 1B strain 8081 was used as a reference sequence. 
Regions containing phage were excluded, as they most likely constitute unique 
acquisition events for the strain and might lead to false positive single nucleotide 
polymorphisms (SNPs) when compared to related, but independently acquired 
phages. These SNPs are therefore non-informative in an evolutionary context. The 
reads obtained from Illumina sequence were mapped against this reference using 
SSAHA (Sequence Search and Alignment by Hashing Algorithm; Ning, Cox, and 
Mullikin, 2001). Strains with low mapping percentage (<50%) to the reference were 
excluded from the analysis. Candidate SNPs were compiled. A conservative 
approach was chosen to minimize false positive and false negative SNP calls by 
removing SNPs with low quality scores and by filtering for SNPs that are present in at 
least 75% of the mapped reads. For each strain, the polymorphisms identified in the 
previous steps replaced the reference sequence. Thus a SNP alignment was 
obtained.  
For estimation of an evolutionary tree based on maximum likelihood RAxML was 
used (Stamatakis, 2006). The general time reversal (GTR) model was used to 
account for differences in rates of nucleotide substitutions, and gamma correction 
was chosen to model the different positions within a triplet codon. 100 random 
bootstraps were performed for node support. Again, Dr Simon R. Harris provided 
scripts for this. In a last step, the SNPs were reconstructed on the tree so that SNPs 
associated with specific branches can be identified. No outgroup was used for the 
Y. enterocolitica tree, but the tree was rooted in retrospect on the non-pathogenic BT 
1A as this is the oldest lineage. 
 
2.5.2 Phylogenetic reconstruction of the genus Yersinia: extended MLST 
scheme 
For the phylogenetic relationship of the genus Yersinia, a concatenated sequence of 
75,651 bases from 85 housekeeping genes (Table 2.4) was used. These genes were 
52 
identified in conserved, syntenic blocks in the Y. enterocolitica genome. The genes 
were chosen by Miquette Hall (NTU) on the basis of exhibiting 10-25% SNP 
divergence between Y. pestis and Y. enterocolitica.     
 
Table 2.4: Housekeeping genes used for construction of the phylogenetic relationship within 
the genus Yersinia. 
ID* gene  ID gene  ID gene  ID gene  ID gene  
YE0003 asnA YE0919 gloB YE2176 ppsA YE2427 kdsA YE3331 galR 
YE0027 glnA YE0926 nrdF YE2209 trpE YE2431 prfA YE3374 lysS 
YE0062 dfp YE0927 nrdE YE2254 xthA YE2432 hemA YE3376 prfB 
YE0093 tpiA YE1009 nadB YE2257 topB YE2477 chaA YE3416 tktA 
YE0134 sthA YE1082 guaA YE2261 ansA YE2783 udk YE3419 speA 
YE0166 rhlB YE1281 aroC YE2281 dadA YE2794 sfcA YE3425 endA 
YE0168 rho YE1538 aroA YE2283 fadR YE2818 folE YE3427 gshB 
YE0251 udp YE1640 tmk YE2284 nhaB YE2928 nadA YE3656 parC 
YE0258 aarF YE1643 ptsG YE2371 minC YE2977 glnS YE3673 rfaE 
YE0263 hemB YE1717 phoQ YE2372 minD YE3067 rosA YE3681 gcp 
YE0354 groEL YE1718 phoP YE2374 rnd YE3088 hemH YE3708 uxaC 
YE0414 mdh YE1720 purB YE2383 zwf YE3089 adk YE3766 pyrB 
YE0600 thrA YE1725 icdA YE2386 msbB YE3202 proB YE4132 fdhE 
YE0610 dnaJ YE1784 purT YE2388 znuA YE3308 argA YE4133 fdoI 
YE0746 pyrG YE1793 pip YE2389 znuC YE3317 thyA YE4151 glyQ 
YE0773 pcm YE1887 kduD1 YE2390 znuB YE3318 lgt YE4170 gyrB 
YE0829 recA YE2114 tyrR YE2397 aspS YE3324 tas YE4206 atpD 
* systematic ID respective to BT 1B strain 8081. 
 
The respective gene sequences for the MLST tree were extracted using a script that 
performs a tblastn search on an assembled query sequence using a translated 
nucleotide subject to search for a matching amino acid string. The genes were 
concatenated into a single super-locus for each strain. Similarly to the phylogeny of 
the species, the alignment of genes was used to estimate a tree with RAxML based 
on the GTR model with gamma correction and bootstrapping (Stamatakis, 2006). Dr 
Thomas R. Connor was responsible for this part of the project. Bayesian analysis of 
population structure (BAPS; Cheng, et al., 2011) was used to identify clusters of 
homologous sequences within the 85 housekeeping genes, and formed the basis for 
the proposition of the new species clusters. Dr Thomas R Connor performed this 
work as well. 
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2.5.3 Phylogenetic reconstruction of the virulence plasmid pYV 
To determine the phylogenetic relationship of the virulence plasmids, the same 
approach as for Y. enterocolitica was used. Both pYV8081 and pYV5604 were used 
as references to map Illumina reads using SSAHA in separate approaches. 
Alignments were created and trees were estimated using RAxML based on the GTR 
gamma model with 100 bootstraps. Both approaches gave the same tree topology. 
Dr Thomas R. Connor and Sandra Reuter both performed parts of this experiment. 
 
2.5.4 Serotyping from sequence data 
As some of the operons for the serotypes of Y. enterocolitica were either known or 
were identified during the annotation of the reference genomes, this information was 
used to perform in silico serotyping on the larger strain collection. This was done 
using an in-house perl script by Nicholas Croucher. This script is based on BWA 
mapping (Burrows-Wheeler Aligner; Li and Durbin, 2009), and will count the number 
of Illumina reads that map to a reference sequence – the operon of interest – and will 
return a percentage of mapping. This gives a good indication whether a specific 
operon is present or absent given the divergence of the different operons. 
 
2.5.5 Phylogenetic reconstruction using 16S rDNA sequence  
The 16S sequences were extracted from the Illumina reads by mapping against the 
BT 1B reference strain 8081. The sequences were then corrected using iterative 
correction of reference nucleotides (iCORN) to improve sequence quality (Otto, 
Sanders, Berriman and Newbold, 2010). Sequences for the previously published 
isolates of the environmental species as well as Y. pestis and Y. pseudotuberculosis 
were obtained from the National Center for Biotechnology Information webpage 
(NCBI; www.ncbi.nlm.nih.gov) and are based on high-quality Sanger sequencing. 
Sequences were aligned using Seaview (Galtier, Guoy, and Gautier, 1996) and 
trimmed for same start and stop of the molecules. A phylogenetic tree was then 
calculated using the PhyML option in Seaview for a maximum likelihood tree, 
employing the GTR gamma model with 100 bootstraps. 
 
2.5.6 Phylogenetic reconstruction including Y. entomophaga and Y. nurmii 
The newly established species Y. entomophaga and Y. nurmii were not included in 
the large-scale sequencing approach. To determine their relationship with the other 
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Yersiniae, the deposited sequences for four housekeeping genes recA, hsp60, gyrB, 
and glnA (Hurst, et al., 2011; Murros-Kontiainen, et al., 2010b) were obtained from 
the NCBI website. These four genes were included in the 85 housekeeping genes, so 
this sequence information was extracted for the worldwide strain collection. The 
genes were concatenated into a superlocus and aligned using Seaview. Again, a 
phylogenetic reconstruction using PhyML in Seaview was carried out.  
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3 Sequencing and Analysis of the Reference Genomes for 
Y. enterocolitica 
3.1 Introduction 
At the start of the project, only one genome sequence for the Y. enterocolitica high-
pathogenic biotype 1B had been published (Thomson, et al., 2006). This strain 8081 
was isolated from a fatal human septicaemia case in America in 1980 (Portnoy, 
Moseley and Falkow, 1981). More recently individual genomes of other BTs have 
been published, and compared to the reference genome of BT 1B (Batzilla, 
Heesemann and Rakin, 2011; Fuchs, Brandt, Starke and Rattei, 2011; Wang, et al., 
2011; Batzilla, et al., 2011a,b). New regions described are a novel T3SS, potential 
membrane transporters and associated metabolic pathways, a toxin complex 
pathogenicity island and other potential toxin clusters, and a second flagella cluster 
Flag-2 (Wang, et al., 2011; Fuchs, Brandt, Starke and Rattei, 2011). 
Currently absent from the analyses are BT 5 strains. A comprehensive comparison of 
“all against all” is also still outstanding but necessary to define the “enterocolitica” 
core and the accessory genes that define the biotypes. A comparison between the 
biotypes is also required to determine whether the regions identified as unique for 
individual strains compared to BT 1B are the same as those described in the other 
studies and whether the regions are indeed functional or show pseudogene 
acquisition when compared with each other. The genotypic and phenotypic 
heterogeneity of Y. enterocolitica justifies further in-depth comparison non-, low- and 
high-pathogenic strains with each other. Strains in this study were chosen as 
representatives based on the prevelance of bioserotypes in the UK in humans and 
animals (McNally, et al., 2004; Tompkins, et al., 1999) and have been characterized 
genotypically and phenotypically (Howard, et al., 2006; Thomson, et al., 2006; 
McNally, et al., 2006). 
Sequencing of representative strains for common Y. enterocolitica bio-serotypes of 
non- and low-pathogenic lineages should allow us to identify general characteristics 
of a Y. enterocolitica genome. The advantage of whole genome sequencing is that it 
gives information about genome organization and topology. It also not only identifies 
new regions but gives information on whether shared regions are orthologous, that is 
of the same evolutionary origin and thus conserved in terms of genomic context, or 
are paralogous, that is if convergent evolution took place. A comparison of all isolates 
should give a full representation of the Y. enterocolitica species.   
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3.2 Results 
3.2.1 Sequencing, assembly and sequence improvement of the 
Y. enterocolitica biotypes genomes 
The genomes of six Yersinia enterocolitica strains (1203, 5603, 5303, 21202, 14902, 
3094; Table 2.1) were sequenced using multiple sequencing technologies. The work 
was carried out at the core genome sequencing facilities at the Wellcome Trust 
Sanger Institute (WTSI), Hinxton, UK. The sequencing process, assembly and 
improvement are outlined in Figure 3.1. 
 
Initially, sequencing started on five representative strains (5303, 21202, 5603, 14902, 
1203) of the predominant bio-serotypes 1A and 2 – 4 in the UK. The first round of 
sequencing was carried out using 454/Roche GS20/FLX shotgun pyrosequencing 
using 3 kb DNA fragment sizes. This produced in excess of 30-fold coverage of each 
genome. Polymerase chain reaction (PCR) products were designed to span gaps in 
contigs and sequenced to close gaps. This was automated by using algorithmic 
based automatic contiguation of assembled shotgun sequence (ABACAS; Assefa, et 
al., 2009), which was under development at the time. This process was supervised 
and carried out by Danielle Walker at the WTSI. The de novo assemblies for strains 
5303 and 1203 were produced using the Newbler software (454 Life Sciences, 
Roche). Initial analysis and annotation was started at this stage.  
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Figure 3.1: Sequencing timeline for the Y. enterocolitica reference genomes. The timeline is 
presented on the left and contrasted with the sequencing progress. The work carried out by Danielle 
Walker and Sandra Reuter is highlighted. The first five reference genomes are split from the last 
genome due to difference in sequencing progress. 
454#GS20#/#FLX#shotgun#
454#Ti##FLX3#/#paired;end#
Annota=on#&#analysis#
Illumina#GAII#/#paired;end#
PCR#gap#closure#(ABACAS)#
2X#Capillary#
Ini=al#annota=on#
PCR#gap#closure#
#RNA#spanning#
Re;Assembly#&#con=g#
arrangement#
Final#Annota=on#&#analysis#
Pseudogene#correc=ons#
Sequencing#technique# Danielle#Walker# Sandra#Reuter#Timeline#
Ini=al#assembly#(Newbler)#
Re;Assembly#
Con=g#arrangement#
iCORN#correc=on#
454#Ti##FLX3#/#paired;end#
Illumina#GAII#/#paired;end#
PCR#gap#closure##
RNA#spanning#
Assembly#&#con=g#arrangement#
Final#Annota=on#&#analysis#
Pseudogene#correc=ons#
Assembly#
Con=g#arrangement#
iCORN#correc=on#
November#
2008#
September
2009#
April#
2009#
March#
2009#
May#
2009#
January#
2010#
May##
2010#
February#
2010#
April#
2010#
August#
2010#
September
2010#
May#
2010#
Strain##
Bi
ot
yp
es
#1
A,
#2
#–
#4
##(
53
/0
3,
#2
12
/0
2,
#5
6/
03
,#1
49
0/
02
,#1
2/
03
)#
Bi
ot
yp
e#
5#
(3
09
4/
96
)#
February#
2008#
58 
Analyses were hampered by the fact that some regions of difference compared to the 
reference genome 8081 were at the end of contigs, thus making it difficult to assess 
the genomic location as well as the completeness of that region. Also, each of the 
genomes was present in more than 300 contigs. This was due to a large number of 
IS elements and repeats as well as several copies of the rRNA operon that are not 
spanned by a single-ended sequencing technique. The newly sequenced genomes 
appear o have the same genome architecture as the reference genome 8081, as the 
large number of contigs can be arranged in a co-linear fashion against the reference 
(Figure 3.2). The non-pathogenic BT 1A strain 5303 shows the largest genome size. 
Some gaps are visible which might be due to lower homology hits being filtered out. 
 
 
Figure 3.2: Initial assembly based on single-end 454 reads and comparison of the six 
Y. enterocolitica reference genomes. Genomes are compared in a pair-wise fashion. Red bars – co-
linear homology >999 bp, blue bars  – inverted homology >999 bp. Due to the large number, contigs 
are not highlighted. 
 
It was then decided to undertake further sequencing. 454/Roche GSFLX Titanium 
(paired-end) was used to generate sequence in excess of 30-times coverage. It also 
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used 3 kb DNA fragment sizes, but employed long-read chemistry and paired-end 
technology (454 Life Sciences, 2008), which had not yet been introduced into the 
WTSI production pipeline when the first round of pyrosequencing had been carried 
out. To further improve the assemblies, the five strains were sequenced by more 
conventional Sanger sequencing using big-dye terminator chemistry on ABI3730 
automated sequencers to approximately 2-fold coverage from pOTW12 (insert size 
5-6 kb) and pMAQ1Sac_BstxI (insert size 9-12 kb) genomic shotgun libraries. These 
subsequent rounds of sequencing with the additional information on the distance of 
both paired-end reads and large insert size libraries were used to help link contigs. 
Thus the total number of contigs was reduced, as was the chance of mis-assemblies, 
because unambiguous placement of physically linked fragments was possible. Finally 
to improve accuracy of the sequence and reduce the possibility of generic errors of 
454/pyrosequencing in homopolymeric tracts further sequence was generated using 
paired-end Illumina sequencing platform on the Illumina GAII Analyser with standard 
200-300 bp fragments and 37 cycles of sequencing to give a coverage with just this 
technology in excess of 60-fold coverage. Danielle Walker again supervised this 
process.  
The Illumina data was assembled, using the de novo Velvet assembler (Zerbino and 
Birney, 2008) with a kmer length of 31 for the 37 cycle runs. The consensus was then 
extracted and artificially broken down into 500 bp fragments. The GS De Novo 
assembly software (Roche, 2011) was used to assemble the 454 reads, capillary 
reads and the artificially fragmented velvet consensus as well as a round of 
automated PCR reactions designed on the 454 scaffolds using ABACAS. This was 
then converted for viewing and analysis in the STADEN – Gap4 software package 
(Bonfield, Smith and Staden, 1995). 
The assembled consensus sequence for strains 5303 and 1203 was annotated and 
this analysis was also used to inform the gap closure process. With additional PCR-
based gap closure and sequencing using a primer walking approach especially over 
large repeat regions such as rDNA operons, Danielle Walker was able to close gaps 
and scaffold large regions. However, it was still not possible to close all gaps and so 
for the 16S operons the consensus sequence of BT 1B strain 8081 was used. 
Finishing this part of the reference genomes was not a priority, and would have been 
too resource-extensive.  
In addition to the gold standard, finished BT 1B genome, only the genome for BT 1A 
could be contiguated that is assembled into only one large contig. For all other 
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reference genomes the sequencing was finalized at a point were all the genomes 
were present in less than eight contigs (Table 3.1). The IS elements present had a 
great impact on the ability to assemble the genomes because IS elements can be 
present as multiple perfect repeats that are usually around 1,000 bp long and thus 
not spanned from unique sequence to unique sequence by paired-end sequencing 
reads. The number of IS elements varied between the biotypes with BT1A having the 
smalles number of IS elements and the low-pathogenic BT possessing a larger 
number. In addition there are 3-8 rRNA operons in the sequenced reference 
genomes. This also impacted on the assemblies, as the operons present a large 
repeat region that has recombinatorial potential.  
The final assemblies of the low-pathogenic BT genomes were based both on 
information on rRNA operons linking contigs as well as on comparisons towards both 
BT 1B and BT 1A. As comparison towards BT 1A and BT 1B yields different contig 
orders, a preference was given towards BT 1A. This biotype contained the least 
number of IS elements and repeats, and thus gave the impression of having 
undergone less genome rearrangement and presenting an ancient lineage. Table 3.1 
gives the contig order and the basis for that particular order. 
 
Table 3.1: Contig ordering in the Y. enterocolitica reference genomes for BT 1A, 2 - 4. 
Strain Contig # Size [bp] Information 
5303 1 4,940,199 Contiguated, cut for same start as 8081 
21202 1 331,132 Cut for same start as 8081 
 2 34,537 Flipped to fit with 5303 
 3 106,274 Joins with #4 by read pair, both flipped to fit with 5303 
 4 485,939 Joins with #3 by read pair, both flipped to fit with 5303 
 5 2,189,202  
 6 1,011,144 Joins with #7 by read pair 
 7 6,554 Joins with #6 by read pair 
 8 400,227 First half from contig #1 
5603 1 19,724 Cut for same start as 8081, flipped to fit 5303 
 2 143,745  
 3 197,661  
 4 760,938  
 5 776,795 Joins with #6 by read pair 
 6 1,405,148 Joins #5 and #7 by read pair 
 7 860,219 Joins with #6 by read pair 
 8 399,855 Joins with #1 
14902 1 18,110 Cut for same start as 8081 
 2 313,931  
 3 701,464 Joins with #4 by read pair 
 4 360,673 Joins with #3 by read pair 
 5 344,361  
 6 2,857,874 Joins with #1 
1203 1 402,778 Cut for same start as 8081 
 2 4,317 Based on read pairs 
 3 1,725,059 Based on read pairs 
 4 2,395,791 Based on read pairs 
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The 6th strain sequenced in this study, BT 5 strain SZ3094/96 (short: 3094), was 
sequenced using the 454/Roche GSFLX with long-read GS FLX Titanium chemistry 
to approximately 25-fold coverage using 8 kb DNA fragment sizes. Sequence was 
also generated using the Illumina sequencing platform on the Illumina GAII Analyser 
to approximately 200-fold coverage with standard 200-300 bp fragments and 54 
cycles of sequencing. A de novo assembly was done for the Illumina reads using 
Velvet (Zerbino and Birney, 2008) with a kmer length of 45 for the 54 cycle run. Again 
the consensus was extracted, broken down into 500 bp fragments, and combined 
with the 454 reads using the GS De Novo assembly software (Roche, 2011). End- 
sequenced PCR products were used to close gaps and scaffold large repeat regions. 
This strain was not analyzed until it was in less than 10 contigs, and assembly was 
based both on information on rRNA operons linking contigs as well as on comparison 
to both BT 1B and BT 1A. Table 3.2 gives the contig order. 
 
Table 3.2: Contig ordering in the Y. enterocolitica reference genome for BT 5. 
Strain Contig # Size [bp] Information 
3094 1 1,118,114 Cut for same start as 8081 
 2 36.977  
 3 262,567  
 4 27,479  
 5 3,220,765  
 
The final assemblies of the reference genomes after gap closure and corrections can 
be seen in Figure 3.3. There are striking differences to the initial assemblies of the 
454/single-end run (Figure 3.2). Each strain shows several extensive inversions and 
even translocations compared to other strains.  The assemblies have been trimmed 
for a common start, and thus share beginning and end, but apart from that no 
common theme of genome organization is visible. The genome rearrangements are 
visible within contigs, not only at the end of contigs, thus can be considered genuine. 
The differences to the initial assemblies can be explained partially by the reduced 
number of contigs in the final assembly. The initial assemblies were missing 
information on read-pairs. Not only did this result in a more fragmented assembly, the 
short contigs were then aligned and orientated according to the reference genome as 
information on linking contigs was missing. These mis-assemblies thus give the 
impression of co-linear organization of the reference genomes visible in the original 
comparison (Figure 3.2). 
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Figure 3.3: Pairwise comparison of final assemblies after gap closure of Y. enterocolitica 
reference genomes. Red bars – homologous, co-linear matches >1,200 bp, blue bars – homologous, 
inverted matches >1,200 bp, alternating orange/brown – contig borders. The non- and high-
pathogenic BTs both consist of only one single contig. 
 
Sequencing of the virulence plasmid pYV contained in BTs 2 – 5 as well as 
sequencing of unique plasmids of individual strains was carried out as for the 
genome of the respective strain. Danielle Walker and Sandra Reuter both manually 
designed primers for closing gaps in the plasmids. 
 
Finally all assemblies were corrected using iterative correction of reference 
nucleotides (iCORN; Otto, Sanders, Berriman and Newbold, 2010). All strains were 
completed to an Improved High-Quality Draft Standard (Chain, et al., 2009), and 
consist of a circular genome with several contigs and varying plasmid numbers.  
 
For further sequence improvement, all CDSs with homopolymeric runs resulting in 
frameshifts and stop codons introduced in the coding sequence (pseudogenes) were 
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checked against the original sequencing data for coverage and sequencing 
technique. If the sequence was questionable in terms of number of reads, or 
contained data from only one sequencing technique, PCR reactions were designed 
for improved quality and the sequence corrected accordingly. This was done for all 
functional classes except those of foreign origin (phage, IS elements) and 
hypothetical, unclassified proteins. This should present an accurate total number of 
the pseudogenes as well as give confidence in the nature of the mutations. 
During this process, between two and 22 bases were changed in the reference 
genomes, yielding an error rate beween 0.00004% and 0.0005% equivalent to up to 
5 wrong base calls in 1,000,000 bases. This is very much dependent on the 
sequencing technologies employed. For instance, reference genome YE3094 was 
sequenced only with pyrosequencing and Illumina technology, and thus has a larger 
number of errors in the sequence that were identified during subsequent analysis. 
There is an undetermined error rate with respect to base changes that do not result 
in immediately visible effects on open reading frames, but judging from the number of 
changes carried out upon pseudogene inspection it can be assumed to be low. 
 
Other single genomes for Y. enterocolitica BT have been made available but vary in 
sequence quality compared to the reference genomes presented here. Two BT 1A 
strains have been sequenced to draft quality, resulting in 74 and 97 contigs (Batzilla, 
Heesemann and Rakin, 2011). The published BT 2 O:9 strain W22703 (Fuchs, 
Brandt, Starke and Rattei, 2011) has been classified as Annotation-Directed 
Improvement, but gap closure has not been carried out and only one sequencing 
technique has been employed. Thus the genome is presently in more than 300 
contigs, making it difficult to do a full characterization of the genome. The published 
BT 3 O:9 strain 105.5R(r) (Wang, et al., 2011) might be classified as High-Quality 
Draft, since two sequencing techniques have been employed and some gap closure 
has been carried out so that the genome is present in 81 contigs. A detailed analysis 
of BT 4 O:3 strain Y11 has been published (Batzilla, et al., 2011a,b). Due to gap 
closure and quality control, this genome may be classified as Improved High-Quality 
Draft, and so has the same genome standard as the reference genomes generated 
for this study. 
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3.2.2 Genome annotation  
The individual steps for preparation of a reference sequence for annotation are 
shown in Figure 3.4. 
 
 
Figure 3.4: Flow chart of the preparation of a genome sequence for annotation and analysis. 
Gene prediction software is used for finding open reading frames. These are then characterized by 
protein searches, such as transmembrane domains, signal domains, etc. Annotation is transferred 
using a reference genome. Both the gene prediction and the glimmer prediction are combined and 
open reading frames without annotation are blasted and annotated using Artemis. The genome 
sequence is also visually compared to the reference genome using ACT. Following annotation, the 
genome can be characterized further with respect to overall composition and orthologous gene sets 
with other genomes. 
 
First of all, Glimmer 3 was used as a model for prediction of potential open reading 
frames (Salzberg, Delcher, Kasif and White, 1998; Delcher, Bratke, Powers and 
Salzberg, 2007). To help characterization of potential new CDSs, searches for 
transmembrane domains (TMHMM; Krogh, Larsson, von Heijne and Sonnhammer, 
2001), signal domains (SignalP; Nielsen, Engelbrecht, Brunak and von Heijne, 1997; 
Brendtsen, Nielsen, von Heijne and Brunak, 2004), helix-turn-helix motifs (HTH), 
protein family domains (Pfam; Finn, et al., 2010) and prosite (Sigrist, et al., 2002; 
Hulo, et al., 2006) were carried out. Using the Artemis Comparison Tool (ACT; 
Carver, et al., 2005), genomes were compared to the reference BT 1B strain 8081 
and to each other to define large-scale regions of difference. The files needed for 
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comparing two genomes with each other were generated using an in-house bigger 
blast script, but can also be obtained from WebACT (www.webact.org). 
 
The reference genomes were annotated by transferring annotation from the 
reference genome BT1B strain 8081. This script compares the reference genome to 
the subject genome and transfers annotation to CDSs that have more than 90% 
BLAST identity. The Glimmer prediction and the annotation transfer were combined, 
and unique regions received new manual annotation using Artemis (Berriman and 
Rutherford, 2003). All CDSs were blasted against prokaryotes using the UniProt 
knowledgebase (UniProt, 2011). Annotation was equally based on sequence 
similarity and indications for protein function.  
Annotation was also transferred from one annotated genome to the other, since 
regions were identified that were absent in BT 1B strain 8081, but shared in the other 
genomes. The annotation transfer was also employed when transferring annotation 
from old sequence versions to updated assemblies. 
For annotation, each CDS is given a set of qualifiers for identification. Apart from a 
unique locus tag or a systematic ID that is allocated automatically to each CDS, each 
CDS is characterized with a product, potentially a gene name if there are well-
characterized homologs, a class and a colour. Class and colour qualifiers both reflect 
the product, but allow easier classification of CDSs into groups (see Table 9.3, p. 
209, and 9.4, p. 213, in appendix). The 14 colours used reflect the function and sub-
cellular location of a protein, e.g. green proteins are associated with the cell wall and 
membrane, such as permease or lipoproteins, whereas black proteins are involved in 
carbon energy metabolism. The class system fulfils a similar purpose, but breaks 
down the functions in more detail. Thus an exported protein may be classified as 
being in the inner membrane, or a protein involved in carbon metabolism can be 
allocated to anaerobic respiration. The product will very specifically give the protein 
name and function, but the class / colour system allows it to bring proteins of different 
names together under a common denominator.  
Notes were added for further explanations if necessary, and homologs from other 
bacterial species were added.  
 
Pseudogenes are defined as carrying mutations that would prevent the expression of 
the gene or would alter the nature of the resultant protein. This includes truncations 
of N and/or C termini, deletions of other parts of the gene, stop codons introduced 
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within the coding sequence and frameshifts. All pseudogenes except IS elements 
and hypothetical proteins were checked for sequence quality and confirmed as 
described above. IS elements were excluded as they are repetitive. Their function 
also might not only be in the expression of the transposase itself, but also lies in 
recombinatorial potential with the same class of IS element in other parts of the 
genome, which is independent of a functional transposase. Due to the large number 
of IS elements, their exclusion from confirming pseudogenes can be justified. 
Similarly, hypothetical proteins were excluded, as their transcription and function is 
unknown. Pseudogenes were annotated in a different way with labelling the product 
as pseudogene, partial, or remnant, stating in a note the nature of the mutation, 
setting the colour to 11 (brown) and adding the qualifiers “/pseudo” and “/partial” 
where applicable. This gives a set of filters that allows for easy identification of 
pseudogenes within a given set of CDSs. Pseudogenes are also made to end on the 
codon before the stop codon (“taken off the stop codon”). These modifications aid in 
downstream analysis of the genomes and simple tracking of pseudogenes. 
 
RNA searches using Rfam (Griffiths-Jones, et al., 2003; Gardner, et al., 2011) were 
performed to establish the location of the RNA components. The location of the 16S 
and 23S rDNA operons was established in comparison with the reference genome of 
BT 1B strain 8081. 
The resultant set of CDSs in the reference genomes was then used for detailed 
gene-by-gene annotation and analysis. 
  
3.2.3 Genome comparison 
For the six biotypes, it was not only interesting to compare strains in a pairwise 
fashion, but it was more important to see which sets of CDSs might characterize 
more than two biotypes. For this, orthologous gene sets were identified by reciprocal 
FASTA searches. This approach is shown in Figure 3.5. 
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Figure 3.5: Identifying sets of orthologous CDSs. Reciprocal FASTA searches are carried out, the 
orthologs are combined in a file and manually curated using 3-way Venn comparisons. The identified 
orthologs can then be grouped. This establishes pan- and accessory genome and allows for a 7-way 
Venn comparison. 
 
Only those pairs of homologous CDSs were retained for further analysis where the 
predicted amino acid identity was ≥ 40% over 80% of the protein length. These 
genes were then subjected to manual curation using gene synteny to increase the 
accuracy of this analysis. 3-way Venn diagrams were employed to facilitate manual 
curation. This curation is specifically needed for paralogous gene families such as IS 
elements, which can be numerous in the genome. Sequence divergence can inhibit 
direct identification of CDSs as orthologs but looking at genome synteny can help 
identify these. Truncated genes might also not be identified in the automated analysis 
as their length and identity can fall below the cutoff. This strategy was applied to 
pairwise comparisons of the genomes of all sequenced biotypes. These identified 
orthologs were then combined together with the annotation file.  
 
3.2.4 General genomic features of the reference genomes 
The Table 3.3 gives a general overview of the properties of the sequenced reference 
genomes for each of the biotypes of Y. enterocolitica. These basic figures can be 
used to characterize genome composition. 
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Table 3.3: General properties of the sequenced reference genomes of Y. enterocolitica 
Property BT 1B  
O:8 
(8081)* 
BT 1A  
O:5 
(5303) 
BT 2  
O:9 
(21202) 
BT 3  
O:9 
(5603) 
BT 3  
O:5,27 
(14902) 
BT 4  
O:3 
(1203) 
BT 5  
O:2a,2b,3 
(3094) 
Genome size (bp) 4,615,899 4,940,199 4,565,009 4,564,085 4,596,413 4,527,945 4,665,902 
Number of genome 
contigs 
1 1 8 8 6 4 5 
Plasmid name and 
size (contiguated) 
pYV 67kb 
 
pSR2-1A 8kb 
pSR3-1A 4kb 
pYV 75kb 
pSR1-2 42kb 
pYV 75kb 
 
pYV 75kb 
 
pYV 75kb 
 
pYV 75kb 
pSR4-5 100kb 
G+C content (%) 47.27 48.42 48.09 48.10 48.16 48.22 48.24 
Number of CDS 4,053 4,365 3,922 3,917 3,978 3,893 4,051 
Coding density (%) 84.7 86.7 85.9 82.7 83.3 80.7 79.8 
Average gene size 
(bp) 
963 965 981 982 975 976 964 
Total number 
pseudogenes 
84 81 157 141 146 235 322 
Number of partial 
genes 
57 39 96 86 97 126 129 
Prophage regions 4 6 2 2 3 2 3 
rRNA operons 7 6 3 3 4 8 7 
tRNA loci 81 77 72 72 71 72 67 
IS elements 60 31 87 85 79 101 110 
* numbers updated from Thomson et al., 2006 
 
The genome sizes of the reference genomes vary between 4.53 and 4.94 Mb, with 
BT1A showing the biggest genome. Relating to the genome size is the number of 
CDSs, which is higher in larger genomes. The G+C content of all strains is similar 
and is about 48%. The coding density lies between 80 – 85%, with BT 5 having the 
lowest and BT 1A having the highest coding density. The average gene size across 
all biotypes was 970bp. 
 
Comparing the reference genomes to the other five published Y. enterocolitica 
genomes, one can see that they are similar to the results obtained here. Limited 
information is available on the two BT 1A strain (Batzilla, Heesemann and Rakin, 
2011), but their genome size estimated at 4.7 Mb and GC content of 47% are similar 
to BT 1A strain 5303. Due to their status as draft genomes, a detailed comparison of 
CDS numbers, pseudogenes, phages, etc. is not possible. 
Genome size for BT 2 O:9 strain W22703 (Fuchs, Brandt, Starke and Rattei, 2011) is 
given as < 4.75 Mb, which is in the same range as the 4.56 Mb obtained for the BT 2 
O:9 reference strain 21202. The GC content and coding density of W22703 (46.9%, 
84.4%) are slightly lower than 21202 (48.1%, 85.9%). The number of CDSs in 
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W22703 exceeds the number of CDSs in 21202 (> 4,003, and 3,922, respectively), 
but given the high number of contigs it could be that some CDSs are in fact split onto 
different contigs. It is more likely though that the higher number of CDSs reflects the 
larger genome size. It is not possible to compare the number of rRNA operons nor 
the number of IS elements as these are likely to present the gaps between the 
contigs. Both BT 2 O:9 strains carry two prophages, but it cannot be assessed 
whether these present the same prophage acquired by the BT 2 O:9 lineage or 
independent phage infections. 
The genome size, GC content, coding density, and number of CDSs of BT 3 O:9 
strain 105.5R(r) (Wang, et al., 2011) are all comparable to the BT 3 O:9 strain 5603. 
The number of tRNAs are exactly the same (71). The number of rRNA operons in 
105.5R(r) is higher than in 5603 (7, and 4 respectively), whereas the number of IS 
elements is lower than in 5603 (67, and 79 respectively). 85 pseudogenes are 
reported for 105.5R(r), which is considerably lower than the 146 pseudogenes found 
in the reference strain 5603. It could be the definition of a pseudogene that causes 
this discrepancy between the values. The number of partial genes and gene 
remnants in 5603 is 97, which is closer to the number stated for 105.5R(r). It could be 
that Wang et al. (2011), did not consider genes with frameshifts and stop codons as 
pseudogenes as the complete gene sequence is present. 
The genome size and GC content of BT 4 O:3 strain Y11 (Batzilla, et al., 2011a,b) 
are similar to the reference genome for BT 4 O:3 strain 1203. The number of CDSs 
(4,355) is higher than for 1203 (3,893). The coding density thus is higher for Y11 than 
for 1203 (85.0%, and 80.7% respectively). The number of tRNA and rRNA operons in 
Y11 (70, and 7 respectively) is close to the numbers present in 1203 (72, and 8 
respectively). The number of pseudogenes as obtained from the available NCBI entry 
(accession number FR729477) is considerably lower for Y11 (92) than for 1203 
(235), similar to the discrepancy observed between the two BT 3 strains. Again, it 
could be due to the definition of a pseudogene, but even only considering the 126 
partial genes and gene remnants in 1203, this number is higher than that for Y11. 
 
Several plasmids were identified in the reference strains with the virulence plasmid 
being common to all pathogenic BT. The variations in the virulence plasmid and the 
unique plasmids found are described in more detail in chapter 5. 
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In summary, the reference genomes are similar in general composition, with an 
average genome size of 4.6 Mb ± 0.13 Mb, a GC content of 48% ± 0.3%, and ~4,000 
CDSs. Significant variations arise in the number and distribution of IS elements and 
pseudogenes. 
 
3.2.5 General characteristics of reference genomes 
Using the annotation information contained in the assigned class qualifier (see 
appendix classification scheme table 9.1) for each gene the overall distribution of 
classes for the whole gene set within the genome could be determined for each of 
the biotypes (Figure 3.6). The classes of CDSs were combined in 20 different 
functional groups (see Table 9.1 in appendix). 
 
All bio-serotypes show a similar distribution of CDSs according to class. About a 
quarter (23.6 – 26.0%) are proteins that have no assigned function or that are 
hypothetical, unconfirmed open reading frames. The predominant assigned functions 
are related to transport proteins (11.7 – 12.3%), cell envelope (14.8 – 16.6%), foreign 
DNA such as phages and IS elements (6.6 – 9.4%), regulation (6.5 – 6.9%), and 
macromolecule synthesis (5.7 – 6.0%). 
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Figure 3.6: Distribution of classes amongst CDSs of all reference genomes. The information on 
class of a CDS was extracted and individual classes were combined in 20 different functional groups. 
The functional groups represent the spectrum of activity that can be performed by a bacterial cell. The 
CDSs in each group were combined to give a percentage of the total number of CDSs.  
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3.3 Discussion 
3.3.1 Generation of Improved High-Quality Draft genome sequences 
The generation of the reference genomes in this study tracked the technological 
advances in next-generation sequencing technologies. 
The initial sequencing and analysis was based on a single-end run of 
pyrosequencing. Although the genome could be assembled into contigs, and gave an 
approximate size for each genome, the assembly was incomplete and often the 
interesting regions of difference were at the end of contigs making it difficult to 
determine the true nature of for example pathogenicity islands or to make statements 
on the completeness of an operon.  
One factor that made assembly of the Y. enterocolitica genomes difficult was the 
presence of large numbers of perfectly repeated IS elements, especially IS1667, in 
the biotype genomes. At the start of sequencing it was not known that this insertion 
sequence element was present in over 30 copies in each of the low-pathogenic BT. 
Other IS elements are also present, plus several copies of the 16S and 23S rRNA 
operons, which also represent perfect extended repeat regions. Similar numbers of 
IS elements are also present in the previously sequenced BT 1B strain 8081 as well 
as in Y. pseudotuberculosis and Y. pestis (Thomson, et al., 2006). Each Yersinia 
genome contains 6-7 copies of the rRNA operon, and Y. pestis has on average more 
than 100 IS elements of varying classes. Using Y. pestis as an example, Pop and 
Salzberg (2008) hypothesize that sequencing the plague bacterium with short reads 
would result in obtaining data for only 93% of the genome, with a very fragmented 
assembly. The length of the read will not be able to bridge the repetitive elements, 
thus the importance of linking information on either side of the repeat reads is 
stressed (Pop and Salzberg, 2008). In particular de novo assembly is impossible 
without read-pair information (Chaisson and Pevzner, 2007; Chaisson, Brinza and 
Pevzner, 2009). Chaisson, Brinza and Pevzner (2007) could even show that the 
information on read-pairs is more important than an increase in read length.  
 
As a result of this it was then decided to initiate further sequencing. Both Illumina and 
454 technologies by that time had the possibility to perform paired-end runs, thus 
giving additional information on contig linking and scaffolding of sequence reads.  
A low coverage Sanger sequencing run was also performed as this was the 
technology with longest reads and established paired-end technology, thus it was 
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hoped to improve sequence quality and assembly. As was later seen in the 
sequencing of BT 5, this would have been redundant, as a combination of paired-end 
pyrosequencing and paired-end Illumina sequencing produced the same result. The 
knowledge on read-pairs was sufficient enough in this case to assemble BT 5 to a 
high quality. Gap closure was still needed as with the other genomes, but a Sanger 
sequencing run was not necessary. 
 
Similar findings on the assembly of genomes from next-generation sequencing data 
have been shown before. In one early study, pyrosequencing was combined with 
Sanger sequencing (Goldberg, et al., 2006). At this point only single-end reads were 
available for 454 sequencing as the paired-end protocol was to be released in early 
2008 (454 Life Sciences, 2008). They found that pyrosequencing data would 
supplement 5X coverage Sanger sequencing in terms of increasing coverage, and 
gap reduction. The pyrosequencing reads also reduced regions with poor sequencing 
due to avoiding amplification bias that is giving in cloning into a vector (Goldberg, et 
al., 2006). Thus an even coverage of the genome is given. The Sanger sequence, on 
the other hand, would have balanced the problems of pyrosequencing in 
homopolymeric runs. 
A later study (Aury, et al., 2008) investigated the combination of Sanger, pyro- and 
Illumina sequencing. They found that with paired-end 454 technology and Illumina 
sequencing a Sanger sequencing run is dispensible. They suggest using 
pyrosequencing with paired-ends as the first strategy for assembly due to it having 
the longer reads. The Illumina reads are then projected or mapped onto the 454 
scaffold and can be used to correct the errors in homopolymeric runs. In this way it is 
possible to circumvent the use of expensive Sanger sequencing (Aury, et al., 2008). 
The implication of using several sequencing technologies to balance the individual 
faults of each is also approached by Harismendy, et al. (2009). They compared error 
rates, coverage, and variant discovery of 454, Illumina, SOLiD, and Sanger 
technology in the human genome. They found that although the next-generation 
sequencing platforms produce large amounts of data, not all of it passes the quality 
filter, and not all of the data passing the quality control will actually map back to the 
target genome. They suggest taking this into account for coverage calculation. The 
coverage, although high, can also vary depending repeat sequences in the target 
sequence. The next-generation technologies showed variation in coverage, but the 
non-uniform coverage was different in the three technologies compared 
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(Harismendy, et al., 2009). Thus a combination of technologies might counteract the 
coverage variation of each other. They also found that the sequencing accuracy is 
high in all next-generation platforms. Pyrosequencing had the lowest false positive 
rate for variant discovery, whereas the lowest false negative rate was for Illumina 
technology. 
 
The reference genomes created can be classified as Improved High-Quality Draft 
Standard according to Chain, et al. (2009). They confirm with manual and automated 
gap closure, reduction of number of contigs and lowered possibility of misassemblies. 
In case of BT 1A strain 5303, the genome could even be contiguated into a single 
molecule. Misassemblies for the low-pathogenic BT genomes are possible, but in 
comparing them to both contiguated genomes attempts were made to find the most 
likely assembly.  
All strains have an unresolved tandem repeat in the Orthologs of YE2684. The repeat 
consists of six amino acids PTDTPE corresponding to CCG ACC GAT ACG CCA 
GAG base sequence at the C-terminal end. This gene encodes a conserved 
hypothetical protein, so that at the current stage further sequencing was deemed 
unnecessary.   
In contrast to a finished, gold standard genome the reference genomes generated 
have an unknown error rate, and bases were only manually re-checked for sequence 
quality in apparent pseudogenes.  
 
3.3.2 General genomic composition of a Y. enterocolitica genome 
Detailed manual annotation of the reference genomes gives confidence in further 
downstream analysis. The general features of the biotypes are very similar with 
respect to GC content, genome size and number of CDSs, as well as coding density 
and gene size. The main differences can be seen in the number of pseudogenes 
which is highest in BTs 4 and 5, and in the number of IS elements which is generally 
higher in the low-pathogenic BT but again highest in BTs 4 and 5. 
Comparison to other published genomes also showed that general composition is 
similar and that the main differences lie in the number of pseudogenes. As 
mentioned before, the differences in pseudogenes observed between the BT 3 O:9 
and the BT 4 O:3 strain to the reference strains generated in this study could be due 
to the definition of a pseudogene. It could be that the other studies did not include 
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genes with a frameshift or an introduced stop codon in the category of pseudogene 
as technically the whole reading frame is still present.  
The differences in the number of pseudogenes might also arise due to the difference 
in pseudogene analysis. Once the phylogenetic relationship between the 
Y. enterocolitica biotypes was established (Chapter 7), the pseudogenes were in fact 
re-examined and compared. The evolutionary relationship gives putative information 
and a trajectory on loss versus acquisition events of regions, aiding in pseudogene 
identification. In this way, even small gene fragments were identified such as a 26 aa 
remnant of focB in the low-pathogenic BTs. Automatic gene prediction software miss 
these small fragments as they fall below the length cut-off. Their correlation score 
which relates the amino acid composition to the translation of the three reading 
frames is probably also lowered. Additionally, the comparative analysis of all BT 
helped to establish whether genes in BT 1B strain 8081 might possibly be new 
pseudogenes as compared to the other BTs. These detailed analyses contributed to 
an increase in the number of pseudogenes. The newly created genomes would need 
to be compared in depth to the reference genomes of this study to compare which 
genes exactly are affected and how, if the genes are orthologous, as well as which 
pathways might be deactivated, in order to establish a true set of pseudogenes for 
each lineage. A larger strain set will also help to distinguish between strain-specific, 
niche-specific, and lineage-specific pseudogene distribution. 
The variability detected with respect to number of pseudogenes might also reflect 
differences in niche adaptation. In case of the BT 4 strains it can be said that Y11 is a 
representative of continental European strains, which is the predominant bio-
serotype isolated of Y. enterocolitica. On the other hand, strain 1203 is a 
representative of UK strains. In the UK, the predominant strains isolated are BT 3 
O:9 and BT 4 O:3 (McNally, et al., 2004). There is no increased prevalence of a 
single bio-serotype. The higher number of pseudogenes in the UK isolate might thus 
reflect decreased survival fitness. A quick comparison of the two strains did not 
reveal any large difference in genomic content, thus extensive acquisition of 
virulence factors in the European isolate can be excluded. 
 
The overall comparison of gene functions of the reference genomes is very similar. 
The predominant functional classes are hypothetical, unknown proteins, transport 
proteins, proteins involved with the cell envelope, regulation, and macromolecule 
synthesis as well as DNA of foreign origin. 
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One could have expected to see an increase in protection responses, adaptation, or 
DNA of foreign origin in the high-pathogenic BT. These functional classes include 
proteins such as cell killing, detoxification, drug sensitivity, adaptation to atypical 
conditions, iron storage, and pathogenicity island-related functions. Such functions 
could be considered to signify “virulence genes” which could explain the increased 
virulence potential of high-pathogenic strains. In the overall comparison, this does not 
seem to be the case, so a closer look into absent, present, and shared regions 
between the biotypes is necessary and will be done in Chapter 4. 
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4 Comparative analysis of the Y. enterocolitica biotypes 
4.1 Introduction 
As seen in the previous chapter, the general composition of the Y. enterocolitica 
genomes are different. Certain genomic islands might only be shared in some 
lineages, such as the HPI in high-pathogenic BT 1B. 
The aim of this chapter is to define sets of orthologous gene clusters in the biotypes 
and to identify biotype-specific marker regions, thus determining the genetic make-up 
of each bio-serotype and see how this relates to the pathogenic potential.  
The main differences observed thus far relate to the number of pseudogenes and 
partial genes as well as the number of IS elements. Hence, the aim is also to 
investigate the nature of the pseudogenes to determine in which genes they occur, 
and to establish the distribution of IS elements. 
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4.2 Results 
4.2.1 The core- and accessory genome of Y. enterocolitica 
In order to determine which CDSs or regions are shared among the biotypes, the 
ortholog qualifiers were taken to group each CDS on the basis of number and 
combination of orthologs in the other strains. The resulting matrix is listed in Table 
9.3 in the appendix and was used as the basis for representing the accessory genes 
shared in different BTs in a 7-way Venn diagram, which was designed in 
collaboration with Dr Timothy Hetherington, NTU. The information obtained was also 
used to characterize the core- and accessory genome of the species 
Y. enterocolitica. 
 
For the sets of orthologous gene clusters, an in-house script was used (see Appendix 
9.5, p. 214). This script takes one genome at a time and determines which genes 
have orthologs in other genomes, and the respective combination. Starting with the 
first genome strain 5303, the other genomes are allocated a genome number, for 
example strain 8081 is genome1, strain 21202 is genome2, etc (Table. 9.6, p. 225). 
The different genome combinations are then sorted into different groups. The first 
group corresponds to the Y. enterocolitica backbone, as it contains CDSs, which 
have orthologs in all of the other genomes. The second group contains CDSs that 
have orthologs in all genomes except genome6. In the case of strains 5303, 8081, 
21202, 5603, 14902, and 1203, this corresponds to strain 3094. In strain 3094, on 
the other hand, genome6 is strain 1203. This shift in the group numbers has to be 
taken into account when evaluating table 9.6, and is due to the fact that only 
orthologs of one genome can be considered at a time. 
Theoretically, certain groups might be of special interest. Apart from the backbone, 
group 2 and group 8 in table 9.3 could be of interest as they exclude BT 5 and BT 
4+5, respectively, and thus could help in identifying the genomic region encoding the 
biotype reaction. Group 6 excludes BT 1B. Group 7 is of particular interest as this 
excludes BT 1A, and thus will contain the sets of genes common in all pathogenic 
BT. Group 22 excludes BT 1A and 1B, giving the shared CDSs of the low-pathogenic 
BT. The human, low-pathogenic isolates are in group 53, whereas the animal isolates 
are in group 56. These two groups could indicate sets of genes involved in niche 
adaptation either to a human or an animal host. Groups 58 to 63 indicate links 
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between individual genomes, and group 64 will contain CDSs that are unique for 
each of the biotypes.  
From looking at the results (Table 9.6, p.225), only a limited number of sets of 
orthologous genes are relevant. Some groups, such as group 11, 12, 13, and others, 
do not contain any genes. For better visualization of these groups, collaboration was 
set up with Dr Timothy Hetherington, NTU, who did the initial design of a 6-way Venn 
diagram. Later, this was modified by Sandra Reuter to include the 7th strain 3094. 
The complete diagram is shown in Figure 4.6, but will be considered in several steps 
for clarity. 
 
The individual unique connections between strains are observed first (Figure 4.1). BT 
1B is only directly connected to BT 1A. Surprisingly, the non- and the high-
pathogenic BT share 85 CDSs. The arsenic resistance operon that is located outside 
the plasticity zone in BT 1B is shared with BT 1A. Two genomic islands are common 
to BT 1A and 1B: YGI-2 and YGI-4. YGI-2 encodes a glycolipoprotein that is also 
found in other Enterobacteriaceae 
(Thomson, et al., 2006). YGI-4 
represents an integrated plasmid. The 
original YGI-4 appears to be retained in 
BT 1A, as the island is 20kb larger than 
in BT 1B. A common theme of the other 
CDSs shared between BT 1A and 1B 
include metabolic regions such as ABC 
transporters predicted to transport 
amino acids and sugars, as well as 
sugar kinases and permeases, exported 
proteins, and membrane efflux proteins. 
BT 1A and 1B also share operons 
encoding a nickel-cobalt efflux system. One of the putative sugar transporters, 
YE2603-YE2609, appears to have been deleted from the low-pathogenic BT, as 
YE2604-YE2608 are absent and YE2603 and YE2609 are both truncated.  
BT 1A and BT 5 share ~30 CDSs, which correspond to a prophage locus. Although 
the phage has integrated at the same chromosomal location and thus could be 
considered orthologous, there are differences within the prophage. As phages are 
mobile elements, the genome locus might also simply present an integrational 
1A#
O:5#
1B#
O:8#4###
O:3#
3##
O:9#
2##
O:9#
3##
O:5,27#
5#O:2a,
2b,3#
Figure 4.1: Connections between individual 
reference genomes based on analysis of 
orthologous genes. 
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hotspot, and the phage would be considered paralogous in BT 1A and BT 5. The 
connection is thus not highlighted in Figure 4.1. 
Connections between some isolates are given through shared parts of the operons 
for O-specific chain synthesis of the outer membrane lipopolysaccharide (LPS). 
BT1A and BT 3 O:5,27 share 17 CDSs. This region contains genes encoding for 
sugar conversions and modifications and a sugar export system and will be 
described in more detail later on (see 4.2.2.3). 
BT 2 O:9 and BT 3 O:9 share a considerable number of CDSs relating to two 
prophage loci, clustered and unclustered hypothetical proteins as well as the O:9 
components of the O:antigen. These two bio-serotypes also share transposases at 
the exact same genomic positions. BT 3 O:5,27 and BT 4 share transposases and 
hypothetical proteins, mostly unclustered. BT 4 O:3 and BT 5 O:2a,2b,3 share an 
operon encoding the O:3 antigen synthesis and transposases. 
Moving on to three-way comparisons, the BT 2 and BT 3 isolates have two common 
prophage loci. The O:9 isolates and BT 4 also share part of a prophage locus. 
 
It appears in general that BTs 2 – 5, the low-pathogenic isolates, are very closely 
related with respect to their shared accessory gene content (Figure 4.2). They share 
~170 CDSs with functions that might 
relate to environmental survival. These 
are a combination of groups 22 and 40 
(Table 9.3) as BT 4 has lost some CDSs 
independently but did contain the 
complete set initially. The low-
pathogenic BTs have unique fimbrial 
proteins that are absent from BT 1A and 
1B and there are also two genomic 
islands, which have been described in 
the past as specific for low-pathogenic 
BT.  
The first is the tc pathogenicity island (PAI) which confers toxicity against insects to 
Y. enterocolitica (Bresolin, et al., 2006a; Fuchs, et al., 2008). Except for one strain, 
these have not been found in the non- or high-pathogenic BTs. The other island 
corresponds to the second flagella cluster Flag-2 (Bresolin, Trček, Scherer and 
Fuchs, 2008). Part of this cluster has been deleted in BT 4 (group 40) due to the 
Figure 4.2: Orthologous genes shared in the 
low-pathogenic BTs. 
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action of transposases. Additionally the low-pathogenic BTs share further 
hypothetical and phage-related proteins. The low-pathogenic BTs are signified by the 
expansion of IS element IS1667. Some of the IS1667 insertions appear to be 
ancient, as the position of the copies is conserved in all low-pathogenic lineages. 
 
The non- and low-pathogenic BTs share ~120 accessory CDSs associated with 
different metabolic traits such as cytochrome c-type biogenesis, utilization of N-
acetyl-D-galactosamine, amino acid 
metabolism, and anaerobic dimethyl 
sulfoxide reduction (Figure 4.3). These 
BTs also possess the same LPS outer 
core region, which has been replaced 
by the O:8 operon in the high-
pathogenic BT 1B. There are also 
some functions that might relate to 
pathogenesis such as a novel 
hemolysin and its activator protein, A 
and B subunits of a cytolethal 
distending toxin, a putative repeat toxin RtxA, and an alternative T3SS. A similar 
T3SS has been identified in the recently published environmental Yersinia (Chen, et 
al., 2010) and it is also found in Y. pestis and Y. pseudotuberculosis. We thus 
propose to call it the Yersinia Genus T3SS (YGT) and it will be described in more 
detail later (4.2.2.1).  
 
Both BT 4 and BT 5 (Figure 4.4) show 
signs of having undergone independent 
genome decay. BT 4 has lost the fes-fep 
iron-uptake operon. A putative amino 
acid transport system and a phospho-
transferase system have been lost from 
BT 5. Further unclustered CDSs that 
have been lost from BT 5 are also 
putatively associated with metabolic 
pathways and membrane transporters. 
Both BTs are missing a putative sugar 
1A#
O:5#
1B#
O:8#4###
O:3#
3##
O:9#
2##
O:9#
3##
O:5,27#
5#O:2a,
2b,3#
Non#+#
Low7
path#
Figure 4.3: Shared genes in non- and low-
pathogenic BTs. 
Figure 4.4: Orthologous gene clusters absent 
from BT 4 and BT 5. 
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transport system that is present in all other biotypes. This loss of metabolic properties 
is also evident in the biotyping scheme used for differentiation of Y. enterocolitica 
biotypes, with BT 5 testing negative or variable for 11 of the 12 reactions. BT 4 has 
five of those negative reactions in common with BT 5 and tests positive for the rest. 
As the absent sugar transporters are missing a definite pathway assignment, a direct 
link between the biotyping reaction and genome locus is not possible. The bases of 
the sorbose and trehalose negative phenotype of BT 5 are mutations in sorB and 
treB, respectively. 
 
One further group is relevant: the “pathogenic core”, shared in low- and high-
pathogenic BTs (Figure 4.5). There are only ~40 chromosomal CDSs in addition to 
the virulence plasmid pYV (~90 CDSs) that are shared exclusively by all pathogenic 
BTs. These functions include the adhesion gene ail, some clustered exported 
proteins, non-clustered hypothetical and conserved hypothetical proteins, a putative 
repeat toxin family protein, and one 
locus encoding genes involved in 
threonine and serine metabolism. This 
last operon however is presumably only 
functional in BT 1B, as it contains 
additional genes encoding a 
dehydrogenase/reductase, an aldo/keto 
reductase, and a transcriptional 
regulatory protein. As the hypothetical 
proteins are not organized in clusters, 
but are rather scattered throughout the 
genome, a function is questionable. 
The attachment invasion locus gene ail is shared in pathogenic BTs, but it is located 
in a different genomic context compared to the low-pathogenic BTs. This is likely to 
be due to IS-mediated transposition, as fragments of IS1328, IS1400 and IS1668 are 
visible in both high- and low-pathogenic BTs. The virulence plasmid pYV and the 
chromosomally located ail consequently constitute the only shared, well-
characterized “virulence factors”. None of the other identified CDSs present 
exclusively in the pathogenic BTs have known functions. 
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1B#
O:8#4###
O:3#
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Excluding#
BT1A#
Figure 4.5: Orthologous genes shared in the 
pathogenic BTs. 
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The individual groups described above are combined in Figure 4.6. It is important to 
note the number of connections between the different low-pathogenic bio-serotypes 
based on shared accessory gene content. It is also striking how both the non- and 
the high-pathogenic BTs stand singled out, with only few, selected connections to the 
other bio-serotypes. 
 
 
Figure 4.6: Combined comparison of orthologous accessory gene sets in the reference 
genomes for the Y. enterocolitica biotypes. As described above, the single lines represent 
connections between isolates. The low-pathogenic BTs are highlighted with a shaded box. Further 
orthologous gene sets are highlighted with boxes for non- and low-pathogenic BTs (blue), all BTs 
except BT 4 (yellow), all BTs except BT 5 (grey), and all BTs except BT 1A (red; the pathogenic BTs). 
 
After consideration of sets of orthologous genes, it was also possible to determine 
the number and type of CDSs that are unique to each bio-serotype.  
BT 1A and BT 1B both show a considerable number of unique CDSs, 728 (16.7% of 
total CDSs) and 540 (13.3% of total CDSs) respectively. For BT 1B, these have been 
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previously described as being specific for high-pathogenic strains and include the 
acquisition of the high-pathogenicity island (HPI), the Ysa T3SS, and the general 
secretion pathway Yst-1. Also unique to the high-pathogenic BT is the Yersinia 
adhesion pathogenicity island, YAPI. Many of the CDSs unique to BT 1A appear to 
extend its metabolic repertoire compared to the other biotypes, including proteins 
involved in transport and metabolism of sugars. Additionally, the non-pathogenic 
BT 1A isolate carries several gene clusters involved in environmental survival such 
as metal resistance and an arsenic resistance operon. The low-pathogenic BT 
isolates generally have a lower number of unique CDSs compared to BT 1A and 1B. 
The reference BT 2 O:9 genome carries five genes that are unique to this strain, and 
reference BT 3 O:9 strain carries no unique genes (Table 9.6 p. 225). Both serotype 
O:9 isolates of BT 2 and 3 are genetically very close, sharing phage and 
transposases, thus it is not surprising that they do not have many unique genes. BT 3 
O:5,27, BT 4 O:3, and BT 5 have 171, 134, and 274 unique CDSs, respectively. The 
majority of these genes are related to several prophage loci, hypothetical and 
conserved hypothetical proteins and transposases. Prophages thus are the largest 
contributors to the accessory genome. 
 
All Y. enterocolitica BT have 3,306 CDSs in common which represent the core 
functions of the species (Figure 4.7, Table 4.1). It has been previously speculated 
that the Yersinia genomic island 1 (YGI-1) encoding the tight adherence (tad) operon 
was associated with enteropathogenicity and specific for Y. pseudotuberculosis and 
the pathogenic Y. enterocolitica biotypes (Howard, et al., 2006; Thomson, et al., 
2006). However the tad operon is actually part of the core genome being found at the 
same locus in all isolates including the non-pathogenic BT 1A strain. The presence of 
the tad operon was also confirmed for the environmental species (Chen, et al., 2010), 
therefore this cluster is probably ancestral. The same is true of other functions known 
to be important for virulence including inv encoding invasion, its regulator RovA and 
the myf fibrillar operon (Badger and Miller, 1998; Ellison, Lawrence and Miller, 2004; 
Iriarte and Cornelis, 1995).  
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Figure 4.7: The pangenome of Y. enterocolitica. The outer scale shows the size in Mbps. From the 
outside in, circle 1 shows the position of CDSs (for colour codes see below). Circle 2 (CDSs coloured 
blue) marks the position of Y. enterocolitica strain 5303 / BT1A O:5 genes. Circle 3 (red) shows the 
position of strain 8081 / BT1B O:8 genes. Circle 4 (light blue) 21202 / BT2 O:9. Circle 5 (light green) 
5603 / BT3 O:9. Circle 6 (yellow) 14902 / BT3 O:5,27. Circle 7 (pink) 1203 / BT4 O:3. Circle 8 (orange) 
3094 / BT5 O:2a,2b,3. Circle 9 (purple) highlights genes shared in all Y. enterocolitica biotypes. Circle 
10 represents the fasta record from which strain the CDSs were written out. Circle 11 shows a plot of 
G+C content (in a 10-kb window). Genes in circles 1 are colour-coded according to the function of 
their gene products: dark green, membrane/surface structures; yellow, central or intermediary 
metabolism; dark blue, pathogenicity island-related functions; cyan, degradation of macromolecules; 
red, information transfer/cell division; cerise, degradation of small molecules; pale blue, regulators; 
salmon pink, pathogenicity/adaptation; black, energy metabolism; orange, conserved hypothetical; 
pale green, unknown; and brown, pseudogenes. The position of important regions (mentioned in the 
text) are marked and labeled in the outermost ring. See Table 4.1 for a description. 
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Table 4.1: Regions of interest identified in the pangenome of Y. enterocolitica (Figure 4.7). 
Region of 
interest # 
Base position Content 
1 1955006..1962863 cytochrome c-type biogenesis proteins 
2 2691400..2698800 Phosphotransferase system for N-acetyl-D-galactosamine 
3 3544600..3554299 outer core LPS biosynthesis operon 
4 4448957..4475254 silver and copper resistance proteins 
5 4502803..4527755 Yersinia Genus T3SS (YGT) 
6 4722584..4745103 putative O:5 LPS biosynthesis cluster 
7 4952491..4960977 serine/threonine metabolism 
8 5274712..5291988 O:8 LPS biosynthesis proteins 
9 5583332..5597425 replaces YGI-3 
10 5697260..5709091 O:9 LPS biosynthesis proteins 
11 5890466..5918695 putative genomic island, similar to Escherichia blattae proteins and 
phage proteins 
12 6006539..6015652 O:3 LPS biosynthesis proteins 
 
The two hydrogenase complexes, hydrogenase 2 (hyb) and hyrdogenase 4 (hyf), 
were thought to be associated with colonisation and survival of the gut. Both clusters 
are present in all Y. enterocolitica biotypes. The hydrogenase 2 operon shows signs 
of truncation in the low-pathogenic BTs as the formate transporter focB (YE2812) is 
fragmented. The hydrogenase 4 complex is truncated in hypB (YE3603) in BT 3 
O:5,27 strain 14902 and BT 4 O:3 strain 1203. In contrast these clusters are probably 
functional in the non-pathogenic isolate. 
The cellulose biosynthesis operon is also present in all BTs. In Salmonella an 
extracellular matrix is formed through the production of cellulose, which could 
increase the time the bacteria are retained in the gut. A similar idea has been 
proposed for Y. enterocolitica (Thomson, et al., 2006). Again, this cluster shows 
signs of mutations. In BT 4 O:3 strain 1203 a stop codon has been introduced in 
bscC (YE4072). An opal stop codon (UGA) has been introduced in bscA (YE4074) in 
BT 1A, which could potentially be decoded by selenocysteine. 
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4.2.2 Regions of difference in Y. enterocolitica biotypes 
Some of the regions identified as regions of difference between the Y. enterocolitica 
bio-serotypes have not been extensively characterized previously. These regions will 
be discussed in turn below. 
 
4.2.2.1 Yersinia Genus Type 3 Secretion System 
The first interesting region of difference is an alternative T3SS we propose to call the 
Yersinia Genus T3SS (YGT) since orthologs have been described in the 
environmental species as well as Y. pseudotuberculosis and Y. pestis. The system is 
located in in the same genomic context in all species, indicating an ancient 
acquisition before the split into separate species, justifying the denomination as a 
common T3SS of the genus. By sequence, this system is most similar to the 
Salmonella pathogenicity island 2 (SPI-2, Figure 4.8). 
 
 
Figure 4.8: Comparison of SPI-2 of Salmonella Typhi with the novel YGT. The apparatus and 
effector regions are highlighted, as well as the 2-component system located upstream of the T3SS in 
both cases. In SPI-2, the YGT is preceeded by the tetrathionate respiration operon. In 
Y. enterocolitica, the tetrathionate respiration operon is located in a different genomic context. 
 
The sequence similarity shared between SPI-2 and YGT is low but is consistent 
across the whole YGT region, and ranges on average around ~40% similarity. 
Upstream of YGT and SPI-2 T3SSs is a 2-component system encoding a sensor 
kinase and a response regulator that might be involved in governing the expression 
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of the T3SS. In SPI-2, the tetrationate respiration operon is loacted within the 
pathogenicity island, whereas for Y. enterocolitica, a highly related operon is located 
elsewhere in the chromosome. 
Comparison of the YGT within different assembled Yersinia spp. shows differences in 
the gene content (Figure 4.9). 
 
 
Figure 4.9: Comparison of YGT within several Yersinia spp. Four representative Y. enterocolitica 
BT (YE BT 1B, 4, 5, and 1A) are compared to Y. pseudotuberculosis (YPSTB: IP32953) and Y. pestis 
(CO92). Effector and apparatus regions are highlighted, as well as the 2-component system. 
 
As mentioned before, the YGT is absent from BT 1B, only three proteins are present: 
the response regulator (YE0311), the AraC-family regulatory protein (YE0312) in the 
central part of the YGT, and an inner membrane protein (YE0313) that is missing the 
N terminus. As the YGT is present in all other Yersiniae, and as the central regulatory 
protein has been retained, this indicates a possible deletion in at least two separate 
steps from BT 1B. 
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The YGT is generally well conserved amongst the non- and low-pathogenic BTs 
although there is evidence that some genes in YGT are defunct in BTs 4 and 5. 
Those mutations are different in BTs 4 and 5, with BT 4 having mutations in three 
apparatus related genes and the deletion of another apparatus protein and BT 5 
having only one independent mutation in an apparatus gene. Moreover the sensor 
kinase of the 2-component system has a stop codon introduced in BT 4 and several 
frameshifts in BT 5. The inner membrane protein (YE0313) is missing the central part 
in BTs 2, 3, and 4, and is only functional presumably in BT 1A and BT 5. Some parts 
of the effector protein region show reduced sequence similarity between non- and 
low-pathogenic BTs. 
A comparison of YGT in several Yersinia spp. to Y. enterocolitica shows that parts of 
the effector protein region have been deleted in Y. pseudotuberculosis and Y. pestis 
(Figure 4.9). Preliminary studies (Golubov, Heesemann and Rakin, 2003; Pujol and 
Bliska, 2003; Balada-Llasat and Mecsas, 2006) have been undertaken on YGT in 
Y. pestis and Y. pseudotuberculosis and have shown that this system plays no 
obvious role in causing disease, but functionality in Y. pestis and 
Y. pseudotuberculosis is probably compromised due to the absence of the effector 
region. The distribution of YGT within the genus suggests that this system is more 
likely to be required for colonisation outside a human host. Initial investigation into 
the phylogeny of the T3SS (Foultier, et al., 2001) is in accordance with the finding 
that this T3SS is most closely related to SPI-2 of Salmonella. 
 
4.2.2.2 Variation of the Plasticity Zone 
Another large-scale region of variation distinguishing different BTs is the plasticity 
zone (PZ). The PZ was first described in the high-pathogenic BT 1B strain 8081 and 
constitutes a region, which contains several operons associated with increased 
pathogenic potential. The region shows signs of having been formed through several 
independent acquisition events, hence being termed plasticity zone (Thomson, et al., 
2006). A comparison of this region with the other BTs confirms this locus to be highly 
variable between BTs (Figure 4.10). The plasticity zone in the high-pathogenic BT 
shows the largest size. The acquisition of the Yersinia adhesion pathogenicity island 
YAPI is possibly specific for strain 8081 where it was originally defined, as it was not 
observed consistently in other BT 1Bs (Thomson, et al., 2006; Carniel, Guilvout, and 
Prentice, 1996). Furthermore BT 1B acquired the ysa T3SS as well as the general 
secretion pathway yst1. At the same locus, the non-pathogenic BT possesses heat 
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shock proteins, hypothetical proteins, and an additional lac operon. No equivalent 
region is present in the low-pathogenic BTs. All BTs have an iron transporter and 
operons for hydrogenase 2 biosynthesis.  
The second flagella cluster Flag-2 is only retained by the low-pathogenic BTs and 
has been independently lost in the non- and the high-pathogenic lineages as 
indicated by the presence of different fragments of Flag-2. This region is also marked 
by the presence of a transposase in BT 4 likely to have been responsible for the loss 
of Flag-2 and additionally the deletion of the fes/fep operon. Both high- and low-
pathogenic BTs then have outer membrane efflux proteins, whereas the low-
pathogenic BTs show a different set of membrane proteins. These membrane protein 
operons have no specifically assigned functions so far. As mentioned before, the 
tigh-adherence operon tad is present in all biotypes. 
 
 
Figure 4.10: Arrangement of the plasticity zone in the different biotypes. Non-pathogenic BT – 
1A, high-pathogenic BT – 1B, low-pathogenic BT – 2,3,4,5. Red – colinear homology, modified from 
an ACT comparison. Light brown – potential inserted region. Dark brown – deleted region. 
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4.2.2.3 Lipopolysaccharide operons 
The lipopolysaccharide (LPS) of Y. enterocolitica has been proposed as a supporting 
virulence factor as it confers resistance to polymyxin and antimicrobial peptides and 
has been associated with virulence in the mouse model (Zhang, et al., 1997; Skurnik, 
et al., 1999; Skurnik, et al., 2007). The LPS structure for serotypes O:8, O:3 and O:9 
is known, and a schematic is shown in Figure 4.11. 
All Y. enterocolitica serotypes share – with minor variations – the same lipid A and 
inner core structures (Müller-Loennies, et al., 1999; Oertelt, Lindner, Skurnik and 
Holst, 2001). It is known that the 
outer core is absent from the high-
pathogenic BT 1B O:8 strains but 
shared in the low-pathogenic BTs 
O:9 and O:3 (Skurnik and 
Bengoechea, 2003). The O-antigens 
differ in sugar composition and in 
linkage of those sugars. The O:8 
antigen is a heteropolymeric 
pentasaccharide in which three 
saccharides are linked in a chain with 
a further two saccharides branching 
off (Zhang, et al., 1997). In O:3 and 
O:9 O-antigens the chain consists of unbranched homopolymers (Zhang, Toivanen 
and Skurnik, 1996; Skurnik and Bengoechea, 2003). The outer core of O:3 and O:9 
serotype strains consists of a branched heteropolymer (Reeves, et al., 1996b; 
Skurnik, et al., 1999). It has been proposed that the outer core presents an ancestral 
O-antigen and that it has been supplemented by later acquisition of homopolymeric 
O-antigens in the low-pathogenic BTs (Müller-Loennies, et al., 1999; Skurnik, et al., 
1999; Sirisena and Skurnik, 2003). 
 
It has been shown before that the O:8 encoding locus is in the same genomic context 
as the outer core operon of serotypes O:3 and O:9 (Zhang, Toivanen and Skurnik, 
1996; Skurnik and Bengoechea, 2003; Figure 4.12). The outer core is located 
beween gsk (inosine-guanosine kinase, YE3069) and hemH (ferrochelatase, 
YE3088). Apart from gsk and hemH, the UDP-glucose 4-epimerase galE has been 
conserved between the outer core and the O-antigen. The same locus also contains 
Figure 4.11: Lipopolysaccharide structure of 
Y. enterocolitica serotypes. Structures with shared 
functions are highlighted with the same colour. 
Adapted from Sirisena and Skurnik, 2003, and 
http://www.hi.helsinki.fi/yersinia/Research1.htm. 
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genes involved in the synthesis of the heteropolymeric lipopolysaccharides of 
Y. pseudotuberculosis and Y. pestis, although five genes are inactivated in the latter 
(Zhang, Toivanen and Skurnik, 1996; Skurnik and Bengoechea, 2003). In a 
comparison between BT 2 O:9, BT 1B O:8, and the environmental Yersiniae, the 
outer core region could be detected in Y. frederiksenii, Y. kristensenii, and Y. rohdei. 
The absence of the outer core in the genome data for the other environmental 
Yersiniae could be due to assembly problems, therefore a definitive answer on the 
distribution of the outer core within the genus is not possible. 
 
 
Figure 4.12: Genomic context of LPS O:8 operon and outer core. Both outer core and O:8 operon 
are located between gsk and hemH. 
 
In the comparative analysis it became clear that the outer core is shared in low- and 
non-pathogenic BTs. Considering that BT 1A shows signs of being the historically 
oldest biotype in that it has fewer IS elements, less genomic reorganization, fewer 
pseudogenes and an extensive metabolic repertoire as apparent from the unique 
regions, it is likely that the outer core is the ancestral form. This supports the idea of 
an exchange of one region for another. 
 
The location of the O-antigen clusters for O:3 and O:9 was unknown, although their 
operon structure has been investigated in the past (Reeves, et al., 1996b; Skurnik 
and Bengoechea, 2003; Skurnik, et al., 2007). The O-antigen clusters for O:3 and 
O:9 are found in the same genomic location between a putative membrane protein 
(YE2779) and gnd, a phosphogluconate dehydrogenase (YE2773, Figure 4.13). 
Both BT 2 O:9 and BT 3 O:9 clusters are identical and are the same O:9 operons 
described in the past (Skurnik, et al., 2007). There are six CDSs involved in sugar 
biosynthesis (manCB, gmd, per, wbcTV). Four CDSs are encoding transferases for 
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linking the sugars (wbcUW galUF). galU and galF are conserved with the O:3 
operon, and are also found in the other biotypes. Two CDSs are then encoding the 
transport proteins (wzm, wzt). 
The O:3 operon is larger than the O:9 operon. An IS element for IS1668 has inserted 
upstream of the locus, and a remnant for IS1400 can be found in the central part of 
the operon. The LPS O:3 operon of BT 4 contains one pseudogene, a hypothetical 
protein carrying a stop codon.  
 
 
Figure 4.13: Genomic context of O:9 and O:3 operons. 
 
The exact serotype of the reference BT 5 isolate is unknown, but the serotype 
typically described for this biotype is often a mixture of O-antigens 2a, 2b, and 3 
(Bottone, 1997; Bottone, 1999; Bartling, et al., 2004). The operon found in BT 5 is 
similar in sequence to the O:3 operon of BT 4 and is thus thought to contribute to the 
serotype of BT 5. There are however differences to the standard O:3 operon. A 
hypothetical protein and a cytidylyl transferase are absent, possibly due to the action 
of transposases, as remnants of these are found upstream and downstream of these 
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CDSs. The hypothetical protein, which has a nonsense mutation in BT 4, is not 
mutated in BT 5. These differences could be an explanation for the difference in 
serotyping. Both O:3 and O:2a,2b,3 homopolymeric repeat units are reported as 6-
deoxy-L-altrofuranose, with the difference for O:2a,2b,3 being that they have O-acyl 
side groups (Reeves, et al., 1996b; Bruneteau and Minka, 2003). 
Both O:3 and O:9 O-antigen operons encode for homopolymeric polysaccharides 
and share the same biosynthesis mechanism. The sugars are assembled to chains 
and then transported across the membrane using ATP-binding cassette (ABC) 
transporters (Zhang, et al., 1997; Samuel and Reeves, 2003). In the new 
nomenclature for bacterial polysaccharide synthesis genes, these are designated as 
wzm and wzt although they do not necessarily share nucleotide homology (Reeves, 
et al., 1996a,b; Samuel and Reeves, 2003). The synthesis of heteropolymeric 
polysaccharides as are found in O:8 differs in that each subunit is assembled and 
then translocated by a flippase wzx before the units are polymerized by Wzz (Zhang, 
Toivanen and Skurnik, 1996; Reeves, et al., 1996a,b; Zhang, et al., 1997; Samuel 
and Reeves, 2003). 
 
The structure of LPS O:5 has not been published yet, although a putative cluster has 
been deposited in GenBank for BT 1A O:5 strain T83 (accession number AY653208; 
Tennant, S.M., Joe, A. and Robins-Browne, R.M., 2004). The putative O-antigen 
operon in BT 1A strain 5303 is located between the glutathione reductase gor 
(YE4057) and the autotransporter protein YapE (YE4059) (Figure 4.14). A 
comparison between the two BT 1A strains showed a high degree of sequence 
similarity in this cluster. BT 3 O:5,27 strain 14902 has a similar operon, but in a 
different genomic context. The putative O-antigen operon is located between YE0502 
and YE0513 and is surrounded by IS elements and fragments of transposases, 
possibly explaining the change in location. This operon is also missing two 
hypothetical proteins, a DNA binding protein, and an alcohol dehydrogenase of the 
presumed O:5 cluster, which could explain the mixed serotyping reaction.  
The sugars of the O:5 serotype have been described as homopolymers of rhamnose 
(Gorshkova, Kalmykova, Isakov and Ovodov, 1986), explaining the presence of two 
polysaccharide export proteins that constitute the ABC transport of the 
homopolymeric chain. Homopolymeric lipopolysaccharide operons are generally 
smaller in size than heteropolymeric operons, as a higher complexity in the number 
of sugars and their linkages calls for more genes (Reeves, et al., 1996a). With a size 
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of ~18 kb it compares well to the other homopolymeric clusters of O:3 (18 kb) and 
O:9 (14 kb). 
 
 
Figure 4.14: Putative O:5 LPS operon. The putative O:5 operon has been deposited in GenBank for 
BT 1A strain T83, but has not been published yet (accession number AY653208). The presumed 
region in BT 1A strain 5303 is presented. A truncated version of this operon is found BT 3 O:5,27, but 
in a different genomic context. 
 
Three genes can be identified that resemble glycosyl transferases, and two 
rhamnose processing genes, rmlCD, are present. Together with the putative export 
system, the three main classes of genes of processing and linking sugars as well as 
sugar pathways involved in O-antigen synthesis are thus present (Reeves, et al., 
1996a,b). The sugar composition of O:5,27 is very similar to O:5. The LPS structure 
for O:5,27 also contains rhamnose but is O-acylated (Gorshkova, Kalmykova, Isakov 
and Ovodov, 1986; Bruneteau and Minka, 2003). This explains the close relatedness 
of the O-antigen synthesis operons.  
 
4.2.3 Pseudogene distribution amongst the Y. enterocolitica biotypes 
Pseudogenes can be defined as CDSs that show mutations that may inhibit the 
expression of a fully functional protein. Mutations include the truncation of the protein 
due to deletion events of the termini or other parts of the protein and the disruption 
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due to the insertion of an IS element into the reading frame. This first category can 
also be described as partial proteins, or fragments/remnants. These might be viewed 
as truly non-functional proteins. In a second category, the pseudogenes show 
mutations such as frameshifts and introduced stop codons that interrupt transcription. 
In this case the complete reading frame is still present and it might be argued that 
stop codons are read through on some occasions and that in the case of 
homopolymeric runs the RNA polymerase might easily slip into the other reading 
frame resulting in a full-length protein. Two examples in the given dataset are 
YE3376, peptide chain release factor 2, which carries a frameshift mutation in all 
orthologs, but has been shown to be functional, and YE4135, the major subunit of 
formate dehydrogenase, which has a read-through of the opal (UGA) stop codon in 
all orthologs. To take these things into consideration, pseudogenes and partial genes 
have to be compared separately. 
 
A list of all pseudogenes found in the Y. enterocolitica reference genomes and their 
orthologs can be found in the appendix (Table 9.7, p. 227). In addition to the above 
described YE3376 and YE4135, only two CDSs are present as pseudogenes in all 
biotypes. YE0416 is a conserved hypothetical protein, and YE2410 a putative 
oxidoreductase.  
As seen in Table 3.3, there is a difference between the biotypes in the total number 
of pseudogenes. BT 1A and 1B have the lowest number of pseudogenes, 81 and 84 
respectively, whereas the low-pathogenic bio-serotypes show more than 140 
pseudogenes each. BT 4 O:3 (strain 1203) and BT 5 O:2a,2b,3 (strain 3094) show a 
marked increase in pseudogenes with 235 and 322 pseudogenes in total, 
respectively. This amounts to 6.0% and 7.9% of the total number of CDSs in each 
genome. In contrast, only about 2% of the genomes of BT 1A and 1B (1.9%, 2.1%) 
show signs of genome decay. BT 2 and 3 possess less than 4% of CDSs with 
potentially impaired function (BT 2 O:9 4.0%, BT 3 O:9 3.6%, BT 3 O:5,27 3.7%). 
This trend of increased genome decay towards BT4 and 5 can be observed when 
only considering partial CDSs, too. Both BT show about 130 CDSs that are non-
functional. 
 
Figure 4.15 shows the split of pseudogenes and partial genes for each of the 
reference strains according to function. One can see that some classes are absent 
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because they constitute essential cell functions. These are genes involved in cell 
division (6) and ribosome constituents (17).  
 
The highest number of pseudogenes and partial genes in hypothetical proteins (1) is 
found in BTs 4 and 5. Hypothetical proteins are putative open reading frames with 
either homologs in E. coli or other bacterial species with unassigned functions or do 
not have any homologs. Their transcriptional and functional status is thus unknown. 
As the contribution towards cell survival under various conditions still needs to be 
assessed, the impact of the pseudogenes in this category is uncertain. 
When looking at cell processes (2), it is striking that BT 1A has the highest number of 
partial genes compared to the other BTs. These are found in chemotaxis and motility 
genes of flagellar cluster 1 and 2. The four copies of the flagellin gene fliC of Flag-1 
are missing 40-70 amino acids, and Flag-2 is only present in remnants. Yet, this 
strain has been studied and was shown to be motile, thus the mutations seen in Flag-
1 do not have an impact on function (McNally et al., 2007). This might be different in 
BTs 4 and 5. BT 4 has lost half of the Flag-2 region, and both BTs show mutations 
and gene deletions in Flag-1 and -2. A similar inactivation of the flagellar clusters is 
apparent in Y. pestis as an adaptation to a niche where motility is not necessary 
(Parkhill et al., 2001a). 
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Figure 4.15: Pseudogene and partial gene distribution in the Y. enterocolitica reference genomes. 
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BT 1A also shows a high number of pseudogenes and partial genes in protection 
responses (3) when compared to the other BTs. Some of these CDSs relate to 
adhesion/hemagglutinin proteins unique to BT 1A, an enterotoxin-like protein of 
Y. pestis, and a hemolysin paralog of BT 1B. Furthermore, BT 1A has a stop codon 
mutation in umuD (YE1733), a UV protection protein. There is a functional unique 
copy of umuD elsewhere in the genome though. Interestingly, in this second operon, 
umuC carries a frameshift mutation. A drug resistance operon shared in BTs 1A and 
1B has been deleted from the low-pathogenic BTs. These retain only fragments of 
two proteins encoded in this region (YE0443, YE0445). A stop codon has been 
introduced into the BT 1A homolog of YE0444, hence the functionality of this 
multidrug efflux protein is compromised. Some mutations are found in the tc PAI. The 
BT 2 O:9 strain has a frameshift mutation in tccC2 due to the fact that this CDS links 
two contigs. Therefore it could be functional, but sequence information is missing. 
Irrespective of this, two additional, functional copies of tccC are present upstream. 
BTs 4 and 5 also show mutations in tc PAI. Both have mutations in the regulator 
tcaR2 and the protein tcaC’(2) in common, and BT 5 additionally has mutation in 
tcaB2. BT 1B has no mutations in protection responses. 
The lowest number of pseudogenes in transport and binding proteins (4) is given in 
BT 1A. The highest number of pseudogenes is given in BTs 4 and 5. Transport 
proteins are involved in sugar uptake and metabolism, and a higher number of 
pseudogenes in pathogenic BTs could reflect the reduced metabolic capabilities 
apparent in the biotyping scheme. With respect to adaptation (5), both BT 1A and BT 
1B only have one partial gene. The acid shock protein Asr (YE0933) is missing 15 aa 
in a repeat region, resulting in a shortened protein. This same mutation is evident in 
the low-pathogenic BTs. Both BT 2 and BT 3 O:9 isolates also show a truncation of 
another copy of this protein (YE2086) which is functional in the other BTs. The 
pseudogenes in BT 5 are located in the haemin storage operon. A stop codon has 
been introduced in hmsF (YE2483), and hmsH (YE2484) shows a frameshift 
mutation in a homopolymeric run. In BT 4 this last protein also has a frameshift, with 
10 amino acids missing. 
BT 1A shows no mutations in macromolecule metabolism (7). A beta-glucosidase 
(YE1236A) has been truncated in both high- and low-pathogenic BTs due to a 
deletion event. The other pseudogene in BT 1B is a putative protease (YE1406). A 
putative DNA-binding protein (YE1874) and a metalloprotease (YE4052) are 
commonly fragmented in the low-pathogenic BT. BTs 4 and 5 again share additional 
100 
pseudogenes. A putative serine protease (YE1389) absent from BT 1A has a stop 
codon introduced in BT 4, and several stop codons plus a frameshift in BT 5. Further 
more in BT 5, there is an exported zinc protease (YE0320) with a frameshift in a 
homopolymeric run. 
The partial genes in macromolecule synthesis and modification (8) found in BT 1A 
are mostly in CDSs that are unique to this strain. Annotation is thus based on 
comparison with homologs in other bacterial species and functionality is unknown. 
This applies also to the pseudogenes in BT 4; these are also not found in the 
backbone of Y. enterocolitica CDSs but within the accessory genome. The 
inactivation of those genes might present niche adaptation. One partial gene in BT 
1A, ampM (YE3285) a methionine aminopeptidase, is also mutated in BT 5. 
Interestingly, BT 1B shows no mutations in this class. 
There are only very few pseudogenes and partial genes in the metabolism of small 
molecules (9). In BT 1A, this is due to an additional copy of trpA involved in 
tryptophan synthesis. This protein is missing 160 amino acids at the N terminus, but 
due to a functional gene copy present elsewhere in the genome, this should have no 
impact on metabolism of tryptophan. In BT 1B the inactivated gene is a unique 
possible homoserine synthase (YE1737) that has been truncated by the insertion of 
an upstream IS element. A common pseudogene in the low-pathogenic BTs is a 
frameshift in the glutamate synthase precursor gltB (YE3735). One of the 
pseudogenes in BT 4 is in the tryptophanase tnaA (YE0650). The protein could be 
responsible for a negative phenotype for indole production in the biotyping reaction, 
but does not explain why BTs 3 and 5 show a negative phenotype as well.  
The group of biosynthesis of cofactors and carriers (10) shows a marked increase in 
partial genes in BT 3 O:5,27 strain 14902. All pathogenic BTs carry pseudogenes in 
genes encoding the metabolism of the cofactors cobalamin and cobinamide, cbiG 
(YE2719) and cobC (YE2708). The exact effect of these mutations is unknown as 
there are potential alternative pathways. BT 5 also possesses two more 
pseudogenes in this pathway affecting the cobinamide kinase CobU and a 
membrane protein (YE2724).  
There are few mutations in central intermediary metabolism (11) in the non- and 
high-pathogenic BTs. BT 1A has one mutation in pldB (YE0207), a 
lysophospholipase. A stop codon has been introduced terminating the protein 7 
amino acids early. An impact of this mutation is equivocal. All BTs except BT 1A 
show various degrees of fragmentation and remnants of YE2586A encoding a CoA 
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transferase familiy protein. All low-pathogenic BTs also only have the 3’ end of ssuD 
(YE1950) encoding an alkanesulfonate moooxygenase. Additionally pseudogenes 
are found in BT 5 in the backbone of Y. enterocolitica. Both amn (YE2052, AMP 
nucleosidase) and ushA (YE3066, UDP sugar hydrolase) are missing the 3’ end, 
amn also shows a frameshift mutation. 
BT 1A shows two pseudogene mutations in the degradation of small molecules (12). 
An opal UGA stop codon has been introduced in idh (YE4026, m-inositol 
dehydrogenase). The other mutation is shared in the non- and low-pathogenic BTs 
and regards the xylose kinase xylB (YE4123). Stop codons have been introduced 
towards the C terminal end of the protein. Both idh and xylB could still be functional, 
as the full coding sequence is still present. xylB could be linked to xylose metabolism, 
but the xylose acid production in the biotyping test for Y. enterocolitica does not 
agree with the mutation pattern. BTs 1A, 1B, 2 and 3 are positive for xylose acid 
production, only BT 4 is negative, and BT 5 variable. The genetic basis for the 
biotyping reaction is unknown. An operon involved in N-acetyl-D-galactosamine 
metabolism has been deleted from BT 1B. This is evident in the gene remnants 
encoding for AgaS (YE2449) and AgaY (YE2450), which are missing the N and C 
terminus, respectively. BT 5 also shows mutations in this operon, with frameshifts 
present in agaS and agaW.  
In carbon energy metabolism (13), most mutations again are evident in the low-
pathogenic BTs, although BT 1A has the highest number of total CDSs in this group. 
The mutations present in BT 1A are outside of the core genome for Y. enterocolitica. 
The mutation present in BT 1B is due to a deletion event of a region involved in 
cytochrome C type biogenesis. Only a remnant of the nitrate reductase nrfG 
(YE1598) is present. The low-pathogenic BTs also show mutations in this cluster in 
nrfF and BT 5 also in nrfE, thus a fully functional operon might only be present in BT 
1A. The carbonic anhydrase cah is absent from BT 1B and has been disrupted in 
BTs 2, 3, and 4 by a transposase. It is only functional in BTs 1A and 5. BT 5 again 
has additional mutations in pathways involving NADH-quinone reductase (ngrC, 
YE3218), formate dehydrogenase (fdhF, YE2810), tetrathionate reductase (ttrA, 
YE1617), and cytochrome C type proteins (napC, YE1158). 
The non- and high-pathogenic BTs have no mutations in proteins involved in fatty 
acid biosynthesis (14). The low-pathogenic BTs have retained a remnant of the 
Yersinia genomic island 2 (fabF, YE0911). The N terminus has been deleted possibly 
due to the presence of a transposase. No mutations are evident in BTs 1A, 1B, 3 
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O:5,27, and 4 for nucleotide biosynthesis (15). The two O:9 isolates have a stop 
codon in the cytosine deaminase codA (YE3964). BT 5 has a N-terminal deletion in a 
protein involved in purine metabolism. 
Most of the CDSs mutated in BT 1A in the cell envelope (16) relate to putative 
exported proteins. The cellulose synthase 1 catalytic subunit gene bcsA has an opal 
stop codon introduced at the 5’ end, thus the function is questionable. The 
pseudogenes found in the low-pathogenic BTs are often shared and related to 
exported proteins without specific functions.  
The highest number of pseudogenes and partial genes is found in genes encoding 
products that belong to the functional group of “foreign DNA” (18). This group 
contains IS elements and phage proteins. These were not corrected or re-checked 
for their mutations, and the true numbers are probably lower than stated here. 
Moreover, especially the low-pathogenic BTs show an expansion of IS elements, 
therefore the number of CDSs contained in this class is higher than in BT 1A and 1B. 
Even though the number of pseudogenes is corrected for the total number of CDSs 
per group, the fact that these CDSs were not re-checked increases their overall 
contribution. 
Most of the pseudogenes in the low-pathogenic BTs involved in regulation (19) are 
shared in all BTs, and a function has only been retained in the high- and non-
pathogenic BTs. For example, the regulator of the tetrathionate reduction operon, ttrS 
(YE1614), has a stop codon introduced in the O:9 BTs 2 and 3, and a frameshift in 
BT 5. As mentioned earlier, BT 5 has an additional mutation in this operon.  
Unclassified and putative assignments (20) constitute proteins of unknown function 
and preliminary assignments, similar to hypothetical proteins (1). It appears that the 
number of CDSs is again highest for pseudogenes found in BT 4 and 5. 
 
To summarize there are certain trends within the pseudogenes. The three lineages of 
high-, low-, and non-pathogenic BTs described for the shared genome content are 
also visible when comparing the pseudogenes. It appears that especially BTs 4 and 5 
have acquired a considerable number of pseudogenes and partial genes. The 
predominant groups (Figure 4.16) for pseudogenes in BT 1A are cell processes, 
macromolecule synthesis and modification, and cell envelope proteins. Pseudogenes 
in the pathogenic BTs relate to transport/binding proteins, proteins related to the cell 
envelope, and regulatory proteins. BTs 4 and 5 additionaly show pseudogenes in 
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degradation of small molecules, which could reflect the reduced metabolic potential 
visible in the biotyping scheme.   
 
 
Figure 4.16: Top 3 pseudogene categories for Y. enterocolitica BTs. Absolute numbers are given 
only for top 3 categories, disregarding possible pseudogenes in other categories. 
 
Fewer pseudogenes are observed in the non- and high-pathogenic BTs than in the 
low-pathogenic BTs. The non-pathogenic BT has more pseudogenes than partial 
genes, whereas it is the other way round in the high-pathogenic BT. Hence, the high-
pathogenic BT shows a higher degree of genome decay than the non-pathogenic BT. 
Quite often the pseudogenes in the low-pathogenic BTs are shared in all of those 
isolates. BTs 4 and especially 5 have additional mutations. The mutations observed 
in the same genes in BTs 4 and 5 are not identical, but appear to have arisen 
independently.  
 
4.2.4 The role of IS elements and recombination in Y. enterocolitica biotypes 
IS elements are believed to have played an essential part in the evolution of Y. pestis 
from Y. pseudotuberculosis through transposition into coding genes and through 
genomic rearrangements between IS elements (Parkhill, et al., 2001a; Deng, et al., 
2002; Chain, et al., 2004). During sequencing and assembly of the Y. enterocolitica 
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biotypes, it became clear that there was a predominance of one particular IS element 
(IS1667). The total breakdown of all IS elements is given in Table 4.2. 
 
Table 4.2: IS elements in the Y. enterocolitica BT 
IS name BT1B – 
8081* 
BT1A – 
5303 
BT2 – 
21202 
BT3 – 
5603 
BT3 – 
14902 
BT4 – 
1203 
BT5 – 
3094 
IS3 2 0 0 0 0 0 0 
IS285 1 0 0 0 0 0 0 
IS1222 1 1 0 0 0 0 0 
IS1328 5 0 8 8 5 4 8 
IS1329 6 0 0 0 0 0 0 
IS1330 8 0 0 0 0 1 4 
IS1400 4 0 2 2 3 1 2 
IS1541 3 0 0 0 0 0 0 
IS1660 6 0 0 0 0 0 0 
IS1664 3 0 0 0 0 0 0 
IS1665 5 0 0 0 0 0 0 
IS1666 1 0 1 1 2 0 0 
IS1667 8 0 37 35 30 53 50 
IS1668 2 0 10 10 9 10 9 
IS1669 5 0 2 3 2 6 3 
unclassified IS – 30 27 26 28 26 34 
total 60 31 87 85 79 101 110 
*taken from Thomson et al., 2006 
 
There is an uneven distribution of IS elements in the BTs. The reference genome for 
BT 1A shows none of the typical IS elements found in the other BTs. A search in 
other BT 1A isolates showed that this might be atypical and copies of IS1329 and 
IS1667 could be present in BT 1A. Additionally, IS1222 is present, but not 
consistently. There are a number of unclassifed IS elements which have homologies 
to ISEhe3 and IS621 found in E. coli, transposases similar to IS116/IS110/IS902 of 
Stenotrophomonas, and transposases similar to IS2 and IS3, but these have not 
been characterized in more detail here. 
The IS elements of BT 1B belong to a wide range of different families, with no more 
than 8 copies of any single IS element. In total, BT 1B carries 60 IS elements. A 
similar number of IS elements can be found in the low-pathogenic BTs 2 – 5, but 
here the distribution is skewed towards IS1667, which is present in more than 30 
copies per strain. Other IS elements present are IS1328, IS1400, IS1668, and 
IS1669. 
The position of IS1667 (Figure 4.17) indicates that it might be mediating intragenomic 
recombination, as it is often found at borders of transpositions and inversions. 
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Figure 4.17: Position of the predominant IS element IS1667 in the reference genome 
assemblies. Genomes are compared in a pair-wise fashion. Red bars – co-linear homology >999 bp, 
blue bars  – inverted homology >999 bp. Contigs are not highlighted. Arrows indicate position and 
orientation of the IS1667. 
 
As is the case in Y. pestis, IS elements can also be shown to promote genome 
instability via recombination. There are examples of IS elements which have inserted 
into CDSs and thus disrupt their expression in the low-pathogenic BTs. One example 
mentioned above is the carbonic anhydrase cah, which has been disrupted by a 
transposase in BTs 2, 3, and 4. Another good example as well is found in BT4 where 
transposase action lead to the loss of half of the flagellar cluster and the iron-uptake 
operon, as described before.  
As can be seen from Figure 4.17 there are some regions in the Y. enterocolitica 
reference genomes that are not to affected by IS mediated recombination or 
disruption. These regions retain the same gene arrangements althought their position 
respective to each other can vary. This concept has been introduced in Y. pestis by 
Deng, et al. (2002), and was used to describe syntenic blocks. Later Chain, et al. 
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(2004) tried to deduce the number of recombinatorial events in Y. pestis since the 
divergence from Y. pseudotuberculosis through the investigation of those syntenic 
blocks. 
This concept can also be applied in Y. enterocolitica, and 29 syntenic blocks could be 
identified through the comparison of the seven reference genomes (Table 4.3). 
 
Table 4.3: Syntenic blocks identified in the reference genomes of Y. enterocolitica. 
Syntenic block start position† end position† CDS start† CDS end† size # CDS 
1 0 107030 YE0001 YE0097 107030 97 
2* 
108300 191330 YE0099 YE0160 83030 61 
191500 202555 YE0161 YE0168 11055 7 
282830 313630 YE0169 YE0273 30800 104 
3 319700 353900 YE0274 YE0303 34200 29 
4 362987 874170 YE0307 YE0747 511183 440 
5 879520 980830 YE0754 YE0852 101310 98 
6 1039400 1251800 YE0911 YE1115 212400 204 
7 1264600 1802600 YE1124 YE1602 538000 478 
8 1802900 1991400 YE1603 YE1798 188500 195 
9 2027865 2087750 YE1846 YE1901 59885 55 
10 2108500 2142600 YE1933 YE1962 34100 29 
11 2154500 2325300 YE1975 YE2124 170800 149 
12 2326000 2406630 YE2125 YE2196 80630 71 
13 2407700 2446400 YE2198 YE2234 38700 36 
14 2447240 2499700 YE2237 YE2285 52460 48 
15 2554700 2591553 YE2365 YE2402 36853 37 
16 2602500 2630230 YE2409 YE2439 27730 30 
17 2640950 2668185 YE2454 YE2477 27235 23 
18 2668285 2709585 YE2478 YE2513 41300 35 
19 2709700 2800900 YE2514 YE2602 91200 88 
20 2854263 3294700 YE2636 YE3022 440437 386 
21 3313400 3544778 YE3048 YE3248 231378 200 
22 3552700 3610900 YE3252 YE3308 58200 56 
23 3610900 3712864 YE3309 YE3399 101964 90 
24 3726200 3761260 YE3413 YE3447 35060 34 
25 3897560 3933900 YE3581 YE3609 36340 28 
26 3960000 4238800 YE3631 YE3882 278800 251 
27 4245400 4464400 YE3883 YE4083 219000 200 
28 4504400 4561500 YE4118 YE4162 57100 44 
29 4561800 4615788 YE4163 YE4215 53988 52 
† labelling respective to BT 1B strain 8081; * 7 CDSs present a clean transposition in BT 5 due to the 
action of transposases; colours correspond to syntenic blocks highlighted in Figure 4.18. 
 
The syntenic blocks vary in size and gene content, ranging from 23 CDSs (17) up to 
478 CDSs (7). It is possible that with sequencing of further Y. enterocolitica genomes 
this number could change, but considering the divergence between these isolates 
gives confidence in the assignment of syntenic blocks. An example for the variable 
positions of the syntenic blocks is given in Figure 4.18. 
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Figure 4.18: Exemplar position of six syntenic blocks. Six syntenic blocks are highlighted in 
yellow, pink, red, orange, blue, and green in the respective reference genomes to illustrate their 
variable positions within the genomes relative to the sequence start. Colours correspond to syntenic 
block colours in Table 4.3. Contigs are highlighted in orange and brown in the low-pathogenic BTs. 
 
As one can see none of the regions appear in the same order and orientation as in 
any of the other genomes. BT 1A and BT 2 do have the same order in the six 
syntenic blocks observed, but the blue and green block show inversions which are 
not easily visible as the syntenic blocks have been artificially allocated to the reverse 
strand to allow for visualization of the contigs on the forward strand. 
The identification of syntenic blocks could help in the design of a multilocus 
sequencing typing (MLST) scheme. One of the underlying principles for MLST is that 
the genes should be evenly distributed around the chromosome to exclude that the 
genes are linked with respect to evolutionary changes and recombination events 
(Maiden, et al., 1998). In chosing genes located within major syntenic blocks one can 
ensure that the genes are unlinked, as the blocks are conserved in structure. Despite 
genomic rearrangements due to recombination that change the position of the 
blocks, the syntenic blocks should cover different parts of the chromosome and 
guarantee an even spread.  
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4.3 Discussion 
4.3.1 High-, low-, and non-pathogenic biotypes have distinct genomic features 
Through the analysis of orthologous gene sets it is apparent that high-, low-, and 
non-pathogenic BTs are very distinct in their genomic content. High- and non-
pathogenic BTs each have a considerable number of unique CDSs, whereas the low-
pathogenic BTs appear as a tight cluster of isolates. The regions specific to the low-
pathogenic BTs are shared in all of the isolates, and unique regions only relate to 
independently acquired phages and LPS operons. It is important to note that BT 2 
and BT 3 are genetically indistinguishable from each other. BT 4 has lost the fes-fep 
iron acquisition operon and half of the second flagellar cluster, and this has been 
confirmed in larger strain collections for fes-fep operon (Schubert, Fischer and 
Heesemann, 1999; Thomson, et al., 2006). The loss of half of the flagellar cluster has 
not been reported before, and could only be detected through in-depth comparison 
between all of the reference genomes. BT 5 is signified by massive genome decay. 
The genetic basis for the biotyping reactions could only be determined for trehalose 
and sorbose, both pseudogenes in BT 5. 
 
It was interesting to see how closely related high- and non-pathogenic BTs appear to 
be with respect to shared gene content. On the other hand, the non- and low-
pathogenic BTs also do have a lot in common. In fact, these two groups incorporate 
more CDSs than the supposedly more important group of pathogenic BTs. A 
common gene set of pathogenic BTs is reduced to the virulence plasmid pYV and the 
attachment/invasion locus protein Ail. There are also no signatures for human-
pathogenic isolates or for animal isolates. A similar finding has been made when 
comparing pathogenic and commensal E. coli strains (Chaudhuri, et al., 2010). The 
authors found only 13 CDSs that resembled potential virulence factors absent from 
the commensal strain. They suggest that this absence of pathogenic signature 
indicates a phylogenetic heterogeneity of enteroaggregative E. coli (Chaudhuri, et al., 
2010). It will be investigated later if this case is similar in Y. enterocolitica (Chapter 
7), but the split into high- and low-pathogenic BTs due to heterogeneity resembles 
the findings in E. coli. 
Many genes and operons have been suggested as “virulence markers” or “virulence 
genes” of pathogenic Yersiniae in the past, only later for homologs to be found in 
environmental species as well. As classic example of this is the presence of hitherto 
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considered Yersinia virulence genes in BT 1A including the invasion gene invA, the 
tight adherence operon and two YGI (Pierson and Falkow, 1990; Thomson, et al., 
2006). Similarly, the host-responsive element rscBACR (Young and Miller, 1997; 
Nelson, Young and Miller, 2001), thought to be involved in the dissemination of 
Y. enterocolitica in the spleen, is found in all BTs. These discoveries may help 
explain why BT 1A is increasingly being associated with mild human intestinal 
infectious disease. The only robust markers for pathogenicity identified in BT 1B 
relate to the HPI, Ysa T3SS, and yst-1.Some important regions and islands of 
Y. enterocolitica and their distribution within the species are shown in Table4.4. 
 
Table 4.4: Distribution of important regions and islands of Y. enterocolitica in reference 
genomes. 
 BT 1A BT 1B BT 2 BT 3 BT 4 BT 5 
YGI-1 (tad) + + + + + + 
YGI-2 + + - - - - 
YGI-4 + (+) - - - - 
Ni-Co efflux + + - - - - 
Ag-Cu efflux + - - - - - 
tc PAI  -* - + + + + 
Flag-1 + + + + + + 
Flag-2 - - + + (+) + 
Outer core LPS + - + + + + 
YGT + - + + + + 
Ysa T3SS - + - - - - 
pYV - + + + + + 
fes-fep + + + + - + 
ail - + + + + + 
HPI - + - - - - 
yst-1 - + - - - - 
yst-2 + + + + + + 
YAPI -  +† - - - - 
inv/rovA + + + + + + 
myf fibrillar operon + + + + + + 
hydrogenase-2,4 + + + + + + 
* only described in one BT 1A isolate so far (T83, Tennant, Skinner, Joe and Robins-Browne, 2005); † not 
consistently present in all BT 1B (Thomson et al., 2006); (+) only truncated versions present 
 
The regions that were thought to be involved in niche adaptation to the human gut 
now need to be re-evaluated for their contribution to disease. The distribution of 
putative virulence factors should also be examined in larger strain collections of 
Y. enterocolitica as well as environmental Yersiniae. 
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4.3.2 Metabolism, pseudogenization and IS elements are important 
evolutionary forces in Y. enterocolitica 
A theme emerging from the comparison of the different BTs is the potential difference 
in metabolic properties. Regions that are unique to BT 1A, regions shared between 
BT 1A and 1B, and regions common to BT 1A and 2 – 5 relate to metabolic pathways 
and transport operons. Similarly, the comparison of the pseudogenes found that 
especially the BTs 4 and 5 show an increase in pseudogenes in operons associated 
with metabolism and transport. This trend of reduced metabolic flexibility is also 
apparent in the biotyping scheme. BT 1A is positive for all of the reactions, then BT 
1B follows, and a reduced number of positive reactions is observed in the low-
pathogenic BTs, finally arriving at BT 5 which is negative or variable for all but one of 
the reactions  (Wauters, Kandolo and Janssens, 1987). 
Metabolism is also a driver in the host-adaptation in other pathogenic bacteria 
(Rohmer, Hocquet and Miller, 2011). Metabolic streamlining to a specific niche can 
be specifically observed in obligate intracellular organisms for instance when 
comparing Mycobacterium tuberculosis and Mycobacterium leprae (Cole, et al., 
2001). Here it was found that M. leprae shows signs of extensive genome decay in 
form of accumulation of a large number of pseudogenes. Predominant functional 
groups of pseudogenes are, similar to Y. enterocolitica, small molecule catabolism, 
energy metabolism, regulatory proteins, synthesis and modification of 
macromolecules, cell envelope proteins, and transport proteins. Similar trends of 
pseudogene acquisition alongside host or niche restrictions are also observed in 
Salmonella enterica serovars Tyhpi (Parkhill, et al., 2001b) and Gallinarum 
(Thomson, et al., 2008). Again, targets for pseudogenization are metabolic pathways. 
Interestingly, there are certain pathways found to be targets of pseudogene formation 
in Y. pestis, S. Typhi, and S. Gallinarum (Parkhill, et al., 2001a,b; Thomson, et al., 
2006, 2008) that are also affected by mutations in the potentially highly successful, 
more host-restricted lineages of Y. enterocolitica (BTs 1B, 4, 5). These relate to 
cobalamin biosynthesis, tetrathionate respiration, and mutations in flagella operons. 
Y. ruckeri was also found to be deficient in cobalamin biosynthesis and tetrathionate 
respiration (Chen, et al., 2010). These could potentially be pathways essential in 
environmental survival and which are lost upon host adaptation due to maintenance 
cost. For tetrathionate respiration it has also been suggested that the loss of the 
pathway could be advantageous for growth outside the intestine (Thomson, et al., 
2008; Rohmer, Hocquet and Miller, 2011). A recent study (De Paepe, et al., 2011) 
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investigated the effect of colonization of germ-free mouse intestines with E. coli and 
found a diversification process. The original E. coli population split into separate 
lineages, one acquiring mutations in the flagellar flhDC operon, another showing 
mutations leading to a maltose-negative phenotype. This microevolution is potentially 
driven by the presence of bile salts (De Paepe, et al., 2011). The authors also 
suggest that maintenance of flagellar operons might require extensive energy, and 
that functionality in the gut is dispensible. A similar dynamic could explain the parallel 
loss of flagellar operons in other pathogenic bacteria. 
It is not known though if the regions uniquely acquired by BT 1A or the regions 
showing pseudogenes in the pathogenic BTs do in fact have a phenotype associated 
with them. This will be investigated further in Chapter 6. Pseudogenes are also said 
to be lost rapidly in populations as their truncated transcript could have negative 
effects on the cell (Kuo and Ochman, 2010). It could thus be that a lot of the 
pseudogenes in BTs 4 and 5 have been acquired recently and thus have not been 
completely deleted yet, or that in fact these pseudogenes still fulfil a function and 
thus are retained. Again, confirmation of pseudogene status is subject to further 
phenotypic experiments. 
 
IS elements also present an important evolutionary driving force. The expansion of 
IS1667 in the low-pathogenic BTs mirrors the overall expansion of IS elements in 
Y. pestis. A similar finding was made in Burkholderia mallei. This horse-pathogen 
evolved out of the environmental B. pseudomallei. It was shown that there has been 
an expansion of three different IS elements in B. mallei since its divergence from 
B. pseudomallei (Song, et al., 2010). These have been attributed to genome decay 
and reduction in overall genome size. Interestingly, the authors found that a large 
number of IS elements were conserved with respect to genomic location in several 
unrelated B. mallei genomes indicating that these might have been acquired during 
evolution of this lineage (Song, et al., 2010). Following geographic spread of the 
bacteria, there have been few further expansions and transpositions of the IS 
elements. This can also be observed to some respect in the low-pathogenic BTs. 
Amongst the orthologous genes of the low-pathogenic BTs, there are 35 
transposases and IS elements, of which 10 belong to IS1667. On the other hand, 
transposition appears to be an ongoing process after the separation into different bio-
serotypes. As an example, some transposase are further shared between BTs 4 and 
5, and BT 5 possesses 35 unique transposases (12 IS1667). Active IS elements 
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have also been observed in Y. pestis when one genomic region was found to be 
present in two orientations suggesting a high genome fluidity (Parkhill, et al., 2001a). 
A proteomic study also found unique peptides corresponding to active transposases 
of IS285, demonstrating that genome recombination is an ongoing process in 
Y. pestis (Payne, Huang and Pieper, 2010). 
 
4.3.3 Differences in niche adaptation 
It is apparent that the non-pathogenic BT 1A is suitably adapted for environmental 
survival. It possesses a large number of operons associated with transport and 
metabolism of various sugars and other metabolites.  
The pathogenic BTs lack most of these properties and seem to have chosen a 
different approach. The high-pathogenic BT seems to have found a unique niche that 
allowed it to get in contact with other bacteria to exchange pathogenicity islands, thus 
acquiring the HPI and the Ysa T3SS. In turn, it loses the YGT and regions associated 
with generalist survival. The YGT is present in all Yersiniae but shows signs of 
fragmentation specifically in more pathogenic lineages. Y. pestis and 
Y. pseudotuberculosis are missing parts of the effector region, explaining why an 
initial investigation into functionality showed no role in pathogenicity (Pujol and 
Bliska, 2003; Balada-Llasat and Mecsas, 2006). This cluster has also been deleted 
from the high-pathogenic BT 1B and shows signs of pseudogenization in BTs 4 and 
5, which are potentially the most host-adapted low-pathogenic BTs. BT 4 is isolated 
from animals and the environment as well, but presents the predominant bio-
serotype in human infections in Europe (McNally, et al., 2004), suggesting some 
degree of host-adaptation over the other low-pathogenic BTs. This inactivation of 
YGT in host-adapted lineages and the distribution in the environmental Yersiniae 
indicate that the YGT possibly has a role in environmental survival rather that in 
causing human disease. YGT resembles the SPI-2 T3SS of Salmonella. This system 
was identified together with the SPI-1 T3SS following signature-tagged mutagenesis 
and isolation of attenuated clones in a mouse infection model (Shea, Hensel, 
Gleeson and Holden, 1996). SPI-2 was later implied to be involved in intracellular 
pathogenesis and survival within macrophages (Hensel, 2000). Recently though it 
has also been associated with survival inside amoebae and it has been suggested 
that the mechanisms for survival inside amoebae is the same as for macrophages 
(Bleasdale, et al., 2009). Insect and protozoa could present an important 
environmental niche not only for Salmonella but also for Yersinia. Further 
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investigations could be carried out to determine a role in colonization of amoeba or 
insects.  
The low-pathogenic BTs have kept the second flagella cluster and possess the tc PAI 
involved in insect toxicity. Instead of a large metabolic repertoire required in the 
general environment, the low-pathogenic BTs appear to have adapted to an insect 
and amoebae niche. Salmonella has been described as containing two flagella 
cluster as well, and it was hypothetized that the second cluster might act as a spare 
tyre in that the loss results in host restriction whereas a retention enables 
colonization of environmental niches (McQuiston, Fields, Tauxe and Logsdon, 2008). 
On the other hand a second flagellar cluster might enable phase variation and thus 
immune evasion, especially in a new niche (McQuiston, Fields, Tauxe and Logsdon, 
2008). No phase variation has been described in Yersinia thus far, and the fact that 
both flagella clusters are deactivated in Y. pestis might argue the point that Flag-2 is 
involved in environmental survival in the low-pathogenic BT, possibly due to their 
reduced metabolic capacities. It has been suggested that a second flagella cluster 
supports the search for an insect vector (Bresolin, Trček, Scherer and Fuchs, 2008).  
Mutations in BTs 4 and 5 on the other hand again possibly reflect host restriction to a 
niche other than insects, similar to findings made in other pathogenic bacteria, 
namely Salmonella Typhi and Gallinarum as well as Y. pestis (Thomson, et al., 2008; 
Parkhill, et al., 2001a).  
 
An important part in infection is immune evasion and how the bacteria present 
themselves to a host through outer membrane proteins. Both core and outer antigen 
are recognized by the adaptive immune response and trigger the host complement 
cascade that results in attraction of phagocytes and lysis of bacterial cells, and are 
also important in bacterial cell membrance integrity and resistance (Prior, et al., 
2001; Skurnik, Venho, Bengoechea and Moriyón, 1999). It is therefore interesting to 
observe the differences in LPS makeup between high-pathogenic BTs on the one 
hand and non- and low-pathogenic BTs on the other hand. Because the pathogenic 
and non-pathogenic Y. enterocolitica lineages exhibit a large number of different LPS 
structures, full protective immunity might only be acquired over time upon infection 
with each lineage. This would impact on vaccine strategies, but are of low impact due 
to the usually self-limiting nature of the disease. 
The fact that the outer core is shared in non- and low-pathogenic BTs indicates that 
this might be the ancestral LPS structure of Y. enterocolitica. It is interesting to see 
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that the high-pathogenic BT 1B abandoned the outer core in favour of a 
heteropolymeric operon, whereas the low- and non-pathogenic BTs seem to have 
acquired additional homopolymeric operons. The LPS structure of the high-
pathogenic BT thus resembles more the structure of Y. pseudotuberculosis and 
Y. pestis (Skurnik and Bengoechea, 2003). It has been suggested that an ancestor of 
the pathogenic Yersiniae had acquired a common ancestral version of this 
heteropolymeric O-antigen (Zhang, Toivanen and Skurnik, 1996). Considering that 
the non-pathogenic BT exhibits signs of being the historically oldest lineage, and that 
it shared the outer core biosynthesis operon with the low-pathogenic BTs, this 
scenario is unlikely. It is more likely that the outer core presents the ancestral form in 
Y. enterocolitica and that it has been replaced in BT 1B upon colonization of a new 
niche. So far, nothing is known about the genetic organization and location of the O-
antigen operons in the environmental Yersiniae, but it has been suggested that the 
outer core is also present in the environmental species (Skurnik, et al., 1999). A 
quick search on the published genomes (Chen, et al., 2010) confirmed the presence 
of outer core in Y. frederiksenii, Y. kristensenii and Y. rohdei, but due to possible 
assembly problems, no definitive answer on the other isolates is possible. Thus the 
directionality of the outer core is loss in the high-pathogenic BT. It also has to be 
considered though that the O-antigens undergo horizontal gene transfer as well. This 
has been well documented in E. coli and Salmonella as well as for 
Y. pseudotuberculosis (Samuel and Reeves, 2003; Skurnik and Bengoechea, 2003).  
 
In conclusion, the comparative analysis carried out enabled a deeper look into what 
is shared and what is different in Y. enterocolitica BTs. This detailed knowled is 
specifically important with respect to truncation and mutations of regions in view of 
BTs 4 and 5. A pathogenic core of genes shared exclusively in high- and low-
pathogenic BTs as such does not exist except for the virulence plasmid pYV and the 
adhesion/invasion locus protein Ail. The presence of some genes that were thought 
to be virulence determinants in the past in BT 1A could explain why it can be 
associated with disease in humans. The lack of markers for increased pathogenic 
potential such as the HPI explains the lowered pathogenicity of BTs 2 – 5 in a mouse 
infection model. The regions unique to low-paths indicate a potential environmental 
niche associated with insects. Evolutionary driving forces for pathogenesis can be 
defined as IS elements and pseudogenization as well as metabolic properties. 
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5 Plasmid Variety and Variability in Y. enterocolitica 
Biotypes 
5.1 Introduction 
The only common “virulence factors” shared in pathogenic BTs of Y. enterocolitica 
are the chromosomally encoded ail as well as the virulence plasmid pYV. It was 
shown in the past that functionality of pYV is conserved, despite marked sequence 
differences and size variations between plasmids of high- and low-pathogenic BTs of 
Y. enterocolitica as well as Y. pseudotuberculosis (Portnoy, Moseley and Falkow, 
1981; Portnoy and Falkow, 1981; Heesemann, et al., 1983; Portnoy, et al., 1984; 
Kapperud and Nesbakken, 1987; Fukushima, Gomyoda, Aleksic and Tsubokura, 
1993). Variability was also shown in the sequence, orientation and position of some 
genes as well as gene content in general (Roggenkamp, et al., 1997; Boland, 
Havaux and Cornelis, 1998; Snellings, Popek and Lindler, 2001; Wagner, et al., 
2009; Foultier and Cornelis, 2003; Oberhettinger, et al., 2011). The plasmids can 
consequently be considered as a "closely related family of plasmids" rather than a 
uniform molecule (Portnoy, Moseley and Falkow, 1981; Portnoy and Falkow, 1981).  
 
A variety of other plasmids are found in the genus Yersinia. Analysis of plasmids in 
Y. enterocolitica strains showed that strains often harbour more than one plasmid of 
different types and sizes (Kapperud and Nesbakken, 1987). Those plasmids vary in 
sequence similarity. Plasmids have also been the object of interest in the non-
pathogenic BT1A with a considerable number of isolates containing plasmids of 
varying sizes (Lewin, et al., 1996). Although BT 1A is considered to be non-
pathogenic due to the lack of the virulence plasmid, this study showed that some of 
the plasmid-bearing strains had atypical biotyping reactions; they exhibited 
autoagglutination, slow and weak Congo Red uptake, and were also resistant to 
serum (Lewin, et al., 1996).  
 
The aim of this chapter is to investigate the differences in virulence plasmids found in 
the pathogenic Y. enterocolitica biotypes. Differences found will be investigated in 
terms of distribution in high- and low-pathogenic BTs and are also compared to 
Y. pseudotuberculosis and Y. pestis. The plasmid repertoire of Y. enterocolitica will 
also be considered as several unique plasmids were identified during sequencing. 
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5.2 Results 
5.2.1 Genetic Organization of the virulence plasmid pYV in Y. enterocolitica 
BT 
General properties of the sequenced virulence plasmids in the reference genomes 
are given in Table 5.1. 
 
Table 5.1: General properties of the sequenced pYV. 
Property 
 
BT1B O:8 
pYVe8081 
BT2 O:9  
pYVe21202 
BT3 O:9  
pYV5603 
BT3 O:5,27  
pYVe14902 
BT4 O:3  
pYVe1203 
BT5  O:2a,2b,3   
pYVe3094 
Plasmid size (bp) 67,721 75,103 75,107 72,395 72,413 72,824 
GC content (%) 43.92 44.16 44.16 44.24 43.98 44.40 
Number of CDS 90 90 92 88 86 91 
Coding density (%) 73.0 70.6 74.0 71.6 71.9 78.5 
Average gene size (bp) 618 671 664 659 678 647 
w/o pseudogenes (bp) 677 698 678 682 694 665 
 
One can see that the plasmids from the low-pathogenic BT range between 72.4 and 
75.1 kb, and thus are considerably larger than the plasmid from the high-pathogenic 
BT, which is only 67.7 kb. The GC content of the plasmids ranges from 43.92 to 
44.4%. Number of CDS, coding density and average gene size can vary, with no 
clear pattern for high- or low-pathogenic strains. 59 CDSs are conserved between all 
pYVs, and a further 22 CDSs are present in pYVs of low-pathogenic BTs. The 
conserved CDSs are part of the Yop T3SS machinery and regulatory proteins and 
are encoded within the virABGC operons. This can also be seen in the overall 
organization of the virulence plasmid (Figure 5.1). From the plasmid comparison one 
highly conserved region is obvious, which corresponds to the type 3 secretion system 
machinery. This region shows no inversions or deletions at all, but appears to be 
essentially the same in gene composition and orientation in all biotypes. In addition 
the plasmids from the low-pathogenic biotypes present only minor variations in gene 
content, relating to fragments or pseudogenes of transposases, and show few 
regions of rearrangement. The orientation of an IS element near the origin can vary 
and is absent in BT 4.  
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Figure 5.1: Alignment and comparison of the sequenced pYV. The plasmid from the high-
pathogenic biotype is presented at the top, with the low-pathogenic biotype pYVs aligned below. 
Regions of specific interest are labelled; OriR – origin of replication. 
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Smaller differences are seen in the orientation of yopM and yscM2. These do not 
show any clear biotype-specific pattern, and this is likely to be explained by the 
transposase fragments and pseudogenes that surround both genes. The gene yopM 
is found in the anticlockwise orientation in pYVe8081, pYV21202, and pYV5603, but 
has the opposite, clockwise orientation in pYV3094, pYV14902, and pYV1203. 
yscM2 found in pYV14902 and pYV1203 is in the opposite orientation to all other 
pYVs. This indicates that the rearrangments probably happened independently over 
time, mediated by adjacent transposases. 
The genes for the targeted effector proteins YopO and YopP/J present the only 
translocations visible in the virulence plasmids. yopOP/J are located upstream of the 
origin of replication in the high-pathogenic BT, but are located downstream of it in the 
low-pathogenic BTs. Transposase remnants are present adjacent to these genes, 
and thus have probably facilitated the translocation. In Y. pestis and 
Y. pseudotuberculosis, yopOP/J are found downstream of the origin of replication, 
thus resembling the pYV of the low-pathogenic BTs (Snellings, Popek and Lindler, 
2001). 
 
It is also obvious that the origin of replication represented at the end of the 
alignments is different in plasmids of low- and high-pathogenic biotypes. This 
difference has been noted before in hybridization experiments (Portnoy and Falkow, 
1981). The origin of replication of pYV8081 has been allocated to the IncL/M 
incompatibility group (Snellings, Popek and Lindler, 2001), and it has been noted that 
this is a feature of other pYVs from high-pathogenic BTs as well (Snellings, Popek 
and Lindler, 2001; Oberhettinger et al., 2011). Sequence similarity of the origin of 
replication in high-pathogenic pYVs to pYVs from low-pathogenic BTs is very low 
with 16% whereas protein identity is higher than 92% for the rest of the plasmid 
(Snellings, Popek and Lindler, 2001). Conversely, the origins of replication of both 
pYVs of low-pathogenic Y. enterocolitica and of Y. pseudotuberculosis as well as 
pCD1 of Y. pestis are similar and belong to the IncFIIA incompatibility group 
(Snellings, Popek and Lindler, 2001). 
 
A major difference in gene content between pYVs of high- and low-pathogenic BTs is 
the presence of an arsenic resistance operon in the low-pathogenic BTs. The 
orientation of this region and with it the position of yomA, yadA, and yscM2 plus 
fragmented transposases can vary amongst the biotypes. 
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The arsenic resistance operon has been described as part of the transposon Tn2502 
(Neyt, Iriarte, Thi and Cornelis, 1997). It contains a total of six CDSs. The first CDS is 
the gene for transposase tnpA. The second CDS tnpR encodes the resolvase. The 
other four CDSs make up the arsenic resistance operon, containing an arsenite-
inducible transcriptional repressor regulator ArsR, the transmembrane channel ArsB 
for export of arsenite, and the arsenate reductase ArsC catalyzing the conversion of 
arsenate to arsenite, which is then exported. The fourth CDS, arsH, is of unknown 
function, but is essential in the full resistance towards arsenite and arsenate. The 
presence of this transposon only in plasmids of low-pathogenic strains has been 
reported previously (Neyt, Iriarte, Thi and Cornelis, 1997). As the transposase is 
presumed to be non-functional in the described plasmid, it has been proposed that 
the acquisition event is ancient, and might be related to the worldwide spread of 
those biotypes where the arsenic resistance is thought to be of importance in 
environmental survival. In the past arsenic has been used as a growth factor in pigs. 
As pigs are thought to be one of the main reservoirs of Y. enterocolitica, their 
treatment with arsenic could have selected for plasmids carrying the operon (Neyt, 
Iriarte, Thi and Cornelis, 1997). Alternative arsenic resistance operons however are 
also found in BT 1B and BT 1A. The high-pathogenic BT 1B carries one unique copy 
inside the plasticity zone. Another copy outside the plasticity zone is orthologous to a 
copy in the non-pathogenic BT 1A. BT 1A also has a unique additional arsenic 
resistance operon. The chromosome or the plasmid can consequently carry arsenic 
resistance operons. pYV-independent arsenic resistance has been reported in the 
high-pathogenic BT 1B strain 8081 (Neyt, Iriarte, Thi and Cornelis, 1997), but nothing 
is known about functionality of arsenic resistance operons found in the non-
pathogenic BT 1A. 
In the presented strains it seems as if the region for the transposon extends beyond 
that described by Neyt, Iriarte, Thi and Cornelis (1997). Not only the Tn2502 region 
changes orientation in different plasmids, but also yscM2, yadA and yomA plus 
fragmented transposases surrounding yscM2. It can be argued that only Tn2502 
might change orientation if it was mobile, as opposed to the whole region between 
positions 58.5 kb and 71.5 kb flipping, as seen here. There is no current evidence or 
experimental data whether these transposition events are ancient or still undergoing 
recombination in current cultures. 
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5.2.2 Generic Map of pYV 
Figure 5.2 summarises all the genetic variations between pYV plasmids. 
 
 
Figure 5.2: Backbone of pYV and variable regions in different Y. enterocolitica biotypes. The 
unvariable backbone of the virulence plasmid is presented on the circle and consists of the operons 
virABGC. Inside the circle the genes of the high-pathogenic BT pYVe8081 are depicted, outside the 
circle are the genes of the low-pathogenic BT pYVs. Orientation of following genes is variable: yopM, 
yadA, yomA, yscM2. Position of yopO, yopP/J is variable. Position of yadAyomA varies due to 
insertion of arsenic resistance cassette (AsR). 
 
The T3SS machinery and regulatory proteins (virABGC) is the backbone of the 
virulence plasmid and comprises about half of the plasmid. The other regions are 
variable. In case of the origin, the region appears to have been swapped for another 
region in high- or low-pathogenic biotypes. It could be argued that the T3SS 
machinery, being the backbone of pYV, was inserted into different, pre-existing 
plasmids in high- and low-pathogenic BTs. This could explain the difference in origin 
of replication. An argument against this is that there are numerous CDSs outside the 
T3SS encoding effector proteins, which then would have had to be introduced 
individually. A more likely scenario is the acquisition and subsequent exchange of the 
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origin of replication possibly after a co-integration event with another plasmid in high-
pathogenic BTs as suggested by Snellings, Popek and Lindler (2001). 
Reciprocal fasta searches and analysis of orthologous gene was used to define the 
core and variable pYV genes comparing the reference plasmid sequences: 38 CDSs 
of a core set of 59 CDS belong to the T3SS region. In the accessory genes, 22 CDSs 
are found commonly in the low-pathogenic biotypes. Most of these low-pathogen 
specific genes are transposase fragments and pseudogenes, ylpA, CDSs that 
represent an alternative origin of replication and the arsenic resistance operon. 28 
CDS are unique to pYVe8081, and account for CDSs of the origin of replication and 
transposase fragments and pseudogenes.  
 
5.2.3 Variability in pYV core gene sequence 
5.2.3.1 yopM 
Heterogeneity has been reported for some of the genes encoded on the virulence 
plasmid. YopM is one of the T3SS effector proteins. Its size can vary between 367 
and 515 amino acids, as the central part contains repeat domains of 60 amino acids, 
with the number of repeats present leading to a difference in size (Boland, Havaux 
and Cornelis, 1998; Snellings, Popek and Lindler, 2001). This heterogeneity though 
does not appear to make a difference in function and does not change the virulence 
potential of strains expressing an altered YopM (Boland, Havaux and Cornelis, 
1998). There is also no apparent link to bio-serotype, as two BT 1B O:8 strains were 
found to encode YopM proteins of different lengths (Boland, Havaux and Cornelis, 
1998; Foultier and Cornelis, 2003). In the plasmids sequenced in this study, the 
same length of yopM as in pYVe8081 was observed. 
 
5.2.3.2 lcrV 
Another protein known to be polymorphic is LcrV (Foultier and Cornelis, 2003; 
Roggenkamp, et al., 1997). This protein is part of the T3SS machinery and encodes 
a translocator (Foultier and Cornelis, 2003). As LcrV is part of the apparatus of the 
T3SS and expressed on the cell surface where it is referred to as the V-antigen 
(Roggenkamp, et al., 1997). Immunization of mice with V-antigen sera conferred 
protection against infection with Y. enterocolitica (Roggenkamp, et al., 1997). 
Comparison of LcrV sequences between serotype O:8 isolates and Y. pestis and 
Y. pseudotuberculosis showed that a 9-amino-acid insertion is present in some BT 
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1B O:8 isolates (Roggenkamp, et al., 1997; Foultier and Cornelis, 2003). Yet, 
similarly to YopM, LcrV variation is not linked to bio-serotype as other O:8 isolates 
were found with sequences identical to those in Y. pseudotuberculosis. A comparison 
of LcrV sequences of the reference strains of this study to exemplar strains studied in 
the past (Roggenkamp, et al., 1997) is shown in Figure 5.3. As was shown before, 
LcrV of BT 1B O:8 strain WA314 is found to be 9 amino acids longer than BT 1B O:8 
strain 8081. There is also variation in LcrV sequences of O:9 isolates. The two 
isolates sequenced in this study show 5 additional amino acids directly upstream of 
the WA314 insertion, which corresponds to amino acid position 225 to 232 of 
Y. pseudotuberculosis. 
 
 
YPS-YPI MIRAYEQNPQHFIEDLEKVRVEQLTGHGSSVLEELVQLVKDKNIDISIKYDPRKDSEVFANRVITDDIELLKKILAYFLPEDAILKGGHYDNQLQNGIKRVKEFLESSPNTQWELRAFMA 
YE-8081 MIRAYEQNPQHFIEDLEKVRVEQLTGHGSSVLEELVQLVKDKKIDISIKYDPKKDSEVFAERVITDDIELLKKILAYFLPEDAILKGGHYDNQLQNGIKRVKEFLESSPNTQWELRAFMA 
YE-WA314   MIRAYEQNPQHFIEDLEKVRVEQLTGHGSSVLEELVQLVKDKKIDISIKYDPKKDSEVFAERVITDDIELLKKILAYFLPEDAILKGGHYDNQLQNGIKRVKEFLESSPNTQWELRAFMA 
YE-W22703  MIRAYEQNPQHFIEDLEKVRVEQLTGHGSSVLEELVQLVKDKKIDISIKYDPKKDSEVFADRVITDDIELLKKILAYFLPEDAILKGGHYDNQLQNGIKRVKEFLESSPNTQWELRAFMA 
YE-21202   MIRAYEQNPQHFIEDLEKVRVEQLTGHGSSVLEELVQLVKDKNIDISIKYDPRKDSEVFANRVITDDIELLKKILAYFLPEDAILKGGHYDNQLQNGIKRVKEFLESSPNTQWELRAFMA 
YE-5603    MIRAYEQNPQHFIEDLEKVRVEQLTGHGSSVLEELVQLVKDKNIDISIKYDPRKDSEVFANRVITDDIELLKKILAYFLPEDAILKGGHYDNQLQNGIKRVKEFLESSPNTQWELRAFMA 
YE-Y96     MIRAYEQNPQHFIGDLEKVRVDQLTGHGSSVLEELVQLVQDKKIDISIKYDPQKDSEVFADRVITDDIELLKKILAYFLPEDAILKGGHYDNQLQNGIKRVKEFLESSPNTQWELRAFMA 
YE-14902   MIRAYEQNPQHFIEDLEKVKVEQLTGHGSSVLEELVQLVKDKKIDISIKYDPKKDSEVFADRVITDDIELLKKILAYFLPEDAILKGGHYDNQLQNGIKRVKEFLESSPNTQWELRAFMA 
YE-Y527    MIRAYEQNPQHFIGDLEKVRVEQLTGHGSSVLEELVQLVQDKKIDISIKYDPKKDSEVFADRVITDDIELLKKILAYFLPEDAILKGGHYDNQLQNGIKRVKEFLESSPNTQWELRAFMA 
YE-1203    MIRAYEQNPQHFIEDLEKVRVEQLTGHGSSVLEELVQLVKDKKIDISIKYDPKKDSEVFANRVITDDIELLKKILAYFLPEDAILKGGHYDNQLQNGIKRVKEFLESSPNTQWELRAFMA 
YE-SZ3094 MIRAYEQNPQHFIEDLEKVRVEQLTGHGSSVLEELVQLVKDKKIDISIKYDLKKDSEVFADRVITNDIELLKKILAYFLPEDAILKGGHYDNQLQNGIKRVKEFLESSPNTQWELRAFMA 
 
 
YPS-YPI VIHFSLTADRIDDDILKVIVDSMNHHGDARSKLREELAELTAELKIYSVIQAEINKHLSSGGTINIHDKSINLMDKNLYGYTDEEIFKASAEYKILEKMPQTTI-----QX--------X 
YE-8081    VMHFSLTADRIDDDILKVIVDSMNHHGDARSKLREELAELTAELKIYSVIQAEINKYLSNSGTINIHDKSINLMDKNLYGYTDEEIFKASAEYKILEKMSQTTI-----KX--------X 
YE-WA314   VMHFSLTADRIDDDILKVIVDSMNHHGDARSKLREELAELTAELKIYSVIQAEINKHLSSSGTINIHEKSINLMDKNLYGYTDEEIFKASAEYKILKKMPQTTI-----KDDELHEVGVI 
YE-W22703  VMHFSLTADRIDDDILKVIVDSMNHHGDARGKLREELAELTAELKIYSVIQAEINKHLSNSDTINIHDKSINLMDKNLYGYTDEEIFKASAEYKILEKMPQTTI-----KX--------X 
YE-21202   VMHFSLTADRIDDDILKVIVDSMNHHGDARSKLREELAELTAELKIYSVIQAEINKHLSNSGTINIHDKSINLMDKNLYGYTDEEIFKASAEYKILEKMPQTTVPPIPGNX--------X 
YE-5603    VMHFSLTADRIDDDILKVIVDSMNHHGDARSKLREELAELTAELKIYSVIQAEINKHLSNSGTINIHDKSINLMDKNLYGYTDEEIFKASAEYKILEKMPQTTVPPIPGNX--------X 
YE-Y96     VMHFSLTADRIDDDILKVIVDSMNHHGDARGKLREELAELTAELKIYSVIQAEINKHLSNSDTINIHDKSINLMDKNLYGYTDEEIFKASAEYKILEKMPQTTI-----KX--------X 
YE-14902   VMHFSLTADRIDDDILKVIVDSMNHHGDARSKLREELAELTAELKIYSVIQAEINKHLSNSGTINIHDKSINLMDKNLYGYTNEEIFKASAEYKILEKMSQTTI-----KX--------X 
YE-Y527    VMHFSLTADRIDDDILKVIVDSMNHHGDARSKLREELAELTAELKIYSVIQAEINKHLSNSDTINIHDKSINLMDKNLYGYTNEEIFKASAEYKILEKMSQTTI-----KX--------X 
YE-1203    VMHFSLTADRIDDDILKVIVDSMNHHGDARSKLREELAELTAELKIYSVIQAEINKHLSNSDTINIHDKSINLMDKNLYGYTNEEIFKASAEYKILEKMSQTTI-----KX--------X 
YE-SZ3094  VMHFSLTADRIDDDILKVIVDSMNHHGDARSKLREELAELTAELKIYSVIQAEINKHLSNSDTINIHNNSINLMDKNLYGYTNEEIFKASAEYKILNNMSQTTT-----KDKX------X 
 
 
YPS-YPI GETEKKIVSIKNFLESEKKRTGALGNLKDSYSYNKDNNELSHFATTCSDKSRPLNDLVSQKTTQLSDITSRFNSAIEALNRFIQKYDSVMQRLLDDTSGK* 
YE-8081    GETEKKIVSIKNFLESENKRTGALGNLKNSYSYNKDNNELSHFATACSDKSRPLNDLVSQKTTQLSDITSRFNSAIEALNRFIQKYDSVMQRLLDDT--R* 
YE-WA314   AGAEKQIVSIKNFLESENKRTGALGNLKDSYSYNKDNNELSHFATACSDKSRPLNDLVSQKTTQLSDITSRFNSAIEALNRFIQKYDSVMQRLLDDT--RL 
YE-W22703  GETEKKIVSIKNFLESENKRTGALGNLKDSYSYNKDNNELSHFATTCSDKSRPLNDLVSQKTTQLSDITSRFNSAIEALNRFIQKYDSVMQRLLDDT--R* 
YE-21202   NGSEKKIVSIKNFLESENKRTGALGNLKDSYSYNKDNNELSHFATTCSDKSRPLNDLVSQKTTQLSDITSRFNSAIEALNRFIQKYDSVMQRLLDDT--R* 
YE-5603    NGSEKKIVSIKNFLESENKRTGALGNLKDSYSYNKDNNELSHFATTCSDKSRPLNDLVSQKTTQLSDITSRFNSAIEALNRFIQKYDSVMQRLLDDT--R* 
YE-Y96     GETEKKIVSIKNFLESENKRTGALGNLKDSYSYNKDNNELSHLGTTCSDKSRPLNDLVSQKTTQLSDITSRFNSAIEALNRFIQKYDSVMQRLLDDT--R* 
YE-14902   GETEKKIVSIKNFLESENKRTGALGNLKDSYSYNKDNNELSHFATTCSDKSRPLNDLVSQKTTQLSDITSRFNSAIEALNRFIQKYDSVMQRLLDDT--R* 
YE-Y527    GETEKKIVSIKNFLESENKRTGALGNLKDSYSYNKDNNELSHLGTTCSDKSRPLNDLVSQKTTQLSDITSRFNSAIEALNRFIQKYDSVMQRLLDDT--R* 
YE-1203    GETEKKIVSIKNFLESENKRTGALGNLKDSYSYNKDNNELSHFATTCSDKSRPLNDLVSQKTTQLSDITSRFNSAIEALNRFIQKYDSVMQRLLDDT--R* 
YE-SZ3094 GKTEKKIVSIKNFLESENKRTGALNNLKESYSYNKDNNELSHFATTCSDKSRPLNDLVSQKTTQLSDITSRFNSAIEALNRFIQKYDSVMQRLLDDT--R* 
 
Figure 5.3: Protein sequence alignment for LcrV. YPS-YPI – Y. pseudotuberculosis YPIII, YE – 
Y. enterocolitica, 8081 and WA314 – BT 1B O:8, W22703, 21202, 5603, and Y96 – BT 2 O:9, 14902 
and Y527 – BT 3 O:5,27, 1203 – BT 4 O:3, SZ3094 – BT 5 O:2a,2b,3. 
 
The difference in sequence between American O:8 isolates and Y. pestis, 
Y. pseudotuberculosis, and European Y. enterocolitica isolates has been implicated 
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in plague epidemiology (Roggenkamp, et al., 1997). The authors suggest that the 
antibodies raised against the Y. enterocolitica V-antigen are cross protective in 
rodents to Y. pestis infection. Since the American O:8 isolates express a different 
antigen it is thought that this cross protection is not given, explaining the plague foci 
found in the Americas (Roggenkamp, et al., 1997). Undoubtedly the insertion of 
additional amino acids can cause a conformational change in the protein and thus 
leads to the expression of an altered epitope, but this variation is not found in all O:8 
isolates. BT 1B strain 8081 was isolated from North America and shows high LcrV 
sequence identity with Y. pseudotuberculosis and Y. pestis and no amino acid 
insertions, suggesting that this isolate should theoretically confer immunity against 
Y. pestis. The variation in the O:9 isolates would presumably not give protective 
immunity against plague, yet these isolates are very common in Europe without 
associated plague foci. An effect on infectivity, virulence potential or severity of 
disease has not been correlated with a changed LcrV epitope. 
 
5.2.3.3 yscP 
YscP forms an essential part of the type III secretion machinery. Deletion mutants 
showed that abolishing the complete gene leads to a loss of secretion of Yops, and a 
functional protein is necessary for the delivery of the effectors into target cells 
(Stainier, et al., 2000). It was noted as well that it shows more variability than any 
other protein in the T3SS between Y. pseudotuberculosis, Y. pestis, and 
Y. enterocolitica (Stainier, et al., 2000). YscP from Y. enterocolitica has additional 60 
amino acids that appear to be part of a repeat compared to Y. pseudotuberculosis 
and Y. pestis. Later investigations showed that YscP controls the length of the 
injectisome needles, acting like a ruler to determine optimum length (Journet, Agrain, 
Broz and Cornelis, 2003). The N and C terminal part of the protein are essential for 
length control in general, as deletion mutants showed a wide range of needle sizes. 
Deletions or insertions into the central part of the protein resulted in proportionally 
shorter or longer needles, therefore being the functional domain responsible for fixed 
needle length (Journet, Agrain, Broz and Cornelis, 2003). Additionally, YscP acts as 
a specificity switch signalling the apparatus to stop producing needle proteins and 
change over to late substrates (Journet, Agrain, Broz and Cornelis, 2003; Wagner, et 
al., 2009). YscP is anchored to the base and the growing tip of the needle so that it is 
stretched alongside the needle during assembly. The content of helix makers such as 
alanine and the overall length of the protein YscP determine the needle length 
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(Wagner, et al., 2009). Once YscP reaches a breaking point when stretched to its 
maximum, it detaches and signals back so that late injectisome molecules are 
produced (Wagner, et al., 2009). 
A comparison between YscP protein sequences previously investigated (Foultier and 
Cornelis, 2003; Wagner, et al., 2009; Oberhettinger, et al., 2011) and sequences 
generated here shows that YscP contains three different repeat units (Figures 5.4 
and 5.5). These repeats are modules that can be duplicated and reorganized in 
different strains. The red repeat contains 13 amino acids, green 25 amino acids, and 
blue 46 amino acids, identical to repeats described before (Wagner, et al., 2009). 
The region of variability begins at amino acid position 219 respective to BT 1B strain 
YE-8081 (Figure 5.4).  
At the beginning of the region of variability there is a first red repeat in all strains 
except for one BT 1B isolate that shows a 24 amino acid deletion. The red repeat is 
followed by the first green repeat that is present in all strains except for BT 5. Instead 
of a green repeat, one BT 5 strain shows blue and red repeat units. The next repeats 
are the first blue and the second red repeats in all low-pathogenic BTs and three BT 
1B isolates. The BT 3 O:5,27 isolate YE-14902 shows an in-frame deletion of 6 bp (2 
amino acids). The three BT 1B isolates are A11/86, WAT-988, and WA314, which 
then also have a second green repeat. The region of variability ends with a second 
blue repeat in all strains.  
The protein sequences of the strains are shown in Figure 5.5 to highlight the modular 
nature of YscP. 
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                      |         |         |          |         |         |         |         |          |         |         |         |      
YERPE M-NKITTRSPLEPEYQPLGKPHHALQACVDFEQALLHNNKGNCHPKEESLKPVRPHDLGKKEGQKGDGLRAHAPLAATSQPGRKEVGLKPQHNHQNNHDFNLSPLAEGATNRAHLYQQDSRFDDRV 
YPSTB M-NKITTRSPLEPEYQPLGKPHHALQACVDFEQALLHNNKGNCHPKEESLKPVRPHDLGKKEGQKGDGLRAHAPLAATSQPGRKEVGLKPQHNHQNNHDFNLSPLAEGATNRAHLYQQDSRFDDRV 
YE-A1186 MANKITTRSPLEPEYQPLGKPHHDLQARVDFEQALLHN-KDNRHPKEEPRRPVRPHDLGKKEGQKGDGLRAHAPLAATFQPGR-EVGLKPQHNHQNNHDFNLSPLAEGATNRKHLYQQDSRFDDRV 
YE-WAT988 MANKITTRSPLEPEYQPLGKPHHDLQARVDFEQALLHN-KDNRHPKEEPRRPVRPHDLGKKEGQKGDGLRAHAPLAATFQPGR-EVGLKPQHNHQNNHDFNLSPLAEGATNRKHLYQQDSRFDDRV 
YE-WA314 M-NKITTRSPLEPEYQPLGKPHHDLQARVDFEQALLHN-KDNRHPKEEPRRPVRPHDLGKKEGQKGDGLRAHAPLAATFQPGR-EVGLKPQHNHQNNHDFNLSPLAEGATNRKHLYQQDSRFDDRV 
YE-8081 M-NKITTRSPLEPEYQPLGKPHHDLQARVDFEQALLHN-KDNRHPKEEPRRPVRPHDLGKKEGQKGDGLRAHAPLAATFQPGR-EVGLKPQHNHQNNHDFNLSPLAEGATNRKHLYQQDSRFDDRV 
YE-A12790 M-NKITTRSPLEPEYQPLGKPHHDLQARVDFEQALLHN-KDNRHPKEEPRRPVRPHDLGKKEGQKGDGLRAHAPLAATFQPGR-EVGLKPQHNHQNNHDFNLSPLAEGATNRKHLYQQDSRFDDRV 
YE-WAT288 MANKITTRSPLEPEYQPLGKPHHDLQARVDFEQALLHN-KDNRHPKEEPRRPVRPHDLGKKEGQKGDGLRAHAPLAATFQPGR-EVGLKPQHNHQNNHDFNLSPLAEGATNRKHLYQQDSRFDDRV 
YE-21202 M-NKITTRSPLEPEYQPLGKLHHDLQARADFEQALLHNNKGNRHPKEEPRRPVRPHDLGKKEGQKGDGLRAHAPLEATFQPGRKEVGLKPQHNHQNNHDLNLSPLAEGVTNRAHLYQQDSRFDDRV 
YE-W22703 M-NKITTRSPLEPEYQPLGKLHHDLQARADFEQALLHNNKGNRHPKEEPRRPVRPHDLGKKEGQKGDGLRAHAPLEATFQPGRKEVGLKPQHNHQNNHDLNLSPLAEGVTNRAHLYQQDSRFDDRV 
YE-E40 M-NKITTRSPLEPEYQPLGKLHHDLQARADFEQALLHNNKGNRHPKEEPRRPVRPHDLGKKEGQKGDGLRAHAPLEATFQPGRKEVGLKPQHNHQNNHDLNLSPLAEGVTNRAHLYQQDSRFDDRV 
YE-5603 M-NKITTRSPLEPEYQPLGKLHHDLQARADFEQALLHNNKGNRHPKEEPRRPVRPHDLGKKEGQKGDGLRAHAPLEATFQPGRKEVGLKPQHNHQNNHDLNLSPLAEGVTNRAHLYQQDSRFDDRV 
YE-14902 M-NKITTRSPLEPEYQPLGKPHHDLQARADFEQALLHNNKGNRHPKEEPRRPVRPHDLGKKEGQKGDGLRAHAPLEATFQPGRKEVGLKPQHNHQNNHDLNLSPLAEGVTNRAHLYQQDSRFDDRV 
YE-1203 M-NKITTRSPLEPEYQPLGKPHHDLQARADFEQALLHNNKGNRHPKEEPRRPVRPHDLGKKEGQKGDGLRAHAPLEATFQPGRKEVGLKPQHNHQNNHDLNLSPLAEGVTNRAHLYQQDSRFDDRV 
YE-SZ3094 M-NKITTRSPLEPEYQPLGKPHHDLQARADFEQALLHNNKGNRHPKEEPRRPVRPHDLGKKEGQKGDGLRAHAPLAATFQPGRKEVGLKPQHNHQNNHDFNLSPLAEGATNRKHLYQQDSRFDDRV 
YE-IP17 MANKITTRSPLEPEYQPLGKPHHDLQARADFEQALLHNNKGNRHPKEEPRRPVRPHDLGKKEGQKGDGLRAHAPLAATFQPGRKEVGLKPQHNHQNNHDFNLSPLAEGATNRKHLYQQDSRFDDRV 
 
                  |         |         |         |         |         |         |         |         |         |         |         |          
YERPE ESIINALMPLAPFLEGVTCETGTSSESPCEPSGHDELFVQQSPIDSAQPVQLNSKPTVQPLNPAADGAEVIVWSVGRETPASIAKNQRDSRQKRLAEEPLALHQKALPEICPPAVSATPDDHLVAR 
YPSTB ESIINALMPLAPFLEGVTCETGTSSESPCEPSGHDELFVQQSPIDSAQPVQLNSKPTVQPLNPAADGAEVIVWSVGRETPASIAKNQRDSRQKRLAEEPLALHQKALPEICPPAVSATPDDHLVAR 
YE-A1186 ESIINALMPLAPFLEGVTCETGTSSESPCEPFGHDELFVQQSPIDSAQPVQLNTKPTVQSLNPAADGAEVMIWSVGRDTLASIAKNQRDSRQKRLAEEPLP------------------------R 
YE-WAT988 ESIINALMPLAPFLEGVTCETGTSSESPCEPFGHDELFVQQSPIDSAQPVQLNTKPTVQSLNPAADGAEVMIWSVGRDTLASIAKNQRDSRQKRLAEEPLPLHQEALPEVCPPAVSTTPDDHLVAR 
YE-WA314 ESIINALMPLAPFLEGVTCETGTSSESPCEPFGHDELFVQQSPIDSAQPVQLNTKPTVQSLNPAADGAEVMIWSVGRDTLASIAKNQRDSRQKRLAEEPLPLHQEALPEVCPPAVSTTPDDHLVAR 
YE-8081 ESIINALMPLAPFLEGVTCETGTSSESPCEPFGHDELFVQQSPIDSAQPVQLNTKPTVQSLNPAADGAEVMIWSVGRDTLASIAKNQRDSRQKRLAEEPLPLHQEALPEVCPPAVSTTPDDHLVAR 
YE-A12790 ESIINALMPLAPFLEGVTCETGTSSESPCEPSGHDELFVQQSPIDSAQPVQLNTKPTVQPLNPAADGAEVMIWSVGRDTLASIAKNQCDSRQKRLAEEPLPLHQEALPEVCPPAVSTTPDDHLVAR 
YE-WAT288 ESIINALMPLAPFLEGVTCETGTSSESPCEPSGHDELFVQQSPIDSAQPVQLNTKPTVQSLNPAADGAEVMISSVGRDTLASIAKNQRDSRQKRLAEEPLPLHQEALPEVCPPAVSTTPDDHLVAR 
YE-21202 ESIINALMPLAPFLKGVTCETGTSSESPCEPSGHDELFVQQSPIDSVQPVQLNTKPTVQPLNPAADGAEVIVWSVGRETPASIAKNQRDSRQKRLAEEPLPLHQEALPEVCPPAVSATPNDHLVAR 
YE-W22703 ESIINALMPLAPFLKGVTCETGTSSESPCEPSGHDELFVQQSPIDSVQPVQLNTKPTVQPLNPAADGAEVIVWSVGRETPASIAKNQRDSRQKRLAEEPLPLHQEALPEVCPPAVSATPNDHLVAR 
YE-E40 ESIINALMPLAPFLKGVTCETGTSSESPCEPSGHDELFVQQSPIDSVQPVQLNTKPTVQPLNPAADGAEVIVWSVGRETPASIAKNQRDSRQKRLAEEPLPLHQEALPEVCPPAVSATPNDHLVAR 
YE-5603 ESIINALMPLAPFLKGVTCETGTSSESPCEPSGHDELFVQQSPIDSVQPVQLNTKPTVQPLNPAADGAEVIVWSVGRETPASIAKNQRDSRQKRLAEEPLPLHQEALPEVCPPAVSATPNDHLVAR 
YE-14902 ESIINALMPLAPFLEGVTCETGTSSESPCEPSGHDELFVQQSPIDSVQPVQLNTKPTVQPLNPAADGAEVIVWSVGRETPASIAKNQRDSRQKRLAEEPLPLHQEALPEVCPPAVSATPNDHLVAR 
YE-1203 ESIINALMPLAPFLEGVTCETGTSSESPCEPSGHDELFVQQSPIDSVQPVQLNTKPTVQPLNPAADGAEVIVWSVGRETPASIAKNQRDSRQKRLAEEPLPLHQEALPEVCPPAVSATPNDHLVAR 
YE-SZ3094 ESIINALMPLAPFLKGVTCETGTSSESPCEPSGHDELFVQQSPIDSVQPVQLNTKPTVQPLNPAADGAEVIVWSVGRETPASIAKNQRDSRQKRLAEEPLPLHQEALPEV---------------- 
YE-IP17 ESIINALMPLAPFLKGVTCETGTSSESPCEPSGHDELFVQQSPIDSVQPVQLNTKPTVQPLNPAADGAEVIVWSVGRETPASIAKNQRDSRQKRLAEEPLPLHQEALPEV---------------- 
  
            |                                                                                                                              
YERPE WCATPVTEV--------------------------------------------------------------------------------------------------------------------- 
YPSTB WCATPVTEV--------------------------------------------------------------------------------------------------------------------- 
YE-A1186 WCATPVAEV------------------------------------------------------------AEKSARFPHKATVQSEQLDMTELADRSQHLTDGVDSSKDTIEPPRPEEPLPLHQEAL 
YE-WAT988 WCATPVAEV------------------------------------------------------------AEKSARFPHKATVQSEQLDMTELADRSQHLTDGVDSSKDTIEPPRPEEPLPLHQEAL 
YE-WA314 WCATPVAEV------------------------------------------------------------AEKSARFPHKATVQSEQLDMTELADRSQHLTDGVDSSKDTIEPPRPEEPLPLHQEAL 
YE-8081 WCATPVAEV--------------------------------------------------------------------------------------------------------------------- 
YE-A12790 WCATPVAEV--------------------------------------------------------------------------------------------------------------------- 
YE-WAT288 WCATPVAEV--------------------------------------------------------------------------------------------------------------------- 
YE-21202 WCATPVAEV------------------------------------------------------------AEKSARFLHKAIVQSEQLDMTELADRSQHLTDGVDSSKDTIELPRPEEPLPLHQEAL 
YE-W22703 WCATPVAEV------------------------------------------------------------AEKSARFLHKAIVQSEQLDMTELADRSQHLTDGVDSSKDTIELPRPEEPLPLHQEAL 
YE-E40 WCATPVAEV------------------------------------------------------------AEKSARFLHKAIVQSEQLDMTELADRSQHLTDGVDSSKDTIELPRPEEPLPLHQEAL 
YE-5603 WCATPVAEV------------------------------------------------------------AEKSARFLHKAIVQSEQLDMTELADRSQHLTDGVDSSKDTIELPRPEEPLPLHQEAL 
YE-14902 WCATPVAEV------------------------------------------------------------AEKSA--SHKATVQSEQLDMTELTDRSQHLTDGVDSSKDTIELPRPEEPLPLHQEAL 
YE-1203 WCATPVAEV------------------------------------------------------------AEKSARFLHKAIVQSEQLDMTELADRSQHLTDGVDSSKDTIELPRPEEPLPLHQEAL 
YE-SZ3094 ---------------------------------------------------------------------AEKSARFPHKATVQSEQLDMTELAARSQYLTDGVDSSKDTIELPRPEEPLPLHQEAL 
YE-IP17 ---------AEKSARFPHKATVQSEQLDMTELAARSQYLTDGVDSSKDTIELPRPEEPLPLHQEALPEVAEKSARFPHKATVQSEQLDMTELAARSQYLTDGVDSSKDTIELPRPEEPLPLHQEAL 
 
 
                                         |         |         |         |         |         |         |         |         |         |         
YERPE ----------------------------AEKSARFPYKATVQSEQLDMTELADRSQHLTDGVDSSKDTIEPPRPEKLLLPREETLPEMYSLSFTAPVVTPGDHLLATMRATRLASVSEQLIQLAQR 
YPSTB ----------------------------AEKSARFPYKATVQSEQLDMTELADRSQHLTDGVDSSKDTIEPPRPEKLLLPREETLPEMYSLSFTAPVVTPGDHLLATMRATRLASVSEQLIQLAQR 
YE-A1186 PEVCPPAVSTTPDDHLVARWCATPVAEVAEKSARFPHKATVQSEQLDMTELADRSQHLTDGVDSSKDTIEPPRPEELLLPREETLPEMYSLSFTAPVITPGDHLLATMRATRLASVSEQLIQLAQR 
YE-WAT988 PEVCPPAVSTTPDDHLVARWCATPVAEVAEKSARFPHKATVQSEQLDMTELADRSQHLTDGVDSSKDTIEPPRPEELLLPREETLPEMYSLSFTAPVITPGDHLLATMRATRLASVSEQLIQLAQR 
YE-WA314 PEVCPPAVSTTPDDHLVARWCATPVAEVAEKSARFPHKATVQSEQLDMTELADRSQHLTDGVDSSKDTIEPPRPEELLLPREETLPEMYSLSFTAPVITPGDHLLATMRATRLASVSEQLIQLAQR 
YE-8081 ----------------------------AEKSARFPHKATVQSEQLDMTELADRSQHLTDGVDSSKDTIEPPRPEELLLPREETLPEMYSLSFTAPVITPGDHLLATMRATRLASVSEQLIQLAQR 
YE-A12790 ----------------------------AEKSARFPHKATVQSEQLDMTELADRSQHLTDGVDSSKDTIEPPRPEELLLPREETLPEMYSLSFTAPVITLGDHLLATMRATRLASVSEQLIQLAQR 
YE-WAT288 ----------------------------AEKSARFPHKATVQSEQLDMTELADRSQHLTDGVDSSKDTIEPPRPEELLLPREETLPEMYSLSFTAPVITPGDHLLATMRATRLASVSEQLIQLAQR 
YE-21202 PEV-------------------------AEKSARFPHKATVQSEQLDMTELAARSQYLTDGVDSSKDTIEPPRPEELLLPREETLLEMYSLSFTAPVVTPGDHLLATMRATRLTSVSEQLIQLAQR 
YE-W22703 PEV-------------------------AEKSARFQHKATVQSEQLDMTELAARSQYLTDGVDSSKDTIEPPRPEELLLPREETLLEMYSLSFTAPVVTPGDHLLATMRATRLTSVSEQLIQLAQR 
YE-E40 PEV-------------------------AEKSARFPHKATVQSEQLDMTELAARSQYLTDGVDSSKDTIEPPRPEELLLPREETLLEMYSLSFTAPVVTPGDHLLATMRATRLTSVSEQLIQLAQR 
YE-5603 PEV-------------------------AEKSARFPHKATVQSEQLDMTELAARSQYLTDGVDSSKDTIEPPRPEELLLPREETLLEMYSLSFTAPVVTPGDHLLATMRATRLTSVSEQLIQLAQR 
YE-14902 PEV-------------------------AEKSARFPHKATVQSEQLDMTELAARSQYLTDGVDSSKDTIEPPRPEELLLPREETLLEMYSLSFTAPVVTPGDHLLATMRTTRLTSVSEQLIQLAQR 
YE-1203 PEV-------------------------AEKSARFPHKATVQSEQLDMTELAARSQYLTDGVDSSKDTIEPPRPEELLLPREETLLEMYSLSFTAPVVTPGDHLLATMRATRLTSVSEQLIQLAQR 
YE-SZ3094 PEV-------------------------AEKSARFPHKATVQSEQLDMTELAARSQYLTDGVDSSKDTIEPPRPEELLLPREETLLEMYSLSFTAPVVTPGDHLLATMRATRLTSVSEQLIQLAQR 
YE-IP17 PEV-------------------------AEKSARFPHKATVQSEQLDMTELAARSQYLTDGVDSSKDTIEPPRPEELLLPREETLLEMYSLSFTAPVVTPGDHLLATMRATRLTSVSEQLIQLAQR 
 
               |         |         |         |         |         |         |         |         |         |        
YERPE LAVELELRGGSSQVTQLHLNLPELGAIMVRIAEIPGKLHVELIASREALRILAQGSYDLLERLQRIEPTQLDFQASDDSEQESRQKRHVYEEWEAEE* 
YPSTB LAVELELRGGSSQVTQLHLNLPELGAIMVRIAEIPGKLHVELIASREALRILAQGSYDLLERLQRIEPTQLDFQASDDSEQESRQKRHVYEEWEAEE* 
YE-A1186 LAVELELRGGSSQVTQLHLNLPELGAIMVRIAEIPGKLHVELIASRETLRILAQGSYDLLERLQRIEPTQLDFQASGDSEQESRQKRHVYEEWEAEE* 
YE-WAT988  LAVELELRGGSSQVTQLHLNLPELGAIMVRIAEIPGKLHVELIASRETLRILAQGSYDLLERLQRIEPTQLDFQASGDSEQESRQKRHVYEEWEAEE* 
YE-WA314 LAVELELRGGSSQVTQLHLNLPELGAIMVRIAEIPGKLHVELIASRETLRILAQGSYDLLERLQRIEPTQLDFQASGDSEQESRQKRHVYEEWEAEE* 
YE-8081 LAVELELRGGSSQVTQLHLNLPELGAIMVRIAEIPGKLHVELIASRETLRILAQGSYDLLERLQRIEPTQLDFQASGDSEQESRQKRHVYEEWEAEE* 
YE-A12790 LAVELELRGGSSQVTQLHLNLPELGAIMVRIAEIPGKLHVELIASRETLRILAQGSYDLLERLQRIEPTQLDFQASGDSEQESRQKRHVYEEWEAEE* 
YE-WAT288 LAVELELRGGSSQVTQLHLNLPELGAIMVRIAEIPGKLHVELIASRETLRILAQGSYDLLERLQRIEPTQLDFQASGDSEQESRQKRHVYEEWEAEE* 
YE-21202  LAVELELRGGSSQVTQLHLNLPELGAIMVRIAEIPGKLHVELIASQEALRILAQGSYDLLERLQRIEPTQLDFQASGDSEQESRQKRHVYEEWEAEE* 
YE-W22703  LAVELELRGGSSQVTQLHLNLPELGAIMVRIAEIPGKLHVELIASQEALRILAQGSYDLLERLQRIEPTQLDFQASGDSEQESRQKRHVYEEWEAEE* 
YE-E40    LAVELELRGGSSQVTQLHLNLPELGAIMVRIAEIPGKLHVELIASQEALRILAQGSYDLLERLQRIEPTQLDFQASGDSEQESRQKRHVYEEWEAEE* 
YE-5603    LAVELELRGGSSQVTQLHLNLPELGAIMVRIAEIPGKLHVELIASQEALRILAQGSYDLLERLQRIEPTQLDFQASGDSEQESRQKRHVYEEWEAEE* 
YE-14902   LAVELELRGGSSQVTQLHLNLPELGAIMVRIAEIPGKLHVELIASQEALRILAQGSYDLLERLQRIEPTQLDFQASGDSEQESRQKRHVYEEWEAEE* 
YE-1203    LAVELELRGGSSQVTQLHLNLPELGAIMVRIAEIPGKLHVELIASQEALRILAQGSYDLLERLQRIEPTQLDFQASGDSEQESRQKRHVYEEWEAEE* 
YE-SZ3094  LAVELELRGGSSQVTQLHLNLPELGAIMVRIAEIPGKLHVELIASQEALRILAQGSYDLLERLQRIEPTQLDFQASGDSEQESRQKRHVYEEWEAEE* 
YE-IP17    LAVELELRGGSSQVTQLHLNLPELGAIMVRIAEIPGKLHVELIASQEALRILAQGSYDLLERLQRIEPTQLDFQASGDSEQESRQKRHVYEEWEAEE* 
 
Figure 5.4: Protein sequence alignment of YscP protein sequences of different Yersinia spp. 
Repeats in amino acid sequences are highlighted in red (13 amino acids), green (25 amino acids), and 
blue (46 amino acids). Variations in amino acids are highlighted in purple. Vertical bars indicate every 
10 amino acids respective to YE-8081 (bold sequence). YERPE – Y. pestis strain IP275, YPSTB – 
Y. pseudotuberculosis strain YPIII, YE- – Y. enterocolitica, BT 1B: A1186 (O:21), WAT988 (O:4), 
WA314 (O:8), 8081 (O:8), A127/90 (O:8), WAT288 (O:13), BT 2: 21202, E40 (O:9), BT 3: 5603 (O:9), 
14902 (O:5,27), BT 4: 1203 (O:3), BT 5: SZ3094 (O2a,2b,3), IP17 (O:2,3). 
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Figure 5.5: Modular nature of YscP in different Yersinia spp. Conserved sequences are shown in 
black, repeat sequences are red (13 amino acids), green (25 amino acids), and blue (46 amino acids). 
Strains are the same as in Figure 5.4. 
 
From Figure 5.5 one can see that there are certain themes concerning the makeup of 
YscP in Yersinia spp. First of all, Y. pestis and Y. pseudotuberculosis show an 
identical YscP protein with a single repeat of each the red, green, and blue module. 
For the high-pathogenic BT 1B of Y. enterocolitica, there are two options. The first 
option is to have the same YscP sequence as Y. pestis. Presumably evolved from 
this is the second option of duplicating the red-green-blue modules. Strain A1186 
shows a deletion of the parts of the red and green modules. This could have 
happened after duplication of the whole repeat region, as it is otherwise identical to 
strains WAT988 and WA314. In the low-pathogenic BTs there are also two 
possibilities. For BTs 2, 3, and 4, the red and blue modules are duplicated. For BT 5, 
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only the red and blue modules are present, and can vary in copy number. A caveat 
for BT 5 has to be added, as so far only these two isolates have been studied and it 
is not known whether this is a common phenomenon for BT 5 isolates. It is also 
unknown whether the differences observed correlate to a change in pathogenicity 
and whether a change in needle length affects efficiency of effector translocation. 
 
5.2.4 Plasmid Variety: Unique plasmids  
In the Y. enterocolitica strains that were sequenced, four unique plasmids were 
identified apart from the virulence plasmid. BT 2 strain 21202 and BT 5 strain 3094 
both had large additional plasmids, and biotype 1A, though lacking the virulence 
plasmid, showed the presence of two small plasmids. 
 
5.2.4.1 Unique plasmids in the reference strain for BT1A: pSR2-1A and pSR3-1A 
Two unique plasmids are present in the reference strain 5303 for BT 1A, which were 
named pSR2-1A and pSR3-1A. pSR2-1A (Figure 5.6) has a size of 8 kb. The GC 
content is 48.0% and therefore remarkably close to the chromosomal GC content of 
strain 5303 (48.42%). The coding percentage is 81.3%. A total of 12 CDSs were 
identified, but function could only be assigned to four of these. The other eight CDSs 
are currently hypothetical proteins with uncharacterized homologs in other bacterial 
species other than E. coli. These homologs are either distantly related or are not well 
characterized, thus a function cannot be allocated. It contains three genes mobABC 
that encode for mobility of the plasmid. There are no transfer genes encoded on this 
plasmid, which means that this plasmid can be co-mobilized if another plasmid with 
tra genes for conjugational transfer is present. 
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Figure 5.6: Linear plasmid map of pSR2-1A found in Y. enterocolitica BT 1A O:5 strain 5303. 
 
 
Figure 5.7: Linear plasmid map of pSR3-1A found in Y. enterocolitica BT 1A O:5 strain 5303. 
 
Similarly, pSR3-1A contains mobABC, but no tra genes (Figure 5.7). This plasmid 
only has a size of 4 kb. The GC content of pSR3-1A is 53.92%. This is higher than 
the GC content of pSR2-1A as well as the chromosome of strain 5303. The coding 
percentage is 104.3%. It is likely that this is an overestimation as half of the putative 
CDSs are of hypothetical nature. 
Both plasmids appear to be cryptic, as they do not contain any genes of assigned 
functions. pSR3-1A contains two genes which might encode for membrane proteins, 
as one of them has a SignalP-domain, and the other shows potential transmembrane 
domains. 
Two cryptic plasmids, pYe4449-1 and pYe4449-2, described in another BT 1A strain 
(Lepka, et al., 2009) show no similarity to the plasmids described here apart from the 
mobilization region mobABC. These plasmids add to the overall gene pool in 
Y. enterocolitica, especially the non-pathogenic BT, but their function and impact is 
unknown. 
  
entry exclusion protein mobABC 
pSR2-1A – 8,329 bp 
mobABC 
pSR3-1A – 4,095 bp 
129 
5.2.4.2 Plasmids in atypical BT 1A/1B strains 
It is know that there are some isolates of Y. enterocolitica that biochemically type as 
BT 1B but which lack all of the determinants of high-pathogenic strains such as the 
virulence plasmid and the high-pathogenicity island. A plasmid profile of potential 
strains matching these criteria was established using the approach of Kado and Liu 
(1981; Figure 5.8). 
 
 
Figure 5.8: Plasmid profile of atypical BT 1A/1B isolates. Lane 1: Mixture of Salmonella plasmids 
of isolates SL1344 and PT4. Lane 2: Mixture of YE5303 and YE21202 plasmids (pSR1-2, pYV, pSR2-
1A, pSR3-1A). Lane 3-7: BT 1A/1B isolates. YE8081 – BT 1B O:8, YE2103 – BT 1B O:19, NZ5-7 – BT 
1B, no serotype information. Red arrows indicate size of pYV. 
 
Plasmid size can be estimated by the use of reference plasmids of known size, 
presented here in lane 1 and 2. In lane 1 there is a mixture of two Salmonella strains. 
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SL1344 has two large plasmids of 80 and 90 kb that form a single band on this gel, 
and further smaller plasmids are not visible. PT4 has a plasmid of about 70 kb size. 
Lane 2 has a mixture of plasmids from strain 5303 (pSR2-1A and pSR3-1A) and 
strain 21202 (pYV and pSR1-2). The high-pathogenic BT 1B reference strain 8081 is 
shown to demonstrate the size difference between high- and low-pathogenic pYVs.  
YE2103 is an atypical BT 1B strain that was isolated during the IID study in the UK 
(Tompkins, et al., 1999). It was obtained from a GP control, i.e. an asymptomatic 
person matched in age and sex to a case subject. It was non-invasive in tissue 
culture (A. McNally, personal communication) and it was shown in a microarray study 
that it is closely related to non-pathogenic isolates (Howard, et al., 2006). One can 
see that this isolate does not possess the virulence plasmid pYV or any other 
plasmid of similar size. Instead, it has two smaller plasmids, one of ~20 kb, the other 
~6 kb. As this strain was not included in the sequencing project (Chapter 7), no 
information on the nature of these plasmids is currently available. 
NZ5–7 were isolated from humans by collaborators in New Zealand (M. DuFour) and 
are lacking serotype information. NZ5 shows no presence of plasmids. NZ6 contains 
two plasmids of 75 kb and ~95 kb. NZ7 also has two plasmids, one of 75 kb, the 
other of 4 kb. From the information that these isolates were typed as BT 1B, it was 
initially assumed that the 75 kb plasmids of NZ6 and NZ7 are pYV. Two of these 
strains, NZ5 (NZ523784) and NZ7 (NZ761915), were sequenced as part of a strain 
collection (Chapter 7). Sequencing of NZ7 revealed that pYV is not present. Both 
NZ5 and NZ7 phylogenetically group with non-pathogenic BT 1A isolates, and HPI, 
Ysa T3SS, and YAPI could not be detected. Whilst nothing can be deduced for NZ6, 
it is clear that NZ5 and NZ7 have been mistyped as BT 1B and that the presence of a 
large plasmid of similar size to pYV may have influenced this decision in NZ7. It 
confirms that large plasmids can be present in non-pathogenic strains and that the 
presence of large plasmids does not indicate the presence of pYV. 
 
5.2.4.3 Unique plasmid in the reference strain for BT2: pSR1-2 
BT 2 O:9 strain 21202 carries a unique plasmid of 42 kb which was named pSR1-2. 
The plasmid has a GC content of 52.2%, which is higher than the chromosomal GC 
content of strain 21202 (48.1%). This would indicate an acquisition of this plasmid 
from a donor outside the genus Yersinia, because the average GC content is 48-49% 
(Sprague and Neubauer, 2005). 54 CDSs have been identified (coding percentage 
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87.8%). It belongs to the IncN incompatibility group, and a map is shown in Figure 
5.9.  
 
 
Figure 5.9: Circular plasmid map of pSR1-2 found in Y. enterocolitica BT 2 O:9 strain 21202. 
Regions of interest are highlighted. 
 
pSR1-2 carries stbABC involved in plasmid stability, as well as anti-restriction 
proteins, DNA-repair modulators, and an EcoRIIm restriction modification enzyme. In 
contrast to pSR2-1A and pSR3-1A, there are only five hypothetical genes. The 
plasmid contains tra genes for pilus formation and conjugational transfer. These 
genes are split into two operons. In between these two operons there is a tetracycline 
resistance cassette. The functionality of this antibiotic resistance cassette has been 
established by growth on LB agar containing 10, 20, and 50 µg/ml tetracycline. 
Compared to the other reference sequence strains, only BT 2 O:9 strain 21202 was 
able to grow on this medium. Five other BT 2 strains and one BT 3 O:9 strain 
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(YE21402) tested negative for growth on LB supplemented with tetracycline. The 
same BT 2 strains were examined for the presence of plasmids (Figure 5.10). 
 
Figure 5.10: Plasmid profile of BT 2 isolates. Lane 1-6: BT 2 isolates. YE21202, YE11902, 
YE22802 – BT 2 O:9, NZ8-10: BT 2, no serotype information. Lane 7: Mixture of Salmonella plasmids 
of isolates SL1344 and PT4. Lane 8: Mixture of YE5303 and YE21202 plasmids (pSR1-2, pYV, pSR2-
1A, pSR3-1A). Red arrows indicate size of pYV.  
 
Strain 21202 shows the clear presence of pYV at 75 kb and pSR1-2 at 40 kb. 
YE11902 has a plasmid of a size corresponding to pYV although in this extraction the 
band is very faint. YE22802 does not contain pYV but has two smaller plasmids of 
~20 kb and ~6 kb. NZ8 (NZ832501) and NZ10 (NZ1032126) both are positive for the 
virulence plasmid, and NZ9 (N2982399) does not carry any plasmids. 
Similar to arsenic, tetracycline is used as a growth promoter in pigs. The BT 2 O:9 
strain 21202 is a pig isolate, whereas the other tested strains are of other origins. 
This might explain the presence of a tetracycline-carrying plasmid in this strain. The 
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BT 3 O:9 pig isolate was not examined for the presence of pSR1-2, as it was 
sensitive to tetracycline. Sequencing of other isolates of BT 2 O:9, BT 3 O:9, BT 2 
O:5,27, and BT 3 O:5,27 (Chapter 7) showed that only one other isolate potentially 
carries a copy of pSR1-2. That respective strain YE0403 is of BT 3 O:5,27 and was 
isolated from human faeces. The acquisition of pSR1-2 in 21202 therefore might 
present a unique event not shared by other isolates of the same niche. 
pSR1-2 shows overall similarity to pMAK-2, a plasmid found in Salmonella Dublin 
(accession number AB366441.1; Akiba, 2007). A comparison between these two 
plasmids is shown in Figure 5.11. 
 
 
Figure 5.11: Comparison between Salmonella Dublin pMAK-2 and Y. enterocolitica pSR1-2. 
BleoR – bleomycin resistance, StrepR – streptomycin resistance, TetR – tetracycline resistance. 
 
pMAK-2 is larger in size than pSR1-2, and contains additional genes encoding for 
bleomycin and streptomycin resistance. Tetracycline resistance is shared in both 
plasmids, but is inverted in pSR1-2. 
Salmonella Dublin is predominantly found in cattle, and tetracycline resistance 
carried on plasmids has been described before (Frech and Schwarz, 1998). It is 
unknown whether there is a shared niche between S. Dublin and Y. enterocolitica 
that could facilitate the specific transfer of tetracycline resistance plasmids. 
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5.2.4.4 Unique plasmid in the reference strain for BT5: pSR4-5 
BT 5 O:2a,2b,3 strain 3094 also carries a unique plasmid which has been named 
pSR4-5. The GC content of the plasmid is lower than the chromosome (42.2% and 
48.2%, respectively). This is a large plasmid of 107 kb (Figure 5.12). 108 CDSs were 
identified (coding percentage 66.3%), of which 42 are hypothetical genes. Its 
replication protein could not be assigned to any incompatibility group. Similar to 
pSR1-2, this plasmid carries its own tra genes encoding a type IV pilus for 
conjugational transfer.  
pSR4-5 also carries a putative hemolysin and its activator protein, a putative 
toxin/antitoxin system, an endonuclease and a transglycosylase, a putative invasion 
protein, and proteins involved in plasmid partitioning. 
 
 
Figure 5.12: Plasmid map of pSR4-5 as found in Y. enterocolitica BT 5 O:2a,2b,3 strain 3094. 
Regions of interest are highlighted. 
 
pSR4-5 was also found to be present in two other BT 5 isolates sequenced in a 
larger strain collection. A similar plasmid, pYE854, has been isolated from a non-
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pathogenic BT 1A strain (Hertwig, Klein, Hammerl and Appel, 2003; Hammerl, et al., 
2008). A comparison between these two plasmids is shown in Figure 5.13. 
 
 
Figure 5.13: Comparison between Y. enterocolitica pYE854 and pSR4-5. Regions of interest are 
highlighted. 
 
Both plasmids have about 60 kb in common, including the conjugative transfer 
region, as well as replication and plasmid partitioning region. Additionally, pYE854 
carries a phosphotransferase system potentially involved with the transport and 
metabolism of sugars, although functionality could not be shown (Hammerl, et al., 
2008). 
pYV854 was shown to be able to transfer not only itself but also mobilize the 
virulence plasmid pYV in experimental studies (Hammerl, et al., 2008). This is 
important, as pYV itself is non-conjugative. Interestingly, pYE854 was isolated from a 
non-pathogenic BT 1A strain, which is known never to carry the virulence plasmid 
(Cornelis, et al., 1987; Lepka, et al., 2009; Wren 2003). The study suggests though 
that self-transmissible plasmids are common amongst Yersiniae as they also found a 
plasmid related to pYE854 which could also mobilize pYV (Hammerl, et al., 2008). 
pYE854 potentially belongs to an unknown incompatibility group as it showed no 
homology with the known incompatibility groups (Hammerl, et al., 2008). Furthermore 
co-carriage of pYE854 with plasmids of various incompatibility groups was shown 
(Hammerl, et al., 2008). As pSR4-5 shares the replication protein with pYE854, they 
might belong to the same incompatibility group.  
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5.3 Discussion 
5.3.1 The virulence plasmid differs in high- and low-pathogenic BTs 
The virulence plasmids of high- and low-pathogenic BTs differ in two important 
points. The low-pathogenic BTs carry an additional arsenic resistance operon, and 
the origin of replication differs between high- and low-pathogenic BTs. 
Arsenic resistance appears to be an important theme in Y. enterocolitica. The low-
pathogenic BTs carry an operon on the virulence plasmid as part of the transposon 
Tn2502. The high- and non-pathogenic BTs on the other hand show the presence of 
operons for arsenic resistance on the chromosome, one of which is orthologous 
between the two BTs. In the last century and largely before World War II, arsenic has 
been used as a therapeutic agent in veterinary and human medicine, in particular in 
pigs (Neyt, Iriarte, Thi and Cornelis, 1997). This is specifically relevant as pigs are 
considered one of the main hosts outside the human and an important source of 
infections. Arsenic resistance thus might promote survival in an important niche. The 
presence of the arsenic resistance on pYV together with the fact that the low-
pathogenic pYVs show few variations in gene content that only relate to IS elements 
can explain why human case and pig isolates showed identical restriction enzyme 
patterns (Kapperud and Nesbakken, 1987; Fukushima, Gomyoda, Aleksic and 
Tsubokura, 1993).  
To carry virulence and resistance genes together on a plasmid is unusual (Neyt, 
Iriarte, Thi and Cornelis, 1997). It is also interesting because the virulence plasmid is 
known to be easily lost under non-selective conditions (Heesemann, et al., 1983). It 
has been suggested that the acquisition of arsenic resistance coincided with the use 
of arsenic compounds, which then lead to a global spread of a low-pathogenic clone 
(Neyt, Iriarte, Thi and Cornelis, 1997). The population structure and relatedness of 
the low-pathogenic BTs cannot be deduced from a virulence plasmid and will be 
investigated in Chapter 7. Given the fluid nature of plasmid maintenance, arsenic 
resistance might also be viewed as a dispensable trait in low-pathogenic BTs. 
 
Analysis of the origin of replication showed dissimilarity between high- and low-
pathogenic BTs. They carry different proteins of distantly related replicons. It has 
been proposed that the two plasmids are of an independent origin (Portnoy, et al., 
1984; Snellings, Popek and Lindler, 2001). The selective pressure is on the type III 
secretion system and the secreted effector proteins; these build the backbone of the 
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plasmid (Portnoy, et al., 1984). The rest of the plasmid shows divergent, independent 
evolution (Snellings, Popek and Lindler, 2001). Different plasmids, one carrying the 
calcium-dependence region, the other carrying a different origin of replication, might 
have been cointegrated to form the present variety of pYVs (Portnoy, et al., 1984; 
Snellings, Popek and Lindler, 2001). It could be argued that the T3SS has integrated 
into pre-existing plasmids as a mobile genetic element. High- and low-pathogenic 
BTs might have carried different plasmids into which the T3SS inserted, explaining 
the difference in the origin of replication. The fact that more than 75% of the plasmid 
sequence is shared, that the only region of difference is the origin, and that important 
effector proteins are located outside of the conserved T3SS operons argue against 
this hypothesis though. The effector proteins located outside the T3SS operons also 
show some degree of conservation with respect to gene order, and their varying 
location is explained by the presence of transposases rather than further 
independent acquisition events. The difference observed in the origins argues for a 
single source for the T3SS, and that there is a distinct repertoire of plasmids (Portnoy 
and Falkow, 1981). The pYV should therefore be rather designated as a family of 
plasmids rather than a clonal molecule that shows no variation (Portnoy and Falkow, 
1981). It is difficult to say, which of the plasmids came first, and how they were 
passed on to other lineages, and how they evolved further. The events leading to the 
family of virulence plasmids have happened a long time in the past, and 
intermediates that are potentially found in environmental bacteria would be needed to 
shed light on the source and evolutionary direction of pYV. 
It has been argued that the degree of divergence between plasmids from 
Y. pseudotuberculosis/Y. pestis and Y. enterocolitica BT 1B is similar to the 
divergence found in the chromosome (Portnoy and Falkow, 1981). Together with 16S 
analysis and biochemical typing, this has probably led to the common conception of 
evolution of pathogenic Yersiniae through a single acquisition event of the virulence 
plasmid and subsequent speciation into Y. pseudotuberculosis and Y. enterocolitica 
(Carniel, 2002; Wren, 2003). The divergence between the virulence plasmid though 
is only based on hybridization values, and presumably focuses on the conserved 
T3SS backbone. Generally the virulence plasmids of Y. enterocolitica appear to be 
hybrids. Sometimes the variations observed in the high-pathogenic pYV more closely 
resemble the organization and single amino acid changes of Y. pseudotuberculosis 
and Y. pestis, at other times the low-pathogenic BTs are closer to Y. pestis, for 
example in the origin of replication. Chapter 7 will investigate the relationship 
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between the Yersiniae more thoroughly, and the consequences for plasmid 
acquisition.  
 
Plasmid variability has also been reported in Y. pestis (Eppinger, et al., 2010). 
Usually, the two Y. pestis unique plasmids pMT1 and pPCP1 are highly conserved. 
Eppinger, et al. (2010) describe a chimeric plasmid pMT-PCP consisting of a 
cointegrate of a single copy of pMT1 and two copies of pPCP1 in Y. pestis biovar 
Pestoides strain Angola. Some other Pestoides isolates were shown to lack one of 
the two plasmids, indicating that virulence plasmids play an important role in disease 
but are not predominant (Eppinger, et al., 2010). Just like in Y. enterocolitica, 
virulence is more than the acquisition and maintenance of a single plasmid and also 
involves the interplay with chromosomally encoded factors (Revell and Miller, 2001). 
 
5.3.2 Sequence variation in single genes: lcrV, yopM and yscP 
Although the T3SS forms a highly conserved part of the virulence plasmid, there are 
a few variations detected in single genes. These differences could be of physiological 
interest if they are predominantly present in certain lineages. 
The epitope LcrV is also known as the V antigen of pathogenic Yersiniae 
(Roggenkamp, et al., 1997). Research has shown that there are two variants 
(Roggenkamp, et al., 1997). The first variant is found in Y. pestis, 
Y. pseudotuberculosis and in European Y. enterocolitica strains as well as the 
biotype 1B strain 8081. The second variant has an additional 9 amino acids in the 
hypervariable region of the protein and is mostly found in American BT 1B isolates of 
Y. enterocolitica (Roggenkamp, et al., 1997). Protective immunity is only given for the 
respective antigen, cross-reactivity in vivo is low; this might help explain why there 
are natural niches for plague in the Americas, whereas in Europe the wild rodent 
population is immunized due to Y. enterocolitica infection resulting in antibody 
production against LcrV (Roggenkamp, et al., 1997).  
Here, a third variation with 5 additional amino acids present in the low-pathogenic 
BTs 2 and 3 O:9 is described. As this variation possibly changes the protein 
structure, a protective immunity would not be given after exposure to this antigen. 
Yet, BTs 2 and 3 are very common in Europe. A physiological role of LcrV as plague 
protection is therefore questionable as the presence of the three variants of LcrV 
does not correlate with the known plague foci. It is unknown though whether this third 
variant is commonly found in BT2 and 3 isolates, as only two strains were examined 
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here. It could also be that these isolates show mutations independent to the rest of 
the lineage.  
 
YopM is the only protein of the Yop regulon that contains leucine-rich repeats. It 
could be shown that the copy number of the repeat region containing 60 aa can vary 
between different strains (Boland, Havaux and Cornelis, 1998). This phenomenon is 
not linked to a specific biotype, as biotype 1B plasmids pYVe8081 and pYVeA127/90 
have different sizes (Boland, Havaux and Cornelis, 1998). In the presently 
investigated strains, no sequence variation compared to BT 1B was detected. The 
size and orientation of YopM does not have any visible effect on its function. 
pYVe8081 and pYVeA127/90 have not only proteins of different sizes, the orientation 
of said gene is also opposite on these plasmids; it is in clockwise orientation on 
pYVeA127/90 and in counter clockwise orientation on pYVe8081 (Foultier and 
Cornelis, 2003; Snellings, Popek and Lindler, 2001).  
 
The needle protein YscP was found to be 60 amino acids shorter in pYVe8081 than 
in pYVe227 (BT 2) (Snellings, Popek and Lindler, 2001), which made the protein 
from pYVe8081 more closely related to the ones from Y. pestis and 
Y. pseudotuberculosis plasmids. It was shown that YscP functions as a molecular 
ruler when the needle of the T3SS is formed (Journet, Agrain, Broz and Cornelis, 
2003; Wagner, et al., 2009). As the needle is built with YscR building blocks, YscP is 
stretched alongside the growth of the needle, until a certain breaking point. YscP 
then has a second function in signalling back to the T3SS to produce late injectisome 
molecules (Wagner, et al., 2009). The functionality of YscP depends both on the 
length of the protein (Journet, Agrain, Broz and Cornelis, 2003) and on the helical 
content determined by amino acid content (Wagner, et al., 2009). It was shown that 
needles were longer when encoded by a longer CDS, but also when helix maker 
alanine was substituted by helix breakers proline and glycine (Wagner, et al., 2009). 
The needle length might relate to the effectiveness of protein transfer into the target 
cell.  
Here, three different repeats were identified. The red repeat contains 13 amino acids, 
the green repeat 25 amino acids, and the blue repeat 46 amino acids. Y. pestis, 
Y. pseudotuberculosis, and Y. enterocolitica BT 1B had a single red-green-blue 
repeat only, except for some BT 1B strains that showed two full red-green-blue 
repeats. The low-pathogenic BTs had one red-green-blue repeat and an additional 
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red-blue repeat, and the low-pathogenic BT 5 strains only showed red-blue repeats in 
variable number. This has not been correlated with any change in mechanism or 
outcome of disease so far. 
 
5.3.3 Plasmid Repertoire in Yersinia 
Several unique plasmids were detected in the sequenced reference strains. The two 
plasmids of the non-pathogenic BT 1A are most likely cryptic, as they are small and 
only potentially encode for few proteins of undefined nature. Large plasmids can also 
be present in non-pathogenic BTs as demonstrated by the atypical BT 1B/1A strains. 
The presence of large plasmid is not indicative for pathogenic potential of a strain 
and might confuse the distinction of high- and non-pathogenic BT. These large 
plasmids warrant further investigation into the genes encoded and their biological 
relevance. The unique plasmid of BT 2 strain 21202 carries an antibiotic resistance 
cassette for tetracycline. Similar to arsenic, this antibiotic has been extensively used 
in pigs in the past, and might explain the acquisition of this plasmid. Although an 
initial search was limited to isolates available in the strain collection at Nottingham 
Trent University, the hypothesis of presence of pSR1-2 in pig isolates of BT 2 could 
not be validated and was not further pursued. Compared with larger strain collection 
it now seems more likely that pSR1-2 is a unique acquisition event in BT 2 O:9 strain 
21202. The BT 5-unique plasmid could be potentially involved in conjugative transfer 
of the virulence plasmid pYV as it shows homology with another plasmid in which 
such a mobilization event was proven (Hammerl, et al., 2008). The unique plasmids 
constitute an extended gene pool for Y. enterocolitica and selection is driven by 
environmental factors such as the pig niche. 
 
  
141 
6 Metabolic profiling of the Y. enterocolitica biotypes 
6.1 Introduction 
6.1.1 Biotyping and speciation based on biochemical properties 
Biochemical tests such as sugar utilization and fermentation and testing for the 
presence of enzymes like ornithine decarboxylase traditionally differentiate bacterial 
species. Given the heterogeneity within Y. enterocolitica and the differences in 
pathogenic potential, this species was further subdivided into several biotypes (see 
Table 1.2; Wauters, Kandolo and Janssens, 1987; Bottone, 1997). Biotyping is 
reasonably robust, and reflects the human pathogenic potential. There have been 
reports however of strains with atypical biotyping reactions (Guiyoule, et al., 1998) as 
well as high-pathogenic strains that lack the typical invasive phenotype, and which 
cluster with non-pathogenic BTs in microarray and AFLP analysis (Fearnly, et al., 
2005; Howard, et al., 2006; McNally, et al., 2006; personal communication M. 
Prentice). This variability arises because biotyping is affected by the media used for 
culturing of the strain before typing and is subject to incubation time and temperature 
(Wauters, Kandolo and Janssens, 1987; Bottone, 1999; Cornelis, et al., 1987; 
Farmer, et al., 1992; Stock, Henrichfreise and Wiedemann, 2002; personal 
communication E. Carniel).  
 
Metabolism is now being recognized as an important factor in colonization not only in 
the environment but also in human, animal or insect hosts (Rohmer, Hocquet and 
Miller, 2011). Transition from environmental lifestyle to a host-adapted niche imposes 
challenges on bacteria in terms of pH, oxygen levels, and nutrient availability such as 
free iron. An extensive metabolic repertoire is needed to accommodate these 
changes. Conversely certain metabolic functions might become redundant with 
limitation to highly specific niches (Rohmer, Hocquet and Miller, 2011). For Y. pestis, 
such a change in lifestyle to become reliant on an insect vector and a warm-blooded 
host has been investigated in the past, and additional nutrient requirements are 
known (Burrows and Gillett, 1966). Less is known about Y. enterocolitica metabolism 
and whether some biotypes have adapted to certain niches. 
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6.1.2 Phenotypic microarray technology 
Generally, biotyping is based on a handful of metabolic properties of a cell, and only 
presents a fraction of the metabolic profile. The phenotypic microarray technology 
produced by Biolog offers a wider range of metabolites that can be tested in an 
automated fashion. An overview of the workflow is shown in Figure 6.1 and 6.2. 
Bacteria grown on solid medium are suspended in a minimal, defined medium 
(Bochner, Gadzinski and Panomitros, 2001; Bochner, 2009). The phenotypic 
microarray is carried out in 96-well plates, with each of the wells containing a 
different nutrient. For the carbon plates, the minimal medium supplies sulphur, 
phosphate and other essential nutrients apart from carbon, which will be supplied 
separately in each of the wells (Bochner, Gadzinski and Panomitros, 2001; Bochner, 
2009). For the nitrogen plates, all nutrients except nitrogen are contained in the 
minimal medium, and so forth.  
The phenotypic microarray is based on cellular respiration reflecting cell activity 
(Figure 6.1; Bochner, Gadzinski and Panomitros, 2001). Transport and metabolism of 
nutrients results in respiration through the production of energy along the electron 
transport chain.  
 
 
Figure 6.1: Respiration is coupled to conversion of tetrazolium violet dye [taken from Bochner, 
Gadzinksi and Panomitros, 2001]. 
 
Respiration is not necessarily coupled to growth and can therefore also detect 
phenotypes that do not produce growth but respiration only (Bochner, Gadzinski and 
Panomitros, 2001; Bochner, 2009). A tetrazolium violet dye added to the reaction is 
reduced in the presence of electrons causing a colour change from colourless to 
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purple (Bochner, Gadzinski and Panomitros, 2001). An increased rate of conversion 
leads to a quicker colour change, because the dye reduction is proportional to the 
electron flow (Bochner, 2009). 
 
 
Figure 6.2: Workflow of phenotypic microarray [adapted from Bochner, Gadzinski and 
Panomitros, 2001; Bochner, 2003]. Redox dye and bacterial suspension are added to the minimal 
medium. This is used to inoculate 96-well plates containing different nutrient sources in each of the 
wells. The plates are placed in the OmniLog incubator/reader, which takes up to 50 plates at one time. 
The camera incorporated in the machine takes readings of the plates. Respiration results in a purple 
colour change in active wells. Different strains can be compared visually and more in detail in the 
kinetic plot, showing strain A in green, strain B in red, and the overlay in yellow.  
 
If either transport of the nutrients or metabolism is dysfunctional, there will be no 
electron flow and consequently no reduction of the dye. Therefore metabolic activity 
can be monitored and quantified through purple colour production. Accumulation of 
the dye is harmless to the cells and the signal is intensified as respiration continues 
(Bochner, Gadzinski and Panomitros, 2001). The 96-well plates are placed in the 
OminLog instrument, which acts as an incubator and measures dye production in 
parallel (Figure 6.2; Bochner, Gadzinski and Panomitros, 2001). Data is recorded 
every 15 minutes over 48 hours.  
The phenotypic microarray can be used instead of an API test to identify bacterial 
species and is potentially more versatile as it can test for 95 different substrates 
simultaneously (Miller and Rhoden, 1991). It has also been used to study microbial 
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communities and the changes in composition upon incubation with different carbon 
sources (Smalla, et al., 1998). 
Chosen for this study were two phenotypic microarray plates with carbon sources, 
PM1 and PM2A, one phenotypic microarray plate with nitrogen sources, PM3B, one 
mixed phenotypic microarray plate with phosphorus and sulphur sources, PM4A, and 
phenotypic microarray plates PM9 and 10 which test for osmolytes and pH. For each 
strain, triplicates were carried out at optimum growth temperature of 28°C and at 
human body temperature of 37°C. Data will mainly be presented on PM1-4 at 28°C. 
The phenotypic microarray was used to establish the metabolic profile of each 
sequenced reference strain. The differences observed in the genomic analysis 
should be reflected in the metabolism of each strain. The phenotypic microarray 
should aid annotation and establish direct links between phenotype and genotype. 
 
  
145 
6.2 Results 
6.2.1 Metabolic activity in Y. enterocolitica biotypes at optimum temperature 
Given the apparent role of metabolism in determining the breadth of host range and 
pathogenic potential and the targeted loss of function as presented in the 
pseudogenes, the reference strains were assayed using the phenotypic microarray 
for their ability to utilise different sources of carbon, nitrogen, sulphur, and phosphate 
at optimum temperature of 28°C. The signal values are given in the appendix Table 
9.6 (p. 242) and the rearranged layout for positive wells plus significant changes 
towards BT 1B strain 8081 are listed in Table 9.7 (p. 254). 
 
The heat map in Figure 6.3A shows the signal values corresponding to the intensity 
of utilization for the different nutrient sources. The three replicates are shown for 
each strain, with blue indicating utilization and red absence of utilization. Figure 6.3B 
shows the change towards BT 1B, with yellow indicating a significantly stronger 
activity and blue a significantly reduced activity compared to the high-pathogenic BT. 
Even from an overview it is apparent that the non-pathogenic BT 1A shows a wider 
metabolic activity with the highest number of positiv signals (Figure 6.3A). This is 
consistent with the biotyping scheme in which this BT is positive for the fermentation 
of all the sugars tested and maintains functionality of metabolism. The metabolic 
activity detected is often also significantly higher than in BT 1B (Figure 6.3B), 
suggesting a more effective metabolism. BT 2 O:9 strain 21202 and BT 3 O:9 strain 
5603 were shown to be nearly identical with respect to genomic content and 
pseudogenes. Looking at their metabolic activity (Figure 6.3A) but specificatlly the 
change towards BT 1B (Figure 6.3B) one can see that they exhibit very similar 
profiles. This confirms their genetic relatedness, and also suggests that there is little 
difference between BTs 2 and 3 if they are of the same serotype. 
Comparing the low- and high-pathogenic BT to the non-pathogenic BT, both have 
lost metabolic pathways with two extreme cases of loss of function presented by BT3 
O:5,27 and BT5. BT 3 O:,27 shows marked reduction of nutrient utilization in nitrogen 
and phosphorus sources. The metabolism of all nutrient sources appears to be 
greatly reduced in BT 5, with only clear positive signals in carbon sources and hardly 
any signals in nitrogen, phosphorus and sulphur sources. The biotyping scheme 
shows an indication for this as well, as BT5 is mostly negative for the fermentation of 
sugars tested. 
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Figure 6.3: Signal values (A) and significant changes towards BT 1B (B) depicted as heatmaps. 
Triplicates are shown for the signal values. C – carbon sources (190), N – nitrogen sources (95), P – 
phosphorus sources (59), S – sulphur sources (35). 
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Determining positive and negative signals, it was also examined whether the change 
observed posed a significant difference towards the BT 1B reference strain 8081 
(Figure 6.3B, Figure 6.4 and 5 for absolute numbers).  
 
 
Figure 6.4: Number of sources that are expressed significantly higher than in BT 1B strain 
8081. 
 
 
Figure 6.5: Number of sources that are expressed significantly lower than in BT 1B 8081. 
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The non-pathogenic BT1A not only shows a wider range of metabolic activity, this 
activity is also significantly higher than in BT 1B. In contrast there are few sources 
that show a significantly lower activity, and two out of these three relate to sources 
that are not utilized in BT 1A. Both BT 2 and 3 O:9 isolates show a significantly 
higher activity in some sources, but also show a significantly lower activity especially 
in carbon and nitrogen sources. The other three BTs show only a selected number of 
sources which are utilized significantly higher than in BT 1B. BT 3 O:5,27 shows a 
significant reduction in nitrogen and phosphorus sources as was already apparent 
from the heatmap. BT 4 shows some reduction in carbon and nitrogen sources, 
similar to the ST O:9 isolates. The absence of metabolic activity in BT 5 is seen in the 
high number of significantly reduced sources in all nutrients. 
 
6.2.1.1 Metabolism of carbon sources 
Looking in more detail at the carbon sources (phenotypic microarray plates PM1 and 
2A), a total of 27 carbon sources (14.2% of total of 190 tested carbon sources) were 
found to be utilised in all biotypes, with a further 14 sources (7.4%) utilised by all but 
BT 5 (Table 9.7). In line with the genomic observations there are a significant number 
of additional metabolic capacities shared by BTs 1A and 1B strains including the 
ability to use D-alanine, L-asparagine, dextrin, succinamic acid, and L-histidine as 
sole carbon sources. Also reflected in the genetic makeup of the BT 1A is a greater 
metabolic capacity than all the other biotypes with 15 carbon sources, which are 
utilized only by BT1A. In addition there are a further 12 carbon sources that BT1A 
shares in combination with one or more of the BT, whereas there are only two carbon 
sources that are present in any of the other BTs and not in 1A. These two carbon 
sources are glycogen, which is only utilized in BT 2 O:9 strain 21202, and m-inositol 
which is metabolized in all BTs except BTs 1A and 5. 
With the exception of the two mentioned carbon sources there are no other carbon 
sources unique to the high- and low-pathogenic BTs that are not present in BT 1A. 
BT 1A is an environmental organism well adapted to a number of niches. Together 
with the fact that it has the lowest number of pseudogenes, this suggests that BT 1A 
is the oldest lineage from which the other BTs evolved through loss of metabolic 
functions.  
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6.2.1.2 Utilization of essential nutrients nitrogen, phosphorus and sulphur 
The utilization of the essential nutrients nitrogen, phosphorus, and sulphur is tested 
for in phenotypic microarray plates PM3B and 4A. BT1A, 1B, and 2-4 have 13 
nitrogen sources (13.7% of total of 95 sources), 2 phosphorus sources (3.4% of total 
59 sources), and 14 sulphur sources (40.0% of total 35 sources) in common. No 
metabolic activity can be seen for BT5 for any of these sources. 
Similar to the observations made for carbon sources, there are two sources which 
are exclusively utilized in BTs 1A and 1B. Both BTs metabolize D-asparagine and L-
phenylalanine as sole nitrogen sources. There are seven nitrogen sources, two 
phosphorus sources and one sulphur source, which are uniquely metabolised in BT 
1A. Further 27 nitrogen sources, 44 phosphorus sources, and 4 sulphur sources 
show shared metabolism in BT 1A and any of the other BTs, underlining the 
increased metabolic flexibility of the non-pathogenic BT. There are three nitrogen 
sources, seven phosphorus, and 2 sulphur sources absent from BT 1A. These are 
listed in Table 6.1. 
 
Table 6.1: Utilization of N, P, and S sources absent from BT 1A. 
 Nutrient source BT 1A BT 1B BT 2 BT 3 BT 3 BT 4 BT 5 
  5303 8081 21202 5603 14902 1203 3094 
N D,L-a-amino-caprylic acid – – + – – – – 
N L-tryptophan – + – – – – – 
N Xanthine – + – – – – – 
P 
Adenosine-5’-
monophosphate 
– + + + – + – 
P D-glucose-6-phosphate – + + + – + – 
P Cytidine-3’-monophosphate – + + – – – – 
P Cytidine-5’-monophosphate – + – + – + – 
P Uridine-5’-monophosphate – + – + – + – 
P O-phospho-L-tyrosine – – + + – – – 
P 
Adenosine-2’,3’-cyclic 
monophosphate 
– – – + – – – 
S Hypotaurine – – – + + – – 
S D,L-ethionine – – – + – – – 
 
Adenosine, cytidine, and uridine phosphates are involved in purine and pyrimidine 
metabolism. Their physiological relevance in BT 1A is unknown. An impairement of 
purine and pyrimidine metabolism is rather apparent in BT 3 O:5,27 and BT 5, as 
these also lack the utilization of guanosine and thymidine phosphates as well as 
further adenosine, cytidine, uridine mono- and cyclic phosphates. 
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As was seen earlier, BT 3 O:5,27 has a defect in nitrogen metabolism. This relates to 
amino acids amongst others. Three of the amino acids which BT 3 O:5,27 cannot 
metabolize are L-arginine, L-glutamic acid, and L-glutamine. These may be grouped 
together in the glutamate family. Apart from these, the other nine amino acids and di-
amino acids cannot be grouped chemically or physiologically. 
 
6.2.1.3 Biotyping reactions 
The sugars used for differentiation of Yersiniae and for biotyping of Y. enterocolitica 
are also found on the phenotypic microarray. A comparison of results is given in 
Table 6.2. 
 
Table 6.2: Comparison of biotyping and phenotypic microarray reactions. 
Substrate Biotyping result * Phenotypic microarray 
substrate  
(PM plate and position) 
Result Agreement biotyping and 
phenotypic microarray 
Glucose All BT + Α-D-Glucose (PM1 C09) All BT + Yes 
Sucrose All BT + Sucrose (PM1 D11) All BT + Yes 
Rhamnose All BT – L-Rhamnose (PM1 C06) All BT – Yes 
Raffinose All BT – D-Raffinose (PM2A D01) BT 1A +, BT 1B, 2, 
3, 4, 5 –  
No 
Melibiose All BT – D-Melibiose (PM1 C11) All BT – Yes 
Cellobiose All BT + D-Cellobiose (PM1 F11) All BT + Yes 
Sorbose All BT +,  
except BT 5 – 
L-Sorbose (PM2A D04) All BT +,  
except BT 5 – 
Yes 
Salicin BT 1A + Salicin (PM2A D02) BT 1A + Yes 
Xylose BT 1A, 1B, 2, 3 +, 
BT 4 –, BT 5 V 
D-Xylose (PM1 B08) BT 1A, 1B, 2, 3 +,  
BT 4 –, BT 5 + 
Yes 
Trehalose BT 5 – D-Trehalose (PM1 A10) BT 5 – Yes 
Inositol All BT + M-Inositol (PM1 F03) BT 1A –, BT1B, 2, 3, 
4 +, BT 5 – 
No 
*adapted from Bottone, 1997, and Wauters, Kandolo and Janssens, 1987. + positive, – negative, V variable. 
 
There are only two sugars in which the biotyping reaction and the phenotypic 
microarray disagree.  
Raffinose utilization is supposed to be absent from Y. enterocolitica but in the 
phenotypic microarray BT 1A gives a positive signal. Looking at the absorbance 
measurements, one can clearly see that BT 1A metabolizes raffinose, although an 
activity can only be detected about 28 hours after the start of the incubation  (Figure 
6.6).  
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Figure 6.6: Kinetic plots for raffinose in Y. enterocolitica biotypes. Triplicates are shown. BT 1A / 
5303 – blue; BT 1B / 8081 – red; BT 2 / 21202 – light blue; BT 3 / 5603 – green; BT 3 / 14902 – 
yellow; BT 4 / 1203 – purple; BT 5 / 3094 – orange. 
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It has been reported that raffinose might be metabolized if the lac permease is 
present conferring lactose uptake as well (Cornelis, Luke and Richmond, 1978). BT 
1A does utilize α-D-lactose as well as lactulose, and a copy of lacIZY is present 
encoding the lactose operon repressor, β-glucosidase, and permease respectively 
(YE5303-03921 - 41). Copies of lacI (YE2591) and lacZ (YE2592) are carried in all 
Y. enterocolitica biotypes but a permease is absent. The presence of transposases in 
some of the strains could potentially indicate a loss of the gene mediated by 
recombination. A definitive genomic basis for the raffinose-positive phenotype could 
not be established but it could be that the lacIZY operon is involved in the 
metabolism of this sugar. Another possibility for a different test result is that the mode 
of the test is different, i.e. utilization under aerobic conditions versus anaerobic 
fermentation. 
The second difference between biotyping reaction and phenotypic microarray result 
is inositol. All BTs are normally positive for the utilization of this sugar, but the 
phenotypic microarray only showed metabolism in BT 1B, 2, 3 and 4. This will be 
explained in 6.2.2.5. 
 
6.2.2 Differences relating to genetic differences 
The general trends observed both in the genome comparisons and the analysis of 
the pseudo- and partial genes highlighted metabolic regions and transport proteins 
(Chapter 4). BT 1A was found to have additional operons relating to the uptake and 
conversion of sugars such as D-arabitol, and BT 5 was shown to contain mutations in 
core genes that might relate to the biotyping reactions. 
These trends are reflected in the metabolic profiling. In the following, some examples 
of linking genotypes to specific phenotypes are given. This task is most 
straightforward when considering carbon metabolism, because well characterized 
examples from E. coli and Salmonella can be found. Nitrogen, phosphorus and 
sulphur metabolism on the other hand is less clear and the metabolites cannot be 
tied into metabolic pathways easily. This is due to the fact that some metabolites are 
not naturally occuring intermediates in standard metabolic pathways and constitute 
synthetic nutrients not found in the environment. Their metabolism is unknown and 
their physiological relevance is unidentified. 
Other difficulties presented in analysing the phenotypic microarray relate to the fact 
that genomic data alone is insufficient for allocation of pathways, as homology to 
known enzymes does not indicate specificity of a transporter or an enzyme, as for 
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example ABC transporters might transport a range of metabolites from amino acids 
to sugars. Additionally, the mutations giving rise to the phenotype might be acquired 
independently in different genes of a pathway. If then a pathway is not clearly defined 
in terms of regulation, associated transporters, secondary pathways, etc., a clear link 
between phenotype and genotype is difficult to establish and requires additional 
experiments with targeted knock-out mutants. The metabolites tested in the 
phenotypic microarray also do not present complete pathways, but rather individual 
points in larger networks. It is therefore not possible to obtain a continuous picture of 
active or disrupted pathways. Nevertheless it is possible to obtain an overall 
impression of metabolic capacities of a cell. 
 
6.2.2.1 L-arabinose 
One clear example for linking phenotype and genotype can be seen in L-arabinose 
metabolism (PM1 A02). This is a carbon source metabolized in all BTs, and the 
respective enzymes are encoded by the araABFGHC operon (Figure 6.7). 
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Figure 6.7: Operon for L-arabinose utilization contrasted with signal values and significant 
changes compared to BT 1B. Utilization (blue +, red -), significant change compared to BT 1B 
(yellow +, black none, blue -). 
 
The transport proteins are AraFGH, araAB encode for an isomerase and a 
L-ribulokinase, respectively, and AraC is the regulatory protein for this operon. 
Although there appear to be slight variations between and within genes (BT 4 
deletion in araG), these do not have an effect as utilization could be shown in all BTs. 
The signal values for all BTs are positive, although there is a significantly higher 
intensity in BT 4 and a significantly lower intensity for BT 5 compared to BT 1B. 
Looking at the absorbance recordings over time (Figure 6.8), one can see that BT 5 
shows utilization of L-arabinose, but only to a limited extent. In contrast, BT 4 is very 
efficient at using L-arabinose. There appears to be a slight delay of 4 hours 
compared to BTs 1A, 1B, 2, and 3 in the onset of utilization, but then BT 4 
outperformes the other BTs in all three replicates.  
Other carbon sources that are metabolized in all BTs and for which unambiguous 
operons exist are N-acetyl-D-glucosamine (nagEBACD), D-galactose (galDBAM), 
D-mannose (manZYXA), glycerol (glpKFTABCR), D-glucuronic acid (uxaC), D-
mannitol (mtlRDA), D-fructose (fruBKAR), and L-serine (sdaBCA). 
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21202$–$BT$2$
5603$–$BT$3$
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Figure 6.8: L-arabinose utlization kinetic plots over time for Y. enterocolitica biotypes. Triplicates 
are shown. BT 1A / 5303 – blue; BT 1B / 8081 – red; BT 2 / 21202 – light blue; BT 3 / 5603 – green; BT 
3 / 14902 – yellow; BT 4 / 1203 – purple; BT 5 / 3094 – orange. 
156 
6.2.2.2 D-trehalose and D-sorbose 
Examples for mutations specific for BT 5 are found in D-trehalose and D-sorbose, 
which are also used in biotyping. The respective tests in the phenotypic microarray 
are found in PM1 A10 and PM2A D04. 
The sorbose operon is shown in Figure 6.9A.  
 
 
Figure 6.9: Mutations specific for biotyping of BT 5 contrasted with signal values and 
significant changes compared to BT 1B. Utilization (blue +, red -), significant change compared to 
BT 1B (yellow +, black none, blue -). A – Sorbose operon. B – trehalose operon. 
 
The sorbose-specific phosphotransferase uptake system (PTS) is made up of several 
components encoded by sorFBAM. SorE is a L-sorbose-1-phosphate reducatase. 
There are two transcriptional regulatory proteins upstream and downstream of the 
operon but it is not known whether any of these or other regulators are involved with 
governing the expression of this operon. BT 5 is the only biotype with a mutation in 
this operon. It is missing a TTTA repeat motif resulting in a frameshift mutation in 
sorB, one of the PTS components. The signal values reflect this mutation. BT 5 is the 
only biotype without metabolic activity in this well, and this reduction is also 
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significant compared to BT 1B. BT 1A shows a significantly higher utilization than BT 
1B. 
The trehalose operon is depicted in Figure 6.9B. Similar to the sorbose operon, BT 5 
shows a frameshift in the PTS system TreB resulting from an insertion of one A. The 
trehalose operon repressor TreR and the trehalose-6-phosphate hydrolase OlgH 
remain intact. Upstream of the trehalose operon is a magnesium transporter encoded 
by mgtA, which also specifically shows a frameshift mutation in BT 5. There is a 
further gene possibly encoding a component of the PTS involved in trehalose 
transport (YE3690). This gene is disrupted by the presence of a transposase in BT 5, 
indicating further mutations in trehalose metabolism. 
 
6.2.2.3 N-acetyl-D-galactosamine 
The utilization of N-acteyl-D-galactosamine (PM2A B01) is encoded by the aga 
operon (Figure 6.10). 
 
 
Figure 6.10: Operon structure for utilization of N-acetyl-D-galactosamine in representative BTs 
contrasted with signal values and significant changes compared to BT 1B. Utilization (blue +, red 
-), significant change compared to BT 1B (yellow +, black none, blue -). BT 1B – deletion of most of 
the operon; BT 1A – representative for BTs 1A, 2, 3, and 4, fully functional; BT 5 – operon present, but 
mutations inhibit functionality. 
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The operon starts with a DeoR-family regulatory protein AgaR. This is present in all 
BTs. The D-tagatose-1,6-bisphosphate aldolase, N-acteylgalactosamine-specific 
phosphotransferase, and the phosophotransferase system encoded by agaWEF 
have been deleted from BT 1B. BT 5 is the only BT to show a frameshift in a 
homopolymeric run of Gs in agaW. The tagatose-6-phosphate ketose/aldose 
isomerase AgaS, and the D-tagatose-1,6-bisphosphate aldolase AgaY have been 
retained as fragments in BT 1B. BT 5 has a 4 base deletion resulting in a frameshift 
mutation in agaS. Both mutations in BT 5 render the utilization of N-acetyl-D-
galactosamine non-functional, as can be seen in the signal values. The biotypes 
metabolising this carbon source show a significantly higher expression than BT 1B. 
A highly conserved, homologous operon is found in E. coli (Reizer, et al., 1996) and 
its functionality was confirmed for the phosphotransferase system of N-acetyl-D-
galactosamine (Brinkkötter, Klöß, Alpert and Lengeler, 2000). Functionality of this 
cluster has been independently studied in a BT 4 O:3 strain (Batzilla, et al., 2011b). 
Complementation studies showed that this operon could confer the ability to grow on 
N-acetyl-D-galactosamine onto BT 1B strains (Batzilla, et al., 2011b), confirming that 
this cluster is responsible for the phenotype. 
 
6.2.2.4 D-arabitol 
The utilization of D-arabitol (PM2A B06) is unique to the BT 1A strain studied here. 
The utilization could be linked to a unique region contained in the BT 1A genome 
(Figure 6.11). 
D-arabitol utilization is encoded for by a mannitol dehydrogenase DalD and a 
xylulose kinase AtlK. A transcriptional regulatory protein of the DeoR2 family guards 
the expression of the operon, and AtlT constitutes the D-arabitol membrane 
transporter. The gene acpD for an acyl carrier protein phosphodiesterase is located 
upstream of the operon. This region has been deleted from the pathogenic BTs. BT 
1B retains a fragment of the regulatory protein, but the operon is completely absent 
from the low-pathogenic BTs. 
A similar, conserved D-arabitol operon structure has been described in 
Klebsiella pneumoniae and function confirmed (Heuel, Turgut, Schmid and Lengeler, 
1997). 
159 
 
Figure 6.11: Unique operon for D-arabitol utilization in BT 1A, contrasted with signal values 
and significant changes compared to BT 1B. Utilization (blue +, red -), significant change 
compared to BT 1B (yellow +, black none, blue -). BT 2 as representative for low-pathogenic BTs. 
 
D-arabitol has been linked to the non-pathogenic biotype before in comparison to 
BT 4 O:3 (Shehee and Sobsey, 2004). A positive D-arabitol phenotype is not 
exclusive to non-pathogenic BTs though (Fantasia Mazzotti, et al., 1985; Fantasia 
Mazzotti, Mingrone and Martini, 1987), as some BT 1A strains can be negative, just 
as some pathogenic BT 3 strains were found to metabolize D-arabitol. 
 
6.2.2.5 m-inositol 
Acid production from inositol is one of the biotyping reactions for which all 
Y. enterocolitica BT are supposed to be positive. The phenotypic microarray also 
tests for this in form of m-inositol (PM1 F03). As could be seen from the signal 
values, with the exception of BT 1A and BT 5, all BTs are positive for the utilization of 
this carbon source. Looking at the absorbance plot over time (Figure 6.12), one can 
see some differences in the kinetic plots.  
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Figure 6.12: Absorbance curves over time for m-inositol utilization. Triplicates are shown. BT 
1A / 5303 – blue; BT 1B / 8081 – red; BT 2 / 21202 – light blue; BT 3 / 5603 – green; BT 3 / 14902 
– yellow; BT 4 / 1203 – purple; BT 5 / 3094 – orange. 
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The strains 8081, 21202, and 5603, representing biotypes 1B and 2/3 O:9, start to 
show activity after about 4 hours. BT 3 O:5,27 strain 14902 starts 6 hours later, 10 
hours into the incubation time. BT 4 O:3 strain 1203 shows signs of metabolic activity 
around 18 hours after the start of the incubation. BT 5 strain 3094 shows no activity 
apart from background noise, but one of the replicates for BT 1A strain 5303 shows 
activity after 35 hours. 
Looking into the genomic data, no basis for the phenotype in BT 5 could be 
established. In BT 1A, the myo-inositol dehydrogenase gene idh shows a point 
mutation (Figure 6.13).  
 
 
Figure 6.13: Point mutation in the idh gene is the basis for BT 1A negative m-inositol 
phenotype. Utilization (blue +, red -), significant change compared to BT 1B (yellow +, black none, 
blue -). Mutation in BT 5 unknown. 
 
The sequence TGG encoding for tryptophan has changed to TGA. The translation 
into UGA results in a premature stop codon, inhibiting the expression of a fully 
functional protein. Therefore the utilization of m-inositol is not possible in this strain. 
The UGA stop codon is peculiar though, as it has been shown to encode for the 
unusual amino acid selenocysteine occasionally. Y. enterocolitica does have a 
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14902$–$BT$3$
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selenocysteine tRNA, so it could be that the stop codon is either read through or 
decoded by selenocysteine, giving a fully functional protein, albeit in lower 
concentrations than normal. This would then result in a delayed response to 
utilization of the carbon source, explaining the metabolic activity observed in one of 
the BT 1A strain 5303 replicates. In a larger strain collection, this point mutation was 
shown to be specific for BT 1A strain 5303, and not representative for BT 1A strains 
in general. It also highlights the problem of strain-to-strain variation in biotyping 
following random inactivating mutations that lead to misidentification of isolates and 
potential misrepresentation of their pathogenic potential. 
 
6.2.3 Metabolic activity of Y. enterocolitica biotypes at human body 
temperature 
The phenotypic microarray was mainly evaluated at 28°C. This represents the 
optimum growth temperature of Y. enterocolitica. The metabolic profile for 37°C is 
given in Figure 6.14. One can see a dramatic overall reduction in metabolism in all 
BTs. BT 5 shows hardly any metabolic activity at all, having lost most of the few 
carbon sources it was utilizing at 28°C. In the other BTs, a specific temperature effect 
can be observed in nitrogen and phosphorus sources. A marked reduction of sulphur 
metabolism can be observed in BT 4. Generally, the non-pathogenic BT 1A still 
shows the highest metabolic flexibility as it shows more metabolically active nutrient 
sources. 
This severe change in metabolism with temperature shift was unexpected as 
Y. enterocolitica causes human infections and thus thrives at 37°C. It could be that 
oxygen levels or the presence of additional nutrients play a role in this temperature 
effect. The basis is most likely less genetic in terms of presence or absence of 
operons, but likely to be of regulatory nature. 
The effect of temperature change from 28°C to 37°C would warrant further in depth 
experiments such as a transcriptional response following temperature shift. 
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Figure 6.14: Signal values depicted as heatmap. Triplicates are shown for the signal values. C – 
carbon sources (190), N – nitrogen sources (95), P – phosphorus sources (59), S – sulphur sources 
(35).  
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6.3 Discussion 
6.3.1 Metabolic profiling of Y. enterocolitica confirms genomic analysis 
The phenotypic microarray mirrors both the observations made in the genomic 
analysis in terms of increased genome decay and loss of metabolic functions in BTs 
4 and 5, as well as the biotyping scheme in that a reduction of metabolism can be 
observed (Figure 6.15). 
 
 
Figure 6.15: Comparison of biotyping reactions and phenotypic microarray. The 12 biotyping 
reactions correspond to the order given in Table 1.2. The phenotypic microarray data has been 
rearranged for the first replicate of BT 1A from negative to positive reactions irrespective of plate and 
well position. The other replicates are linked to the BT 1A ordering so that differential utilization of 
nutrients is reflected. 
 
The non-pathogenic, environmental BT 1A shows the ability to use a wider repertoire 
of nutrient sources that it can utilize. Of the metabolic capacities it shares with other 
BTs, it can metabolize these better or more efficiently resulting in higher signal 
intensity.  The high-pathogenic BT 1B and the low-pathogenic BTs 2 O:9, 3 O:9, and 
4 O:3 show some reduction in metabolism compared to BT 1A. A marked reduction 
in metabolic flexibility can be observed in two strains. BT 3 O:5,27 is deficient 
specifically in nitrogen and phosphorus sources. This strain type is of interest in that 
it is predominantly associated with asymptomatic carriage in livestock, and is less 
frequent in human diarrheal samples (McNally, et al., 2004). This isolate specifically 
was isolated in cattle and represents the UK O:5,27 isolates. The reduction in 
metabolism therefore could be a result of adaptation to a cattle host. The metabolism 
of BT 5 is greatly reduced, very little metabolic activity can be observed in carbon 
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sources and no utilization of nitrogen, phosphorus, or sulphur sources is detectable. 
It might thus be no coincidence that BT5 is the rarest of all biotypes. It is referred to 
as the “hare-biotype”, and has not been isolated from humans (Swaminathan, 
Harmon and Mehlman, 1982; Wuthe and Aleksic, 1997; Bartling, et al., 2004). It is 
possible that BT5 has adapted to a very narrow niche that makes survival outside 
this niche near impossible. It may even present a dying lineage. This resembles the 
extreme loss of function and degenerate genome of another pathogenic Yersinia: 
Y. pestis. It was shown that Y. pseudotuberculosis and Y. enterocolitica can both 
grow on minimal medium at 28°C with few extra nutrients, but that Y. pestis needs 
further additives for adequate growth (Burrows and Gillett, 1966; Perry and 
Fetherston, 1997; Navid and Almaas, 2009). This is due to the biphasic lifecycle of 
Y. pestis, being present either in a warm-blooded host or in the flea. Y. pestis is not 
subjected to environmental metabolic challenges, and at the same time the 
bacterium depends on the host to provide for nutrients (Navid and Almaas, 2009). 
Both situations lead to accumulation of mutations in metabolic pathways. The genus 
Yersinia thus presents two examples of extreme niche adaptation to warm-blooded 
animals – Y. pestis and Y. enterocolitica BT5 – that have evolved independently. It is 
possible that BT 5 would have needed additives of amino acids or other nutrients to 
improve metabolic activity. This could potentially be uncovered by incubation on PM 
5, which tests for common biosynthetic pathways via the utilization of nutrient 
supplements. An addition of a nutrient supplement though would have influenced the 
kinetic plots making a direct comparison to the other BTs impossible. 
 
In contrast to the biotyping scheme, the phenotypic micorarray also highlighted some 
nitrogen, phosphorus, and sulphur sources that are absent from BT 1A. These could 
potentially be used for differentiation resulting in an improved biotyping scheme or 
maybe the development of new media. Unusual sources might present a possible 
advantage to also distinguish Y. enterocolitica from other enterobacteriaceae. These 
sources would need to be screened in a wider BT selection.  
Metabolic properties thus play an important role in niche adaptation for 
Y. enterocolitica. BT1A is the metabolically most diverse biotype reflecting its 
ubiquitous nature and wide range of niches. High- and low-pathogenic biotypes have 
lost some metabolic flexibility. Especially in the predominant animal isolate BT3 
O:5,27 and the rare BT5 there are signs of extreme niche adaptation, reflected in a 
significant loss of metabolic activities.  
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6.3.2 Linking genomic and phenotypic differences 
The phenotypic microarray has been originally designed to study isogenic mutants, 
that is the wild-type strain against a single-gene mutant (Bochner, Gadzinski and 
Panomitros, 2001; Bochner, 2003; Zhou, Lei, Bochner and Wanner, 2003; Johnson, 
et al., 2008). This way very clean phenotypes could be observed. For instance, a 
wild-type strain of E. coli was compared to a malF mutant, and it could be shown that 
the metabolism of maltose, maltotriose, and dextrin is coupled to the functionality of 
that gene (Bochner, 2003). Here, several strains are compared at the same time, 
with differences in gene content and pseudogene distribution. BT 5 for example 
differs in more than one pseudogene compared to its nearest neighbour BT 4, 
therfore it is difficult to assign phenotypes to a single gene or even operons. It is 
possible for alternative secondary transporters or enzymes to complement mutations, 
obscuring possible links. Often, genes thought to be involved in certain pathways are 
either not mutated in any BT although differential expression is detected or mutations 
are found in the “wrong” BT, i.e. a BT utilizing the source, whereas no mutation is 
observed in a phenotype-negative BT. In addition to the principle of “One transporter 
– one substrate”, one needs to consider “One transporter – several substrates” as 
well as “Several transporters – one substrate”. Only very clear-cut phenotypes such 
as the maintenance of the D-arabitol operon in BT 1A can be observed and 
annotated unambiguously. For most cases of BT 1A-unique regions, there are 
indications of encoding metabolic pathways, but either no high-homologous hits in 
other bacteria to justify a clearer enzyme assignment or no good reference to base 
the annotation on. In the phenotypic microarray, there are new indications of possible 
pathways encoded, but no indication if several pathways could be activated by one 
and the same operon. 
A study used the phenotypic microarray to detect changes in metabolism caused by 
mutations in 2-component systems (Zhou, Lei, Bochner and Wanner, 2003). 2-
component systems consist of a sensor kinase and a response regulator. The sensor 
protein is a membrane-associated protein which detects environmental signals and 
passes them on to the response protein which is either a transcription factor or acts 
on sigma factors to modulate gene expression. Zhou, Lei, Bochner and Wanner 
(2003) confirmed links between NtrBC to nitrogen metabolism and PhoRB to 
phosphorus metabolism. No mutations in these or other 2-component systems 
implicated with phenotypic changes are mutated in any of the Y. enterocolitica 
biotypes except creC (YE3383) in BT 4. This component system is thought to be 
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involved in carbon/energy metabolism (Chaudhuri, et al., 2010), but a direct link 
cannot be established in the Y. enterocolitica dataset. BTs 4 and 5 show mutations in 
regulatory proteins, including potential 2-component systems, thus these could be 
the reason for the widespread metabolic defects visible especially in BT 5. The 2-
component systems of Y. enterocolitica as well as of Y. pestis and 
Y. pseudotuberculosis have not been as extensively characterized as in E. coli and 
regulatory relationships are theoretical and deduced from DNA homology (Marceau, 
2004). It is possible that either the E. coli-homologous systems in Y. enterocolitica 
fulfil a different role, or that one of the uncharacterized 2-component systems is in 
fact taking the place of one of the well-established E. coli 2-component systems. 
 
The phenotypic microarray has highlighted general metabolic capacities of each 
strain, and has lowered the possibilities of nutrients that could be encoded for in the 
unique regions or the pseudogenes affected. In this way, the phenotypic microarray 
facilitates future annotation. 
Variability of phenotypic tests has also been described in Y. pestis. Most notably is 
rhamnose fermentation. Classically, Y. pestis is negative for rhamnose fermentation; 
a positive phenotype is associated only with Biovar Pestoides (Achtman, et al., 
2004). Rare rhamnose-positive mutants are observed in Y. pestis after prolonged 
incubation (Englesberg, 1957a,b). The rhamnose operon rhaTRSBAD is present in 
all Y. pestis, and BetB, a betaine-aldehyde dehydrogenase, and RhaS, a 
transcriptional regulator, have been suggested as the genetic basis for this 
phenotype (Navid and Almaas, 2009; Eppinger, et al., 2010). This ability of Y. pestis 
for phenotypic gain of function is known as meiotrophy, and has also been 
documented for ammonia assimilation, urease, production of inv, fermentation of 
melibiose, and biosynthesis of certain amino acids (Brubaker, 1991). The respective 
gene regions are presumably present and inactivated by reversible mutations or 
highly regulated (Brubaker, 1991). This variability also makes assignments of 
phenotype to genotype difficult. 
Achtman, et al. (2004) demonstrated that biovar designation does not reflect the 
genetic relationship in Y. pestis. The distinction of Y. pestis into different biovars is 
based on fermentation patterns of glycerol, rhamnose, melibiose, and nitrate 
reduction and characterizes the three classic biovars Orientalis, Medievalis, and 
Antiqua, as well as atypical biovars Pestoides and Microtus. Rhamnose, as 
described above, is known to be variable and strains can show a positive phenotype 
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upon prolongued incubation. The phylogenetic relationship in Y. pestis also showed 
that the inability to metabolize sugars or reduce nitrate can arise independently in 
several lineages and can thus have a different genetic basis (Achtman, et al., 2004). 
The same biovar might therefore be allocated to very different lineages. The grouping 
in Y. pestis was revised on the basis of evolutionary relationships rather than 
metabolic traits, which do not have the correlation with evolutionary origin (Achtman, 
et al., 2004). It is even suggested that biovars and metabolic traits are unsuitable for 
distinction into taxonomic groups (Achtman, et al., 2004). Given the metabolic 
variety, variable biotyping reactions, and inactivating mutations as found in BT 1A 
strain 5303 in the utilization of m-inositol, the grouping of Y. enterocolitica might need 
to be re-evaluated likewise, to move away from phenotypic variability. 
 
6.3.3 The influence of temperature on metabolism in Y. enterocolitica 
It is known that Y. enterocolitica displays differential expression of genes upon 
changes in temperature. Certain genes thought to be involved in environmental 
survival as well as insect pathogenicity such as genes in the tc PAI and motility and 
chemotaxis genes as well as genes potentially involved in nitrogen utilization could 
be shown to be upregulated in low-temperature conditions of 10°C (Bresolin, 
Neuhaus, Scherer and Fuchs, 2006b). Genes such as inv and ail involved in 
pathogenicity in a human host are upregulated when the bacteria are exposed to 
37°C corresponding to human body temperature (Straley and Perry, 1995). Most 
famous is the low-calcium response coupled with temperature increase that triggers 
the expression of the Yop T3SS on the virulence plasmid (Straley and Perry, 1995; 
Bochner, 2009; Brubaker, 1991). The optimum temperature of Yersinia though is 25 - 
28°C (Cornelis, et al., 1987). 
In the first set of experiments conducted at optimum growth temperature 
Y. enterocolitica showed a wide range of metabolic activities that were dependent on 
the bio-serotype. Repeating these experiments at 37°C, one could have expected a 
possible upregulation of nutrient utilization in pathogenic biotypes as a response to 
conditions similar to those found in the human body. The results however showed a 
severe reduction in metabolic activity specifically in nitrogen and phosphorus 
sources. BT 4 also had a reduction of sulphur metabolism. This might have several 
explanations. First of all, it could be that the human host provides specific trace 
elements or other nutrients that are essential for growth under high temperatures. As 
these are absent under the conditions tested (only L-cystine was added as a reduced 
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sulphur source at both temperatures) this could explain the absence of metabolic 
activity. Secondly, it could also be that certain metabolic pathways are restricted for 
use under anaerobic conditions. The 96-well plates do not allow for much oxygen 
circulation, but can still be considered rather aerobic. For the anaerobe 
Streptococcus pneumoniae it could be shown that sealing of the 96-well plates in 
bags under anaerobic conditions and subsequent incubation had a great influence on 
experimental outcome (T. Feltwell, personal communication). 
 
For all Yersinia spp. additional nutrient requirements were demonstrated upon 
temperature shift (Burrows and Gillett, 1966). Defined minimal medium 
complemented with sodium metabisulphite and amino acids isoleucine, valine, 
cystine, methionine, and phenylalanine was enough for growth of Y. pestis at 28°C, 
but had to be further complemented with glutaminc acid and thiamine and replacing 
cystine with thiosulphate. Y. pseudotuberculosis and Y. enterocolitica also had 
additional requirements at 37°C, although to a lower degree than Y. pestis (Burrows 
and Gillett, 1966; Brubaker, 1991). It is entirely possible that addition of other 
nutrients at 37°C could increase the metabolic activity and possibly show the 
activation of sources specific to pathogenic BTs. Unpublished results indicate that 
calcium might play an important role in adaptation to higher temperatures (Bochner 
2009; Holtz-Morris, 2005; Fodor, et al., 2005), but unfortunately a direct comparison 
with the data obtained for Y. enterocolitica is not possible. Other signals could 
include magnesium concentration, pH, or acidic conditions (Bochner, 2009). One 
microarray study showed that following temperature shift specific metabolic pathways 
are differentially regulated (Motin, et al., 2004). They could demonstrate that a full 
citric acid cycle is present at 37°C, whereas nitrogen and amino acid metabolism 
appear downregulated. These differences are not as clear in Y. enterocolitica and 
might be due to differences in the culture media used thus supplying nutrients that 
influence metabolic state. Not all metabolic pathways or all intermediates of those 
pathways are present on the phenotypic microarray either, making a full assessment 
of metabolic state difficult. A further experiment could be carried out, testing growth 
at 37°C first on PM 5 for nutrient supplements. Depending on the outcome, essential 
nutrients could be added to the inoculation medium and the experiment repeated at 
37°C. Alternatively, the experiment could be repeated with the present medium, but 
under anaerobic conditions. Either way, only one of the parameters should be altered 
at any point to allow for comparison and determine which trigger is decisive.  
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It might not only be the acquisition of beneficial factors enabling survival / potential 
pathogenesis in the human body that is important, it might also be the loss of 
metabolic flexibility that drives the colonization of new niches and associated putative 
virulent behaviour. To fully assess all aspects of Y. enterocolitica biology, one further 
interesting experiment to carry out would be to repeat the phenotypic microarray at 
10°C. This would complement the current data set of optimum temperature and 
human body temperature with temperature found under environmental conditions 
and conditions associated with potential insect hosts. 
 
Generally, the phenotypic microarray results reflected the regions of difference and 
pseudogenization noticed in the reference genomes. Comparing the results with 
traditional biotyping, there were only two discrepancies found, one of which could be 
related back to a unique mutation in the reference strain chosen for BT 1A. Prediction 
of metabolic operons from the microarray data is restricted by annotation, i.e. some 
annotation is potentially too general to relate an operon to a specific metabolic 
function. The other way round, annotation is limited by the lack of clear phenotypic 
results that can be unambigiously linked to metabolic pathways. The phenotypic 
microarray data can be used in future for directed experiments to link phenotype and 
genotype, and might help identification of new pathways such as the utilization of N-
acetyl-D-galactosamine. 
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7 Phylogeny of the Genus Yersinia and the species 
Y. enterocolitica 
7.1 Introduction 
From the data presented thus far it appears that the driving forces of pathogen 
evolution are the same in Y. enterocolitica, Y. pseudotuberculosis and Y. pestis. It is 
thought that the pathogenic Yersiniae evolved out of a common ancestor that 
acquired the virulence plasmid pYV, enabling the coloniziation of new niches such as 
warm-blooded animals including humans (Carniel, 2002; Wren, 2003). 
Y. enterocolitica and Y. pseudotuberculosis then evolved separately, and 
Y. pseudotuberculosis gave rise to the Y. pestis biovars. The evolution of Y. pestis 
has been studied in detail (Achtman, et al., 1999; Achtman, et al., 2004; Morelli, et 
al., 2010) and is characterized by the expansion of IS elements leading to wide-
ranged genome rearrangements and subsequent gene loss (Parkhill, et al., 2001a).  
Unlike the Y. pseudotuberculosis/pestis cluster the evolutionary dynamics of 
Y. enterocolitica are understudied and knowledge is currently limited to microarray 
and amplified fragment length polymorphism studies (Fearnley, et al., 2005; Howard, 
et al., 2006). As seen in the previous chapters, Y. enterocolitica presents as a 
heterogeneous groups of organisms with very clear distinctions in gene content. It is 
necessary to establish the evolution of the Y. enterocolitica lineages to obtain a 
trajectory for acquisition and loss events of genomic islands, and clarify the presence 
of remnants of genes and islands and their potential influence on the evolution of 
pathogenesis in Y. enterocolitica. 
 
This chapter aims to elucidate the evolutionary relationships within Y. enterocolitica 
as well as with respect to the whole genus Yersinia and to investigate the inter-
relationships between the different lineages. This should help to identify any shared 
ancestry or patterns of evolution for the human pathogenic lineages of this genus.  
Sequencing more than one genome for each lineage will also clarify the status of 
reference sequences amongst a larger strain collection. The assumptions made for 
the reference genomes will be integrated with their respective lineage and confirm 
their role as representatives of the respective BT.  
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7.2 Results  
7.2.1 Phylogeny of the species Y. enterocolitica 
In addition to the seven reference genomes a further 89 Y. enterocolitica isolates 
were sequenced (Table 9.1, p. 204). These were contributed by collaborators from 
Europe and New Zealand and sequenced using Illumina technology. The strains 
represent human case isolates as well as isolates from humans without disease 
association, animal isolates, and environmental isolates. Twenty-four BT 1A, seven 
BT 1B, thirteen BT 2, twenty-two BT 3, twenty-one BT 4, and two BT 5 isolates were 
included. Only two BT 5 isolates were sequenced, as this is a rarely isolated biotype. 
 
The phylogeny of the Y. enterocolitica species was obtained from genome-wide 
single nucleotide polymorphism (SNP) distribution by mapping against the BT1B 
reference strain 8081. The four prophage regions were excluded from the analysis as 
they would result in false-positive SNPs from distantly related phages present in 
other BTs. This work was carried out in close collaboration with Dr Simon R. Harris 
and Dr Thomas R. Connor at the Wellcome Trust Sanger Institute. 
 
It is evident from Figure 7.1 that there are three different Y. enterocolitica lineages 
corresponding to non-, high-, and low-pathogenic BTs. The different lineages show 
considerable differences in the SNP variation across the tree. This is also evident 
from the number of SNPs in the different lineages (Table 7.1). Individual biotype 1A 
strains are differentiated by up to 32,000 SNP sites. Since most of these isolates 
came from passive sampling from abattoirs and some clinical studies, this diversity is 
likely to be a significant underestimate of the genuine diversity of this clade as true 
environmental isolates such as strains isolated from water are currently 
underrepresented. Within this non-pathogenic clade there are five non-BT 1A strains. 
Two of these strains were typed as BT 1B and were donated to the study from 
collaborators in New Zealand. Both strains were isolated from humans and had no 
serological information. 
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Figure 7.1: The maximum likelihood phylogenetic tree of Y. enterocolitica based on the SNP 
differences across the whole genome excluding laterally acquired phages. The tree highlights 
the key acquisition events of the virulence plasmid pYV in the pathogenic lineages of Y. enterocolitica, 
and the acquisition of markers of high-pathogenic BT. The low-pathogenic BTs are marked by an 
expansion of the IS element IS1667. The number of pseudogenes that are shared within specific 
lineages and that have functional orthologs in other lineages is given (pg*). The different lineages are 
characterized by biotype (BT), biological origin, and serotype (ST). The biochemical tests used for 
biotyping of Y. enterocolitica are presented for each strain.  
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Table 7.1: Numbers of SNPs between different lineages of Y. enterocolitica. 
  BT 1A BT 1B BT 2/3 O:9 BT 2/3 O:5,27 BT 4 BT 5 
BT 1A 0 –  
31,690 
     
BT 1B 87,039 – 
117,383 
11 –  
29,511 
    
BT 2/3 O:9 79,461 – 
115,724 
63,727 – 
92,073 
0 –  
5,582 
   
BT 2/3 O:5,27 81,599 – 
115,965 
64,399 – 
92,699 
1,607 – 
7,265 
1 –  
250 
  
BT 4 80,828 – 
115,651 
63,808 – 
91,888 
4,075 – 
8,202 
4,637 –  
5,685 
8 –  
882 
 
BT 5 84,994 – 
114,528 
72,361 – 
89,850 
5,406 – 
9,691 
7,503 – 
10,734 
8,211 – 
11,461 
82 –  
2,883 
Blue – range of SNPs within a BT/ST lineage; green – range of SNPs between BT 1A and other lineages; red – 
range of SNPs between 1B and other lineages; yellow – range of SNPs within the low-pathogenic BTs. 
 
It has been noted before that BT 1A strains can be mistyped as BT 1B strains, but 
they commonly lack the virulence factors associated with the high-pathogenic BT 
(personal communication A. McNally, M. Prentice; Fearnley, et al., 2005). Analysis of 
these two strains showed that they do not carry the virulence plasmid, and do not 
have the Ysa T3SS, or the HPI. On the contrary, these two strains have operons for 
the utilization of D-arabitol and N-acetyl-D-galactosamine, and they also possess the 
YGT. 
Three other isolates also do not group according to their biotyping reaction but 
cluster with BT 1A. These are a BT 3 O:5,27 isolate, one BT 4 O:3 strain, and a BT 2 
strain. The BT 2 strain, YE228/02, is known to give variable biotyping reactions, and 
which consequently might explain the discrepancy between typing and clustering of 
this particular strain (personal communication A. McNally, T. Cheasty). Sequences of 
the other isolates were mapped to the respective serotype operon but did not yield 
any homologous hits, suggesting difficulties in typing these strains. 
 
Although there is a reduced number of true 1B isolates, like BT 1A, they also show 
significant genetic divergence with up to 30,000 SNPs defining this lineage. In 
contrast it is evident from Figure 7.1 that despite the large number of samples, the 
average divergence between BT 2 – 5 isolates is much lower than the BT 1A and BT 
1B (~12,000 SNPs), resulting in very short terminal branch lengths within this clade. 
As the included strains represent a wide temporally and geographically dispersed 
collection the possibility of this feature being due to a sampling artefact is unlikely. 
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Another explanation is that the low genetic diversity is a signature consistent with a 
relatively recent population bottleneck.  
While it is apparent from Figure 7.1 that there is no obvious clustering of the isolates 
according to human or animal origin, the phylogeny of the pathogenic 
Y. enterocolitica lineages is fully congruent with serotype and partially with biotype. 
Although there is some variation in the results of these biochemical tests they appear 
largely phylogenetically robust: BT 1A isolates show a much higher metabolic 
potential whilst, even from these limited biochemical tests, it is clear that metabolic 
flexibility is sequentially reduced when moving from the high pathogenic 1B lineages 
across the low pathogenic lineages (Figure 7.1). This trend of reduced metabolic 
flexibility was observed on a much larger scale in the phenotypic microarray (Chapter 
6) and is consistent with an increased number of pseudogenes in the low-pathogenic 
BTs and an expansion of IS1667. The observed variation in the biochemical tests 
confusing the assignments of BT2, BT3 and BT4 isolates is largely explained by 
differences in the ability to catabolise D-xylose and the production of indole. The 
latter test is known to show a high degree of methodological variation. In particular 
BTs 2 and 3 are distinguishable only by a variable indole reaction, and Chapter 4 
illustrated that the two O:9 isolates are identical apart from three transposases and 
two putative phage proteins. Both BTs even present the same pseudogene mutations 
with very few exceptions. Phylogenetically BTs 2 and 3 intermingle and isolates are 
only clearly separated by serotype. 
 
For the reference strains, the number of pseudogenes in each branch with functional 
orthologs in other lineages has been highlighted on the tree. The pseudogenes 
defining a lineage are listed in Table 7.2.  
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Table 7.2: Pseudogenes in the core genome of Y. enterocolitica lineages. 
ID 1B 8081 
1A 
5303 
2 O:9 
21202 
3 O:9 
5603 
3 O:5,27 
14902 
4 O:3 
1203 
5 
3094 product mutation 
YE0416 Δ Δ Δ Δ Δ Δ Δ conserved hypothe-
tical protein   
stop codon 
YE2410 Δ Δ Δ Δ Δ Δ Δ putative oxidoreduc-
tase   
FS deletion 
YE0207 + Δ + + + + + putative lysophospho-
lipase   
stop codon 
YE0480 + Δ + + + + + putative exported 
protein   
stop codon 
YE0688 + Δ + + + + + putative type II secre-
tion system protein   
FS deletion 
YE0972 + Δ + + + + + conserved hypothe-
tical protein   
stop codon 
YE1432 + Δ + + + + + hypothetical protein   FS deletion 
YE1733 + Δ + + + + + putative UV protection 
and mutation protein   
stop codon 
YE1743 + Δ + + + + + putative AraC-family 
transcriptional 
regulatory protein   
stop codon 
YE1759 + Δ + + + + + conserved hypothe-
tical protein 
disrupted by 
IS element 
YE2179 + Δ + + + + + hypothetical protein   stop codon 
YE2521 + Δ + + + + + flagellin   deletion 
YE3354 + Δ + + + + + putative oxidoreduc-
tase   
disrupted by 
IS element 
YE4026 + Δ + + + + + myo-inositol 2-
dehydrogenase   
opal stop 
codon 
YE4074 + Δ + + + + + cellulose synthase 1 
catalytic subunit  
opal stop 
codon 
YE4185 + Δ + + + + + Probable two-compo-
nent sensor kinase   
stop codon 
YE0522 Δ + Δ Δ Δ Δ Δ putative exported 
protein   
deletion N 
terminus 
YE1236A Δ + Δ Δ Δ Δ Δ 6-phospho-beta-
glucosidase   
deletion 
YE1400 Δ + Δ Δ Δ Δ Δ Putative type I 
secretion protein 
FS mutation 
YE2586A Δ + Δ Δ Δ Δ Δ putative coA transfe-
rase family protein 
FS mutation 
YE2708 Δ + Δ Δ Δ Δ Δ α-ribazole-5'-phos-
phate phosphatase 
deletion 
YE2719 Δ + Δ Δ Δ Δ Δ conserved 
hypothetical protein 
deletion 
YE3341 Δ + Δ Δ Δ Δ Δ prepilin peptidase FS insertion 
YE0270 Δ + + + + + + conserved hypothe-
tical protein 
stop codon 
YE0936 Δ + + + + + + putative MFS family 
transport protein 
FS deletion 
YE0944 Δ + + + + + + hypothetical protein   stop codon, 
FS mutation 
YE1406 Δ + + + + + + putative protease FS mutation 
YE1488 Δ + + + + + + putative inner mem-
brane protein   
FS mutation 
YE1598 Δ + + + + + + nitrite reductase gene 
remnant 
deletion 
YE1728 Δ + + + + + + putative sugar per-
mease 
FS deletion 
YE1729 Δ + + + + + + putative sucrose 
operon repressor 
FS deletion 
YE2450 Δ + + + + + + putative D-tagatose-
1,6-bisphosphate 
aldolase subunit 
deletion C 
terminus 
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YE2640 * Δ + + + + + + putative membrane 
protein 
opal stop 
codon 
YE3168 Δ + + + + + + conserved hypothe-
tical protein 
disrupted by 
IS element 
YE3180 Δ + + + + + + phosphate binding 
protein 
stop codon 
YE0324 + + Δ Δ Δ Δ Δ putative ATP/GTP-
binding protein   
deletion C 
terminus 
YE0443 + + Δ Δ Δ Δ Δ multidrug efflux protein   deletion C 
terminus 
YE0445 + + Δ Δ Δ Δ Δ probable outer mem-
brane efflux lipoprotein   
deletion N 
terminus 
YE0483 + + Δ Δ Δ Δ Δ putative LysR-family 
transcriptional 
regulatory protein   
deletion 
YE0807 + + Δ Δ Δ Δ Δ putative transcriptional 
regulatory protein 
deletion 
YE0911 + + Δ Δ Δ Δ Δ 3-oxoacyl-[ACP] 
synthase II   
deletion N 
terminus 
YE0934 + + Δ Δ Δ Δ Δ hypothetical protein   deletion N 
terminus 
YE0935 + + Δ Δ Δ Δ Δ AraC-family transcrip-
tional regulator   
deletion N 
terminus 
YE0941 + + Δ Δ Δ Δ Δ AraC-family transcrip-
tional regulator   
FS deletion 
YE1005 + + Δ Δ Δ Δ Δ phospholipase A   FS insertions 
Ye1165 + + Δ Δ Δ Δ Δ putative LyxR-family 
transcriptional 
regulatory protein 
deletion 
YE1166 + + Δ Δ Δ Δ Δ putative LysR-family 
transcriptional 
regulatory protein   
FS mutation, 
deletion C 
terminus 
YE1251 + + Δ Δ Δ Δ Δ putative regulatory 
protein   
deletion N 
terminus 
YE1252 + + Δ Δ Δ Δ Δ putative exported 
protein   
deletion 
YE1409 + + Δ Δ Δ Δ Δ putative prophage 
repressor protein   
stop codon 
YE1610 + + FS 
deletion 
FS 
deletion 
FS 
deletions 
FS 
deletions 
stop 
codon 
putative MFS-family 
transport protein   
independent 
mutations 
YE1874 + + Δ Δ Δ Δ Δ putative DNA-binding 
protein 
deletion 
YE1905 + + Δ Δ Δ Δ Δ hypothetical protein   stop codon 
YE1944 + + FS 
insertion 
FS 
insertion 
FS 
insertion, 
stop 
codon 
FS 
insertion, 
stop 
codon 
stop 
codon 
putative membrane 
permease   
independent 
mutations 
YE1950 + + Δ Δ Δ Δ Δ alkanesulfonate 
monooxygenase   
deletion 
YE2286 + + Δ Δ Δ Δ Δ acyl-[ACP]--UDP-N-
acetylglucosamine o-
acyltransferase 
deletion 
YE2603 + + Δ Δ Δ Δ Δ putative sugar kinase   deletion C 
terminus 
YE2609 + + Δ Δ Δ Δ Δ ABC transporter, 
substrate binding 
component   
deletion 
YE2812 + + Δ Δ Δ Δ Δ putative formate 
transporter 
deletion 
YE3630 + + Δ Δ Δ Δ Δ putative cation efflux deletion 
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system protein   
YE3694 + + Δ Δ Δ Δ Δ Putative transcriptional 
regulator   
deletion, FS 
mutation 
YE3735 + + Δ Δ Δ Δ Δ glutamate synthase 
[NADPH] large chain 
precursor   
FS deletion 
YE3989 + + Δ Δ Δ Δ Δ conserved 
hypothetical protein 
deletion N 
terminus 
YE4052 + + Δ Δ Δ Δ Δ metalloprotease   deletion 
YE1410 + + + + Δ Δ + probable phage anti-
termination protein Q   
deletion C 
terminus 
YE1971 + + + + FS 
deletion 
opal stop 
codon 
+ probable membrane 
transport protein   
independent 
mutations 
YE0924 + + Δ Δ + + Δ glycine betaine/L-
proline transport 
system permease   
deletion 
YE1614 + + stop 
codon 
stop 
codon 
+ + FS 
insertion 
tetrathionate reduc-
tase complex: sensory 
transduction histidine 
kinase   
independent 
mutations 
YE1746 + + Δ Δ + + Δ hypothetical protein   disrupted by 
IS element 
YE2036 + + disrupted 
by IS 
element 
disrupted 
by IS 
element 
+ + deletion 
N 
terminus 
conserved 
hypothetical protein   
independent 
mutations 
YE4106 + + FS 
insertion 
FS 
insertion 
+ + deletion 
N 
terminus 
Hypothetical ROK 
family protein   
independent 
mutations 
+ – functional ortholog; Δ – mutation; column mutation lists shared mutational inactivation, further mutations possible for 
individual isolates; independent mutations are listed within the table. 
 
There are two pseudogenes which are shared in all BTs and which show the same 
mutational inactivation. The non-pathogenic BT 1A has acquired 14 pseudogenes. 
There is no predominant class among those pseudogenes, four are in hypothetical 
proteins and two are in regulatory proteins. All pathogenic lineages share seven 
pseudogenes in the core genome. These have been acquired in single events before 
the split of high- and low-pathogenic lineages because the same mutations are 
discernible. It has to be mentioned though that some of these genes have acquired 
further mutations following the split of the lineages. The high-pathogenic BT has 12 
pseudogenes with functional orthologs in the other lineages, three of which are in 
hypothetical proteins, and four are involved in metabolism and transport. 
A high accumulation of pseudogenes is apparent in the low-pathogenic BTs, again 
indicating a potential bottleneck evolution of this lineage. The low-pathogenic BTs 
have 29 pseudogenes of which only two have been acquired independently. These 
independent mutations target a transport protein and a membrane permease. The 
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shared pseudogenes are predominantly found in transport proteins (4 pseudogenes), 
proteins involved in metabolism (6 pseudogenes), and regulatory proteins (8 
pseudogenes). This supports the reduced metabolic flexibility observed in the 
phenotypic micorarray for these biotypes. The branch leading to the O:3 and O:5,27 
lineages has accumulated only two further pseudogenes, one in a shared phage, the 
other acquired independently in a membrane protein. Five pseudogenes are found in 
the branch leading to the O:9 and O:2a,2b,3 lineages. Of these, only two are shared. 
These are present in a transport permease and a hypothetical protein. The 
independent mutations are found in the histidine kinase controlling the tetrathionate 
respiration operon, and in hypothetical proteins. The two O:9 isolates show identical 
mutational inactivations, but these mutations were acquired independently in BT 5. 
A significant expansion of core pseudogenes in the terminal branches of the low-
pathogenic BTs is visible in BT 4 O:3 (58 pseudogenes) and BT 5 O:2a,2b,3 (109 
pseudogenes). These two isolates can be considered the two most host-adapted 
lineages of Y. enterocolitica. BT 4 O:3 is the predominant isolate found in human 
cases, and BT 5 is responsible for disease in hares. BT 5 is very niche-restricted. 
After accumulation of a massive amount of pseudogenes, it appears to struggle to 
survive outside its host and is very rarely isolated in general. The increased amount 
of pseudogenes also again reflects the loss of metabolic flexibility detected in the 
phenotypic micorarray (Chapter 6). 
 
As mentioned before (Chapter 4), some trends found within the pseudogenes also 
translate in a broader context. Cobalamin biosynthesis, tetrathionate respiration, and 
the flagella cluster are not only affected by mutations in Y. enterocolitica lineages, but 
are also targets of pseudogene formation in Y. pestis, S. Typhi, and S. Gallinarum 
(Parkhill, et al., 2001a,b; Thomson, et al., 2006, 2008). Fish pathogen Y. ruckeri has 
also been described as lacking cobalamin biosynthesis and tetrathionate respiration 
(Chen, et al., 2010). Evolution from environmental survival to host adaption has 
probably driven the loss of these properties. 
 
It has been proposed to sub-speciate BT 1B into Y. enterocolitica subspecies 
enterocolitica and BT 1A, 2-5 into Y. enterocolitica subspecies palearctica 
(Neubauer, et al., 2000). This distinction of two subspecies is based on variations in 
12 SNPs over the full length of the 16S rRNA gene (1637 bp). However, this 
differentiation is not supported by our data. Based on SNP distribution in all core 
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genes three distinct lineages can be observed. Very specifically, the proposed 
subspecies Y. enterocolitica palearctica is based on the worldwide distribution of 
those isolates but their very distinct genomic content argues against this. Obviously, 
the resolution power is much greater using the full genome information as opposed to 
a single, highly conserved gene.  
 
Judging solely from our tree, it appears that the virulence plasmid pYV has been 
acquired in the pathogenic lineages of Y. enterocolitica. Signifying the split into high-
pathogenic BTs is the uptake of the HPI and operons within the plasticity zone. 
Indicative for the low-pathogenic BTs is the expansion of IS1667. From this tree, the 
non-pathogenic BT seems to be the oldest lineage. The second flagella cluster Flag-
2, which is only consistently present in the low-pathogenic BTs, has been lost 
independently in high- and low-pathogenic BTs. The shape of the tree dictates this, 
but different gene fragments of Flag-2 in those BTs are also suggestive of 
independent loss events. Further to this, there are some BT 1A isolates that have 
retained Flag-2, but there is no link to a specific biological origin. 
 
7.2.2 Phylogeny of the genus Yersinia 
To determine sequence based phylogeny of the Yersinia genus we examined a 
representative sample of pathogenic isolates composed of Y. pseudotuberculosis (33 
in total; 29 sequenced in this study) and Y. pestis (using the published genomes of 
CO92/Parkhill, et al., 2001; KIM5/Deng, et al., 2002; Yp91001/Song, et al., 2004) as 
well as the relatively understudied lineage of Y. enterocolitica (98 isolates). To 
explore the large number of environmental Yersinia spp., 81 isolates from all species 
except the recently described Y. entomophaga (Hurst, et al., 2011) and Y. nurmii 
(Murros-Kontiainen, et al., 2010a) were included. These isolates are listed in Table 
9.2 (p. 206) in the appendix. In total 199 Yersinia isolates were sequenced which had 
been conventionally typed using biochemical and serological techniques. Some 
isolates that had been assigned to species but showed atypical biochemical profiles 
were included as well. 
As the genus Yersinia shows a very high sequence divergence, an approach based 
on mapping sequence reads to gain information on the whole genome could not be 
carried out. As seen in Y. enterocolitica, even within a single species of Yersinia 
> 250, 000 SNPs differentiate members of that species. Instead, the syntenic blocks 
identified in Y. enterocolitica (Chapter 4) were used to sample a set of 85 
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housekeeping genes common to all members of the Yersiniae. The housekeeping 
genes were identified on the basis of showing 10-25% SNP divergence between 
Y. pestis and Y. enterocolitica. This work was carried out in collaboration with 
Miquette Hall, NTU. The genes identified are given in Table 2.3 and their locations 
with respect to the BT 1B reference genome for strain 8081 is shown in Figure 7.2 
 
 
Figure 7.2: Distribution of the 85 housekeeping genes used for construction of the 
phylogenetic relationship within the genus Yersinia. The first circle shows regions naturally 
excluding the presence of housekeeping genes, such as phage, and pathogenicity islands. In the 
second circle, each bar represents a single housekeeping gene. The third circle highlights the 29 
syntenic blocks in alternating colours of orange and brown (see Table 4.3). 
 
There are some syntenic blocks that are not represented with genes (#3, 10, 18, 19, 
22, 25, 27). This can be due to several reasons. First of all, the blocks were identified 
purely on the basis of being a stretch of DNA sequence that did not show any 
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recombination in the different Y. enterocolitica BT. Some blocks, like #3 and #10, are 
small in size and only contain ~30 CDSs. This restricts the number of possible genes, 
and the genes contained in these blocks might not be housekeeping genes to start 
with, or do not comply with the required divergence levels. The absence of 
housekeeping genes in larger regions such as #27 could be explained by the fact 
that housekeeping genes were identified, but they could not be obtained from 
sequence reads for Y. ruckeri. This species is arguably part of the genus Yersinia 
(Sulakvelidze, 2000) and notably very distantly related to the other members of the 
genus. There were occasions when housekeeping genes were easily identified in all 
species except Y. ruckeri and thus had to be excluded from an initial set of potential 
genes. 
Region #25 corresponds to a conserved region within the plasticity zone, but does 
not contain any housekeeping genes. 
 
Bayesian Analysis of Population Structure (BAPS) was used to divide the population 
into groups of shared sequence similarity. Phylogenetic analyses are usually based 
on a concatenated sequence. In contrast, BAPS compares individual genes and thus 
can look at a broader level of relationships, including potential recombination events 
and linkage between genes. This BAPS clustering resolved the genus into 12 distinct 
species clusters (SC; Figure 7.3). Definition of Yersinia spp. has been based on 
biochemical differences, which have been overlayed onto the tree. It is obvious that 
some Yersinia spp. show a similar biochemical profile, yet are distantly related. This 
is the case for Y. frederiksenii. The type strain is part of SC 7, but a distantly related 
group can be found in SC 2, together with isolates designated as Y.  massiliensis. 
This phenomenon has been noted before (Sulakvelidze, 2000; Virdi and Sachdeva, 
2005; Merhej, et al., 2008). On the other hand, SC 3 groups three species, 
Y. aleksiciae, Y. bercovieri, and Y. mollaretii, with similar biochemical profiles 
together. Y. mollaretii and Y. bercovieri were originally classified as Y. enterocolitica 
BT 3A and 3B, respectively (Sulakvelidze, 2000). They were later speciated based 
on differential tests of sorbose, sucrose, indole, and inositol (Sulakvelidze, 2000). 
Here, they are once again grouping together in one heterogeneous lineage. 
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Figure 7.3: The phylogeny of the genus Yersinia and the virulence plasmid pYV. The maximum 
likelihood phylogenetic tree of the genus Yersinia is based on the concatenated sequence of 85 
housekeeping genes. Current species assignments (colour circle borders) are contrasted with the 
species complexes (coloured circles) as allocated by BAPS analysis and the biochemical typing 
scheme used for speciation. There are three separate Y. frederiksenii lineages, labelled ‘frederiksenii’, 
thus subject to renaming to differentiate them. The type strain (Chen, et al., 2010) is depicted by *. An 
arrow shows the two independent acquisition events of the virulence plasmid pYV. The maximum 
likelihood phylogenetic tree of pYV is based on the whole sequence of the plasmid mapping against 
pYVe8081. The colours are the same as for the species complexes in which the plasmid is detected. 
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Y. pestis and Y. pseudotuberculosis form a tight, almost indistinguishable group 
which is consistent with previously published results (Achtman, et al., 1999; 
Kotetishvili, et al., 2005). They form a species complex with Y. similis. This non-
pathogenic species was recently split off from Y. pseudotuberculosis on the basis of 
a melibiose-negative phenotype and differences in the 16S rRNA gene sequence 
(Sprague, Scholz, Amann and Busse, 2008). Furthermore, isolates of Y. similis do 
not possess the virulence plasmid pYV (Sprague, Scholz, Amann and Busse, 2008). 
Based on clustering analysis, it shows significant sequence similarity to be still 
considered part of the Y. pseudoutberculosis/pestis species cluster. 
The other environmental species occupy branches between the 
Y. pseudotuberculosis complex and Y. enterocolitica, which is positioned 
diametrically opposed to Y. pseudotuberculosis at the other side of the tree. The only 
exception to this is Y. ruckeri, which forms an independent, long branch, and is 
clearly distantly related to the other members of the genus Yersinia. As was seen in 
Figure 7.1, Y. enterocolitica forms three separate lineages corresponding to non-, 
high-, and low-pathogenic BTs. As suggested from the genomic data, BT 1A is 
indeed the oldest lineage. One early branching isolate potentially reflects the diversity 
inherent in this environmental lineage. The pathogenic lineages are signified by the 
acquisition of the virulence plasmid after their separation from the non-pathogenic 
BT 1A. 
 
Two new species have been recently described as members of the genus Yersinia: 
Y. entomophaga and Y. nurmii (Hurst, et al., 2011; Murros-Kontiainen, et al., 2010a). 
These isolates were not included in the sequencing collections, as they were too 
recently suggested. Both are described as being closely related to Y. ruckeri. This is 
interesting, as Y. ruckeri presents the most outlying lineage of the genus, and so far 
no intermediates to other lineages have been identified. The description of two such 
species now raises the question whether these are the same species described by 
two research teams independently and where they can be positioned with respect to 
the other lineages identified. 
For these two species, only the sequences of the four housekeeping genes glnA, 
gyrB, hsp60, and recA are currently available. Although these genes might not be 
informative representatives to re-establish the phylogeny of the genus, as especially 
recA shows a high level of conservation, in combination with the known lineages and 
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their evolutionary history it is possible to establish the position of Y. entomophaga 
and Y. nurmii (Figure 7.4).  
 
 
Figure 7.4: The phylogeny of the genus Yersinia based on recA, glnA, gyrB, and hsp60. The 
maximum likelihood phylogenetic tree of the genus Yersinia is based on the concatenated sequence 
of four housekeeping genes. The same species complexes (coloured circles) as allocated by BAPS 
analysis (Figure 7.3) are highlighted. The type strains are depicted by open circles. Y. entomophaga 
and Y. nurmii form SC13, with Y. entomophaga shown as open circle. 
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From Figure 7.4 one can see that the branching order differs in these four 
hosuekeeping genes from the 85 genes, yet the exact same species clusters are 
formed and can be used to establish the dimension of divergence or clonality of 
Y. entomophaga and Y. nurmii. It is obvious that Y. entomophaga and Y. nurmii form 
a single lineage. Whilst no clustering analysis is available, comparison with the 
diversity of other lineages makes it likely that these form a single species complex 
SC13.  
The 17 officially described and recognized species of Yersinia therefore from 13 
different species cluster. Of the old species definition, eight designations do not 
agree with the species complexes, and taxonomy and nomenclature will need to be 
revised to clarify the nature of the isolates. 
 
7.2.3 Phylogeny of the genus Yersinia based on 16S rDNA sequences 
The independent evolution of pathogenic lineages in Yersinia has not been noticed 
before, but it was assumed due to their pathogenic potential in humans that they 
shared a common pathogenic predecessor. The evolutionary distance of 
environmental, “Y. enterocolitica-like” species (Sulakvelidze, 2000) appears to have 
been hugely underestimated as well. The study of only few genes or of genes that 
are not phylogenetically informative or robust might have skewed the image of an 
evolutionary relationship as well. One example for this is the 16S rRNA gene (Figure 
7.5). 
Although this representation of the 16S rRNA genes in the genus is based on 
corrected Illumina reads and not on finished Sanger sequencing, the sequences for 
the representative type strains of the environmental Yersiniae fall together with other 
isolates of their species cluster (Figure 7.5). This indicates that the sequencing data 
is comparable to the Sanger sequencing approach. Overall, there is very little 
variation within the 16S gene. 95.69% of the gene, or 1398 out of 1461 bases 
investigated, are invariable and phylogenetically non-informative. One highly variable 
region is detected between bases 429 and 449. Based on this data set, one can see 
that the phylogeny based on 16S rDNA is in disagreement with the 85 housekeeping 
genes. There is still an indication of clustering according to species cluster, and the 
Y. enterocolitica and Y. pseudotuberculosis/pestis lineages are still at opposite ends 
of the tree. Notably though, in Y. enterocolitica pathogenic and non-pathogenic 
lineages intermingle. The distinction of two subspecies was based on variation in 12 
bases only (Neubauer, et al., 2000), and the corrected Illumina data might not reflect 
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this, yet these subspecies are invalid nonetheless with respect to the whole genome 
phylogeny.  
 
 
Figure 7.5: The phylogeny of the genus Yersinia based on 16S rDNA sequences. The maximum 
likelihood phylogenetic tree of the genus Yersinia is based on 1461 bases of the 16S rRNA gene. The 
species complexes (coloured circles) as allocated by BAPS analysis are shown. The type strains 
sequenced in previous studies are depicted by open circles. 
 
The clusters formed are the same clusters originally described by Ibrahim, et al. 
(1993 and 1997). The environmental Yersiniae generally form a heterogeneous 
cluster. The branching order of individual lineages that was seen in the phylogeny of 
85 housekeeping genes cannot be observed, Y. frederiksenii has changed its 
position to be closer to Y. pseudotuberculosis/pestis, and some isolates of 
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Y. mollaretii/bercovieri/aleksiciae as well as Y. intermedia are found on two different 
branches. 
The phylogenetic analysis of 85 housekeeping genes therefore provides much 
greater resolution of the genus than is possible using the 16S gene sequence, which 
fails to adequately resolve the environmental Yersinia strains. The limitations of 
species delineation (and assignation) by biochemical tests and 16S sequence 
illustrates the necessity of using a finer scale approach to distinguish between 
members of the genus, and the need for thorough assessment of the genomic 
signature of novel species currently being reported in the Yersinia genus. 
 
7.2.4 Acquisition of the virulence plasmid pYV in pathogenic Yersiniae 
Also shown in Figure 7.3 (inset) is the phylogeny of the virulence plasmid pYV. The 
acquisiton of this plasmid is thought to be a key element in the evolution of 
pathogenic Yersiniae lineages. So far, the plasmid has only been found in pathogenic 
Yersinia spp., and this is confirmed in the present strain collection as pYV was only 
detected in the Y. pseudotuberculosis/Y. pestis cluster as well as the pathogenic 
Y. enterocolitica BTs 1B and 2 – 5. The previous model for the evolution of Yersinia 
postulated a single acquisition event of pYV in a pathogenic predecessor and 
subsequent loss in the non-pathogenic Y. enterocolitica BT 1A (Figure 1.2; Portnoy 
and Falkow, 1981; Carniel, 2002; Wren, 2003). From Figure 7.3 it is evident that this 
is unlikely. With the environmental isolates positioned between the pathogenic 
lineages a more parsimonious justification is the acquistion of pYV in two separate 
events by the pathogenic lineages. Further support to this is given in the evolutionary 
distance between virulence plasmids that does not equal the distance of 
Y. enterocolitica to the Y. pseudotuberculosis/Y. pestis cluster. Drawn to scale, the 
diversity within the plasmids is considerably less than in the genome (Figure 7.3). 
Looking more in detail at the plasmid phylogeny (Figure 7.6) one can see that it 
relates to the phylogeny seen in the Y. enterocolitica lineages. 
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Figure 7.6: Phylogeny of the plasmid pYV compared to the phylogeny of the chromosome in 
Y. enterocolitica. * not drawn to scale of each other. Red – BT 1B O:8; orange – BT 5 O:2a,2b,3; 
purple – BT 4 O:3; yellow – BT 2/3 O:5,27; green – BT 2/3 O:9. 
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The different lineages of the virulence plasmid exactly reflect the lineages in the 
pathogenic BT, although the branching order is slightly different. This is consistent 
with a single acquisition event, but also indicates that the plasmid then co-evolved 
with a specific lineage and was not transferred between bio-serotypes. It would 
indicate that the pathogenic strains have adapted to specific niches, which were 
enabled by the genes encoded on the virulence plasmid. The low-pathogenic BTs 
show signs of evolving into specific ecotypes, with no exchange of genetic material 
between them, be it LPS operons, or the virulence plasmid. 
The acquisition of the virulence plasmid therefore has added significantly to the 
pathogenic potential of two different pathogenic species, in independent events and 
in different genetic backgrounds. 
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7.3 Discussion 
7.3.1 The evolution of pathogenic Y. enterocolitica lineages 
The phylogeny of Y. enterocolitica shows that there are three very distinct lineages. 
BT 1A is the oldest lineage, from which the pathogenic lineages have evolved 
through the acquisition of the virulence plasmid on at least one independent 
occasion. The non-pathogenic BT shows heterogeneity, as indicated by the large 
number of SNPs between individual isolates resulting in long branch lengths. Due to 
predominant sampling in a clinical setting and during an abbatoir study, this 
divergence is likely to be an underestimate. Analysis of the other sequenced isolates 
might yield a considerable number of unique CDSs other than phage, and the pan-
genome of BT 1A can be considered open. 
The position of BTs 1A at the root of the Y. enterocolitica tree explains some of the 
features of the reference genome. When considering regions of difference between 
BT 1A and the other BTs, it is now apparent that loss in the pathogenic lineages is a 
driver for evolution rather than acquisition events in the non-pathogenic BT. 
Inspection for example of the D-arabitol cluster (Chapter 6) shows that most of it has 
been lost during the evolution of the pathogenic lineages, and that the last gene 
remnant was lost without trace in the low-pathogenic BTs, whilst the remnant 
remains in BT 1B. This trajectory also helps to explain the differences in 
pseudogenes and remnants of the second flagella cluster Flag-2; the operons have 
been lost independently in BT 1A and 1B, and the genome decays has happened in 
different genes in the cluster. A search for Flag-2 genes in the Y. enterocolitica strain 
collection showed that some BT 1A isolates even retain the complete cluster. It is not 
known, however, whether the clusters are still functional, yet their frequent loss in 
individual branches indicates a dispensable nature. 
 
The pathogenic BTs have a common evolutionary path, acquiring seven 
pseudogenes, before splitting into high- and low-pathogenic BTs. The high-
pathogenic BT is marked by the acquisition of previously mentioned markers of 
isolates with increased pathogenicity, the HPI, and the Ysa T3SS in the plasticity 
zone. Considering that only five strains were sequenced, there is still considerable 
diversity amongst this BT, although it is not comparable with the heterogeneity in BT 
1A. As for the distribution of the pathogenicity islands, the larger strain collection 
confirmed the Ysa T3SS and the HPI as specific for BT 1B of Y. enterocolitica, 
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whereas the YAPI appears to be an acquisition specific to strain 8081. This was 
found before (Thomson, et al., 2006), and it is similar to Y. pseudotuberculosis, which 
shows a variable distribution of the HPI and YAPI in different combinations 
(Fukushima, et al., 2001; Eppinger, et al., 2007). 
The low-pathogenic BTs have evolved through genome rearrangements and gene 
loss, as indicated by the increased number of IS1667 and the marked 
pseudogenization. The phylogeny of the low-pathogenic BTs of Y. enterocolitica is 
strictly based on serotype. Serotypes O:9, O:5,27, O:3, and O:2a,2b,3 each form 
their own branch. This is surprising, as the LPS operons can be exchanged in other 
bacteria, for instance Streptococcus pneumoniae, and serotype switching may occur 
so that an evolutionary signal based on serotype is not visible (Croucher, et al., 
2011). In Y. enterocolitica, the different lineages strictly adhere to serotype, with no 
indication of serotype recombination. This is also different from the population 
structure of Y. pseudotuberculosis where recombination is frequent, and where parts 
of the serotype operons appear to undergo exchange and recombination with other 
clusters (Ch’ng, et al., 2011). The population structure of the low-pathogenic 
Y. enterocolitica BTs suggest niche adaptation following a bottleneck leading to 
specific ecovars. This niche could involve different insect vectors suggested by the 
presence of insecticidal toxin complexes. 
One caveat has to be added – the serotypes investigated in this study present the 
dominant, most prevalent serotypes. The low-pathogenic BTs may exhibit other 
serotype as well, but these are infrequent and not associated with disease (McNally, 
et al., 2004; Bottone, 1999). It would be interesting to see where they appear on a 
phylogenetic tree of the low-pathogenic BTs. 
 
Also in contrast to Y. pseudotuberculosis, the differentiation of BTs in 
Y. enterocolitica into high-, low-, and non-pathogenic lineages appears to be ancient, 
with a clear phylogenetic signal and long branches. Although Y. pseudotuberculosis 
was divided in high- and low-pathogenicity groups as well, these do not present in 
specific lineages in a MLST tree (Ch’ng, et al., 2011). This population appears to be 
more dynamic in terms of exchange of pathogenicity islands, whereas 
Y. enterocolitica seems to have a long history of adaptation, with recent clonal 
expansion of the low-pathogenic BTs. The short branches in the low-pathogenic BTs, 
and the fact that unique regions of the reference genomes pertain to phage, this 
might suggest a closed pan-genome for BTs 2 – 5. This means that further sequence 
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analysis is unlikely to uncover new pathogenicity islands, similar to the closed pan-
genome of Y. pestis (Eppinger, et al., 2010). This is in contrast to the non-pathogenic 
BT 1A, and possibly the high-pathogenic BT, which show a reasonable diversity to 
suggest a pan-genome that is still open for new discoveries. 
 
7.3.2 The genus Yersinia and the virulence plasmid pYV – independent 
evolution of pathogenicity 
The phylogeny of the whole genus Yersinia and the virulence plasmid pYV do not 
agree with the current evolution of pathogenic lineages of Yersinia. The pathogenic 
lineages are positioned diametrically at opposite ends of the genus tree. The most 
parsimonious explanation for this is the independent acquisition of the virulence 
plasmid on at least two separate occasions; this presents 2+ events as opposed to a 
single gain in the last common ancestor of Yersinia and 10+ loss events for each 
environmental lineage. Further to this, not only is the virulence plasmid not present in 
any of the environmental lineages, the evolutionary distance between the virulence 
plasmids is too recent to compete with the ancient lineages presented in the analysis 
of the chromosome. It could be argued that the virulence plasmid is under strict 
selection and therefore shows less sequence variation. Yet, pYV is only essential 
inside a warm-blooded host, and the life cycle of Yersinia includes environmental and 
insect stages. The housekeeping genes on the other hand are under constant 
selection no matter the environmental condition as they perform essential function for 
cellular survival. Their divergence should thus give a more accurate estimate and 
scale of the relationship within the genus. 
Interestingly, the virulence plasmid also shows signs of co-evolution with specific 
lineages in Y. enterocolitica. This indicates that the acquisition was a key event that 
led to a marked change in lifestyle and niche. It implies that the exchange of mobile 
genetic elements is not important in the low-pathogenic BTs, possibly due to the 
adaptation to specific niches. This would also explain the strict adherence to serotype 
in the phylogenetic grouping. 
 
Considering the genus as a whole, it is apparent that both the human pathogenic 
lineages share patterns of evolution. Their development following the acuqisition of 
the virulence plasmid is characterised by functional gene loss. In one lineage, this 
lead to the emergence of the acutely pathogenic Y. pestis, and in the other lineage to 
the low-pathogenic Y. enterocolitica biotypes. Functional gene loss is also observed 
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in other human pathogens, such as M. tuberculosis and Salmonella, and can thus be 
considered an emerging pattern on the road to human pathogenicity. 
 
The evolution of Y. pestis through gene loss, genomic rearrangements, expansion of 
IS elements, and metabolic streamlining is exactly mirrored in the low-pathogenic 
BTs of Y. enterocolitica, especially BTs 4 and 5. BT 4 is ubiquitous, but is the biotype 
that is predominantly isolated from human cases in mainland Europe (McNally, et al., 
2004; Batzilla, et al., 2011), which indicates some degree of host adaptation, and BT 
5 is the hare biotype. 
 
7.3.3 Differentiation of species in the genus Yersinia 
Several papers have already pointed out that commerically available biochemical 
tests are insufficient to distinguish Y. enterocolitica from environmental, 
Y. enterocolitica-like species (Stock, Henrichfreise and Wiedemann, 2002; Merhej, et 
al., 2008). Especially with identification of new species in the genus, the list of 
possible phenotypic tests is growing and might become unmanagle, confusing, and 
impractical. A more useful approach is needed, that unambiguously speciates 
isolates, without dependency on phenotypes that might vary with reagents, 
incubation conditions, and are subject to random inactivating mutations. 
The 16S rDNA gene that has been commonly used to establish a tree of life is 
unsuitable for speciation in Yersinia. It has been noted before that the 16S rDNA is 
only useful up to the genus level, but that sequences most often are too conserved to 
distinguish individual species (Drancourt and Raoult, 2002; Janda and Abbott, 2007). 
This is the case for example in Staphylococcus, where for example rpoB, the RNA 
polymerase gene, and others are used instead of 16S gene to speciate isolates 
(Drancourt and Raoult, 2002; Ghebremedhin, Layer, König and König, 2008; Janda 
and Abbott, 2007). It has also been shown that, despite the high degree of 
conservation, and despite the essentiality of the small ribosomal subunit, an 
exchange of 16S rDNA genes between different species is possible and that active 
recombination between species does not exclude the 16S gene (Asai, Zaporojets, 
Squires and Squires, 1999; Schouls, Schot and Jacobs, 2003). Adding to this the fact 
that the 16S rDNA gene is commonly present in several copies in a single genome 
(Schouls, Schot and Jacobs, 2003; Janda and Abbott, 2007), and that sequence 
variation – however small – are known, makes the 16S rDNA inapt to Yersinia 
speciation. 
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With the 85 housekeeping genes presented here, the development of an MLST 
scheme reflecting the evolution of the genus is a self-evident proposal. Improvement 
on the MLST scheme proposed by Kotetishvili, et al. (2005) is currently under way by 
Miquette Hall to establish a set of seven genes that can be used to differentiate 
Yersinia isolates exactly, and that will also allow for future identification of potential 
new species. The Yersinia taxonomy has to be updated to incorporate the findings of 
this study, and an MLST approach circumvents the reliance on biochemistry. 
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8 Overall Discussion and Future Work 
8.1 Analysis of reference genomes and plasmids 
The sequencing of the reference genomes highlighted the fact that a single genome 
might not be representative of a whole species, depending on the heterogeneity of 
said species. Although the general genome composition is similar in all 
Y. enterocolitica BTs with respect to overall size, coding density, and functional 
classes of CDSs, significant differences can be observed on closer inspection 
relating to pseudogenes and regions that are absent or inactivated in certain 
lineages. 
All BTs have about 80% of their CDSs in common, signifying the Y. enterocolitica 
core functions. Amongst these are the flagella cluster Flag-1, the tigh-adherence 
operon, and both hydrogenase operons. A considerable number of CDSs is shared in 
BT 1A and BT 1B as well as BT 1A and the low-pathogenic BTs, indicating 
differential loss after the split of the pathogenic BTs. The non- and high-pathogenic 
BTs share two genomic islands, YGI-2, encoding a glycolipoprotein, and YGI-4, an 
integrated plasmid, as well as regions relating to resistance to heavy metals nickel, 
cobalt, and arsenic. The non- and low-pathogenic BTs share the Yersinia Genus 
T3SS, the outer core as part of their LPS, and metabolic properties. On the other 
hand, only 40 CDSs are shared in all pathogenic BTs apart from the virulence 
plasmid pYV. Most of these are related to hypothetical or conserved hypothetical 
proteins and have therefore no allocated or confirmed function in a role in disease, 
except for the adhesion invasion locus ail. Therefore there is no conserved 
pathogenic core present in high- and low-pathogenic BTs apart from ail and the 
virulence plasmid pYV. 
The non-pathogenic BT has unique regions involved in arsenic, silver and copper 
resistance as well as other metabolic operons. The HPI, YAPI, general secretion 
pathway yst1 and Ysa T3SS were confirmed to be unique to the high-pathogenic BT. 
The low-pathogenic BTs share the tcPAI and a second flagella cluster. The low-
pathogenic BTs are further signified by the expansion of IS1667 leading to wide-
ranged genome rearrangements. 
 
The virulence plasmid pYV shows considerable variation regarding its organization, 
and should therefore rather be considered a family of closed related plasmids as 
suggested by Portnoy, Moseley and Falkow (1981). The Yop T3SS forms the 
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conserved part of the plasmid, whereas other CDSs can change orientation and 
position. Nevertheless, the overall functionality of the virulence plasmid is preserved. 
Smaller variations concerning YscP have been correlated with needle length, but 
there are no indications that BTs with different needle length show a difference in 
efficiency of protein transfer into the target cell.  
The variations seen between pYV plasmids of high- and low-pathogenic BTs suggest 
divergent evolution of the virulence plasmid in Y. enterocolitica. The origins of 
replication in low-pathogenic BTs is the same as in Y. pestis and 
Y. pseudotuberculosis, which could mean that the high-pathogenic pYV evolved 
through co-integration with a plasmid of a different incompatibility group (Snellings, 
Popek and Lindler, 2001). The exact evolutionary history and potential exchanges of 
pYV between Y. pseudotuberculosis/pestis and Y. enterocolitica BTs cannot be 
established, unless a similar, intermediate plasmid is discovered in an environmental 
bacterium outside the Yersinia genus. 
 
The unique plasmids add to the overall genetic pool of Y. enterocolitica. Whilst the 
plasmids sequenced from BT 1A are cryptic, pSR1-2 is potentially important for 
tetracycline resistance in the pig host, and pSR4-5 might be able to mobilize the 
virulence plasmid based on homology with a similar conjugative plasmid. 
 
8.2 Analysis of phenotypic microarray 
A recurring theme in regions of difference and pseudogene targets are metabolic 
operons. Metabolism is both a driver and a consequence of host or niche adaptation; 
it is a driver because the search for nutrients drives bacteria into exploring new 
environments, and it is a consequence as subsequent metabolic streamlining locks 
bacteria in a niche. The best example for this are Y. enterocolitica BT 5 and Y. pestis, 
which exhibit reduced ability to survive outside their respective hosts. 
 
Owing to the fact that BT 1A is a ubiquitous, environmental organism, it can utilize a 
wide range of different metabolites, and is adaptable to very different conditions. This 
provides a survival advantage in the environment, as conditions change with season 
and with respective current environment such as aquatic or soil environments that 
pose very different challenges on a bacterium. The unique operons involved in 
metabolism of nutrients carried in the non-pathogenic BT confirm this. 
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The increased number of pseudogenes observed in the low-pathogenic BTs 
correlates with the decreased metabolic flexibility that is apparent in the phenotypic 
microarray. The pathogenic BTs have lost part of their metabolic flexibility upon 
adaptation to human hosts and warm-blooded animals. Both human and animal 
hosts provide a stable surrounding compared to the outside environment regarding 
temperature and available nutrients. On the other hand, nutrients might be available 
that are not found outside the gut environment and that require specialized transport 
and metabolic operons. Additionally, the availability of other nutrients may be limited 
and targeted acquisition systems are needed. Examples in the latter category are 
iron and heme acquisition systems, for example encoded on the high-pathogenicity 
island of BT 1B, that allow for capturing and utilization of this trace element. The 
phenotypic microarray thus far only highlighted the loss of functions in the pathogenic 
BTs rather than the gain of utilizing new nutrients compared to the environmental BT 
1A. An in-depth analysis of the 37°C data might yield results, but it is possible that 
the conditions tested do not activate the utilization of those nutrients. Considering the 
conditions found in the gut, oxygen starvation and change in pH might be important 
signalling factors that could be investigated in the future using the phenotypic 
micorarray. 
 
8.3 Revised model for the evolution of pathogenicity in the genus 
Yersinia 
The themes of gene loss, expansion of IS elements, metabolic streamlining and 
acquisition of mobile genetic elements in the high- and low-pathogenic BTs is 
reminiscent of the evolutionary path of Y. pestis. To investigate the relationships 
between different Yersinia species, 85 housekeeping genes were chosen for 
comparison. This extensive set of genes should give a robust representation of this 
diverse genus. The phylogeny of the genus Yersinia showed that the 
humanpathogenic lineages evolved independently out of the environmental species, 
yet employing the same driving forces of “add, stir, and reduce” that have been 
suggested for Y. pestis (Wren, 2003). 
The comparison of the phylogeny of the chromosome of Yersinia spp. against the 
phylogeny of the virulence plasmid pYV showed that the virulence plasmid has been 
acquired in at least two instances and more recently than the divergence of the 
Y. pseudotuberculosis and Y. enterocolitica lineages. This is in disagreement with the 
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notion that the pathogenic Yersiniae had a common, pathogenic precursor that 
acquired the virulence plasmid in a single event. 
It also needs to be considered that the environmental species form very distinct 
lineages from Y. enterocolitica and should therefore not be considered 
‘Y. enteroclitica-like’ species purely based on the fact of similar biochemical typing 
reactions. 
 
The model for the evolution of pathogenicity in the genus Yersinia needs to be 
revised and one suggestion is presented in Figure 8.1. 
From the ancestral Yersinia, several lineages evolved. On opposite ends of the 
spectrum of diversity are the pathogenic lineages, with the environmental, 
supposedly non-humanpathogenic species situated in between.  
The humanpathogenic lineages have evolved independently, yet employing the same 
mechanisms. Both have acquired novel genetic material that distinguishes them from 
environmental species. For Y. pseudotuberculosis, the hemin storage locus and the 
high-pathogenicity island play an important role. The distinguishing features for 
Y. enterocolitica are less clear; in the past the enterotoxin yst has been suggested 
(Wren, 2003). Research is currently underway to determine the distribution of 
virulence factors within the genus, which will also establish descriptors for 
Y. enterocolitica. For both pathogenic lineages, the acquisition of the virulence 
plasmid has been crucial in opening a new niche in a warm-blooded host. In 
Y. enterocolitica, this gain has happened after the split of the non-pathgenic, 
environmental BT 1A. Clustering based on BAPS suggests BT 1A as a separate 
species cluster, and given the very different nature and environment of BT 1A, this is 
a reasonable suggestion. Although BT 1A is considered non-pathogenic, it is isolated 
from healthy and ill individuals (Bottone, 1999; Tennant, Grant and Robins-Browne, 
2003; Tennant, Skinner, Joe and Robins-Browne, 2005). Research shows though 
that the ability to cause disease and the mechanism to do so differs markedly from 
the other pathogenic Y. enterocolitica BT, in that survival and hibernation inside 
macrophages might play a role (McNally, et al., 2006). On the other hand, the 
pathogenic BTs are not signified by gaining a large number of CDSs, and the non-
pathogenic BT shares a considerable number of operons with both high- and low-
pathogenic BTs respectively. 
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Figure 8.1: Revised model of the evolution of pathogenicity in the genus Yersinia. 
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8.4 Future Work 
“As our circle of knowledge expands, so does the circumference of darkness 
surrounding it.” – Albert Einstein 
 
Now that the evolutionary relationships between the Yersinia spp. have been 
established, and it was shown that a biotyping approach might not be as suitable for 
identification as molecular techniques, research is currently underway to determine a 
set of seven genes for the use in MLST. The genes will be chosen to reflect the 
lineages identified using BAPS clustering, and will improve speciation in the genus 
Yersinia. This study should also include the putative species cluster 13, which 
contains the newly described Y. entomophaga and Y. nurmii, to confirm the initial 
observation with respect to their relationship to Y. ruckeri and as a single species 
cluster. 
A way of improved identification within Y. enterocolitica could be the design of a 
PCR-based approach testing for the presence of O-antigens associated with 
pathogenic isolates. As only very specific bio-serotype combinations are known to be 
causing disease, a PCR reaction for genes specific to those serotypes in combination 
with biochemical data could improve identification of pathogens. The drawbacks are 
the unknown O-antigen operons that can potentially cross-react. Instead, primers 
could also be designed to amplify biotype-specific regions, such as the HPI in the 
high-pathogenic BT 1B, or the tc PAI in low-pathogenic BTs. The caveat for this 
approach is that a search for important islands and virulence operons is still out-
standing. This should determine whether homologous sequences of certain genes 
are present in the environmental Yersinia species. It would also clarify what defines 
the species “enterocolitica” as opposed to the environmental species. 
In terms of identification, the data from the phenotypic microarray could also be used 
to potentially define metabolic reactions that reliably distinguish pathogenic and non-
pathogenic BTs, but the nutrients identified as different between the BTs would need 
to be tested in a larger strain collection. A further requirement would be a clear link 
between phenotype and genotype to avoid past problems of meiotrophy and 
phenotype reversal due to genes inactivated with revocable mutations. 
 
One interesting region identified during the comparison of the reference genomes of 
Y. enterocolitica and beyond is the Yersinia Genus T3SS (YGT). The distribution in 
all Yersinia spp. and the apparently targeted inactivation in humanpathogenic 
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lineages of Y. pseudotuberculosis/pestis and Y. enterocolitica BT 1B, 4, and 5 might 
indicate a possible role in environmental survival. This could include interaction with 
insects such as greater wax moth Galleria mellonella and tobacco hornworm 
Manduca sexta, nematodes such as roundworm Caenorhabditis elegans or amoeba.  
 
Another open question concerns the essential genes needed during the infection 
process. As was seen in the comparative analysis, only 30 CDSs plus the virulence 
plasmid pYV are shared in the pathogenic Y. enterocolitica BTs. It would deepen the 
understanding of mechanisms of disease to find out about the role of these 30 CDSs 
in the infection process. One could use RNAseq (Croucher, et al., 2009) to 
investigate the transcripts of the cell under the experimental condition and give a 
reflection of active genes and pathways. To complement expression studies, knock-
out mutants could be examined for their effect, and an interesting advance is the use 
of TraDIS (Langridge, et al., 2009), the Transposon directed insertion-site 
sequencing, in which the whole genome is covered with transposon insertions. 
Genes that are absent of any insertions are thought to be essential under the 
condition tested (Langridge, et al., 2009). In common to these methods is their global 
view of the bacterial cell, in trying to understand larger systems and interactions as a 
whole instead of single entities. This might be important in the case of high- and low-
pathogenic BTs that potentially utilize a different combination of genes to establish 
disease. 
Similarly, the phenotypic microarray layout could be used to identify metabolic 
operons. In this case, only a subset of carbon sources would be studied for a mutant 
library of one strain. The genes identified under all conditions would represent the 
normal respiration of a cell, whereas the absence of transposon insertions in some 
genes under certain conditions only might represent the genes involved specifically in 
the metabolism of that nutrient. Similarly, RNAseq could identify genes that are 
generally expressed in carbon metabolism, and also highlight those genes that are 
specifically upregulated only under certain carbon sources. This would significantly 
increase annotation precision, and might identify new proteins or assign functions to 
hypothetical proteins in metabolic pathways. 
 
Further open questions in the phenotypic microarray relate to the role of oxygen 
saturation in metabolism at 37°C. The marked reduction of metabolic activity with an 
increase in temperature might be centrally regulated, and might be triggered in low 
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oxygen concentration. A complementation of the phenotypic microarray could be to 
repeat the experiments under anaerobic conditions at 37°C. Given the potential roles 
of insects as vectors and hosts in the environment it could also be of interest to 
examine the metabolic activities of the BTs at 10-15°C. 
 
Although the reference genomes of this study have been extensively compared to 
one another, a comparison to the other recently published genomes would be 
interesting. The genomes are similar in terms of size, GC content, number of coding 
sequences, but marked differences were observed in the number of pseudogenes. 
As the reference genomes presented here are of a high quality draft standard, they 
could be best compared to the deposited BT 4 O:3 strain Y11 (Batzilla, et al., 
2011a,b) of the same quality. The comparison could highlight differences between 
mainland Europe isolates and UK isolates that relate to their difference in incidence.  
In this same area, it would also be interesting to take the SNP data one step further 
than for establishing an evolutionary relationship and relate the SNPs to a biological 
function. It could be that certain SNPs define human pathogenic isolates despite 
them not clustering together due to independent SNPs, especially with respect to 
comparing non-pathogenic and low-pathogenic isolates. It could also be interesting to 
investigate the SNPs leading to the definition of a lineage, to see whether certain 
themes relating to membrane proteins and antigen presentation to the host immune 
system dominate. 
 
Bottone (1999) considered Y. enterocolitica as the “apex of bacterial versatility”, but 
this may also be applied for the whole genus that produced two independent 
humanpathogenic lineages and a wide range of environmental, underrepresented 
species. Even nearly 35 years after Bottone’s first review of Y. enterocolitica (1977), 
Yersinia remains an enigmatic and charismatic organism as ever.  
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9 Appendix 
 
Table 9.1: Y. enterocolitica strain collection. 
Strain  Biotype Serotype Source country Lab 
209-36/84 1B O:21 Human Germany Fuchs 
H1527/93 1A O:5 Human Germany  Fuchs 
H230/89 3 O:5,27 Human Germany Fuchs 
H324/78 3 O:9 Pig nd  Fuchs 
H450/87 4 O:3 Human nd Fuchs 
H469/87 4 O:3 Pig nd Fuchs 
H608/87 4 O:3 Human nd Fuchs 
H692/94 2 O:9 nd  Germany Fuchs 
H7580/93 3 O:9 nd nd Fuchs 
IP10393 4 O:3 clinical (stool) France Carniel 
IP20322 2 O:5,27 alimentary Greece Carniel 
IP20851 2 O:9 clinical (stool) Spain Carniel 
IP21447 2 O:9 pig (stool) England Carniel 
IP22276 4 O:3 clinical (stool) Australia Carniel 
IP26249 2 O:5,27 clinical (stool) France Carniel 
IP26618 1A O:5 alimentary Italy Carniel 
IP26656 4 O:3 clinical (stool) France Carniel 
IP26766 2 O:9 clinical (stool) France Carniel 
IP29194 3 O:3 clinical (stool) France Carniel 
IP29228 3 O:5,27 clinical (stool) France Carniel 
IP29610 4 O:3 clinical (stool) France Carniel 
N2118599 3 nd Human New Zealand DuFour 
N21282756 3 nd Human blood New Zealand DuFour 
N21383523 3 nd Human blood New Zealand DuFour 
N2153435 1A nd Human New Zealand/Fidji DuFour 
N21572344 4 O:3 Animal New Zealand DuFour 
N21622789 4 nd Dog New Zealand DuFour 
N21873627 4 nd Human blood New Zealand DuFour 
N22084574 4 nd Human blood New Zealand DuFour 
N2214757 4 nd Human blood New Zealand DuFour 
N22232770 4 nd Human blood New Zealand DuFour 
N22373947 1A nd Sheep New Zealand DuFour 
N2982399 2 nd Human blood New Zealand DuFour 
NZ1032126 2 nd Animal meat New Zealand DuFour 
NZ1484423 3 nd Human New Zealand DuFour 
NZ198109 4 nd Human blood New Zealand DuFour 
NZ28081 1A nd Human New Zealand/Asia DuFour 
NZ523784 1B nd Human New Zealand DuFour 
NZ761915 1B nd Human New Zealand DuFour 
NZ832501 2 nd Human blood New Zealand DuFour 
SZ166/96 5 nd nd   nd  Fuchs 
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SZ375/04 1B O:8 Human Germany Fuchs 
SZ506/04 1B O:8 Human Germany Fuchs 
SZ5108/01 1B O:8 Human Germany Fuchs 
SZ662/97 1A O:5 Human Germany Fuchs 
W22703 2 O:9 Human Belgium Fuchs 
Y127 2 O:9 nd  nd Fuchs 
Y286 1B O:8b,e,f,i nd USA Fuchs 
YE03/03 4 O:3 Human faeces UK McNally 
YE04/03 3 O:5 Human faeces UK McNally 
YE07/03 4 O:3 Human faeces UK McNally 
YE08/03 4 O:3 Human faeces UK McNally 
YE09/02 1A nd Sheep UK McNally 
YE09/03 1A O:6,30 Human faeces UK McNally 
YE11/03 3 O:9 Human case  UK McNally 
YE111/02 3 O:5,27 Sheep UK McNally 
YE119/02 2 O:9 Sheep UK McNally 
YE13/02 1A O:6,30 Cattle UK McNally 
YE13/03 1A O:6,30 Human faeces UK McNally 
YE17/03 3 nd Human blood UK McNally 
YE201/02 4 O:3 Pig UK McNally 
YE204/02 4 O:3 Pig UK McNally 
YE205/02 1A O:6,30 Pig UK McNally 
YE208/02 1A O:5 Pig UK McNally 
YE213/02 4 O:3 Pig UK McNally 
YE214/02 3 O:9 Pig UK McNally 
YE215/02 3 O:9 Pig UK McNally 
YE218/02 3 O:9 Pig UK McNally 
YE221/02 1A O:6,30 Pig UK McNally 
YE226/02 3 O:5,27 Pig UK McNally 
YE227/02 4 O:3 Pig UK McNally 
YE228/02 2 nd Pig  UK McNally 
YE231/02 3 O:5,27 Pig UK McNally 
YE232/02 3 O:5,27 Pig UK McNally 
YE237/02 3 O:9 Pig UK McNally 
YE24/03 3 O:9 Human control UK McNally 
YE2702 1A O:5 Sheep UK McNally 
YE30/03 1A O:5 Human case UK McNally 
YE34/03 1A O:5 Human control UK McNally 
Ye3502 1A nd Human case UK McNally 
YE38/03 1A O:6,30 Human case UK McNally 
YE41/03 1A O:6,30 Human case UK McNally 
YE46/02 1A nd Cattle UK McNally 
YE519-36/88 5 nd nd   nd  Fuchs 
YE53/30444 1A O:7,8 Pig Germany Fuchs 
YE58/03 3 O:9 Human control UK McNally 
YE69/03 1A O:19,8 Human case UK McNally 
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Table 9.2: Worldwide strain collection of Yersinia spp. 
Strain  Acc. No Species Serotype Source Country Lab 
ATCC35236 NZ_ACCB00000000 aldovae nd Drinking water 
Czechoslovaki
a 
n/a 
404/81  aleksiciae O:16 Human stool Finland Skurnik 
127/84  bercovieri nd Human stool Finland Skurnik 
3016/84  bercovieri O:58,16 Human stool Finland Skurnik 
ATCC43970 NZ_AALC00000000 bercovieri nd Human stool France n/a 
FE80217  enterocolitica nd Human stool Finland Sihvonen 
1127  enterocolitica nd Human Ireland Prentice 
58735  enterocolitica nd Human Ireland Prentice 
2/C/53NMD7  enterocolitica O:9 Pig Ireland Prentice 
3430  frederiksenii nd Human Ireland Prentice 
112/02  frederiksenii O:16 Sheep UK McNally 
120/02  frederiksenii O:16 Sheep UK McNally 
22714/85  frederiksenii nd Human stool Finland Skurnik 
28/85  frederiksenii nd nd Finland Skurnik 
3317/84  frederiksenii O:35 Human stool Finland Skurnik 
3400/83  frederiksenii O:16 Human stool Finland Skurnik 
38/83  frederiksenii O:48 Human stool Finland Skurnik 
498/85  frederiksenii nd Human stool Finland Skurnik 
ATCC33641 NZ_AALE00000000 frederiksenii nd Sewage Denmark n/a 
BR166/97  frederiksenii nd nd Finland Skurnik 
FCF208  frederiksenii O:16 Water Brazil Falcao 
FCF224  frederiksenii O:16 Water Brazil Falcao 
FCF343  frederiksenii O:2,3 Water Brazil Falcao 
FCF467  frederiksenii O:16a,58 Water Brazil Falcao 
FE80151  frederiksenii nd Human stool Finland Sihvonen 
FE80258  frederiksenii nd Human stool Finland Sihvonen 
FE80988  frederiksenii nd Human stool Finland Sihvonen 
IP23047  frederiksenii O3 nd France Skurnik 
IP23698  frederiksenii O:16 nd France Carniel 
IP25924  frederiksenii O:46 nd France Carniel 
RS-42  frederiksenii nd Retail meat Ireland Prentice 
58735  intermedia nd Human Ireland Prentice 
109/02  intermedia O:16 Sheep UK McNally 
141/02  intermedia rough Sheep UK McNally 
182/02  intermedia O:52,53 Cattle UK McNally 
821/84  intermedia O:52,54 Human stool Finland Skurnik 
9/85  intermedia O:16,21 nd Finland Skurnik 
93/02  intermedia O:4,32 Cattle UK McNally 
94/02  intermedia nd Sheep UK McNally 
ATCC29909 NZ_AALF00000000 intermedia nd Human urine nd n/a 
BR16597  intermedia nd nd Finland Skurnik 
FCF130  intermedia O:4,32 Sewage water Brazil Falcao 
FCF202  intermedia O:10 Sea water Brazil Falcao 
FCF335  intermedia O:48 Polluted water Brazil Falcao 
FCF84  intermedia O:4,32 Water Brazil Falcao 
IP10066  intermedia O:4,32 nd France Carniel 
IP10209  intermedia O:4,32 nd France Carniel 
R148  intermedia nd Mouse ? Fukushima 
Y25  intermedia nd nd ? Fukushima 
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542  kristensenii nd nd ? Fukushima 
119/84  kristensenii O:12,25 Human stool Finland Skurnik 
ATCC33638 NZ_ACCA00000000 kristensenii nd Human urine nd n/a 
FCF221  kristensenii O:61 Water Brazil Falcao 
FCF324  kristensenii O:61 Polluted water Brazil Falcao 
FCF326  kristensenii O:11,24 Polluted water Brazil Falcao 
FCF580  kristensenii O:61 Oyster Brazil Falcao 
FE80982  kristensenii nd Human stool Finland Sihvonen 
IP24139  kristensenii Nag nd France Carniel 
IP6945  kristensenii O:16 nd France Carniel 
OK6311  kristensenii nd Marten ? Fukushima 
IP27925  kristensenii O3 nd France Carniel 
24070  massiliensis nd Human Ireland Prentice 
107/02  mollaretii nd Sheep UK McNally 
159/02  mollaretii rough Sheep UK McNally 
61/02  mollaretii O:1,2a,3 Sheep UK McNally 
64/02  mollaretii O? Sheep UK McNally 
92/84  mollaretii O:59(20,36,7) Human stool Finland Skurnik 
ATCC43969 NZ_AALD00000000 mollaretii nd Soil USA n/a 
FE82747  mollaretii nd Human stool Finland Sihvonen 
IP22404  mollaretii O3 nd France Carniel 
IP25089  mollaretii O20 nd France Carniel 
A125KOH2  pekkanenii nd Lettuce Finland Skurnik 
CO92 NC_003143 pestis Orientalis na Fatal human case USA Parkhill 
KIM5 NC_004088 pestis Medievalis na nd [Iran] Perry 
Yp91001 NC_005810 pestis Microtus na Vole China Yang 
260  pseudotuberculosis O:1a Human Canada Fukushima 
1231  pseudotuberculosis O:4b Rodent Russia Fukushima 
2888  pseudotuberculosis O:1a Bird Italy Fukushima 
D585  pseudotuberculosis O:3 Dog Japan Skurnik 
IH111554  pseudotuberculosis O:1a Cat Finland Siitonen 
IP31758 NC_009708 pseudotuberculosis O:1b Human stool former USSR Carniel 
IP32463  pseudotuberculosis O:5 Guinea pig Switzerland Carniel 
IP32544  pseudotuberculosis O:3 Pig France Carniel 
IP32670  pseudotuberculosis O:1 Pig UK Carniel 
IP32881  pseudotuberculosis O:2 Monkey Switzerland Carniel 
IP32921  pseudotuberculosis O:2 Hare France Carniel 
IP32938  pseudotuberculosis O:3 Cattle Argentina Carniel 
IP32953 NC_006155 pseudotuberculosis O:1 Human case France Carniel 
IP33038  pseudotuberculosis O:1 marsupial Australia Carniel 
IP33054  pseudotuberculosis O:2 human Spain Carniel 
IP33177  pseudotuberculosis O:1 cabbage Russia Carniel 
IP33250  pseudotuberculosis O:3 human Russia Carniel 
MW109-2  pseudotuberculosis O:11 Water nd Fukushima 
N912  pseudotuberculosis O:2b Rabbit China Fukushima 
N916  pseudotuberculosis O:13 Rat Finland Skurnik 
No5  pseudotuberculosis O:2b Goat New Zealand Fukushima 
OK5586  pseudotuberculosis O:3 Racoon dog Japan Fukushima 
OK6088  pseudotuberculosis O:10 Racoon dog Japan Skurnik 
PB1/+ NC_010634 pseudotuberculosis nd nd nd Nikolich 
PT682  pseudotuberculosis O:2b Pig Japan Fukushima 
R819  pseudotuberculosis O:5b Mouse nd Fukushima 
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WP-931201  pseudotuberculosis O:15 Water Korea Fukushima 
Y428  pseudotuberculosis nd Badger Germany Scholz 
Y716  pseudotuberculosis O:1a nd nd Scholz 
Y718  pseudotuberculosis O:1b Human Germany Scholz 
Y719  pseudotuberculosis nd Human Germany Scholz 
Y722  pseudotuberculosis O:1 Human Germany Scholz 
YPIII NC_010465 pseudotuberculosis nd nd nd Nikolich 
3343  rohdei nd Human Ireland Prentice 
82589  rohdei nd nd Finland Skurnik 
011/02  rohdei O:46 Sheep UK McNally 
56/02  rohdei O? Sheep UK McNally 
65/02  rohdei O? Sheep UK McNally 
68/02  rohdei O:52 Sheep UK McNally 
ATCC43380 NZ_ACCD00000000 rohdei nd Dog faeces Germany n/a 
ATCC29473 NZ_ACCC00000000 ruckeri nd Trout (clinical) Idaho_USA n/a 
OMBL4  ruckeri nd Fish Finland Skurnik 
RS41  ruckeri nd nd Finland Skurnik 
Y228  similis O:6 rabbit Germany Scholz 
Y233  similis O:5b Mole Japan Scholz 
Y252  similis OL5a Mole Japan Scholz 
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Table 9.3: Class key 
Functional Group Description Classification 
1 – Unknown function, no homologues Unknown function, no known homologues 0.0.0  
 Conserved in E. coli 0.0.1  
 Conserved in other organism than E.coli 0.0.2  
2 – Cell processes Cell processes 1.0.0   
 Chemotaxis and mobility 1.1.1  
 Chromosome replication 1.2.1  
 Chaperones 1.3.1  
3 – Protection responses Protection responses 1.4.0   
 Cell killing 1.4.1  
 Detoxification 1.4.2  
 Drug/analogue sensitivity 1.4.3  
 Radiation sensitivity 1.4.4   
4 – Transport/binding proteins Transport/binding proteins 1.5.0  
 Amino acids and amines 1.5.1  
 Cations 1.5.2  
 Carbohydrates, organic acids and alcohols; PTS 1.5.3  
 Anions 1.5.4  
 Other 1.5.5  
5 – Adaptation Adaptation 1.6.0   
 Adaptations, atypical conditions 1.6.1  
 Osmotic adaptation 1.6.2  
 Fe storage 1.6.3  
 Nodulation-related 1.6.4   
6 – Cell division Cell division 1.7.1  
 Sporulation, differentiation and germination 1.8.1   
7 – Macromolecule metabolism Macromolecule metabolism 2.0.0   
 Macromolecule degradation 2.1.0   
 Degradation of DNA 2.1.1  
 Degradation of RNA 2.1.2  
 Degradation of polysaccharides 2.1.3  
 Degradation of proteins, peptides, glycoproteins 2.1.4  
8 – Macromolecule synthesis, modification Macromolecule synthesis, modification 2.2.0  
 Amino acyl tRNA synthesis; tRNA modification 2.2.1  
 Proteins - translation and modification 2.2.10  
 RNA synthesis, modification, DNA transcription 2.2.11  
 tRNA 2.2.12  
 Basic proteins - synthesis, modification 2.2.2  
 DNA - replication, repair, restriction/modification 2.2.3  
 Glycoprotein 2.2.4   
 Lipopolysaccharide 2.2.5  
 Lipoprotein 2.2.6  
 Phospholipids 2.2.7  
 Polysaccharides - (cytoplasmic) 2.2.8  
 Protein modification 2.2.9  
9 – Metabolism of small molecules Metabolism of small molecules 3.0.0   
 Amino acid biosynthesis 3.1.0  
 Alanine 3.1.1   
 Histidine 3.1.10  
 Isoleucine 3.1.11  
 Leucine 3.1.12  
210 
 Lysine 3.1.13  
 Methionine 3.1.14  
 Phenylalanine 3.1.15  
 Proline 3.1.16  
 Serine 3.1.17  
 Threonine 3.1.18  
 Tryptophan 3.1.19  
 Arginine 3.1.2  
 Tyrosine 3.1.20  
 Valine 3.1.21   
 Asparagine 3.1.3   
 Aspartate 3.1.4   
 Chorismate 3.1.5   
 Cysteine 3.1.6  
 Glutamate 3.1.7  
 Glutamine 3.1.8  
 Glycine 3.1.9   
10 – Biosynthesis of cofactors, carriers Biosynthesis of cofactors, carriers 3.2.0  
 Acyl carrier protein (ACP) 3.2.1  
 Pantothenate, CoA? 3.2.10  
 Pyridine nucleotide, NAD 3.2.11  
 Pyridoxine 3.2.12  
 Riboflavin 3.2.13  
 Thiamin 3.2.14  
 Thioredoxin, glutaredoxin, glutathione 3.2.15   
 Biotin carboxyl carrier protein (BCCP) 3.2.16   
 Ferredoxin 3.2.17   
 Biotin 3.2.2  
 Cobalamin 3.2.3  
 Enterochelin 3.2.4   
 Folic acid 3.2.5  
 Heme, porphyrin, cytochrome biogenesis 3.2.6  
 Lipoate 3.2.7   
 Menaquinone, ubiquinone 3.2.8  
 Molybdopterin 3.2.9  
11 – Central intermediary metabolism Central intermediary metabolism 3.3.0   
 2'-Deoxyribonucleotide metabolism 3.3.1  
 Nucleotide hydrolysis 3.3.10   
 Nucleotide interconversions 3.3.11   
 Oligosaccharides 3.3.12   
 Phosphorus compounds 3.3.13  
 Polyamine biosynthesis, Putrescine 3.3.14  
 Pool, multipurpose conversions of intermediate metabolism 3.3.15  
 S-adenosyl methionine 3.3.16   
 Salvage of nucleosides and nucleotides 3.3.17  
 Sugar-nucleotide biosynthesis, conversions 3.3.18  
 Sulfur metabolism 3.3.19  
 Amino sugars 3.3.2   
 Amino acids 3.3.20   
 Other 3.3.21  
 Nitrogen metabolism (urease) 3.3.22  
 Entner-Douderoff 3.3.3  
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 Gluconeogenesis 3.3.4  
 Glyoxylate bypass 3.3.5  
 Incorporation metal ions 3.3.6  
 Misc. glucose metabolism 3.3.7  
 Misc. glycerol metabolism 3.3.8  
 Non-oxidative branch, pentose pwy 3.3.9  
12 – Degradation of small molecules Degradation of small molecules 3.4.0   
 Amines 3.4.1  
 Amino acids 3.4.2  
 Carbon compounds, Cachetuate catabolism 3.4.3  
 Fatty acids 3.4.4  
 Other 3.4.5  
13 – Energy metabolism, carbon Energy metabolism, carbon 3.5.0   
 Aerobic respiration 3.5.1  
 Anaerobic respiration 3.5.2  
 Electron transport, cytochromes + redox 3.5.3  
 Fermentation 3.5.4  
 Glycolysis 3.5.5  
 Oxidative branch, pentose pathway 3.5.6  
 Pyruvate dehydrogenase 3.5.7   
 TCA cycle 3.5.8  
 ATP-proton motive force 3.5.9  
14 – Fatty acid biosynthesis Fatty acid biosynthesis 3.6.0  
 Fatty acid and phosphatidic acid biosynthesis 3.6.1  
15 – Nucleotide biosynthesis Nucleotide biosynthesis 3.7.0   
 Purine ribonucleotide biosynthesis 3.7.1  
 Pyrimidine ribonucleotide biosynthesis 3.7.2  
 Secondary metabolism 3.8.0   
 Polyketide synthases 3.8.1   
 Non-ribosomal peptide synthases 3.8.2   
16 – Cell envelope Cell envelope 4.0.0   
 Membrane/exported/lipoproteins 4.1.0  
 Inner membrane 4.1.1  
 Murein sacculus, petidoglycan 4.1.2  
 Outer membrane 4.1.3  
 Surface polysaccharide & antigens, EPS 4.1.4  
 Surface structures 4.1.5  
 G+ membrane 4.1.6   
 G+ exported/lipoprotein 4.1.7   
 G+ surface anchored 4.1.8   
 G+ peptidoglycan, teichoic acid 4.1.9   
17 – Ribosome constituents Ribosome constituents 4.2.0   
 Ribosomal and stable RNAs 4.2.1   
 Ribosomal proteins - synthesis, modification 4.2.2  
 Ribosomes - maturation and modification 4.2.3  
 Extrachromosomal 5.0.0   
18 – Foreign DNA Laterally acquirred elements 5.1.0   
 Colicin-related functions 5.1.1   
 Phage-related functions and prophages 5.1.2  
 Plasmid-related functions 5.1.3   
 Transposon-related functions 5.1.4  
 Pathogenicity island-related functions 5.1.5   
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19 – Regulation Regulation 6.0.0  
 Two component system 6.1.0   
 Sensor kinase 6.1.1  
 Response regulator 6.1.2  
 Sensor kinase/response regulator fusion 6.1.3  
 RNA polymerase core enzyme binding 6.2.0  
 sigma factor 6.2.1  
 anti sigma factor 6.2.2   
 anti sigma factor antagonist 6.2.3   
 Defined families 6.3.0  
 AsnC 6.3.1  
 DeoR 6.3.10  
 LuxR (GerR) 6.3.11  
 MerR 6.3.12  
 ArsR 6.3.13  
 PadR 6.3.14   
 LytR 6.3.15   
 AraC 6.3.2  
 GntR 6.3.3  
 IclR 6.3.4  
 LacI 6.3.5  
 LysR 6.3.6  
 MarR 6.3.7  
 TetR 6.3.8  
 ROK 6.3.9  
 Protein kinases 6.4.0   
 Serine/threonine 6.4.1   
 Tyrosine 6.4.2   
 Others 6.5.0   
20 – Not classified Not classified (included putative assignments) 7.0.0  
 DNA sites, no gene product 7.1.1   
 Cryptic genes 7.2.1  
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Table 9.4: Colour-coding key of CDSs. 
Colour – 
code 
Colour Function – Chromosome Function - Plasmid 
0 White Pathogenicity / adaptation / 
chaperones 
Pathogenicity / adaptation 
1 Grey Energy metabolism (glycolysis, 
electron transport, etc.) 
Partitioning and maintenance 
2 Red Information transfer (transcript-
tion/translation + DNA/RNA 
modification 
Plasmid replication 
3 Green Surface (inner membrane, outer 
membrane, secreted proteins, 
LPS, etc.) 
Surface (inner membrane, outer 
membrane, secreted proteins, pili, 
etc.) 
4 Dark blue Stable RNA Inorganic compound / metal 
resistance / UV, etc. 
5 Bright blue Degradation of large molecules Conjugal transfer 
6 Bright pink Degradation of small molecules Antibiotic resistance, surface 
exclusion, restriction / 
modification systems 
7 Yellow Central / intermediary / 
miscellaneous metabolism 
Host metabolism 
8 Pale green Unknown / hypothetical Unknown / hypothetical 
9 Pale blue Regulators Regulators 
10 Orange Conserved hypothetical Conserved hypothetical 
11 Brown Pseudogenes and partial genes 
(remnants) 
Pseudogenes and partial genes 
(remnants) 
12 Pale pink Phage / IS elements IS elements 
13 Pale grey Some miscellaneous information, 
e.g. prosite, but no function 
Some miscellaneous information, 
e.g. prosite, but no function 
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Appendix 9.5: perl script for identification of sets of orthologous genes in seven reference 
genomes for Y. enterocolitica 
#!/usr/local/bin/perl -w 
 
use strict; 
use Bio::PSU::SeqFactory; 
 
my $file = shift; 
my $seqi = Bio::PSU::SeqFactory->make(-file   => $file,   
          -format => 'embl'); 
my $obj=Bio::PSU::IO::FTHandler->new; 
 
my (@all_gen_ortho, @gen1_gen2_gen3_gen4_gen5_ortho, @gen1_gen2_gen3_gen4_gen6_ortho, 
@gen1_gen2_gen3_gen5_gen6_ortho, @gen1_gen2_gen4_gen5_gen6_ortho, @gen1_gen3_gen4_gen5_gen6_ortho, 
@gen2_gen3_gen4_gen5_gen6_ortho, @gen1_gen2_gen3_gen4_ortho, @gen1_gen2_gen3_gen5_ortho, 
@gen1_gen2_gen3_gen6_ortho, @gen1_gen2_gen4_gen5_ortho, @gen1_gen2_gen4_gen6_ortho, @gen1_gen2_gen5_gen6_ortho, 
@gen1_gen3_gen4_gen5_ortho, @gen1_gen3_gen4_gen6_ortho, @gen1_gen3_gen5_gen6_ortho, @gen1_gen4_gen5_gen6_ortho, 
@gen2_gen3_gen4_gen5_ortho, @gen2_gen3_gen4_gen6_ortho, @gen2_gen3_gen5_gen6_ortho, @gen2_gen4_gen5_gen6_ortho, 
@gen3_gen4_gen5_gen6_ortho, @gen1_gen2_gen3_ortho, @gen1_gen2_gen4_ortho, @gen1_gen2_gen5_ortho, 
@gen1_gen2_gen6_ortho, @gen1_gen3_gen4_ortho, @gen1_gen3_gen5_ortho, @gen1_gen3_gen6_ortho, @gen1_gen4_gen5_ortho, 
@gen1_gen4_gen6_ortho, @gen1_gen5_gen6_ortho, @gen2_gen3_gen4_ortho, @gen2_gen3_gen5_ortho, @gen2_gen3_gen6_ortho, 
@gen2_gen4_gen5_ortho, @gen2_gen4_gen6_ortho, @gen2_gen5_gen6_ortho, @gen3_gen4_gen5_ortho, @gen3_gen4_gen6_ortho, 
@gen3_gen5_gen6_ortho, @gen4_gen5_gen6_ortho, @gen1_gen2_ortho, @gen1_gen3_ortho, @gen1_gen4_ortho, @gen1_gen5_ortho, 
@gen1_gen6_ortho, @gen2_gen3_ortho, @gen2_gen4_ortho, @gen2_gen5_ortho, @gen2_gen6_ortho, @gen3_gen4_ortho, 
@gen3_gen5_ortho, @gen3_gen6_ortho, @gen4_gen5_ortho, @gen4_gen6_ortho, @gen5_gen6_ortho, @gen1_only_ortho, 
@gen2_only_ortho,@gen3_only_ortho, @gen4_only_ortho, @gen5_only_ortho, @gen6_only_ortho, @no_ortho, $feature ); 
 
# genome1 first comparator genome (gen1), second comparator genome (gen2) are those you are comparing to your genome $gen1 and 
$gen2 relate to the identifiers you have used to store the orthologue information. You must also fill in your generic gename pattern YE**** 
and the qualifier under which it is held eg locus_tag or systematic_id. 
# script extended to generate numbers / groups for comparison of seven different genomes. 
 
my $gen1= "8081" . "_orthologue"; 
my $gen2= "21202" . "_orthologue"; 
my $gen3= "5603" . "_orthologue"; 
my $gen4= "14902" . "_orthologue"; 
my $gen5= "1203" . "_orthologue"; 
my $gen6= "3094" . "_orthologue"; 
my $genid= "YE5303-"; 
my $genqualifier="locus_tag"; 
#my $genqualifier="systematic_id"; 
   
                        while (my $seq = $seqi->next_seq)  
                               { 
       if (my $fnum = $seq->has_features) 
       { 
           foreach $feature ($seq->features) 
           {  
        if ($feature->key() eq "CDS") 
        {  
            if ($feature->qexists("$gen1") and $feature->qexists("$gen2") and  
       $feature->qexists("$gen3") and $feature->qexists("$gen4") and 
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       $feature->qexists("$gen5") and $feature->qexists("$gen6")) { 
         push (@all_gen_ortho, $feature); 
 
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen2") and  
       $feature->qexists("$gen3") and $feature->qexists("$gen4") and 
       $feature->qexists("$gen5")) { 
         push (@gen1_gen2_gen3_gen4_gen5_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen2") and 
       $feature->qexists("$gen3") and $feature->qexists("$gen4") and 
       $feature->qexists("$gen6")) { 
         push (@gen1_gen2_gen3_gen4_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen2") and 
       $feature->qexists("$gen3") and $feature->qexists("$gen5") and 
       $feature->qexists("$gen6")) { 
         push (@gen1_gen2_gen3_gen5_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen2") and 
       $feature->qexists("$gen4") and $feature->qexists("$gen5") and 
       $feature->qexists("$gen6")) { 
         push (@gen1_gen2_gen4_gen5_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen3") and 
       $feature->qexists("$gen4") and $feature->qexists("$gen5") and 
       $feature->qexists("$gen6")) { 
         push (@gen1_gen3_gen4_gen5_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen2") and $feature->qexists("$gen3") and 
       $feature->qexists("$gen4") and $feature->qexists("$gen5") and 
       $feature->qexists("$gen6")) { 
         push (@gen2_gen3_gen4_gen5_gen6_ortho, $feature);  
 
            } elsif  ($feature->qexists("$gen1") and  $feature->qexists("$gen2") and 
        $feature->qexists("$gen3") and $feature->qexists("$gen4")) { 
         push (@gen1_gen2_gen3_gen4_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen2") and 
       $feature->qexists("$gen3") and $feature->qexists("$gen5")) { 
         push (@gen1_gen2_gen3_gen5_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen2") and 
       $feature->qexists("$gen3") and $feature->qexists("$gen6")) { 
         push (@gen1_gen2_gen3_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen2") and 
       $feature->qexists("$gen4") and $feature->qexists("$gen5")) { 
         push (@gen1_gen2_gen4_gen5_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen2") and 
       $feature->qexists("$gen4") and $feature->qexists("$gen6")) { 
         push (@gen1_gen2_gen4_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen2") and 
       $feature->qexists("$gen5") and $feature->qexists("$gen6")) { 
         push (@gen1_gen2_gen5_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen3") and  
       $feature->qexists("$gen4") and $feature->qexists("$gen5")) { 
         push (@gen1_gen3_gen4_gen5_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen3") and 
       $feature->qexists("$gen4") and $feature->qexists("$gen6")) { 
         push (@gen1_gen3_gen4_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen3") and 
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       $feature->qexists("$gen5") and $feature->qexists("$gen6")) { 
         push (@gen1_gen3_gen5_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen4") and 
       $feature->qexists("$gen5") and $feature->qexists("$gen6")) { 
         push (@gen1_gen4_gen5_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen2") and $feature->qexists("$gen3") and 
       $feature->qexists("$gen4") and $feature->qexists("$gen5")) { 
         push (@gen2_gen3_gen4_gen5_ortho, $feature);  
            } elsif ($feature->qexists("$gen2") and $feature->qexists("$gen3") and 
       $feature->qexists("$gen4") and $feature->qexists("$gen6")) { 
         push (@gen2_gen3_gen4_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen2") and $feature->qexists("$gen3") and 
       $feature->qexists("$gen5") and $feature->qexists("$gen6")) { 
         push (@gen2_gen3_gen5_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen2") and $feature->qexists("$gen4") and 
       $feature->qexists("$gen5") and $feature->qexists("$gen6")) { 
         push (@gen2_gen4_gen5_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen3") and $feature->qexists("$gen4") and 
       $feature->qexists("$gen5") and $feature->qexists("$gen6")) { 
         push (@gen3_gen4_gen5_gen6_ortho, $feature); 
 
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen2") and  
$feature->qexists("$gen3")) { 
          push (@gen1_gen2_gen3_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen2") and  
$feature->qexists("$gen4")) { 
         push (@gen1_gen2_gen4_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen2") and  
$feature->qexists("$gen5")) { 
         push (@gen1_gen2_gen5_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen2") and  
$feature->qexists("$gen6")) { 
         push (@gen1_gen2_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen3") and  
$feature->qexists("$gen4")) { 
         push (@gen1_gen3_gen4_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen3") and  
$feature->qexists("$gen5")) { 
         push (@gen1_gen3_gen5_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen3") and  
$feature->qexists("$gen6")) { 
         push (@gen1_gen3_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen4") and  
$feature->qexists("$gen5")) { 
         push (@gen1_gen4_gen5_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen4") and  
$feature->qexists("$gen6")) { 
         push (@gen1_gen4_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen5") and  
$feature->qexists("$gen6")) { 
         push (@gen1_gen5_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen2") and $feature->qexists("$gen3") and 
 $feature->qexists("$gen4")) { 
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         push (@gen2_gen3_gen4_ortho, $feature);  
            } elsif ($feature->qexists("$gen2") and $feature->qexists("$gen3") and  
$feature->qexists("$gen5")) { 
         push (@gen2_gen3_gen5_ortho, $feature);  
            } elsif ($feature->qexists("$gen2") and $feature->qexists("$gen3") and  
$feature->qexists("$gen6")) { 
         push (@gen2_gen3_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen2") and $feature->qexists("$gen4") and  
$feature->qexists("$gen5")) { 
         push (@gen2_gen4_gen5_ortho, $feature);  
            } elsif ($feature->qexists("$gen2") and $feature->qexists("$gen4") and  
$feature->qexists("$gen6")) { 
         push (@gen2_gen4_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen2") and $feature->qexists("$gen5") and  
$feature->qexists("$gen6")) { 
         push (@gen2_gen5_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen3") and $feature->qexists("$gen4") and  
$feature->qexists("$gen5")) { 
         push (@gen3_gen4_gen5_ortho, $feature);  
            } elsif ($feature->qexists("$gen3") and $feature->qexists("$gen4") and  
$feature->qexists("$gen6")) { 
         push (@gen3_gen4_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen3") and $feature->qexists("$gen5") and  
$feature->qexists("$gen6")) { 
         push (@gen3_gen5_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen4") and $feature->qexists("$gen5") and  
$feature->qexists("$gen6")) { 
         push (@gen4_gen5_gen6_ortho, $feature);  
 
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen2")) { 
          push (@gen1_gen2_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen3")) { 
         push (@gen1_gen3_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen4")) { 
         push (@gen1_gen4_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen5")) { 
         push (@gen1_gen5_ortho, $feature);  
            } elsif ($feature->qexists("$gen1") and $feature->qexists("$gen6")) { 
         push (@gen1_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen2") and $feature->qexists("$gen3")) { 
         push (@gen2_gen3_ortho, $feature);  
            } elsif ($feature->qexists("$gen2") and $feature->qexists("$gen4")) { 
         push (@gen2_gen4_ortho, $feature);  
            } elsif ($feature->qexists("$gen2") and $feature->qexists("$gen5")) { 
         push (@gen2_gen5_ortho, $feature);  
            } elsif ($feature->qexists("$gen2") and $feature->qexists("$gen6")) { 
         push (@gen2_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen3") and $feature->qexists("$gen4")) { 
         push (@gen3_gen4_ortho, $feature);  
            } elsif ($feature->qexists("$gen3") and $feature->qexists("$gen5")) { 
         push (@gen3_gen5_ortho, $feature);  
            } elsif ($feature->qexists("$gen3") and $feature->qexists("$gen6")) { 
         push (@gen3_gen6_ortho, $feature);  
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            } elsif ($feature->qexists("$gen4") and $feature->qexists("$gen5")) { 
         push (@gen4_gen5_ortho, $feature);  
            } elsif ($feature->qexists("$gen4") and $feature->qexists("$gen6")) { 
         push (@gen4_gen6_ortho, $feature);  
            } elsif ($feature->qexists("$gen5") and $feature->qexists("$gen6")) { 
         push (@gen5_gen6_ortho, $feature);  
             
            } elsif  ($feature->qexists("$gen1") xor $feature->qexists("$gen2") 
xor $feature->qexists("$gen3") xor $feature->qexists("$gen4")  
xor $feature->qexists("$gen5") xor $feature->qexists("$gen6")) { 
          
         if ($feature->qexists("$gen1")) { 
             push (@gen1_only_ortho, $feature);  
         } elsif ($feature->qexists("$gen2")) { 
             push (@gen2_only_ortho, $feature);  
         } elsif ($feature->qexists("$gen3")) { 
             push (@gen3_only_ortho, $feature);  
         } elsif ($feature->qexists("$gen4")) { 
             push (@gen4_only_ortho, $feature);  
         } elsif ($feature->qexists("$gen5")) {  
              push (@gen5_only_ortho, $feature);  
         } elsif ($feature->qexists("$gen6")) { 
              push (@gen6_only_ortho, $feature);  
         }  
            } else {   
             push (@no_ortho, $feature);  
         }  
        } 
           } 
       }  
          } 
my $n=0;  
my $m=0; 
my $l=0; 
my $y=0; 
 
#print "*****genes shared with all genomes*******:\n"; 
foreach my $feature1 (@all_gen_ortho) { 
$feature1->qadd('group', 1); 
    print $obj->make_feature_block($feature1);} 
 
#print "*****genes shared with genome1 ($gen1), genome2 ($gen2), genome3 ($gen3), genome4 ($gen4) and genome5 ($gen5)*****:\n"; 
foreach my $feature2 (@gen1_gen2_gen3_gen4_gen5_ortho) { 
   $feature2->qadd('group', 2); 
    print $obj->make_feature_block($feature2);} 
 
#print "*****genes shared with genome1 ($gen1), genome2 ($gen2), genome3 ($gen3), genome4 ($gen4) and genome6 ($gen6)*****:\n"; 
foreach my $feature3 (@gen1_gen2_gen3_gen4_gen6_ortho) { 
   $feature3->qadd('group', 3); 
    print $obj->make_feature_block($feature3);} 
 
#print "*****genes shared with genome1 ($gen1), genome2 ($gen2), genome3 ($gen3), genome5 ($gen5) and genome6 ($gen6)*****:\n"; 
foreach my $feature4 (@gen1_gen2_gen3_gen5_gen6_ortho) { 
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   $feature4->qadd('group', 4); 
    print $obj->make_feature_block($feature4);} 
 
#print "*****genes shared with genome1 ($gen1), genome2 ($gen2), genome4 ($gen4), genome5 ($gen5) and genome6 ($gen6)*****:\n"; 
foreach my $feature5 (@gen1_gen2_gen4_gen5_gen6_ortho) { 
   $feature5->qadd('group', 5); 
    print $obj->make_feature_block($feature5);} 
 
#print "*****genes shared with genome1 ($gen1), genome3 ($gen3), genome4 ($gen4), genome5 ($gen5) and genome6 ($gen6)*****:\n"; 
foreach my $feature6 (@gen1_gen3_gen4_gen5_gen6_ortho) { 
   $feature6->qadd('group', 6); 
    print $obj->make_feature_block($feature6);} 
 
#print "*****genes shared with genome2 ($gen2), genome3 ($gen3), genome4 ($gen4), genome5 ($gen5) and genome6 ($gen6)*****:\n"; 
foreach my $feature7 (@gen2_gen3_gen4_gen5_gen6_ortho) { 
   $feature7->qadd('group', 7); 
    print $obj->make_feature_block($feature7);} 
 
#print "*****genes shared with genome1 ($gen1), genome2 ($gen2), genome3 ($gen3) and genome4 ($gen4)*****:\n"; 
foreach my $feature8 (@gen1_gen2_gen3_gen4_ortho) { 
   $feature8->qadd('group', 8); 
    print $obj->make_feature_block($feature8);} 
 
#print "*****genes shared with genome1 ($gen1), genome2 ($gen2), genome3 ($gen3) and genome5 ($gen5)*****:\n"; 
foreach my $feature9 (@gen1_gen2_gen3_gen5_ortho) { 
   $feature9->qadd('group', 9); 
    print $obj->make_feature_block($feature9);} 
 
#print "*****genes shared with genome1 ($gen1), genome2 ($gen2), genome3 ($gen3) and genome6 ($gen6)*****:\n";          
foreach my $feature10 (@gen1_gen2_gen3_gen6_ortho) { 
   $feature10->qadd('group', 10); 
    print $obj->make_feature_block($feature10);} 
 
#print "*****genes shared with genome1 ($gen1), genome2 ($gen2), genome4 ($gen4) and genome5 ($gen5)*****:\n"; 
foreach my $feature11 (@gen1_gen2_gen4_gen5_ortho) { 
   $feature11->qadd('group', 11); 
    print $obj->make_feature_block($feature11);} 
 
#print "*****genes shared with genome1 ($gen1), genome2 ($gen2), genome4 ($gen4) and genome6 ($gen6)*****:\n"; 
foreach my $feature12 (@gen1_gen2_gen4_gen6_ortho) { 
   $feature12->qadd('group', 12); 
    print $obj->make_feature_block($feature12);} 
 
#print "*****genes shared with genome1 ($gen1), genome2 ($gen2), genome5 ($gen5) and genome6 ($gen6)*****:\n"; 
foreach my $feature13 (@gen1_gen2_gen5_gen6_ortho) { 
    $feature13->qadd('group', 13); 
    print $obj->make_feature_block($feature13);} 
 
#print "*****genes shared with genome1 ($gen1), genome3 ($gen3), genome4 ($gen4) and genome5 ($gen5)*****:\n; 
foreach my $feature14 (@gen1_gen3_gen4_gen5_ortho) { 
    $feature14->qadd('group', 14); 
    print $obj->make_feature_block($feature14);} 
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#print "*****genes shared with genome1 ($gen1), genome3 ($gen3), genome4 ($gen4) and genome6 ($gen6)*****:\n"; 
foreach my $feature15 (@gen1_gen3_gen4_gen6_ortho) { 
    $feature15->qadd('group', 15); 
    print $obj->make_feature_block($feature15);} 
 
#print "*****genes shared with genome1 ($gen1), genome3 ($gen3), genome5 ($gen5) and genome6 ($gen6)*****:\n"; 
foreach my $feature16 (@gen1_gen3_gen5_gen6_ortho) { 
    $feature16->qadd('group', 16); 
    print $obj->make_feature_block($feature16);} 
 
#print "*****genes shared with genome1 ($gen1), genome4 ($gen4), genome5 ($gen5) and genome6 ($gen6)*****:\n"; 
foreach my $feature17 (@gen1_gen4_gen5_gen6_ortho) { 
    $feature17->qadd('group', 17); 
    print $obj->make_feature_block($feature17);} 
 
#print "*****genes shared with genome2 ($gen2), genome3 ($gen3), genome4 ($gen4) and genome5 ($gen5)********:\n"; 
foreach my $feature18 (@gen2_gen3_gen4_gen5_ortho) { 
    $feature18->qadd('group', 18); 
    print $obj->make_feature_block($feature18);} 
 
#print "*****genes shared with genome2 ($gen2), genome3 ($gen3), genome4 ($gen4) and genome6 ($gen6)********:\n"; 
foreach my $feature19 (@gen2_gen3_gen4_gen6_ortho) { 
    $feature19->qadd('group', 19); 
    print $obj->make_feature_block($feature19);} 
 
#print "*****genes shared with genome2 ($gen2), genome3 ($gen3), genome5 ($gen5) and genome6 ($gen6)********:\n"; 
foreach my $feature20 (@gen2_gen3_gen5_gen6_ortho) { 
    $feature20->qadd('group', 20); 
    print $obj->make_feature_block($feature20);} 
 
#print "*****genes shared with genome2 ($gen2), genome4 ($gen4), genome5 ($gen5) and genome6 ($gen6)********:\n"; 
foreach my $feature21 (@gen2_gen4_gen5_gen6_ortho) { 
    $feature21->qadd('group', 21); 
    print $obj->make_feature_block($feature21);} 
 
#print "*****genes shared with genome3 ($gen3), genome4 ($gen4), genome5 ($gen5) and genome6 ($gen6)********:\n"; 
foreach my $feature22 (@gen3_gen4_gen5_gen6_ortho) { 
    $feature22->qadd('group', 22); 
    print $obj->make_feature_block($feature22);} 
 
#print "**********genes shared with genome1 ($gen1), genome2 ($gen2) and genome3 ($gen3)***************:\n"; 
foreach my $feature23 (@gen1_gen2_gen3_ortho) { 
    $feature23->qadd('group', 23); 
    print $obj->make_feature_block($feature23);} 
 
#print "**********genes shared with genome1 ( $gen1 ), genome2 ( $gen2 ) and genome4 ($gen4)**********:\n";  
foreach my $feature24 (@gen1_gen2_gen4_ortho) {     
    $feature24->qadd('group', 24); 
    print $obj->make_feature_block($feature24);} 
 
#print "**********genes shared with genome1 ($gen1), genome2 ($gen2) and genome5 ($gen5)**********:\n"; 
foreach my $feature25 (@gen1_gen2_gen5_ortho) { 
    $feature25->qadd('group', 25); 
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    print $obj->make_feature_block($feature25);} 
 
#print "**********genes shared with genome1 ($gen1), genome2 ($gen2) and genome6 ($gen6)**********:\n"; 
foreach my $feature26 (@gen1_gen2_gen6_ortho) { 
    $feature26->qadd('group', 26); 
    print $obj->make_feature_block($feature26);} 
 
#print "**********genes shared with genome1 ($gen1), genome3 ($gen3) and genome4 ($gen4)**********:\n"; 
foreach my $feature27 (@gen1_gen3_gen4_ortho) { 
    $feature27->qadd('group', 27); 
    print $obj->make_feature_block($feature27);} 
 
#print "**********genes shared with genome1 ($gen1), genome3 ($gen3) and genome5 ($gen5)**********:\n"; 
foreach my $feature28 (@gen1_gen3_gen5_ortho) {       
    $feature28->qadd('group', 28); 
    print $obj->make_feature_block($feature28);} 
 
#print "**********genes shared with genome1 ($gen1), genome3 ($gen3) and genome6 ($gen6)**********:\n"; 
foreach my $feature29 (@gen1_gen3_gen6_ortho) { 
    $feature29->qadd('group', 29); 
    print $obj->make_feature_block($feature29);} 
 
#print "**********genes shared with genome1 ($gen1), genome4 ($gen4) and genome5 ($gen5)**********:\n"; 
foreach my $feature30 (@gen1_gen4_gen5_ortho) {   
    $feature30->qadd('group', 30); 
    print $obj->make_feature_block($feature30);} 
 
#print "**********genes shared with genome1 ($gen1), genome4 ($gen4) and genome6 ($gen6)**********:\n"; 
foreach my $feature31 (@gen1_gen4_gen6_ortho) { 
    $feature31->qadd('group', 31); 
    print $obj->make_feature_block($feature31);} 
 
#print "**********genes shared with genome1 ($gen1), genome5 ($gen5) and genome6 ($gen6)**********:\n"; 
foreach my $feature32 (@gen1_gen5_gen6_ortho) { 
    $feature32->qadd('group', 32); 
    print $obj->make_feature_block($feature32);} 
 
#print "**********genes shared with genome2 ($gen2), genome3 ($gen3) and genome4 ($gen4)**********:\n"; 
foreach my $feature33 (@gen2_gen3_gen4_ortho) { 
    $feature33->qadd('group', 33); 
    print $obj->make_feature_block($feature33);} 
 
#print "***********genes shared with genome2 ($gen2), genome3 ($gen3) and genome5 ($gen5)*********:\n"; 
foreach my $feature34 (@gen2_gen3_gen5_ortho) { 
    $feature34->qadd('group', 34); 
    print $obj->make_feature_block($feature34);} 
 
#print "**********genes shared with genome2 ($gen2), genome3 ($gen3) and genome6 ($gen6)**********:\n"; 
foreach my $feature35 (@gen2_gen3_gen6_ortho) { 
    $feature35->qadd('group', 35); 
    print $obj->make_feature_block($feature35);} 
 
#print "***********genes shared with genome2 ($gen2), genome4 ($gen4) and genome5 ($gen5)*********:\n"; 
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foreach my $feature36 (@gen2_gen4_gen5_ortho) { 
    $feature36->qadd('group', 36); 
    print $obj->make_feature_block($feature36);} 
 
#print "**********genes shared with genome2 ($gen2), genome4 ($gen4) and genome6 ($gen6)**********:\n"; 
foreach my $feature37 (@gen2_gen4_gen6_ortho) { 
    $feature37->qadd('group', 37); 
    print $obj->make_feature_block($feature37);} 
 
#print "**********genes shared with genome2 ($gen2), genome5 ($gen5) and genome6 ($gen6)**********:\n"; 
foreach my $feature38 (@gen2_gen5_gen6_ortho) { 
    $feature38->qadd('group', 38); 
    print $obj->make_feature_block($feature38);} 
 
#print "************genes shared with genome3 ($gen3), genome4 ($gen4) and genome5 ($gen5)**************:\n"; 
foreach  my $feature39 (@gen3_gen4_gen5_ortho) {     
    $feature39->qadd('group', 39);  
    print $obj->make_feature_block($feature39);} 
 
#print "************genes shared with genome3 ($gen3), genome4 ($gen4) and genome6 ($gen6)**************:\n";        
foreach  my $feature40 (@gen3_gen4_gen6_ortho) {     
    $feature40->qadd('group', 40);  
    print $obj->make_feature_block($feature40);} 
 
#print "************genes shared with genome3 ($gen3), genome5 ($gen5) and genome6 ($gen6)**************:\n"; 
foreach  my $feature41 (@gen3_gen5_gen6_ortho) {     
    $feature41->qadd('group', 41);  
    print $obj->make_feature_block($feature41);} 
 
#print "************genes shared with genome4 ($gen4), genome5 ($gen5) and genome6 ($gen6)**************:\n"; 
foreach  my $feature42 (@gen4_gen5_gen6_ortho) {     
    $feature42->qadd('group', 42);  
    print $obj->make_feature_block($feature42);} 
 
#print "****************genes shared with genome1 ( $gen1 ) and genome2 ( $gen2 ) *****************:\n"; 
foreach my $feature43 (@gen1_gen2_ortho) {     
    $feature43->qadd('group', 43); 
    print $obj->make_feature_block($feature43);} 
 
#print "*****************genes shared with genome1 ($gen1) and genome3 ($gen3)******************:\n"; 
foreach my $feature44 (@gen1_gen3_ortho) { 
    $feature44->qadd('group', 44); 
    print $obj->make_feature_block($feature44);} 
 
#print "*****************genes shared with genome1 ($gen1) and genome4 ($gen4)******************:\n"; 
foreach my $feature45 (@gen1_gen4_ortho) { 
    $feature45->qadd('group', 45); 
    print $obj->make_feature_block($feature45);} 
 
#print "*****************genes shared with genome1 ($gen1) and genome5 ($gen5)******************:\n"; 
foreach my $feature46 (@gen1_gen5_ortho) {       
    $feature46->qadd('group', 46); 
    print $obj->make_feature_block($feature46);} 
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#print "*****************genes shared with genome1 ($gen1) and genome6 ($gen6)******************:\n"; 
foreach my $feature47 (@gen1_gen6_ortho) {       
    $feature47->qadd('group', 47); 
    print $obj->make_feature_block($feature47);} 
 
#print "*****************genes shared with genome2 ($gen2) and genome3 ($gen3)******************:\n"; 
foreach my $feature48 (@gen2_gen3_ortho) { 
    $feature48->qadd('group', 48); 
    print $obj->make_feature_block($feature48);} 
 
#print "*****************genes shared with genome2 ($gen2) and genome4 ($gen4)******************:\n"; 
foreach my $feature49 (@gen2_gen4_ortho) { 
    $feature49->qadd('group', 49); 
    print $obj->make_feature_block($feature49);} 
 
#print "*****************genes shared with genome2 ($gen2) and genome5 ($gen5)******************:\n"; 
foreach my $feature50 (@gen2_gen5_ortho) { 
    $feature50->qadd('group', 50); 
    print $obj->make_feature_block($feature50);} 
 
#print "*****************genes shared with genome2 ($gen2) and genome6 ($gen6)******************:\n"; 
foreach my $feature51 (@gen2_gen6_ortho) {       
    $feature51->qadd('group', 51); 
    print $obj->make_feature_block($feature51);} 
 
#print "****************genes shared with genome3 ($gen3) and genome4 ($gen4)*******************:\n"; 
foreach my $feature52 (@gen3_gen4_ortho) { 
    $feature52->qadd('group', 52); 
    print $obj->make_feature_block($feature52);} 
 
#print "*****************genes shared with genome3 ($gen3) and genome5 ($gen5)******************:\n"; 
foreach my $feature53 (@gen3_gen5_ortho) { 
    $feature53->qadd('group', 53); 
    print $obj->make_feature_block($feature53);} 
 
#print "*****************genes shared with genome3 ($gen3) and genome6 ($gen6)******************:\n"; 
foreach my $feature54 (@gen3_gen6_ortho) {       
    $feature54->qadd('group', 54); 
    print $obj->make_feature_block($feature54);} 
 
#print "*****************genes shared with genome4 ($gen4) and genome5 ($gen5)******************:\n"; 
foreach my $feature55 (@gen4_gen5_ortho) { 
    $feature55->qadd('group', 55); 
    print $obj->make_feature_block($feature55);} 
 
#print "*****************genes shared with genome4 ($gen4) and genome6 ($gen6)******************:\n"; 
foreach my $feature56 (@gen4_gen6_ortho) {       
    $feature56->qadd('group', 56); 
    print $obj->make_feature_block($feature56);} 
 
#print "*****************genes shared with genome5 ($gen5) and genome6 ($gen6)******************:\n"; 
foreach my $feature57 (@gen5_gen6_ortho) {       
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    $feature57->qadd('group', 57); 
    print $obj->make_feature_block($feature57);} 
 
#print "*****************genes shared with genome 1 ( $gen1 ) only******************************:\n"; 
foreach  my $feature58 (@gen1_only_ortho) {     
    $feature58->qadd('group', 58);  
    print $obj->make_feature_block($feature58);} 
 
#print "****************genes shared with genome 2 ( $gen2 )only *******************************:\n"; 
foreach my $feature59 (@gen2_only_ortho) { 
    $feature59->qadd('group', 59); 
    print $obj->make_feature_block($feature59);} 
 
#print "****************genes shared with genome 3 ($gen3) only************************:\n"; 
foreach my $feature60 (@gen3_only_ortho) { 
    $feature60->qadd('group', 60); 
    print $obj->make_feature_block($feature60);} 
 
#print "****************genes shared with genome 4 ($gen4) only************************:\n"; 
foreach my $feature61 (@gen4_only_ortho) { 
    $feature61->qadd('group', 61); 
    print $obj->make_feature_block($feature61);} 
 
#print "****************genes shared with genome 5 ($gen5) only************************:\n"; 
foreach my $feature62 (@gen5_only_ortho) { 
    $feature62->qadd('group', 62); 
    print $obj->make_feature_block($feature62);} 
 
#print "****************genes shared with genome 6 ($gen6) only************************:\n"; 
foreach my $feature63 (@gen6_only_ortho) { 
    $feature63->qadd('group', 63); 
    print $obj->make_feature_block($feature63);} 
 
#print "*****************Your genome ( $genid ) unique genes ******************************:\n"; 
foreach my $feature64 (@no_ortho) { 
    $feature64->qadd('group', 64); 
    print $obj->make_feature_block($feature64);} 
 
#print "********************************************************************************\n"; 
 
#print "there are $n unique ( $genid ) genes \n"; 
#print "there are $m genes shared with genome1( $gen1 ) and genome2 ( $gen2 )\n"; 
#print "there are $l genes shared with genome1 ( $gen1 ) only \n"; 
#print "there are $y genes shared with genome2 ( $gen2 ) only \n"; 
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Table 9.6: Matrix of orthologous gene sets. 
  5303  8081  21202  5603  14902  1203  3094 
               
 genome1 8081  5303  5303  5303  5303  5303  5303 
 genome2 21202  21202  8081  8081  8081  8081  8081 
 genome3 5603  5603  5603  21202  21202  21202  21202 
 genome4 14902  14902  14902  14902  5603  5603  5603 
 genome5 1203  1203  1203  1203  1203  14902  14902 
 genome6 3094  3094  3094  3094  3094  3094  1203 
               
groups content # CDS  # CDS  # CDS  # CDS  # CDS  # CDS  # CDS 
1 all_gen_ortho 3306  3307  3307  3305  3305  3307  3306 
               
2 gen1+2+3+4+5 31  32  32  32  33  33  18 
3 gen1+2+3+4+6 17  18  18  19  18  0  0 
4 gen1+2+3+5+6 0  0  0  0  0  0  0 
5 gen1+2+4+5+6 0  0  0  0  1  0  0 
6 gen1+3+4+5+6 0  0  121  119  118  119  120 
7 gen2+3+4+5+6 118  39  40  40  40  40  42 
               
8 gen1+2+3+4 9  8  8  8  8  1  2 
9 gen1+2+3+5 1  1  1  1  0  0  0 
10 gen1+2+3+6 2  2  3  2  0  0  0 
11 gen1+2+4+5 0  0  0  0  0  0  0 
12 gen1+2+4+6 0  0  0  0  0  0  0 
13 gen1+2+5+6 0  0  0  0  2  2  2 
14 gen1+3+4+5 0  0  2  2  2  2  3 
15 gen1+3+4+6 0  0  3  4  3  0  0 
16 gen1+3+5+6 0  0  0  0  0  0  0 
17 gen1+4+5+6 2  2  0  0  0  0  0 
18 gen2+3+4+5 3  4  4  4  4  4  0 
19 gen2+3+4+6 3  0  0  0  0  0  0 
20 gen2+3+5+6 2  0  0  0  0  1  0 
21 gen2+4+5+6 0  1  0  0  1  0  0 
22 gen3+4+5+6 0  0  154  153  156  153  155 
               
23 gen1+2+3 0  0  0  0  0  0  0 
24 gen1+2+4 0  0  0  0  0  0  0 
25 gen1+2+5 0  0  0  0  2  2  0 
26 gen1+2+6 0  0  0  0  0  0  0 
27 gen1+3+4 0  0  0  1  1  0  1 
28 gen1+3+5 0  0  0  0  0  0  0 
29 gen1+3+6 0  0  1  1  0  0  0 
30 gen1+4+5 2  2  0  0  0  0  0 
31 gen1+4+6 0  0  0  0  0  0  0 
32 gen1+5+6 0  0  0  0  0  0  0 
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33 gen2+3+4 0  1  2  2  2  1  3 
34 gen2+3+5 0  1  1  1  0  0  0 
35 gen2+3+6 0  5  4  5  0  0  0 
36 gen2+4+5 0  0  0  0  0  0  0 
37 gen2+4+6 0  0  0  0  0  0  0 
38 gen2+5+6 0  0  0  0  0  0  0 
39 gen3+4+5 0  0  8  8  9  6  24 
40 gen3+4+6 0  0  22  24  21  15  13 
41 gen3+5+6 0  0  16  16  0  2  0 
42 gen4+5+6 0  0  0  1  0  1  1 
               
43 gen1+2  0  0  0  0  0  0  0 
44 gen1+3  0  0  0  0  0  0  0 
45 gen1+4  0  0  0  0  0  0  0 
46 gen1+5  0  0  0  0  0  0  1 
47 gen1+6  0  1  0  0  1  0  0 
48 gen2+3  0  2  1  1  0  0  0 
49 gen2+4  0  0  0  0  0  0  0 
50 gen2+5  0  0  0  0  0  0  0 
51 gen2+6  1  0  0  0  0  1  1 
52 gen3+4  0  0  37  37  36  18  8 
53 gen3+5  0  0  16  16  0  0  0 
54 gen3+6  0  0  8  8  0  0  0 
55 gen4+5  0  0  0  0  0  0  0 
56 gen4+6  1  0  0  0  0  0  0 
57 gen5+6  0  1  0  0  5  8  8 
               
58 gen1 only 82  82  0  0  15  2  32 
59 gen2 only 0  0  0  0  1  1  2 
60 gen3 only 0  0  106  106  0  2  0 
61 gen4 only 17  0  0  0  0  2  0 
62 gen5 only 3  1  2  1  11  11  9 
63 gen6 only 37  3  0  0  10  25  26 
               
64 no ortho 728  540  5  0  171  134  274 
               
 total CDS 4365  4053  3922  3917  3978  3893  4051 
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Table 9.7: Pseudogenes and their orthologs in the Y. enterocolitica reference genomes. 
Green – functional gene, light brown – pseudogene with frameshift or stop codon, * - UGA / opal stop 
codon, dark brown – partial gene (missing N, C, both termini or central part or protein sequence), - - 
no ortholog in this isolate. Numbers given are the unique CDS identifiers. Class assignment as per 
Table 9.1. 
 
1B - 8081 
1A - 
YE5303 
2 - 
YE21202 
3 - 
YE5603 
3 - 
YE14902 
4 - 
YE1203 
5 - 
YE3094 
class product 
YE0010 40761 31211 20091 16071 16741 00091 1.5.3 
putative sugar transport system, permease 
protein 
YE0012A 40791 31241 20061 16041 16711 00121 6.1.1 ribose operon repressor 
YE0036 43161 31491 39311 38920 00251 - 6.1.1 LuxR family transcription regulatory protein   
YE0037 - 31491 39301 38921 02241 00372 6.1.1 LuxR family transcription regulatory protein   
YE0048 43071 31591 25351 38821 00351 00471 2.2.3 putative DNA ligase 
YE0050 43051 31611 25371 38801 00371 00491 4.1.1 putative membrane protein 
 -   -   -   -  38721 00471   -  5.1.4 transposase for IS1668   
 -   -  31841 25601 38561 00671 00841 0.0.2 hypothetical membrane protein 
 -   -  31851 25611 38551 00691 00861 0.0.2 hypothetical membrane protein 
 -   -   -   -   -  00981  -  5.1.2 putative phage tail fibre assembly protein   
 -   -  32081 25831 38331 01201 01091 1.4.1 putative nematicidal protein 
 -   -  32091 25841 38321 01211 01111 5.1.4 putative transposase   
 -   -   -   -   -  17351 01131 5.1.4 putative transposase for IS1667   
 -   -  30481 20801 16791 17441 01221 4.1.0 putative exported protein 
YE0098 42491 32111 25861 38291 01251 40591 3.3.0 putative fructose 1,6-bisphosphatase 
YE0122 42281 32330 26071 38081 01481 40371 1.5.5 putative TonB dependent receptor protein 
YE0123 42271 32331 26081 38071 01491 40361 1.5.5 hemophore hasA   
YE0124 42261 32341 26091  -  01501 - 1.5.5 hemophore hasA   
YE0129 42211 32391 26141 38021 01561 40311 4.1.1 putative membrane protein   
YE0130 - - - - - 40301 5.1.4 transposase for IS1330   
 -   -  32671 17501 36731  -  - 1.4.0 putative pyocin S2   
 -   -  32621 17451 36681 01851   40071 0.0.0 hypothetical protein   
YE0158 41021 32721 17551 36781 01951 39991 4.1.0 putative exported protein 
YE0159 41031 32731 17561 36791 01961 39971 4.1.3 putative outer membrane usher protein 
YE0207 41481 33191 18011 37251 02461 39391 3.3.13 putative lysophospholipase   
 -   -  33391 18221 37461 02681 39191 0.0.0 hypothetical protein   
 -   -   -   -  37471  -   -  5.1.4 putative transposase   
YE0241 41801 33541 18351 37601 02831 29051 1.5.3 
sn-glycerol-3-phosphate-binding periplasmic 
protein   
 -   -   -   -  37711 02951    -  5.1.4 putative transposase for IS1667   
YE0255 41941 33681 18501 37751 02991 38911 7.0.0 putative DNA recombinatin protein 
YE0270 42091 33841 18651 37901 03141 38761 0.0.2 conserved hypothetical protein 
YE0277 43621 39341 38561 40431 03431   38681 7.0.0 putative acetyltransferase   
YE0313 30741 19591 14011 25121 20801 30861 4.1.1 inner membrane protein 
YE0320 30661 19661 14081 25191 20891 37981 2.1.4 probable exported Zinc protease 
YE0322 30661 19691 14091 25201 20911 37951 4.1.1 putative inner membrane transprt protein 
YE0324 30641 19711 14121 25231 20941 37931 7.0.0 putative ATP/GTP-binding protein   
 -  30531  -   -   -   -  - 4.1.0 putative exported protein   
 -  30011  -   -   -   -  - 0.0.2 hypothetical protein   
 -  30001  -   -   -   -  - 0.0.2 hypothetical protein   
 -  29921  -   -   -   -  - 2.2.3 putative restriction enzyme beta subunit   
 -  29911  -   -   -   -  - 2.2.3 putative restriction enzyme alpha subunit   
YE0344  -   -   -   -   -  - 5.1.1 putative HlyD-family secretion protein   
YE0345  -   -   -   -   -  - 5.1.4 integrase   
YE0386 29481 20241 14651 25771 21481  * 37401 7.0.0 putative acyl-CoA dehydrogenase   
 -  29371 20332 14761 25881 21581 37291 1.6.0 
regulator of cell morhogenesis and NO 
signalling 
YE0409 29261 20441 14871 25991 21711 37171 1.1.1 methyl-accepting chemotaxis protein 
YE0416 29201 20511 14931 26051 21781 37111 0.0.2 conserved hypothetical protein   
YE0443 28931 20781 14192 26312 22071 36842 1.4.3 multidrug efflux protein   
228 
YE0444 28921 *  -   -   -   -  - 1.4.3 multidrug efflux protein   
YE0445 28911 20791 15201 26321 22081 36841 4.1.3 probable outer membrane efflux lipoprotein   
YE0453 28841 20861 15271 26391 22151 36771 0.0.2 conserved hypothetical protein 
YE0470 28701 21001 15411 26531 22321  * 36631 3.3.13 PhnN protein   
YE0475 28651 21051 15461 26581 22371   36581 3.3.13 PhnI protein   
YE0480 28601 21101 15511 26631 22421 36531 4.1.0 putative exported protein   
YE0483 28571 21131 15541 26661 22451 36510 6.1.1 
putative LysR-family transcriptional 
regulatory protein   
YE0491 28491 21202 15591 26711 22501 36451 1.5.0 ABC transporter, substrate binding protein 
 -  -  -  -  - 22551    -  5.1.4 putative transposase for IS1667   
 -  -  -  -  - 22631    -  0.0.1 conserved hypothetical protein   
YE0505 * 28391 21301 15691 26811 *  -  36341 5.1.4 integrase 
 -  -  -  -  -  - 36331 5.1.4 putative transposase 
 -  -  -  -  -  - 36321 5.1.4 putative transposase 
 -   -   -   -  26831  -   -  0.0.2 hypothetical protein   
 -   -   -   -  26851  -   -  5.1.4 integrase   
 -   -   -   -  26861  -   -  2.1.1 
putative type I site-specific 
deoxyribonuclease   
 -   -   -   -  26881  -   -  0.0.1 hypothetical protein   
 -   -   -   -  27061  -   -  5.1.4 putative transposase   
 -   -  21331 15721  -   -  - 2.2.3 
putative type I restriction-modification 
system   
 -   -  21361 11271 27071 22691 - 2.2.3 superfamily I DNA helicase   
YE0511  -   -   -   -   -  - 5.1.4 putative phage-related protein   
YE0517  -  21431 11312  -  -  - 4.1.1 putative membrane protein   
 -  28141  -   -   -   -  - 0.0.1 conserved hypothetical protein   
YE0518 28081 21441 11321 27121 22741 - 1.5.0 putative permease   
YE0522 28051 21481 11351 27151 22771 36281 4.1.0 putative exported protein   
YE0534 27941 21591 11461 27261 22901 36161 1.5.1 arginine/ornithine antiporter 
YE0545 27841 21691 11561 27361 23011 36061 7.0.0 putative oxidoreductase   
YE0546 27831 21701 11571 27371 23021  * 36051 0.0.0 hypothetical protein   
YE0559 27691 21841 11711 27511 23211 35911 6.1.1 LysR-family regulatory protein 
YE0580 27521 22011 11881 27681 23411 35721 6.1.1 transcriptional regulator NadR 
YE0583  -  22041 11911 27711 23441 35691 0.0.2 conserved hypothetical protein   
YE0591 27421 22121 11991 27791 23531 35601 0.0.2 conserved hypothetical protein 
 -  27011 22522 12391 28201 23971 35211 5.1.5 putative adhesin/invasin protein 
YE0650 26881 22661 12531 28341 24161 35071 3.1.19 tryptophanase   
YE0656 26821 22721 12591 28401 24231 35001 7.0.0 putative AMP-binding enzyme-family protein 
YE0688 26531 23011 12881 28691 24561 34711 1.5.5 putative type II secretion system protein   
YE0695 26471 23071 12941 28751 24621 34651 1.5.1 aromatic amino acid transport protein   
 -  26422 23131 12991 28801 24681 34591 0.0.2 hypothetical protein   
YE0717 26211 23281 13141 28951 24851  34451 0.0.2 conserved hypothetical protein   
YE0725 26141 23351 13211 29021 24921 34381 6.1.1 DnaK suppressor protein homologue 
YE0787 - 25021 36720 31330 38063 09069 0.0.0 hypothetical protein   
YE0789 25511 25041 36701 31311 38061   09071 2.2.9 putative thiol:disulfide interchange protein   
YE0791 25491 25061 36681 31291 38041 09081 1.5.0 ABC transporter, ATP-binding component 
 -   -  25141 36601  -  37961 - 5.1.4 putative transposase for IS1667   
YE0799  - 25161 35431 31211 37951 09161 7.0.0 putative aminotransferase 
YE0807 25311 25191 35451 31191 37931 09181 6.0.0 putative transcriptional regulatory protein 
 -  25281  -   -   -   -  - 1.4.0 putative enterotoxin-like protein   
YE0813 25221 25251 35511 31131 37871 09251 1.5.3 
sorbose-specific PTS uptake system 
component 
 -  25191 25272 35541 31101 37841 09281 3.5.0 conserved hypothetical protein   
 -  24941 25282 35641 31001 37741 09381 3.5.2 
anaerobic dimethyl sulfoxide reductase 
chain A   
 -  24911 25285 35681 30961 37711 09421 1.3.1 putative oxidoreductase component   
 -   -  25291 35691 30951 37701 09431 5.1.4 putative transposase for IS1667   
YE0840 24701 25421 35801 30841 37581 09531 4.1.1 putative membrane protein 
YE0847 24631 25491 35871 30771 37511 09631 * 4.1.0 putative exported protein 
 -   - 25551 35931 30711 37451 09701 5.1.4 transposase for IS1328   
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YE0911 06591 00021 38181 19541 03481 32661 3.6.1 3-oxoacyl-[acyl-carrier-protein] synthase II   
YE0915 06621 00051 38151 19571 03531 32621 1.5.5 MFS-family transporter 
 -   -  00071 38121 19601 03561 32601 5.1.4 transposase for IS1328   
YE0924 06701 00141 38051 19671 03641 32531 1.5.1 
glycine betaine/L-proline transport system 
permease   
YE0933 06780 00221 37951 19771 03731 32441 1.6.1 putative acid shock protein   
YE0934 06781 00231 37941 19781 03741 32431 0.0.0 hypothetical protein   
YE0935 06791 00241 37931 19791 03751 32421 6.1.1 AraC-family transcriptional regulator   
YE0936 06801 00242 37921 19801 03761 32411 1.5.0 putative MFS family transport protein 
YE0938 06821 00271 37901 19821 03791 32391 4.1.1 putative membrane protein 
YE0941 06851 00301 37871 19861 03801 32351 6.1.1 AraC-family transcriptional regulator   
YE0944 06881 00323 37831 19891 03831 32321 0.0.2 hypothetical protein   
 -   -  00531 22222 20091 04061 32121 5.1.4 transposase for IS1667   
YE0972 07131 00601 22161 20161 04131 32051 0.0.2 conserved hypothetical protein   
 -   -  00651 22121  -   -  - 5.1.2 putative prophage integrase   
 -   -  00691 22081  -   -  - 0.0.2 hypothetical protein   
 -   -  00771 22001  -   -  - 2.2.3 putative RNA directed DNA polymerase   
 -  07391  -   -   -   -  - 5.1.2 prophage regulatory protein   
YE0974  -   -   -   -   -  - 5.1.2 prophage integrase 
YE1005 07621 00911 21861 20301 04271 31931 5.1.5 phospholipase A   
 -   -   -   -   -  04301 31901 5.1.4 putative transposase for IS1667   
 -   -  00931 21841 20321 04311 31891 5.1.4 transposase for IS1328   
YE1023 07791 01091 21681 20481 04481 31731 1.5.3 putative gluconate transporer 
YE1034 07882 01211 21582 20580 04580 31632 4.1.1 putative exported protein   
YE1036 07901 01231 21571 20591 04591   31621 4.1.0 putative lipoprotein   
 -  08181 01501 21291 20871 04891 31351 1.5.0 putative autotransporter protein   
YE1068 08211 01531 21261 20901 04931   31311 4.1.0 putative exported protein   
 -   -  01631 21161 21001 *  -  31211 5.1.4 putative transposase for IS1667   
YE1078 08311 01651 04111 21021 05051   31201 4.1.1 putative membrane protein   
YE1085 08381 01721 04041 21091 05141   31131 0.0.0 hypothetical protein   
YE1086 08391 01731 04031 21101 05151 31121 5.3.5 putative cytochrome c 
 -   -  01741 04021 21111 05161 31091 5.1.4 putative transposase for IS1667   
YE1101  -   -   -   -   -  - 0.0.0 hypothetical protein   
YE1116 08631 01971 03781 21351 
05511   
30791 4.1.1 
putative inner membrane protein [region 
flipped, protein torn apart on opposite 
strands] 
05511B 
YE1117 08641 09181 03771 21361 05501 30781 1.5.2 putative divalent cation transport protein 
 -  08711 02021 03701 21431 05521 30711 1.1.1 flagellin lysine-N-methylasec EC=2.1.1.-   
 -   -  02211 03511 21621 05721 30531 0.0.2 hypothetical protein   
 -   -  02261 03471 21651 05771 30501 5.1.2 transposase for IS1328   
 -   -  02271 03461 21652 05801 30492 5.1.2 hypothetical phage-related protein   
 -   -  02301 03431 21691 05821 30481 5.1.4 transposase for IS1668   
YE1158 09051 02451 03291 21831 05971 30341 3.5.3 cytochrome C-type protein NapC 
 -   -   -   -   -   -  30421 5.1.4 putative transposase 
Ye1165 09081 02511 03252 21852 06010 30302 6.1.1 
putative LyxR-family transcriptional 
regulatory protein 
YE1166 09091 02521 03251 21861 06011 30301 6.1.1 
putative LysR-family transcriptional 
regulatory protein   
YE1184  -   -   -   -   -  - 3.3.15 putative acetyltransferase   
 -  09421  -   -   -   -   -  7.0.0 putative acetyltransferase   
YE1199 09581 02721 03071 22051 06191   30111 1.5.0 
putative ABC transporter, ATP-binding 
protein   
YE1228 09831 02991 02821 22301 06491 29851 6.1.1 two-component system histidine kinase 
YE1234 - 03079 02763 22359 06549 29793 4.1.0 putative lipoprotein   
YE1236A 09911 03080 02762 22360 06550 29792 2.1.4 6-phospho-beta-glucosidase   
YE1238 09931 03091 02751 22371 06561 29781 1.5.1 putative membrane transport protein   
YE1246 10011 03171 02671 22451 06651 29701 1.5.0 MFS-family membrane transport protein   
YE1251 10061 03221 02621 22501 06711 29652 6.1.1 putative regulatory protein   
YE1252 10071 03231 02611 22511 06721 29651 4.1.0 putative exported protein   
YE1261  -   -   -   -   -  - 5.1.2 putative phage integrase   
230 
YE1262 10561 03341 02511 22711 06821   29481 4.1.1 putative inner membrane protein   
 -   -  03361 02501  -   -  29461 5.1.4 putative transposase for IS1667   
YE1288 10821 03611 02251 22961 07081   29201 0.0.2 conserved hypothetical protein 
YE1298 10921 03711 02151 23061 07191 29091 1.1.1 
putative flagellar assembly regulatory 
protein Flk 
YE1304 10981 03771 02091 23121 07291 29031 4.1.1 putative inner membrane protein   
YE1305 10991 03781 02081 23131 07301 29021 4.1.1 putative membrane protein 
 -  10161  -   -   -   -  - 1.4.1 putative hemolysin   
 -  10211  -   -   -   -  - 0.0.2 hypothetical protein   
 -  10281  -   -   -   -  - 0.0.1 hypothetical protein   
 -  10301  -   -   -   -  - 0.0.1 hypothetical protein   
 -  10321  -   -   -   -  - 1.4.0 putative hemagglutinin/hemolysin   
 -  10351  -   -   -   -  - 1.4.0 putative adhesin/hemagglutinin   
YE1322  - 03941 01921 23291 07471   28851 * 5.1.5 putative RTX-family protein   
YE1325 11171 03971 01891 23321 07501 28801 0.0.2 conserved hypothetical protein 
 -   -  03991 * 01871 23341 07521 28771 5.1.4 putative transposase for IS1667   
YE1379 11631 04441 01431 23781 08031 28331 3.2.8 putative O-succinylbenzoic acid--CoA ligase   
YE1384  -   -   -   -   -  - 4.1.0 putative exported protein   
 -  11461 04271 01591 23621 07841 28491 0.0.0 hypothetical protein   
YE1389  - 04521 01351 23861 08121   28261 2.1.4 putative serine protease 
YE1391 11691 04541 01331 23881 08151 28230 7.0.0 putative iron-sulphur binding protein 
YE1400 11821 04631 01231 23991 08251 28131 1.5.5 Putative type I secretion protein 
YE1406 11881 04691 01171 24051 08351 28071 2.1.4 putative protease 
YE1409 11901 04711 01151 24071 08371 28051 5.1.2 putative prophage repressor protein   
YE1410 11911 04721 01141 24081 08381 28041 5.1.2 probable phage antitermination protein Q   
 -  11941 04733 01122 24100 08401 28011 3.3.0 putative ATP-binding protein 
 -  11981  -   -   -   -  - 5.1.2 putative bacteriophage coat protein   
 -  12131 04780   01091 24131 08451 27971 3.5.0 carbonic anhydrase, EC=4.2.1.1   
 -   -  04821 01061 24141  -  27951 5.1.4 transposase for IS1668   
YE1412  -   -   -   -   -  - 5.1.4 transposase for insertion element IS285   
 -  12071  -   -   -   -  - 5.1.2 hypothetical phage protein   
 -  12651  -   -   -   -  - 2.2.3 protein umuC   
YE1432 12801 04992 00880 24340 08641 27762 0.0.0 hypothetical protein   
 -   -  05241 00631 24581 08921 27531 4.1.0 putative exported protein 
YE1488 13361 05551 00321 40061 09261 27211 4.1.1 putative inner membrane protein   
YE1529  -  05881 40091 40382 09611 26881 5.1.4 putative transposase for IS1667   
 -   -  05891 40101 00001 09621 26871 5.1.4 transposase   
 -  -  -  -  - 09671    -  5.1.4 putative transposase for IS1667   
YE1576 14121 06341 29351 00461 10131 26431 3.6.1 
putative 3-oxoacyl-[acyl-carrier- 
protein]synthase II   
 -  14371 06565 29101 01121 10411 26171 3.5.3 
putative cytochrome C-type biogenesis 
protein 
 -  14391 06567 29081 01141 10431 26151 3.5.3 cytochrome c biogenesis protein   
YE1598 14401 06568 29071 01151 10441 26141 3.5.2 nitrite reductase gene remnant 
 -  - 06631 29021  - 10491   26091 5.1.4 putative transposase for IS1667   
YE1610 14501 06701 19981 01261 30181 26031 * 1.5.0 putative MFS-family transport protein   
YE1614 14541 06751 19931 01311 30121 25971 6.1.1 
tetrathionate reductase complex: sensory 
transduction histidine kinase   
YE1617 14571 06781 19901 01341 30091 25921 3.5.2 tetrathionate reductase subunit A 
YE1656  -   -   -   -   -  - 5.1.4 putative transposase 
YE1696  -  07071 19611 01631 29761 25661 1.5.0 
putative ABC transport protein, ATP-binding 
component 
YE1697  -  07081 19601 01641 29751 25651 4.1.0 putative exported protein 
YE1698  -  07091 19591 01651 29741 25641 0.0.2 conserved hypothetical protein   
YE1700 14841 07111 19561 01681 29701 25621 3.1.5 putative shikimate dehydrogenase 
YE1716 15001 07271 19391 01851 29521 25441 * 0.0.2 conserved hypothetical protein 
 -   -  07381 19281 01951 29391 25331 5.1.4 transposase for IS1668   
 -   -  07391 19261 01961 29371 25321 5.1.2 putative prophage terminase small subunit   
YE1728 15141 07442 19201 02011 29301 25281 1.5.3 putative sugar permease 
231 
YE1729 15161 07451 19181 02031 29281 25261 6.1.1 
putative sucrose operon repressor (LacI-
family regulator) 
YE1733 15211 07491 19131 02081 29221 25221 1.4.4 putative UV protection and mutation protein   
YE1737  -   -   -   -   -  - 3.1.14 possible homoserine synthase 
 -   -  07541 19071 02140 29141 25161 0.0.0 hypothetical protein   
YE1743 15431 07561 19051 02151 29121 25141 6.1.1 
putative AraC-family transcriptional 
regulatory protein   
 -  15481 07621 18981 02201 29071 25081 5.1.5 putative cytolethal distending toxin subunit A   
YE1746 15741 07591 19011 02191 02981 25091 7.0.0 hypothetical protein   
YE1748 15511 07651 18951 02231 29041 25051 1.5.0 
putative ABC transporter, ATP-binding 
protein   
YE1759 15611 07731 18871 02311 28921 24971 0.0.1 conserved hypothetical protein 
YE1767 15681 07801 18801 02381 28851   24921 4.1.2 peptidoglycan synthetase   
Ye1771 15721 07832 18751 02431 28811 24871 4.1.3 ferrichrome receptor protein 
YE1803A  -   -   -   -   -  - 5.1.2 IS1329 transposase A   
YE1804  -   -   -   -   -  - 5.1.2 terminase, ATPase subunit 
YE1821  -   -   -   -   -  - 5.1.4 transposase   
YE1823  -   -   -   -   -  - 5.1.4 IS1400 transposase B   
YE1824  -   -   -   -   -  - 0.0.2 conserved hypothetical protein   
YE1844 21032 12891 15841 07601  -  19611 1.5.0 sodium/glutamate symport carrier protein 
 -   -  12881 15861 07581  -  19621 5.1.4 transposase for IS1328   
 -   -  12701 16041 07401 13171 19811 0.0.0 hypothetical protein   
 -   -  12471 16261  -  27921 20051 5.1.4 transposase for IS1328   
YE1845 21031 12461 16271 03231 27901  20071 4.1.1 putative inner membrane protein 
YE1848 21001 12431 16301 03261 27871 20101 7.0.0 putative transferase   
YE1853 20971 12401 16331 03291 27821 20121 0.0.2 conserved hypothetical protein   
YE1855 20951 12381 16351 03311 27801   20151 0.0.2 conserved hypothetical protein   
YE1874 20801 12231 16501 03461 27641 20272 2.0.0 putative DNA-binding protein 
YE1875 20791 12221 16511 03471 27621 20281 1.5.0 putative transport protein 
 -   -   -   -  - 27571    -  5.1.4 putative transposase for IS1667   
YE1879 20751 12181 16551 03511 27561  20341 1.5.3 putative transport protein   
YE1895 20581 12011 16741 03701 27351 20531 3.6.0  methylmalonyl-CoA mutase   
YE1897 20561 11991 16761 03721 27331 20561 1.5.2 
chelated iron transport system membrane 
protein   
 -   -  11641 17111 06441  -   -  5.1.4 transposase   
YE1905 20491 09121 35401 03791 27252 20622 0.0.0 hypothetical protein   
YE1920  -   -   -   -   -  - 5.1.4 IS1400 transposase B   
YE1925  -   -   -   -   -  - 5.1.4 putative transposase 
YE1935  - - - - 11451 18411 5.1.4 transposase for IS1330   
YE1944 22921 19221 25071 08971 11561 * 18501 * 1.5.0 putative membrane permease   
YE1947 22891 19251 25101 08941 11601 * 18541 7.0.0 putative hydrolase   
YE1950 22681 19281 25131 08911 11631 18571 3.3.19 alkanesulfonate monooxygenase   
YE1951 22851 19291 25141 08901 11651 18581 6.1.1 
putative TetR-family transcriptional 
regulatory protein   
YE1953  -   -   -   -   -  - 5.1.2 bacteriophage late control protein   
YE1954  -   -   -   -   -  - 5.1.2 bacteriophage major tail sheath protein   
YE1960 22801 19341 25191 08851 11711 18631 4.1.0 putative exported protein   
 -   -  19311 25161 08881 11681 18601 5.1.4 putative transposase   
 -  -  -  -  - 11671   -  5.1.2 putative phage integrase   
 -  22711  -   -   -  11811 - 5.1.2 putative phage integrase   
 -  -  -  -  - 11821    -  5.1.4 putative transposase subunit   
 -   -   -   -  08691  -   -  5.1.2 putative phage tail fibre protein   
 -   -   -   -  08391  -   -  5.1.4 putative transposase   
 -   -   -   -  08351  -   -  5.1.2 putative phage protein   
 -   -  11941 16811  -   -  - 5.1.4 putative transposase for IS1667 (pseudo) 
YE1971 18221 11481 17271 06271 14451 * 23231 1.5.0 probable membrane transport protein   
 -   -  -  -  - 16171  -  5.1.4 putative transposase for IS1667   
YE1984 18351 11331 29911 06131 16161 - 4.1.1 putative membrane protein   
Ye1997 18461 11211 30031 06011 16011 22581 3.3.15 probable formate--tetrahydrofolate ligase 
YE1998 18471 11201 30041 06001 15991   22571 1.5.5 putative RTX-family toxin transporter   
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YE1999 18481 11191 30051 05991 15981  22551 5.1.5 hemolysin transport protein   
YE2000 18491 11181 30061 05981 15971 22531 1.5.5 putative toxin transport protein   
YE2011 18601 11061 30181 05861 15851  22371 1.5.0 
PTS system, maltose and glucose-specific 
IIabc component   
YE2012 18611 11051 30191 05851 15841   22361 6.1.1 maltose regulon regulatory protein   
 -  18621 11042 30201 05841 15831 22341 1.4.2 putative acetyltransferase   
 -   -  -  -  - 15791    -  5.1.4 putative transposase for IS1667   
YE2019 18681 10991 30261 05781 15761 22281 1.4.3 beta-lactamase precursor   
YE2025 18741 10931 30331 05711 15681 22211 4.1.1 putative membrane protein 
YE2026A 18771 10911 30361 05681 15641 - 0.0.2 conserved hypothetical exported protein 
YE2027 18781 10901 30371 05671 15631 22210 4.1.0 putative exported protein 
YE2030 18811 10871 30401 05641  - 22200 4.1.0 putative exported protein 
YE2035 18821 10841 30421 05621  -  - 1.5.0 putative membrane transport protein   
 -  -  -  -  - 15461    -  5.1.2 putative phage-related membrane protein   
 -  -  -  -  - 15451    -  0.0.2 conserved hypothetical protein   
YE2036 18841 10831 30441 05601 15431 22191 0.0.1 conserved hypothetical protein   
YE2037 18851 10801 30461 05591 15421 22181 4.1.0 putative exported protein 
 -  18871 10781 30481 05571 15401 22171 0.0.0 hypothetical protein   
 -  18881 10773 30491 05561 15391 22161 4.1.0 putative exported protein   
YE2041 18950 10760 30531 05511 15351 22151 1.5.0 putative amino acid transporter, permease 
YE2043 18951 10751 30541 05501 15331   22141 1.5.0 
amino acid transport system permease 
protein   
YE2044 18961 10741 30551 05491 - 22131 1.5.0 
amino acid-binding periplasmic protein 
precursor 
YE2047 18981 10721 30571 05471 15301 - 7.0.0 putative hydrolase   
 -   -  10720 30581 05421  -  - 5.1.4 transposase   
 -  -  -  -  - 15251    -  5.1.4 putative site-specific recombinase   
YE2052 19001 10681 30591 05411 15241 22121 3.3.17 putative AMP nucleosidase 
YE2055 19031 10651 30621 05381 15211 22091 6.1.1 putative inner membrane regulatory protein 
YE2057 19041 10631 39771 05361 15181   - 7.0.0 putative virulence factor   
YE2058 19051 10621 39781 05351 15171 22081 7.0.0 putative virulence factor   
YE2059 19061 10611 39791 05341 15161 22071 7.0.0 putative virulence factor   
YE2060 19071 10671 28131 05311 15121  22041 3.1.11 putative acetolactate synthase large subunit   
YE2064 19111 10531 28171 05271  -  - 0.0.0 hypothetical protein   
YE2066 19131 10511 28181 05261 15071 - 1.5.0 L-fucose permease   
 -   -  10501 28191  -   -  22001 5.1.3 transposase   
YE2067 19141 10491 28201 05251 15061   21991 3.4.3 putative carbohydrate kinase   
YE2069 19151 10481 38211 05241 15051 21981 3.3.13 putative short chain dehydrogenase 
YE2073 19191 10441 28251 05201 15001 21931 0.0.2 conserved hypothetical protein   
YE2085 19311 10321 28371 05011 14861   21821 7.0.0 putative carboxypeptidase   
YE2086 19321 10312 28380 05001 14851 21811 1.6.1 putative acid shock protein   
YE2094 19391  -   -   -   -  - 6.1.1 putative transcriptional regulatory protein 
YE2099 19441 10211 28471 04901 14741 21721 4.1.0 putative lipoprotein   
YE2102 19471 10181 28511 04861 14701 21681 7.0.0 putative pyruvate-flavodoxin oxidoreductase 
 -   -  10161 28521 04851 14691  -  2.2.7 putative phospholipase   
YE2115 19581 10071 28601 04771 14593 21591 0.0.2 conserved hypothetical protein 
YE2116 19591 10061 28611 04761 14592 21581 0.0.2 conserved hypothetical protein 
 -   -   -   -   -   -  21391 5.1.4 putative transposase for IS1667   
YE2134 19771 09871 28791 04561 16411 21381 0.0.2 conserved hypothetical protein 
YE2138 19811 09831 28831 04521 16461 21341 3.3.15 pyridoxamine kinase 
YE2141 19841 09801 28861 04491 16501 21311 4.1.0 putative lipoprotein   
YE2152 19951 09691 28981 04371 16631 21201 7.0.0 
NADH:flavin oxidoreductase / NADH 
oxidase family protein 
 -   -  09671 29011 04351 16661 21181 5.1.4 transposase for IS1668   
YE2163 20061 09561 34961 04231 26791 21071 1.5.0 putative transport protein 
YE2179 20212 09401 35112 04072 26960 20912 0.0.0 hypothetical protein   
YE2181 20231 09381 35131 04061 26971 20891 1.5.5 hemin transport protein 
YE2182 20241 09371 35141 04051 26981 20881 1.5.5 hemin-binding periplasmic protein 
YE2184 20261 09351 35161 04031 27001 20851 2.2.6 putative lipoate-protein ligase A 
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 -  17921  -   -   -   -  - 3.1.19 
tryptophan synthase alpha chain, 
EC=4.2.1.20   
 -   -   -   -   -   -  22791 5.1.2 hypothetical phage protein 
 -   -   -   -   -   -  22801 0.0.2 hypothetical protein   
 -   -   -   -   -   -  23091 0.0.1 hypothetical protein   
      
23071 5.1.2 putative exinuclease protein 
 -   -  11571 17181 06371 14361 23311 0.0.0 hypothetical protein   
YE2216A 17891 11761 16991 06561 14131   23491 0.0.2 conserved hypothetical protein   
 -   -  09081 37151  -   -  - 4.1.0 putative transposase for IS1667   
YE2243 17641 09011 37221 06801 13871   23711 6.1.1 probable response regulator   
YE2245 17621 08991 37241 06821 13851 23731 0.0.0 hypothetical protein   
YE2256 17561 08921 37301 06881 13761 23790 4.1.0 putative exported protein 
YE2263 17481 08851 37371 06951 13681 23861 0.0.2 conserved hypothetical protein 
 -  17161  -   -   -   -  - 5.1.2 phage replication protein   
YE2273 17021 08761 37431 07011 13591   23921 0.0.2 conserved hypothetical protein 
YE2278 16971 08711 37491 07071 13541   23971 7.0.0  putative phosphodiesterase   
YE2279 16961 08701 37501 07081 13531 23981 1.4.3 putative multidrug resistance protein 
YE2286 16891 08612 37562 07142 13460 24061 4.1.4 
acyl-[acyl-carrier-protein]--UDP-N-
acetylglucosamne o-acyltransferase 
 -   -  08611 37591 03221 13401 24081 5.1.4 transposase for IS1328   
 -   -  08561 33631 03181 27991 24121 5.1.4 transposase for IS1668   
 -   -  08161 34061 02751 28411 24531 6.3.11 
putative LyxR-family transcriptional 
regulatory protein 
 -   -  08131 34091 02711 28451 24571 5.1.2 putative bacteriophage protein   
 -   -   -   -  02721 28441  -  5.1.4 putative transposase   
 -   -  08181 34021 02791 * 28361  -  5.1.4 transposase   
 -   -   -   -  07181  -   -  5.1.4 transposase for IS1328   
YE2376 16771 12601 16141 07301 13281 19921 4.1.0 putative lipoprotein   
 -   - 12981 39541 07751 12811    -  0.0.0 hypothetical protein   
 -   -  13051 39471 07821 12741 19391 5.1.4 putative transposase subunit   
 -   -  13071 39461 07831 12731 19381 5.1.4 putative transposase for IS1669   
YE2410 16461 13261 36551 07991 12521 19181 7.0.0 putative oxidoreductase   
YE2416 16421 13301 36522 08022 12491 19142 4.1.1 putative inner membrane protein 
YE2422 16371 13351 36481 08071 12431 19101 7.0.0 putative oxidoreductase   
 -   -  13661 36181  -  12111 18821 5.1.4 IS1400 transposase A   
 -  -  -  -  - 12101    -  5.1.2 putative phage major capsid protein   
 -  -  -  -  - 12091    -  5.1.2 putative phage holin   
 -   -  13791 36081  - 11971    -  5.1.2 putative variable tail fibre protein   
 -   -  13801 36071  -  11951 - 5.1.2 putative phage tail fiber assembly protein   
 -   -  13941 35991  -   -  - 5.1.2 putative bacteriophage tail fiber protein   
 -   -  13771 36101  -  40661 18771 5.1.2 putative phage baseplate assembly protein 
 -   -   -   -   -   -  18761 5.1.2 putative phage tail protein 
 -   -  13951 40131  -  -  18751 5.1.2 putative bacteriophage late gene regulator   
 -  
 
13961 40132  -   -  18731 5.1.4 putative transposse for IS1667 
 -  16021  -   -   -   -  - 0.0.1 conserved hypothetical protein   
YE2445  -   -   -   -   -  - 5.1.4 transposase   
 -  21111 12924 15791 07681 12921 19541 1.5.0 
putative phoshpotransferase system 
enzyme subunit 
YE2449 21141 12931 15761 07711 12891 19511 3.4.3 
putative tagatose-6-phosphate ketose / 
aldoseisomerase   
YE2450 21151 12941 15751 07721 12881 19491 3.4.3 
putative D-tagatose-1,6-bisphosphate 
aldolase subunit 
YE2458 21191 13001 39521 07771 12791 19441 * 0.0.2 conserved hypothetical protein 
YE2461 21221 13031 39491 07801 12761 19411 3.4.2 imidazolonepropionase 
YE2474 21341 13201 39351 07941 12581 19261 6.1.1 
putative LysR-family transcriptional 
regulatory protein   
 -   -  13211 39352  -  12571 19241 5.1.4 putative transposase for IS1667   
YE2483 21341 08501 33691 03121 28051 24181 1.6.3 haemin storage system, HmsF protein 
YE2484 21441 08491 33701 03111 28061 24191 1.6.3 
haemin storage system, HmsH protein, 
precursor   
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YE2487 21181 12991 39531 07761 12801 19451 4.1.0 hypothetical protein   
YE2488 21481 08451 33741 03071 28101 24251 6.1.1 
putative LysR-family transcriptional 
regulatory protein   
YE2499 21591 08341 33851 02961 28211 24371 4.1.1 putative membrane protein 
YE2502 21621 08311 33881 02931 28241  24401 7.0.0 putative class II aldolase-family protein   
YE2508 21681 08251 33941 02871 28301   24461 1.5.1 L-asparagine permease   
 -  21761  -   -   -   -  - 5.1.2 putative phage integrase   
 -  23022 19111 24961 09081 11422 18381 0.0.2 conserved hypothetical protein   
YE2520 23091 19031 24881 09161 11341 18291 2.2.11 flagellin lysine-N-methylase   
 -  23101  -   -   -   -  - 1.1.1 flagellin   
YE2521 23111 19021 24871 09171 11331 
YE3904-
18281 
1.1.1 flagellin   
YE2522 23121 19011 24861 09181  -  - 1.1.1 thermoregulated motility protein   
YE2523 23131 19001 24851 09191  -  18271 1.1.1 flagellin   
YE2531  - 18911 24771 09271 11241   18204 0.0.0 hypothetical protein   
YE2535  -  18900 24762 09280 11230 18202 5.1.2 IS1329 transposase B   
YE2564 23481 18561 24471 09571 10911 17921 5.1.5 invasin 
YE2586A 23691 18351 24261 09780 10651 17691 3.3.0 putative coA transferase family protein 
YE2594  -   -   -   -   -  - 5.1.4 
transposase for insertion sequence element 
IS1665   
 -   -  18281 39880 09831  -   -  5.1.4 transposase   
YE2597 23791 18251 * 39861 * 09861 10551 17621 6.1.1 
AsnC-family transcriptional regulatory 
protein   
YE2598 23801 18241 39851 09871 10531    -  0.0.1 conserved hypothetical protein   
YE2600 23821 18221 39831 09891 10511 17591 3.3.15 probable histidine acid phosphatase 
 -  23851 18175 34831 09931 30271 17551 4.1.5 
putative outer membrane fimbrial usher 
protein 
 -  23861 18174 34821 09941 30281 17541 4.1.0 putative exported protein 
YE2603 23891 18171 34791 09971 30311 17501 3.4.3 putative sugar kinase   
YE2609 23951 18151 34781 09981 30321 17491 1.5.0 
ABC transporter, substrate binding 
component   
 -   -   -   -   -  30361   -  3.3.0 putative hydrolase   
 -   -   -   -   -  30401    -  2.2.3 putative antirestriction protein   
 -   -   -   -   -  30421    -  2.2.3 putative NTPase   
YE2611  -   -   -   -   -  - 5.1.2 integrase   
YE2624  -   -   -   -   -  - 5.1.4 
transposase for insertion sequence element 
IS1328   
YE2640 * 24071 18001 34641 10121 30601 17341 4.1.1 putative membrane protein 
YE2644 24091 17971 34621 10141 30631 17321 1.5.3 
putative C4-dicarboxylate transporter, 
periplasmic protein 
YE2646 24111 17951 34601 10161 30651 17291 1.5.3 
putative C4-dicarboxylate transporter, large 
subunit 
YE2652 24171 17891 34541 10221 30711   17221 3.3.15 citrate lyase acyl carrier protein   
YE2654 24191 17871 34521 10241 30731 17201 6.1.1 sensor kinase protein 
YE2662 24271 18121 34761 10001 30471   17471 6.1.1 putative two-component response regulator   
YE2663 24281 18111 34751 10011 30481 17461 6.1.1 putative virulence sensor protein 
YE2666 24311 18081 * 34721 10041 30511 17421 4.1.5 probable fimbrial usher protein   
 -   -  18201 34851 09911 30251 17571 5.1.4 putative transposase for IS1667   
 -   -   -   -   -   -  17191 5.1.4 putative transposase 
YE2670 24351  -   -  10341 30841 17081 6.1.1 putative GntR-family regulatory protein   
YE2671 24381 17771 34431 10351 30851 17072 0.0.0 
putative short chain dehydrogenase / 
reductase family protein   
YE2684 31121 17641 32241 10491 31001   16921 0.0.2 
conserved hypothetical protein [unresolved 
tandem repeat] 
YE2686 31141 17621 32221 10511 31021 16901 4.1.1 putative OmpA family protein 
YE2693 31211 17551 32151 10581 31091 16831 4.1.0 outer membrane usher protein 
YE2705 31331 17411 32031 10701 31221   16701 6.1.1 putative luxR-family regulatory protein   
 -  31341 17410 32021 10711 31222 16691 1.5.0 xanthosine permease   
YE2706  -   -   -   -   -  - 7.0.0 
transcription regulator/permease fusion 
protein   
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YE2708 31391 17391 32001 10731 31241 16661 3.2.3 alpha-ribazole-5'-phosphate phosphatase 
YE2710 31411 17371 31981 10751 31261 16641 3.2.3 cobinamide kinase and guanylyltransferase 
YE2719 31501 17271 31881 10851 31361 16541 0.0.2 conserved hypothetical protein 
YE2724 31571 17211 31821 10911 31421 16481 4.1.1 putative membrane protein 
YE2762 31941 16831 31451 11281 31811  16111 1.5.0 
putative ABC transport system ATP-binding 
protein   
 -   -   -   -   -  31971 15691 5.1.4 transposase   
 -   -   -   -   -   -  15951 5.1.4 putative transposase 
 -   -   -   -   -  32011   15941 5.1.4 IS1400 transposase B  
YE2810 32391 16251 10721 11731 32471 15541 3.5.2 formate dehydrogenase H 
YE2812 32411 16231 10710 11750 32482 15512 1.5.3 putative formate transporter 
YE2829 32581 16071 10531 11921 32661 15341 3.2.9 molybdopterin biosynthesis protein 
YE2832 32601 16041 10511 11951 32711 15301 0.0.0 hypothetical protein   
YE2852 32801 15841 10311 12151 32931 15091 7.0.0 putative peptidase   
YE2859 32871 15761 10241 12221 33021  15021 6.1.1 LysR family transcription regulatory protein   
YE2866 32941 15691 10171 12291 33111   14951 4.1.1 putative fatty acid desaturase   
YE2867 32951 15681 10161 12301 33121 14931 0.0.2 conserved hypothetical protein 
YE2883 33121 15521 10001 12461 33291 14771 3.5.1 D-lactate dehydrogenase   
YE2885 33141 15491 09971 12491 33331 14750 0.0.2 conserved hypothetical protein 
YE2900 33271 15361 09841 12621 33471 14621 0.0.2 conserved hypothetical protein 
 -   -   -   -   -   -  14361 5.1.2 putative phage protein 
 -   -   -   -   -   -  14311 5.1.2 putative bacteriophage protein 
YE2922 - 15131 09611 12851 33731 13941 7.0.0 putative protease 
YE2955A 33811 14811 09291 13171 34121   13621 0.0.2 conserved hypothetical protein   
 -  33861 14761 09241 13221 34171 13561 5.1.5 putative cytotoxin RtxA   
 -  33881 14741 09221 13241 34191   13541 0.0.2 putative uncharacterized protein RtxH   
YE2966 33961 14661 09141 13321 34281 13461 5.1.5 putative hemolysin   
YE3007 34461 14251 08731 13731 34711 13031 3.2.7 lipoate-protein ligase B   
YE3014 34531 14181 08661 13801 34791 12962 6.1.1 putative LyxR-family regulatory protein 
YE3021 34601 14111 08591 13871 34871 12911 7.0.0 
putative phenylalanine and histidine 
ammonia-lyase 
YE3025 24651 27571 39931 13911 - 12861 6.1.1 
putative two-component system sensor 
protein 
 -   -  27551 39921 13921  -  12841 0.0.0 hypothetical protein   
 -   -   -   -   -  34901  -  5.1.2 putative phage integrase   
 -   -  27502 39891 13951 34941 12811 0.0.2 conserved hypothetical protein   
 -   -   -  39892 13961 34951 12801 0.0.2 conserved hypothetical protein 
 -   -  27501 23351 13991 35001 - 5.1.2 putative phage primase   
YE3026 34661  -   -   -   -  - 4.1.0 putative exported protein   
YE3028 34681  -   -   -   -  - 4.1.0 putative exported protein 
YE3037  -   -   -   -   -  - 0.0.0 hypothetical protein   
YE3038  -   -   -   -   -  - 5.1.4 integrase   
 -   -  27471 23331 14041 35061 12791 5.1.2 putative integrase   
 -   -   -   -   -   -  12501 5.1.2 lysozyme 
 -   -   -   -   -   -  12281 2.2.3 
putative adenine-specific modification 
methylase 
YE3066 35381 27281 
YE5630-
23141 
14231 35261 12081 0.0.2 UDP-sugar hydrolase 
YE3097 35611 27111 22911 14461 35541 11871 1.5.2 putative potassium efflux system 
 -   -  26491 22291 15081 36311   11231 0.0.0 hypothetical protein   
 -   -  26441 22231 15141 36371 11171 5.1.4 putative transposase for IS1667   
YE3168 36291 26442 32811 15151 36391 11161 0.0.2 conserved hypothetical protein 
YE3180 36381 26351 32721 15241 36491 11071 5.1.4 phosphate binding protein 
YE3190 36481 26251 32621 15341 36601 10961 0.0.1 conserved hypothetical protein   
YE3196 36541 26191 32561 15401 36681 10901 4.1.4 putative cyclic beta 1-2 glucan synthetase 
YE3199 36571 26161 32561 15431 36711 10851 1.5.3 
PTS system, alpha-glucoside-specific IIBC 
component 
YE3208 36661 26071 32441 15521 36821 10751 0.0.2 conserved hypothetical protein 
 -   -  25861  -   -   -  -  5.1.4 putative transposase for IS1667   
 -   -  25621  -   -   -   -  5.1.2 putative transposase for IS1667   
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 -   -  25601 35981 40831  -  09751 5.1.4 transposase for IS1668   
YE3218 36761 25971 32341 15621 36921 10641 3.5.3 
Na+-translocating NADH-guinone reductase 
subunit C 
YE3225 36831 25901 32271 15691 37001 10561 5.1.5 putative accessory processing protein 
YE3226 36841 25891 32261 15701 37021 10551 5.1.5 putative adhesin   
 -   -   -   -   -   -  10131 5.1.2 putative phage replication protein 
 -   -   -   -   -   -  10121 5.1.2 putative DNA replication protein 
 -   -   -   -   -   -  10111 5.1.2 putative phage replication protein 
 -  36931 25790 39021 15791 37121  10001 3.4.2 putative amino acid hydrolase   
 -  36941 25789 39011 15801 37131 09991 3.7.1 putative purine catabolism protein 
YE3285 06081 34221 04451 30331 26331 33001 2.2.10 methionine aminopeptidase 
 -   -  24571 31431 30121 38571 - 5.1.4 putative transposase for IS1667   
 -   -  24691 30741 31661 38431 08751 0.0.0 hypothetical protein   
 -   -  24651 37081 31701 38471 08711 3.3.0 putative oxidoreductase   
 -   -  24632 37100 31720 38511   08701A 5.1.2  putative integrase   
YE3321 05760 24441  -  - 25941 * 33332 0.0.1 conserved hypothetical protein   
YE3326 05721 24401 31271 29961 25901 33371 4.1.1 putative membrane protein 
YE3328  -   -   -   -  25882 - 5.1.4 putative transposase for IS1667   
YE3338 05621 24291 31171 29861 25791 33491 1.1.1 
putative methyl-accepting chemotaxis 
protein   
YE3341 05591 24253 31131 29821 25741 33531 1.5.5 prepilin peptidase 
YE3342 05581 24252 31121 29811 25731 33541 4.1.0 putative exported protein 
YE3344 05551 24241 
YE6503-
31101 
29781 25711   33561 1.5.5 general secretion pathway protein K   
YE3345 05531 24221 31081 29761 25681   33581 1.5.5 general secretion pathway protein I   
YE3347 05511 24201 31061 29741 25661  33601 1.5.5 general secretion pathway protein   
YE3349 05491 24181 31041 29721 25631 33631 1.5.5 general secretion pathway protein D   
YE3354 05421 24131 30991 29671 25581 33681 7.0.0 putative oxidoreductase   
YE3358 05381 * 24081 30941 29631  -  - 1.5.3 putative sugar transporter   
 -   -  24041 30901 29591 25551  -  5.1.4 putative transposase for IS1667   
YE3367 05271 24001 30871 29551 25521 33741 0.0.1 conserved hypothetical protein   
 -   -   -   -   -   -  33801 5.1.4 tnpA-like protein 
 -   -   -   -   -   -  33861 5.1.4 tnpA-like protein 
YE3376 04861 23831 30691 29471 25431 33901 2.2.10 
peptide chain release factor 2 - ALL 
ORTHOLOGS WITH FS!!! Shown to be 
functional 
YE3383 04801 23751 13611 29411 25371 33961 6.1.1 putative histidine kinase sensor 
 -  -  -  -  - 25321   34011 5.1.4 putative transposase for IS1667   
YE3455  -   -   -   -   -  - 5.1.4 transposase for IS3-like insertion sequence   
YE3456  -   -   -   -   -  - 5.1.4 transposase for IS3-like insertion sequence   
YE3516  -  34811 05031 32141 38971 08271 5.1.2 putative integrase   
YE3521  -   -   -   -   -  - 0.0.2 conserved hypothetical protein   
YE3522  -   -   -   -   -  - 7.2.1 Putative exported protein   
YE3524  -   -   -   -   -  - 5.1.4 putative transposase   
YE3524A  -   -   -   -   -  - 0.0.0 hypothetical protein 
YE3527 03881 34921 03881 32221 39061 08201 3.3.20 ornithine decarboxylase, inducible   
YE3528 03871 34931 05121 32231 39071 08181 4.1.1 putative membrane protein 
YE3532 03831 34971 05161 32271 39121 08151 0.0.0 hypothetical protein 
YE3580  -   -   -   -   -  - 5.1.4 putative IS285-like transposase 
YE3587 03751 35058 05241 32351 39221   08061 7.0.0 putative O-methyltransferase   
 -  03741 35059 05251 32361 39241 08051 * 4.1.1 hypothetical membrane protein 
 -  03721 35062 05270 32382 39280 08040 3.3.0 putative FMN-binding protein 
YE3588 03711 35061 05271 32381 39281 08031 1.5.0 putative transporter protein   
YE3590 03691 35081 05291 32401 39311 08001 7.0.0 putative hydrolase   
 -  03641 35130 05341 32451 39360 07951 0.0.1 conserved hypothetical protein   
YE3595 03621 35131 05351 32461 39361 07941 1.4.3 putative integral membrane efflux protein   
 -   -  39380 38529  -  03463 38722 5.1.4 putative transposse for IS1669 
 -   -  39381 38530  -  03462 38721 5.1.4 transposase for IS1328   
YE3603 03531 35251 05451 32561 39461 07841 2.2.9 
hydrogenase isoenzymes nickel 
incorporation protein   
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YE3610A  -   -   -   -   -  - 1.1.1 putative flagellar biogenesis protein   
YE3611  -   -   -   -   -  - 6.1.1 
putative transmembrane transcriptional 
activator 
YE3612  -   -   -   -   -  - 5.1.4 transposase for IS1330   
YE3617 03401 35751 05981 33081  -  07261 1.5.3 putative membrane transport protein   
YE3622 03351 35801 06031 33131  -  07211 1.6.3 enterochelin esterase   
YE3624 03341  -   -   -   -  - 1.6.3 gerrichrysobactin receptor precursor 
YE3626 03331  -   -   -   -  - 4.1.0 putative exported protein, precursor   
 -  03441 35729 05941 33041  -  07301 1.1.1 putative flagellar biosynthesis protein   
 -  03451 35350 05541 32651 39521 07751 1.1.1 flagellar motor protein motB   
 -   -  35381 05581 32691 39561   07711 1.1.1 flagellar hook-length control protein fliK   
 -   -  35431 05631 32741 39641 07651 6.0.0 putative regulatory protein   
 -   -  35591 05801 39821  -  07451 5.1.4 putative transposase for IS1667   
 -   -  35641 05851 32951  -  07391 1.1.1 putative flagellar M-ring protein 
 -   -   -   -   -   -  07181 5.1.4 putative transposase for IS1667   
 -  03962  -   -   -   -  - 2.2.3 putative exinuclease   
 -  03971  -   -   -   -  - 5.1.4 putative transposase subunit   
 -  03991  -   -   -   -  - 5.1.4 putative transposase   
 -  04121  -   -   -   -  - 2.2.9 putative peptidase   
 - 05041  -  -  -  - - 3.5.3 
nickel-dependent hydrogenase, b-type 
cytochrome subunit   
 -   -  35831 06051 33151 39831 07161 5.1.4 putative transposase   
 -  
 
35850 06060 33160 39851 07142 6.0.0 putative transcriptional regulatory protein 
 -   -  35880 06092 33192 39901 07103 5.1.4 putative transposase   
YE3630 03291 35921 06141 33231 40010 07071 1.5.2 putative cation efflux system protein   
YE3636 03241 35981 06191 33281 40051 07021 1.5.0 putative secretion system protein 
YE3671 02911 36351 06531 33621 40401 06681 0.0.2 conserved hypothetical protein   
 -   -  36481 06671 33761 40541 06541 5.1.4 putative transposase for IS1667   
 -   -   -   -   -  40841  -  5.1.2 putative phage terminase 
 -   -   -   -  33869  -   -  5.1.2 putative phage terminase, ATPase subunit 
 -   -  36611 06851 40775  -   -  5.1.2 putative phage protein 
 -   -  36621 06861 33891  -  - 5.1.2 putative phage replication protein   
YE3690 02721 36761 07011 34031 41061 06461 1.5.3 photransferase system IIBC component 
YE3694 02681 36792 07042 34062 41101 06430 6.0.0 Putative transcriptional regulator   
YE3697 02651 36811 07061 34081 41111   06411 4.1.1 putative membrane protein 
YE3700  -  36861 07111 34121 41171   06361 4.0.0 hypothetical protein 
YE3722 02401 37081 07331 34341 41421   06141 3.3.4 
probable NADP-dependent alcohol 
dehydrogenase   
 -   -   -   -   -   -  06041 5.1.4 transposase   
 -   -   -   -   -  
YE1293-
41551 
06021 0.0.0 hypothetical protein 
YE3734 02291 37231 07491 34501 41671   05931 0.0.2 conserved hypothetical protein 
YE3735 02281 37241 07501 34511 41681 05921 3.1.7 
glutamate synthase [NADPH] large chain 
precursor   
YE3753 02101 37421 07681 34701 41891 05731 1.5.2 putative sodium/calcium exchanger protein 
YE3774 01911 37611 07871 34891 42101 05541 1.5.3 
PTS system, trehalose-specific IIBC 
component 
YE3776 01891 37631 07891 34911 42131 05501 1.5.2 Mg2+ transporter ATPase 
YE3778 01871 37661 07921 34941 42181 05471 4.1.0 putative exported protein 
YE3779 01861 37671 07931 34951 42191 05451 0.0.2 conserved hypothetical protein 
 -   -  37771 08031  -  42291 05341 5.1.4 putative transposase for IS1667   
 -  01721  -   -   -   -  05301 5.1.2 hypothetical phage-related protein   
 -  01711  -   -   -   -  05281 5.1.2 hypothetical phage-related protein   
 -  01581  -   -   -   -  05151 5.1.2 putative tail sheath protein 
 -  01571  -   -   -   -  05141 5.1.2 hypothetical phage-related protein   
 -  01501  -   -   -   -  05061 5.1.2 putative portal vertex protein 
 -   -  37861 08111  -   -  - 5.1.2 putative phage tail sheath protein   
 -   -  37921 08171  -   -   -  5.1.2 putative phage tail protein   
 -   -  38151 08501 35141 42391  04881 6.3.6 putative lysR-family transcriptional regulator   
 -   -  38171 08521 35161 42411 04861 1.4.1 putative insecticidal toxin complex protein   
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 -   -  38181 08531 35171 42421   04841 5.1.5 putative insecticidal toxin complex protein   
 -   -  38241 26241  -   -  - 1.4.1 putative insecticidal toxin complex protein   
YE3818 01101 38481 26471 35441 42711 04551 6.1.1 possible regulator invovled in cell signalling 
YE3825  -   -   -   -   -  - 5.1.4 
transposase for insertion sequence element 
IS1328   
YE3828 01041 * 38541 * 26512 35500 42772 04502 * 7.0.0 hypothetical protein 
YE3837 00971 38641 26581 35561 42851 04431 * 4.1.1 putative inner membrane protein 
 -   -   -   -  35761  -   -  5.1.2 putative phage tail protein   
 -   -   -   -  36081  -   -  5.1.2 putative phage protein   
YE3860  -  38901 26831 36341 43121 04171 4.1.0 putative exported protein   
 -  00061 39021 26961 36471 43241 04021 5.1.2 hemolysin 
 -   -   -   -  36541 43302 03951 5.1.4 putative transposase   
 -   -  00001 39951 19531 03480 32671 5.1.4 transposase   
 - 30761 19588 13981 25091 20771   38081 5.1.5 putative type III secretion protein   
 - 30841 19580 13901 25011 20691   38161 5.1.5 putative pathogenicity island protein   
 - 30861 19578 13881 24991 20681   38181 5.1.5 putative pathogenicity island protein   
 -  30891 19575 13851 24961 20651 38202 5.1.5 putative type III secretion apparatus 
 - 31051 19482 13691 24801 20491   38381 6.1.1 putative sensor protein   
 -   -  27711 39571 19401 20291 03831 5.1.4 transposase for IS1668   
YE3956 37891 28341 27501 18781 19651 03261 * 4.1.1 putative membrane protein   
YE3964 37971 28421 27421 18701 19561 03181 3.7.2 cytosine deaminase   
YE3967 38001 28541 27391 18671 19521 03151 1.5.4 putative nitrite transporter 
YE3970 38031 28481 27361 18641 19491 03111 3.4.3 phosphoglycolate phosphatase 
 -   -  28811 27031  -  19121 02761 5.1.4 putative transposase for IS1667   
YE3989 38361 28880 24151  18271 19071 02711 0.0.2 conserved hypothetical protein 
YE4001 38240 28721 27121 18401 19221 02861 1.5.5 putative MFS-family transport protein   
YE4002  - 28711 27131 18411 19231 02871 7.0.0 hypothetical protein 
YE4026 38581 * 29081 23931 18051 18851 02491 3.4.3 myo-inositol 2-dehydrogenase   
YE4041 38751 29231 23771 17891 18681 02331 3.4.2 glutamate mutase 
YE4046 38801 29281 23721 17841 18631  02281 1.5.1 
putative sodium-dicarboxylic acid 
transporter family protein, precursor   
 -   -   -   -   -   -  02271 0.0.2 hypothetical protein 
 -   -   -   -   -   -  02241 0.0.2 hypothetical protein 
 -   -   -   -   -   -  02141 5.1.4 Tn7-like transposition protein 
YE4052 38861 29341 23661 17781 18571 02061 2.1.4 metalloprotease   
 -  39081  -   -   -   -  
 
5.1.4 putative integrase   
YE4062 39151 29421 23581 17701 18491 01971 4.1.0 putative exported protein 
YE4072 39261 29521 23481 17601 18381   01871 4.1.4 
probable BcsC protein involved in cellulose 
synthesis   
YE4074 39291 * 29551 23451 17571 18351 08141 4.1.1 
cellulose synthase 1 catalytic subunit[UDP- 
forming]   
YE4086 39411 29711 38471 17411 18141   39841 4.1.0 putative exported protein, precursor   
 -   -  29751 38431 17371 18091 39891 5.1.3 transposase   
 - 39521 29882 38921 17231 17911    -  4.1.5 putative fimbrial usher protein   
YE4096 39511 29921 38272 17222 17902 - 0.0.0 hypothetical protein 
YE4097  -  29911 38273 17223 17903 - 0.0.0 hypothetical protein 
YE4101 39561 29851 38331 17271 17971 - 4.1.3 Putative outer membrane porin   
YE4106 39611 29801 38381 17321 18021 39941 7.0.0 Hypothetical ROK family protein   
 -   -  29891 38281  -   -   -  5.1.4 putative transposase for IS1667   
YE4113  -  30041 38202 13991 35001 01631 5.1.2 putative phage primase   
YE4114  -  30061 38204  -   -  01611 7.2.1 conserved hypothetical protein   
YE4115  -  30091 38205  -   -  01601 7.2.1 conserved hypothetical protein   
 -  -  -  - 17181 17861  *  -  5.1.4 transposase subunit istA   
YE4118 39741 30111 21141 17131 17791   01581 6.1.1 
putative AraC-family transcriptional 
regulator   
YE4123 39791 30161 21091 17081 17741 01531 3.4.3 xylulose kinase   
YE4125 39821 30191 21061 17051 17711 01501 6.1.1 Putative transcriptional regulator   
YE4135 39901 30291 20981 16971 17631 01421 3.5.3 
formate dehydrogenase-o, major subunit   -  
ALL ORTHOS WITH READ-THROUGH OF 
STOP CODON 
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YE4142 39961 30351 20921 16911 17561 01351 7.0.0 hypothetical protein 
YE4145 39991 30381 20891 16881 17531 01321 4.1.1 Putative inner membrane protein   
YE4167 40211 30651 20631 16621 17301   40661 7.0.0 pyridoxal-phosphate dependent enzyme   
YE4174 40291 30730 20561 16551 17212 40722 0.0.0 hypothetical protein 
YE4185 40401 30831 20451 16441 17101 40811 6.1.1 Probable two-component sensor kinase   
 -  40981 32651 17481 36711 01891 40041 5.1.1 putative Colicin   
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Table 9.8: Number of total CDSs, pseudogenes, and partial genes per group for the 
Y. enterocolitica reference genomes. 
group description 5303 8081 21202 5603 14902 1203 3094 
1 
Unknown function, no known 
homologues 
857 662 662 663 686 664 722 
pseudo 7 3 10 11 11 28 36 
partial 8 9 13 12 14 19 14 
2 
Cell processes 95 84 118 118 118 102 117 
pseudo 2 0 1 1 1 1 5 
partial 7 1 0 1 1 2 0 
3 
Protection responses 69 54 60 59 57 55 56 
pseudo 3 0 0 0 0 0 7 
partial 3 0 3 1 2 2 1 
4 
Transport/binding proteins 533 497 483 483 483 477 472 
pseudo 4 3 6 5 5 14 23 
partial 1 8 10 9 10 14 17 
5 
Adaptation 52 56 49 49 49 45 49 
pseudo 0 1 0 0 0 0 3 
partial 1 0 3 3 1 2 1 
6 
Cell division 25 24 24 24 24 24 24 
pseudo 0 0 0 0 0 0 0 
partial 0 0 0 0 0 0 0 
7 
Macromolecule metabolism 87 86 89 89 89 88 86 
pseudo 0 1 0 0 0 1 2 
partial 0 1 3 3 4 3 3 
8 
Macromolecule synthesis, 
modification 
255 229 233 233 235 232 232 
pseudo 2 0 2 1 2 2 4 
partial 5 0 2 2 1 5 1 
9 
Metabolism of small 
molecules 
108 100 100 101 101 100 99 
pseudo 0 0 1 1 1 2 2 
partial 1 1 0 0 0 1 0 
10 
Biosynthesis of cofactors, 
carriers 
129 128 128 128 128 128 128 
pseudo 1 0 1 0 0 1 2 
partial 0 1 2 2 3 2 1 
11 
Central intermediary 
metabolism 
170 158 159 158 161 160 160 
pseudo 1 0 0 0 1 4 4 
partial 0 2 5 4 5 4 9 
12 
Degradation of small 
molecules 
124 123 121 120 120 120 118 
pseudo 2 0 1 1 1 2 3 
partial 0 2 1 1 1 2 4 
13 
Energy metabolism, carbon 159 127 143 143 142 142 142 
pseudo 1 0 0 0 1 0 6 
partial 1 1 2 2 3 3 1 
14 
Fatty acid biosynthesis 28 28 23 24 24 24 24 
pseudo 0 0 0 0 1 1 1 
partial 0 0 1 1 1 1 1 
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15 
Nucleotide biosynthesis 27 26 27 27 28 27 27 
pseudo 0 0 1 1 0 0 0 
partial 0 0 0 0 0 0 1 
16 
Cell envelope 648 674 635 636 630 632 624 
pseudo 8 5 4 1 4 10 26 
partial 4 2 10 10 8 15 19 
17 
Ribosome constituents 67 67 67 67 67 67 67 
pseudo 0 0 0 0 0 0 0 
partial 0 0 0 0 0 0 0 
18 
Extrachromosomal 370 340 265 260 300 278 380 
pseudo 6 11 27 24 17 25 43 
partial 6 20 26 25 29 37 37 
19 
Regulation 284 280 270 271 272 266 267 
pseudo 2 0 3 5 3 7 15 
partial 0 3 10 8 11 11 13 
20 
Not classified (included 
putative assignments) 
278 310 264 264 264 262 258 
pseudo 2 3 4 4 1 11 11 
partial 3 6 5 2 3 3 6 
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Table 9.9: Signal values for Y. enterocolitica biotypes. 
  
BT 1A O:5 BT 1B O:8 BT 2 O:9 BT 3 O:9 
 
well 5303_1 5303_2 5303_3 8081_1 8081_2 8081_3 21202_1 21202_2 21202_3 5603_1 5603_2 5603_3 
C PM1-A01 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
C PM1-A02 241.176 200.562 193.850 184.028 175.074 163.372 196.353 194.261 144.022 208.628 210.233 151.099 
C PM1-A03 258.504 185.932 195.264 172.622 122.717 94.532 246.721 214.416 107.101 239.961 216.084 188.005 
C PM1-A04 -0.799 -2.058 -6.778 -1.818 -8.464 -1.624 -0.813 -2.779 -2.804 -3.782 2.097 -1.625 
C PM1-A05 199.845 220.725 191.599 161.857 157.349 139.443 156.592 66.034 159.289 11.783 174.145 6.780 
C PM1-A06 272.304 261.607 255.479 243.979 255.362 249.279 271.713 260.684 223.811 250.451 268.886 198.951 
C PM1-A07 248.851 261.086 206.379 211.217 197.992 192.501 180.938 11.867 183.176 9.071 205.122 1.705 
C PM1-A08 52.307 6.146 5.325 17.457 66.507 47.261 105.617 67.653 57.139 7.689 65.739 8.313 
C PM1-A09 44.171 33.714 18.509 76.626 76.807 71.609 3.842 2.163 4.772 -1.895 1.209 -6.080 
C PM1-A10 165.200 126.650 133.330 135.545 101.422 107.236 173.805 147.395 86.961 179.257 166.201 126.221 
C PM1-A11 178.542 88.459 94.772 105.843 77.858 79.176 168.592 152.493 124.851 167.374 170.997 93.203 
C PM1-A12 8.103 7.603 7.604 -0.067 3.974 6.517 52.500 12.192 7.700 1.417 6.555 10.053 
C PM1-B01 271.741 269.005 275.807 2.857 3.175 0.120 157.834 0.103 -0.739 2.117 5.300 -0.816 
C PM1-B02 236.516 211.220 209.955 156.905 138.324 131.226 212.780 189.246 103.321 177.779 177.983 142.509 
C PM1-B03 210.745 147.296 146.320 161.575 133.720 120.101 112.500 113.183 82.274 94.466 113.720 77.020 
C PM1-B04 4.589 -7.330 -3.214 -0.122 -4.076 -2.812 3.050 0.183 -0.099 -1.275 -2.601 -4.904 
C PM1-B05 292.233 290.274 288.182 216.776 237.013 219.259 282.005 274.286 227.104 250.759 266.679 213.230 
C PM1-B06 301.589 292.374 294.604 225.409 248.554 224.046 285.282 284.932 240.789 276.405 283.451 216.333 
C PM1-B07 208.853 213.496 210.010 96.216 116.664 93.525 207.004 177.822 105.737 165.067 195.411 111.458 
C PM1-B08 242.786 190.076 195.857 204.086 183.771 171.134 194.387 184.447 152.320 204.467 200.436 143.457 
C PM1-B09 8.624 -1.492 -0.086 4.503 -6.278 -2.543 85.530 0.992 0.138 3.533 1.651 1.825 
C PM1-B10 72.570 90.757 78.026 -5.771 -2.329 0.403 8.195 13.230 0.097 1.938 9.842 6.596 
C PM1-B11 224.943 187.486 194.759 137.768 108.242 111.591 171.203 168.376 82.026 197.683 150.679 136.724 
C PM1-B12 68.588 76.179 55.338 62.912 82.192 90.726 137.732 133.289 137.988 13.807 124.067 18.720 
C PM1-C01 260.664 249.316 240.900 220.117 212.755 199.447 254.759 263.343 227.571 240.076 261.934 194.120 
C PM1-C02 48.946 118.237 117.133 0.284 1.005 -2.307 0.104 1.767 -3.214 -1.354 -2.133 -0.103 
C PM1-C03 202.671 216.174 201.872 177.388 159.433 137.899 190.914 179.005 136.212 4.307 247.880 3.836 
C PM1-C04 218.421 171.712 168.029 174.987 144.312 139.836 154.822 148.120 100.616 183.468 187.746 97.167 
C PM1-C05 49.307 45.971 23.326 8.905 4.489 10.839 12.801 8.346 5.841 4.739 6.933 8.642 
C PM1-C06 2.054 -6.151 -1.367 -2.237 -8.070 -3.624 3.470 -2.738 -2.525 -2.828 -1.841 -3.892 
C PM1-C07 120.701 58.826 64.508 79.913 52.370 61.076 186.318 159.091 76.389 220.229 144.541 151.151 
C PM1-C08 193.379 160.957 161.138 113.049 102.834 114.853 139.628 124.705 82.374 137.882 151.916 87.482 
C PM1-C09 176.970 99.007 115.584 85.746 53.350 59.462 224.408 196.166 71.659 213.571 174.557 162.949 
C PM1-C10 208.180 155.657 162.913 173.616 162.661 161.334 205.725 179.722 160.012 189.782 199.507 156.158 
C PM1-C11 2.659 -7.974 -6.992 0.022 -5.943 -4.357 84.626 -1.849 -0.380 -2.224 0.624 -2.063 
C PM1-C12 42.786 19.500 20.496 11.458 0.350 6.138 1.484 11.196 13.107 13.707 7.188 11.307 
C PM1-D01 192.583 187.875 169.132 154.275 129.886 128.361 9.817 8.287 148.975 2.663 103.457 0.205 
C PM1-D02 -1.546 -8.368 -6.075 -6.984 -9.787 -9.424 -3.036 -10.766 -3.447 -6.758 -10.609 -13.279 
C PM1-D03 0.904 -4.408 -7.175 -3.245 -8.914 -5.817 1.612 -3.395 -0.245 -3.789 -4.225 -8.375 
C PM1-D04 3.843 0.251 4.491 3.103 -1.051 -1.624 4.889 2.650 -1.608 0.939 4.592 0.822 
C PM1-D05 106.316 4.674 118.725 -0.328 -1.014 -0.870 4.445 3.950 1.025 -0.942 1.217 0.578 
C PM1-D06 0.005 -7.545 -4.566 -6.112 -7.522 -6.874 1.879 -1.220 -5.036 -3.964 -9.222 -4.228 
C PM1-D07 0.272 -5.789 -7.878 -6.605 -8.149 -11.078 -4.718 3.197 -8.232 -3.330 -1.299 -5.497 
C PM1-D08 2.124 -7.179 1.314 -1.957 -2.129 -3.954 3.883 1.143 -2.733 -3.876 -0.992 -1.145 
C PM1-D09 203.461 116.243 138.660 -2.500 -6.442 -2.845 1.789 0.557 -0.953 0.829 1.193 1.407 
C PM1-D10 90.712 122.411 80.599 0.134 -3.201 -1.783 3.872 2.464 1.668 0.686 0.113 -4.101 
C PM1-D11 111.366 68.858 79.520 79.405 64.463 71.200 207.958 143.382 60.322 174.809 86.155 147.410 
C PM1-D12 158.414 150.678 153.528 39.620 20.712 21.962 144.024 124.174 41.292 83.617 136.028 31.461 
C PM1-E01 56.732 62.997 20.966 5.676 8.482 6.624 6.528 53.154 106.855 3.545 89.401 5.584 
C PM1-E02 -1.070 -2.562 -2.862 -5.188 -2.211 -8.500 -0.930 0.225 -2.675 -8.321 -8.043 -1.347 
C PM1-E03 258.734 254.450 250.682 207.187 195.982 190.928 253.762 235.328 193.595 223.129 248.471 185.716 
C PM1-E04 246.358 235.766 233.250 187.483 196.397 183.096 258.391 244.387 199.704 220.537 254.901 135.305 
C PM1-E05 14.482 5.634 7.464 27.249 4.743 28.817 7.625 8.578 4.539 3.130 11.492 1.829 
C PM1-E06 18.229 20.754 -5.682 -3.392 -4.878 -2.182 8.228 4.997 -2.041 1.947 0.084 -2.855 
C PM1-E07 2.842 -8.454 -0.593 -0.887 -5.676 -5.564 0.609 0.745 -2.766 -1.509 -2.004 -3.861 
C PM1-E08 208.886 132.305 150.013 182.275 157.529 155.555 193.567 190.892 159.505 192.682 176.257 138.218 
C PM1-E09 2.849 0.976 -0.789 -1.914 -8.813 -7.399 2.257 2.705 -3.564 -0.155 2.017 -4.870 
C PM1-E10 169.264 98.225 110.663 143.363 127.538 128.174 191.792 159.907 130.422 190.428 169.634 139.701 
C PM1-E11 224.818 224.801 231.818 121.275 131.200 133.020 200.750 191.437 121.782 181.137 194.845 139.207 
C PM1-E12 233.875 231.226 224.045 126.228 136.720 109.512 236.863 208.037 143.195 191.362 212.401 136.118 
C PM1-F01 215.928 194.618 192.146 92.704 83.592 97.579 191.304 16.622 38.392 20.128 178.766 13.864 
C PM1-F02 -2.395 -6.904 -2.045 -3.589 -3.134 -5.724 1.896 -3.982 -1.100 -6.184 -9.836 -8.259 
C PM1-F03 2.954 76.620 1.467 215.187 220.780 202.538 242.091 218.986 197.404 220.105 240.278 191.329 
C PM1-F04 0.409 -9.493 -6.205 -2.196 -8.167 -6.082 3.170 -4.192 0.536 -3.789 -7.757 -8.076 
C PM1-F05 246.484 260.901 239.008 177.589 170.076 110.815 42.109 21.083 155.938 3.654 27.105 2.759 
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C PM1-F06 131.317 121.233 121.243 52.467 28.437 -0.378 3.900 73.403 52.876 1.183 105.816 0.237 
C PM1-F07 -3.200 -8.238 -6.449 6.495 -3.780 -9.079 2.588 0.925 -1.112 0.822 3.929 -6.934 
C PM1-F08 3.441 -1.024 1.270 1.654 1.214 -2.553 -2.139 2.661 0.442 0.826 6.375 0.474 
C PM1-F09 -1.070 -2.696 -9.886 -4.407 -8.366 -5.534 -4.295 -4.047 -4.329 -6.207 -6.197 -7.439 
C PM1-F10 -4.728 -9.846 -5.589 -4.451 -5.372 -7.003 -9.161 -2.942 -6.586 -4.695 -2.911 -7.832 
C PM1-F11 200.979 151.621 164.954 147.455 134.616 129.005 183.676 171.095 118.855 171.130 179.690 127.735 
C PM1-F12 222.025 215.132 227.580 79.664 95.016 81.447 186.547 179.491 117.062 180.424 183.278 127.030 
C PM1-G01 161.858 140.783 132.726 94.113 127.093 105.617 130.611 115.337 84.855 99.676 149.724 56.808 
C PM1-G02 -1.700 -3.057 -2.516 -5.451 -2.922 -4.451 0.816 -0.632 -4.159 -1.671 -1.441 -6.296 
C PM1-G03 275.480 269.484 265.546 184.238 212.125 201.120 262.463 249.742 224.174 243.280 260.899 198.788 
C PM1-G04 2.021 -2.509 -1.804 20.045 1.109 27.195 3.620 3.926 45.403 0.988 -0.307 -3.179 
C PM1-G05 188.217 187.704 188.710 91.826 79.745 79.626 177.689 161.100 135.155 140.301 161.792 131.428 
C PM1-G06 153.349 163.438 139.703 117.095 107.917 101.040 142.672 130.771 105.701 125.588 152.766 107.493 
C PM1-G07 7.843 0.762 4.750 4.421 3.950 5.205 2.149 6.100 2.020 2.967 3.789 1.620 
C PM1-G08 238.850 231.224 239.439 213.174 216.525 205.396 229.687 231.812 184.976 220.921 234.486 197.307 
C PM1-G09 73.941 38.395 29.055 43.491 32.000 15.042 14.271 9.174 17.396 10.647 24.113 6.082 
C PM1-G10 213.525 193.962 189.749 140.216 121.899 132.945 201.913 192.164 141.628 170.509 189.950 118.196 
C PM1-G11 1.841 2.491 1.612 1.055 2.312 0.463 -0.338 2.732 2.426 -1.970 -4.178 0.343 
C PM1-G12 232.237 240.071 228.122 183.451 173.880 158.120 188.845 185.821 166.749 41.950 238.621 10.413 
C PM1-H01 177.061 159.684 152.147 137.889 160.524 147.657 227.857 196.172 188.199 195.671 212.283 172.714 
C PM1-H02 2.654 1.342 2.979 -0.462 2.875 -0.821 94.688 9.586 2.499 0.325 5.324 1.738 
C PM1-H03 -2.028 0.428 0.317 0.296 -0.296 -5.263 131.853 9.445 4.001 -0.218 -1.724 -5.779 
C PM1-H04 2.080 7.314 3.737 -2.126 4.441 -0.700 5.333 3.417 4.158 -1.245 3.561 1.271 
C PM1-H05 11.886 6.453 7.900 2.979 6.096 2.575 0.499 5.136 4.757 -0.254 0.043 2.741 
C PM1-H06 31.442 2.022 4.642 3.908 -0.300 -3.692 -2.587 -7.930 -1.130 -2.300 -1.575 -4.601 
C PM1-H07 14.878 -2.236 4.293 11.078 3.796 1.161 -0.780 4.087 2.743 10.392 7.054 1.964 
C PM1-H08 239.428 240.089 241.874 143.795 175.682 145.436 236.333 241.818 199.788 184.316 251.008 143.707 
C PM1-H09 4.289 1.017 4.814 4.296 5.084 1.207 2.129 5.292 4.228 2.378 12.146 5.634 
C PM1-H10 253.942 250.847 260.285 203.979 218.941 216.903 245.039 247.797 239.274 246.408 249.561 222.618 
C PM1-H11 -1.345 -1.134 2.116 -3.558 3.141 -3.250 -2.478 2.271 3.711 -1.153 8.046 4.313 
C PM1-H12 -1.774 2.711 1.474 -4.511 0.049 -4.057 -3.461 3.107 2.446 -3.024 5.055 2.803 
C PM2-AA01 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
C PM2-AA02 -4.030 -8.268 -8.393 -2.882 -2.705 -4.283 -7.175 -6.688 -5.455 3.453 -7.305 -4.884 
C PM2-AA03 -3.608 -2.251 -4.446 -0.516 -1.305 -3.113 -2.345 -5.796 -3.608 2.643 -7.445 -5.066 
C PM2-AA04 -3.767 -3.163 -4.151 -1.987 -1.609 -2.780 -3.651 -5.612 -4.267 1.900 -6.633 -6.026 
C PM2-AA05 -4.263 -5.033 -10.083 -2.792 -2.012 -5.028 -5.645 -9.436 -5.022 -1.255 -8.380 -6.847 
C PM2-AA06 84.113 68.784 48.717 37.413 41.446 34.183 40.901 7.401 32.172 70.026 42.251 3.570 
C PM2-AA07 -4.289 -5.196 -9.259 -3.574 -4.401 -3.951 -8.046 -8.087 -6.908 -4.720 -10.857 -5.825 
C PM2-AA08 1.304 -0.576 -1.991 -2.793 -1.336 -1.055 -1.186 -5.608 -1.743 5.083 -9.297 -6.266 
C PM2-AA09 -4.476 -7.682 -5.775 -2.143 -1.324 -2.184 -3.971 -10.668 -3.920 -3.263 -10.550 -8.114 
C PM2-AA10 -7.659 -9.803 -7.070 -3.145 -2.168 -7.501 -4.359 -9.909 -6.668 -1.842 -12.332 -6.864 
C PM2-AA11 -3.193 -1.345 -3.772 -3.033 -2.666 -1.943 -2.200 -8.655 -2.237 2.183 -9.703 -7.782 
C PM2-AA12 176.596 157.680 129.262 94.907 113.217 96.012 201.807 160.011 104.447 30.587 175.884 87.991 
C PM2-AB01 171.041 174.616 191.495 -4.203 -2.136 -2.876 167.903 151.432 143.399 168.296 144.942 130.468 
C PM2-AB02 241.600 246.405 243.889 185.030 206.486 182.668 236.112 219.287 210.128 223.542 227.770 187.729 
C PM2-AB03 -7.157 -9.030 -11.143 -7.830 -9.433 -10.793 -10.172 -13.784 -12.589 -2.733 -13.689 -13.642 
C PM2-AB04 4.792 0.738 -6.534 -4.184 -2.839 -4.112 -5.214 -11.182 -6.447 -3.258 -11.154 -9.388 
C PM2-AB05 -8.080 -7.347 -10.511 -6.057 -5.197 -7.920 -9.391 -15.375 -10.505 -0.772 -12.218 -11.311 
C PM2-AB06 259.628 252.371 254.628 -6.722 -5.959 -6.609 -6.737 -11.676 -9.305 -1.430 -14.500 -8.783 
C PM2-AB07 -5.503 -7.434 -7.579 -6.195 -8.121 -8.017 -5.096 -15.211 -9.616 -2.157 -14.117 -9.991 
C PM2-AB08 194.016 190.438 199.961 135.978 136.563 157.158 38.659 7.476 2.832 5.762 -2.807 -3.088 
C PM2-AB09 132.229 114.605 125.655 109.992 112.372 89.586 174.718 85.866 57.663 119.925 154.543 105.616 
C PM2-AB10 -13.439 -13.664 -14.936 -9.788 -9.662 -13.896 -9.982 -16.588 -12.204 -6.874 -19.558 -13.437 
C PM2-AB11 -9.664 -9.147 -11.433 -6.283 -8.514 -7.996 -10.168 -13.951 -8.095 -5.346 -15.672 -10.946 
C PM2-AB12 200.166 201.497 194.883 12.466 8.143 15.305 9.742 1.541 2.114 28.141 -1.271 7.220 
C PM2-AC01 125.987 126.261 124.750 124.547 112.450 115.466 204.958 187.463 177.218 200.283 201.737 144.384 
C PM2-AC02 -4.653 -4.514 -9.197 -5.543 -7.084 -8.786 -6.961 -11.955 -8.366 -1.418 -10.049 -6.687 
C PM2-AC03 -5.147 -7.275 -9.809 -5.455 -9.629 -8.562 -7.293 -13.876 -8.754 -1.842 -14.384 -14.755 
C PM2-AC04 -5.974 -7.903 -10.957 -5.982 -6.704 -6.787 -7.454 -13.529 -8.193 -1.530 -13.589 -11.932 
C PM2-AC05 -5.801 -7.455 -7.409 -4.341 -9.880 -6.042 -4.732 -10.637 -6.553 -0.317 -11.316 -8.891 
C PM2-AC06 -7.238 -6.963 -9.838 -9.421 -9.534 -9.334 -10.822 -12.462 -10.276 0.533 -15.599 -12.032 
C PM2-AC07 90.151 106.462 84.850 -3.091 -2.899 -3.491 1.386 -3.509 1.346 1.676 -8.014 -7.403 
C PM2-AC08 -4.339 -4.687 -7.137 -5.962 -8.884 -8.376 -7.846 -11.571 -10.967 -1.276 -14.122 -9.346 
C PM2-AC09 -8.334 -9.972 -13.882 -8.978 -11.393 -12.009 -8.051 -15.539 -13.253 -4.134 -17.767 -14.687 
C PM2-AC10 -11.954 -11.379 -13.968 -10.649 -9.363 -12.447 -9.524 -16.803 -11.912 -5.758 -18.675 -12.253 
C PM2-AC11 -7.538 -1.525 -9.247 -5.934 -4.711 -7.187 -8.063 -10.299 -9.339 -2.484 -14.432 -8.888 
C PM2-AC12 -6.859 -4.755 -7.418 -5.124 -4.287 -3.736 -3.076 -9.955 -3.486 0.766 -15.296 -5.970 
C PM2-AD01 55.949 83.774 42.850 -3.132 -3.822 -5.403 -2.888 -9.970 -5.195 1.878 -10.579 -8.983 
C PM2-AD02 213.626 214.393 219.499 -6.159 -4.207 -6.387 -0.704 -11.020 -8.101 1.251 -10.379 -10.518 
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C PM2-AD03 -5.505 -4.546 -8.216 -5.712 -4.816 -4.668 -6.347 -9.621 -8.433 -0.586 -8.632 -8.663 
C PM2-AD04 161.620 165.739 170.645 115.897 118.236 101.391 158.566 123.836 115.480 123.340 122.493 87.286 
C PM2-AD05 -8.207 -7.603 -10.432 -3.793 -6.464 -8.033 -10.317 -10.003 -8.150 -0.543 -12.987 -9.108 
C PM2-AD06 -4.207 -2.096 -4.841 -5.286 -4.674 -5.692 -5.001 -7.150 -7.542 2.045 -6.842 -5.709 
C PM2-AD07 -2.518 -9.987 -11.263 -3.389 -8.512 -5.842 -6.450 -12.678 -4.530 0.796 -10.567 -10.184 
C PM2-AD08 -6.091 -9.770 -10.933 -6.392 -6.566 -8.053 -6.587 -10.253 -8.013 -2.668 -11.937 -9.139 
C PM2-AD09 -7.525 -9.499 -12.866 -7.411 -10.496 -8.075 -8.029 -13.195 -12.338 -2.143 -16.672 -10.850 
C PM2-AD10 -7.543 -7.386 -9.667 -8.164 -8.504 -8.737 -7.147 -13.467 -8.958 -3.688 -15.250 -8.561 
C PM2-AD11 -9.529 -9.611 -10.613 -8.559 -5.564 -12.454 -10.811 -13.391 -10.799 -2.824 -15.403 -9.547 
C PM2-AD12 -4.093 -5.176 -8.763 0.651 -0.030 -2.900 -5.272 -12.261 -5.061 1.558 -8.526 -3.911 
C PM2-AE01 -11.563 -9.364 -22.391 -16.491 -12.083 -16.639 -17.833 -13.649 -14.696 -7.538 -17.779 -15.443 
C PM2-AE02 -2.020 -3.533 -5.378 -2.847 -6.058 -3.762 -3.334 -4.884 -14.187 4.717 -7.607 -8.282 
C PM2-AE03 -4.034 -1.757 -5.912 -5.422 -4.222 -8.836 -4.453 -7.746 -8.583 -0.728 -7.443 -9.709 
C PM2-AE04 -7.028 -6.933 -7.630 -6.632 -8.457 -8.964 -6.286 -8.186 -12.241 -1.426 -6.611 -13.826 
C PM2-AE05 220.189 229.026 234.767 185.068 204.612 194.866 225.476 213.812 215.143 214.036 223.161 189.596 
C PM2-AE06 -9.579 -11.017 -13.242 -7.479 -9.079 -11.520 -12.512 -16.439 -14.907 -3.596 -15.983 -13.283 
C PM2-AE07 -6.876 -5.720 -8.776 -6.800 -5.180 -8.687 -6.542 -12.263 -12.714 -2.046 -12.095 -9.033 
C PM2-AE08 -6.062 -1.829 -7.134 -6.342 -6.059 -9.526 -7.312 -12.621 -9.291 0.146 -11.842 -8.583 
C PM2-AE09 -7.030 -3.997 -7.653 -5.163 -8.172 -9.491 -7.336 -9.322 -8.471 -1.100 -9.546 -5.892 
C PM2-AE10 -8.593 -8.347 -10.707 -6.536 -3.962 -11.989 -7.511 -14.126 -11.153 -3.075 -15.587 -11.412 
C PM2-AE11 -11.699 -11.404 -23.445 -10.225 -16.689 -12.711 -14.475 -18.568 -9.662 -2.405 -20.230 -14.899 
C PM2-AE12 199.638 188.380 194.180 103.034 117.379 121.055 218.175 183.068 146.968 160.259 172.609 158.288 
C PM2-AF01 0.747 2.909 -2.516 -1.758 -1.559 -2.109 1.447 -2.943 -5.621 6.214 -2.361 -1.928 
C PM2-AF02 -1.324 -0.821 -5.959 -0.271 3.647 -2.654 -5.013 -5.030 -8.099 4.297 -4.163 -6.041 
C PM2-AF03 1.145 -0.011 -4.375 -3.746 -7.757 -7.078 108.522 -10.716 -5.703 3.008 -7.654 -6.871 
C PM2-AF04 -4.718 -2.234 -7.734 -5.770 -3.525 -5.458 -8.084 -8.254 -6.099 0.045 -6.855 -8.493 
C PM2-AF05 -4.589 -4.247 -6.649 -4.117 -4.868 -1.747 -6.670 -12.146 -7.012 -2.553 -7.416 -11.616 
C PM2-AF06 -3.520 -4.504 -8.741 -5.788 -5.034 -9.357 -6.464 -10.513 -9.463 -1.563 -8.754 -8.384 
C PM2-AF07 -5.664 -1.713 -8.516 -4.887 -4.457 -5.514 -8.468 -9.147 -9.930 1.105 -10.087 -7.034 
C PM2-AF08 -4.896 -6.557 -12.197 -9.246 -7.825 -10.705 -4.153 -16.007 -13.738 -0.650 -12.251 -14.064 
C PM2-AF09 -3.726 -8.339 -8.814 -7.218 -9.099 -9.483 -6.438 -11.661 -11.274 -1.263 -14.416 -10.642 
C PM2-AF10 31.155 47.866 21.967 23.347 27.474 17.200 14.225 -5.979 14.142 -4.200 2.921 -5.551 
C PM2-AF11 -9.280 -4.542 -8.229 -7.463 -5.750 -6.884 -11.221 -8.778 -8.817 -1.884 -14.501 -6.461 
C PM2-AF12 -0.637 1.991 -1.604 1.459 0.514 2.730 -1.767 -2.575 -5.083 5.107 -8.880 1.113 
C PM2-AG01 -0.966 -2.857 -4.370 -4.868 2.539 -1.888 -6.162 -3.495 -4.129 1.000 -3.041 -3.682 
C PM2-AG02 -0.184 -0.889 -2.307 -3.012 -4.832 -5.764 3.787 -2.391 -6.068 64.716 -0.839 -7.200 
C PM2-AG03 -7.745 -0.621 -9.089 -3.564 -6.804 -5.474 -5.679 -18.117 -9.921 2.064 -7.576 -8.886 
C PM2-AG04 -4.195 -4.301 -7.151 -3.871 -3.905 -7.786 -5.724 -11.159 -7.267 0.939 -11.407 -10.841 
C PM2-AG05 -4.632 -5.700 -7.241 -8.745 -6.564 -6.789 -6.045 -11.500 -11.407 1.626 -10.196 -12.030 
C PM2-AG06 205.472 251.191 215.575 44.820 65.678 56.500 -0.357 97.570 146.709 3.475 125.930 -11.974 
C PM2-AG07 -8.400 -4.196 -10.653 -8.158 -7.582 -9.734 -11.211 -14.387 -12.005 -1.139 -15.964 -9.230 
C PM2-AG08 -5.279 -5.243 -8.133 -4.446 -3.751 -6.925 -4.204 -11.449 -5.729 3.784 -11.082 -9.189 
C PM2-AG09 -5.829 -10.149 -11.936 -6.526 -5.800 -7.284 -11.211 -13.625 -9.472 -2.554 -12.037 -10.839 
C PM2-AG10 -14.782 -20.379 -17.521 -5.808 -8.333 -6.861 -14.683 -26.279 -8.146 -5.379 -18.267 -8.813 
C PM2-AG11 -7.305 -6.612 -7.445 -4.937 -5.409 -5.784 -8.086 -11.124 -6.442 -3.441 -14.904 -6.971 
C PM2-AG12 -7.074 -3.374 -3.016 -1.553 0.566 -1.141 -4.717 -8.384 -1.407 4.593 -9.880 0.629 
C PM2-AH01 0.795 1.282 -4.974 -0.818 -3.562 -5.417 -0.346 -1.492 -3.022 2.364 -5.525 -5.033 
C PM2-AH02 1.804 2.949 -1.278 -0.276 -4.580 -2.386 -1.520 -8.658 1.914 5.626 -4.850 -3.833 
C PM2-AH03 5.808 4.659 0.195 3.561 1.683 -0.817 -1.041 -1.561 -1.332 9.271 -4.812 -4.282 
C PM2-AH04 0.984 -2.830 -4.289 -3.751 -5.297 -3.504 -5.164 -5.891 0.204 5.743 -4.303 -6.354 
C PM2-AH05 -4.429 -0.883 -4.559 -6.897 0.408 -3.684 -5.843 -8.516 -4.272 -0.607 -7.324 -8.992 
C PM2-AH06 -8.143 -7.067 -13.016 -2.745 -7.493 -9.758 -12.634 -14.839 -12.799 0.549 -11.455 -16.837 
C PM2-AH07 -1.136 0.466 -0.203 -0.530 2.284 -2.536 -0.289 -1.825 -0.082 4.929 -4.296 -4.939 
C PM2-AH08 2.080 1.636 -9.158 -1.609 12.557 -5.976 -0.087 -6.730 1.292 2.129 -5.295 -6.171 
C PM2-AH09 -11.184 -18.337 -9.995 -10.637 -13.282 -17.012 -14.700 8.251 -15.466 -5.150 -25.574 2.845 
C PM2-AH10 -7.128 -4.532 -8.916 -2.209 -5.472 -4.426 -5.564 -10.024 -2.438 1.603 -11.038 -6.082 
C PM2-AH11 1.699 -0.083 -2.720 2.505 1.814 -0.647 -2.943 -12.826 -3.097 4.401 -12.154 -0.145 
C PM2-AH12 2.757 4.589 3.855 2.971 4.554 -0.678 3.167 -3.274 0.358 5.043 -4.941 -3.696 
N PM3-BA01 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
N PM3-BA02 229.267 231.834 221.362 115.321 128.717 109.933 196.847 208.853 174.132 191.216 201.893 148.771 
N PM3-BA03 8.424 10.351 24.266 7.496 2.279 8.916 7.370 2.399 2.964 2.120 3.914 -0.346 
N PM3-BA04 12.258 5.925 5.892 1.825 -0.983 2.457 12.053 5.572 3.714 5.537 3.536 -0.825 
N PM3-BA05 244.296 250.391 234.711 105.335 106.484 84.716 184.004 213.971 149.730 160.884 205.879 111.811 
N PM3-BA06 3.149 1.408 0.761 -2.791 -7.055 -5.487 20.011 2.176 -2.200 0.599 -1.709 -3.276 
N PM3-BA07 234.904 234.387 228.783 116.053 140.055 112.147 192.301 209.433 188.767 172.126 205.260 148.236 
N PM3-BA08 226.804 225.266 211.930 121.407 129.401 108.368 146.808 151.687 138.900 111.926 162.287 96.443 
N PM3-BA09 256.011 261.001 261.284 217.472 224.754 222.343 229.305 228.316 219.867 185.650 246.305 192.324 
N PM3-BA10 267.053 275.892 262.553 222.835 238.580 229.550 253.667 243.185 223.863 230.828 251.049 213.784 
N PM3-BA11 270.136 261.661 268.571 20.355 284.349 280.904 67.601 276.488 274.117 270.684 277.157 260.636 
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N PM3-BA12 220.151 224.312 216.001 188.060 201.047 203.780 203.634 171.829 191.896 127.210 185.313 118.129 
N PM3-BB01 247.001 234.417 245.291 201.087 200.367 207.368 225.962 226.722 210.932 210.764 230.967 183.603 
N PM3-BB02 194.325 190.395 186.763 80.071 70.300 54.984 149.954 127.783 103.188 95.389 150.404 58.524 
N PM3-BB03 255.350 250.421 246.432 182.412 192.971 177.216 238.730 209.846 199.643 180.150 220.628 82.688 
N PM3-BB04 45.514 58.003 64.130 10.711 17.546 8.629 22.497 7.738 11.263 6.421 19.138 2.489 
N PM3-BB05 128.980 123.318 121.695 10.591 7.833 4.374 80.357 91.239 22.712 57.530 107.879 21.626 
N PM3-BB06 11.339 13.343 9.158 -5.103 -8.811 -8.245 2.537 0.547 -3.847 -3.833 -1.158 -6.568 
N PM3-BB07 130.651 136.630 118.395 76.354 85.739 62.229 46.575 61.645 46.800 6.530 78.866 -3.437 
N PM3-BB08 120.064 122.704 116.425 46.000 41.232 37.087 38.405 22.132 28.841 0.405 46.705 0.467 
N PM3-BB09 150.611 164.278 151.203 131.385 143.512 124.303 166.813 163.458 168.936 107.668 165.854 109.512 
N PM3-BB10 224.437 229.861 219.447 154.407 160.149 139.991 215.267 213.295 187.872 201.732 213.437 182.480 
N PM3-BB11 97.901 136.407 119.453 55.741 63.638 64.411 51.079 88.371 66.897 3.878 100.145 6.243 
N PM3-BB12 43.597 140.845 24.279 68.905 73.186 64.014 -2.175 0.396 0.264 -4.887 1.843 2.695 
N PM3-BC01 -17.313 -17.409 -19.088 -9.376 -26.143 -22.383 -17.351 -17.978 -22.497 -12.412 -24.442 -27.728 
N PM3-BC02 40.155 54.782 49.100 12.422 25.695 6.908 7.486 22.938 20.978 3.551 30.462 0.508 
N PM3-BC03 198.241 203.822 194.645 128.864 142.212 110.413 174.841 144.185 162.242 77.267 157.504 76.188 
N PM3-BC04 127.761 125.671 116.353 38.403 50.868 33.389 8.600 3.349 3.564 0.508 2.343 -4.612 
N PM3-BC05 -4.891 -5.751 -5.907 -9.603 -8.493 -9.645 -6.263 -3.663 -6.655 -8.372 -5.845 -7.895 
N PM3-BC06 -13.608 -11.493 -10.295 -9.600 -11.611 -8.489 -9.047 -7.179 -8.471 -10.907 -9.779 -10.047 
N PM3-BC07 -5.291 -4.983 -3.087 -4.801 -7.100 -5.905 -4.317 -3.671 -4.363 -6.432 -7.459 -7.109 
N PM3-BC08 203.561 198.287 221.396 -6.066 -7.372 -5.151 -7.645 -0.862 -4.763 -3.296 -3.816 -3.225 
N PM3-BC09 -0.357 0.721 3.404 -1.954 -1.361 1.964 -1.930 -2.093 0.903 -5.287 -4.729 -5.350 
N PM3-BC10 9.113 13.707 11.197 -1.171 0.947 1.753 0.638 -0.751 -2.282 -5.572 -1.266 -3.901 
N PM3-BC11 -0.767 2.971 2.868 -1.655 -2.359 3.721 2.247 2.570 14.825 -1.147 1.838 -0.832 
N PM3-BC12 81.571 119.576 76.972 10.205 18.908 19.463 30.482 26.599 37.162 25.486 42.246 26.609 
N PM3-BD01 -7.775 -6.717 -3.678 -0.425 -2.254 0.684 -1.424 -3.412 0.900 -4.934 -6.217 -4.112 
N PM3-BD02 -10.703 -7.797 -6.271 -5.738 -6.111 -5.857 -5.604 -5.208 -8.967 -5.508 -7.275 -6.922 
N PM3-BD03 1.182 7.349 6.000 3.533 9.284 8.643 2.095 18.333 56.093 -0.918 47.792 -1.950 
N PM3-BD04 -5.926 -6.120 -4.321 -3.071 -4.726 -1.813 -1.264 -4.433 -1.283 -4.264 -6.662 -5.707 
N PM3-BD05 -11.747 -11.254 -11.592 -10.667 -11.726 -11.750 -10.253 -9.671 -10.455 -11.349 -10.221 -8.900 
N PM3-BD06 -9.137 -7.779 -7.288 -7.057 -8.970 -7.979 -6.257 -5.495 -7.391 -8.989 -7.088 -8.562 
N PM3-BD07 -4.601 -3.617 -1.645 -5.005 -5.379 -4.132 -3.779 -3.537 -0.886 -7.003 -5.412 -5.297 
N PM3-BD08 -5.186 -4.142 -1.695 -5.876 -6.457 -4.255 -5.447 -4.072 -3.491 -5.645 -5.575 -5.779 
N PM3-BD09 -2.278 -4.745 -2.016 -4.678 -5.828 -2.764 -3.978 -3.593 -2.912 -5.967 -4.143 -5.484 
N PM3-BD10 -8.537 -7.222 -3.212 -6.338 -3.266 -0.230 -0.708 -5.443 -0.513 -5.075 -6.880 -5.432 
N PM3-BD11 -9.946 -6.201 -4.570 -8.111 -4.770 -2.075 -2.288 -3.638 -3.882 -6.214 -4.396 -4.909 
N PM3-BD12 -5.732 -1.786 -0.239 -2.672 0.451 6.918 9.729 -1.143 3.675 -3.275 -0.171 0.541 
N PM3-BE01 -7.384 -7.892 -4.851 -2.037 -3.053 -0.661 -0.700 -2.325 -2.151 -4.583 -5.661 -3.812 
N PM3-BE02 -9.261 -6.420 -5.120 -4.307 -5.408 -4.937 -3.442 -4.718 -6.211 -6.758 -6.726 -6.012 
N PM3-BE03 -7.103 -4.355 -1.647 -3.050 -4.541 -4.667 -2.733 -2.867 -5.392 -5.293 -5.051 -5.007 
N PM3-BE04 -4.862 -6.355 -2.283 -3.353 -4.345 -2.151 -2.454 -2.313 -1.971 -5.293 -5.728 -5.370 
N PM3-BE05 -5.520 -3.775 -0.463 -2.576 -2.003 2.496 2.659 -2.946 3.167 -2.124 -4.186 -4.659 
N PM3-BE06 1.675 37.995 39.243 11.839 36.476 24.729 3.767 11.588 37.279 6.913 33.416 2.233 
N PM3-BE07 186.483 192.587 181.737 -3.036 -4.543 -2.645 40.607 131.799 140.792 41.811 132.867 71.121 
N PM3-BE08 212.559 178.724 204.001 145.191 135.601 126.074 219.958 184.834 149.532 188.432 192.200 167.297 
N PM3-BE09 -6.151 -7.783 -2.649 -3.637 -3.803 -2.163 -1.945 -3.700 -1.233 -4.743 -6.200 -4.462 
N PM3-BE10 -11.628 -7.789 -6.816 -6.978 -6.341 -2.271 -2.345 -6.478 -0.571 -7.374 -8.108 -6.634 
N PM3-BE11 81.864 83.641 85.046 80.614 78.634 40.987 203.524 171.637 20.425 186.867 170.093 164.775 
N PM3-BE12 116.980 144.559 138.961 -4.529 -2.926 2.225 185.283 158.942 48.558 201.555 169.284 153.362 
N PM3-BF01 160.178 167.407 169.228 143.738 160.400 147.682 196.414 163.137 127.899 161.417 182.276 168.263 
N PM3-BF02 -11.925 -17.022 -16.800 -5.253 -20.212 -12.445 -3.557 -12.166 -11.339 -10.976 -13.228 -7.322 
N PM3-BF03 232.649 232.334 235.349 186.666 201.917 192.072 227.030 225.495 203.201 214.182 232.667 196.938 
N PM3-BF04 262.188 260.393 264.663 202.088 213.946 209.576 264.713 250.355 227.530 238.472 243.296 206.818 
N PM3-BF05 26.566 33.299 39.358 34.780 50.878 31.096 1.286 -2.830 1.633 -4.076 -5.678 -5.007 
N PM3-BF06 -7.503 -8.686 9.868 -6.517 -2.225 -3.579 3.357 -6.187 -8.962 2.392 -8.833 -8.180 
N PM3-BF07 -6.900 -13.882 -9.741 -23.397 -18.687 -21.324 -3.661 -1.582 -12.287 -19.661 -25.003 -21.537 
N PM3-BF08 -3.900 -0.695 5.301 9.241 14.512 11.442 1.782 -4.239 5.325 -2.733 -4.762 -3.562 
N PM3-BF09 11.936 12.153 15.879 26.180 42.683 36.103 -1.263 -3.388 0.026 -4.208 -5.030 -3.793 
N PM3-BF10 -0.122 -0.566 5.614 6.318 9.287 9.263 -0.326 -5.600 -0.036 -4.937 -5.709 -6.242 
N PM3-BF11 5.093 2.966 8.161 15.518 28.693 20.609 0.368 -4.811 0.013 -5.049 -5.749 -4.486 
N PM3-BF12 -8.408 -5.809 -3.268 -4.909 -3.417 0.001 -3.170 -4.788 -5.038 -5.459 -3.250 -5.347 
N PM3-BG01 16.086 25.880 49.124 38.329 51.676 42.301 25.004 7.289 2.021 0.430 3.384 3.450 
N PM3-BG02 30.061 66.441 75.593 34.841 46.445 27.287 53.353 3.900 -0.383 4.387 5.739 0.937 
N PM3-BG03 42.891 44.738 51.359 8.074 13.466 7.738 25.576 -18.108 13.259 11.483 14.188 -5.447 
N PM3-BG04 2.222 20.730 28.971 -10.817 -0.539 -1.534 -8.213 0.061 -0.651 0.136 -0.425 -0.182 
N PM3-BG05 18.064 31.039 34.395 -0.397 0.836 2.204 5.691 4.541 5.709 2.046 2.949 2.697 
N PM3-BG06 6.542 30.336 32.846 3.536 8.576 14.163 12.234 3.039 12.796 3.772 2.559 2.832 
N PM3-BG07 135.647 151.072 120.501 29.226 50.822 24.483 59.413 101.007 91.701 102.792 129.683 89.440 
N PM3-BG08 78.613 102.480 113.499 46.841 72.826 51.311 103.407 28.116 47.032 18.720 70.445 8.092 
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N PM3-BG09 71.400 68.758 99.978 45.924 63.795 51.714 97.172 11.578 36.839 8.188 48.457 5.622 
N PM3-BG10 -22.226 63.738 60.813 -6.516 19.501 9.339 -6.179 48.709 36.400 39.433 67.392 37.872 
N PM3-BG11 -1.888 -3.324 2.089 -2.545 0.804 3.943 1.142 -3.618 1.401 -5.189 -4.324 -2.832 
N PM3-BG12 90.707 96.747 73.607 12.020 28.282 8.639 37.821 48.083 27.049 27.480 48.387 17.537 
N PM3-BH01 255.661 258.078 255.558 235.605 226.807 232.179 244.353 229.755 223.279 230.489 240.943 208.203 
N PM3-BH02 255.439 257.039 254.549 233.830 232.986 237.488 242.246 239.364 213.350 219.700 235.766 186.961 
N PM3-BH03 267.121 261.945 261.837 246.993 235.889 242.178 246.612 232.163 214.690 216.989 239.764 193.236 
N PM3-BH04 238.042 234.471 234.516 174.434 191.588 156.057 220.538 215.355 195.737 203.397 215.971 172.603 
N PM3-BH05 233.564 241.458 240.551 85.534 116.218 72.513 212.901 209.875 177.832 197.066 219.099 156.809 
N PM3-BH06 191.786 190.587 195.028 35.559 71.217 40.875 113.051 166.722 81.730 162.934 172.310 169.217 
N PM3-BH07 226.434 232.549 225.700 119.276 147.786 131.947 205.360 204.549 188.443 193.350 204.126 185.433 
N PM3-BH08 253.689 257.287 262.670 223.283 226.626 235.434 252.067 232.072 224.951 231.160 245.947 207.417 
N PM3-BH09 250.718 249.621 262.222 205.005 215.826 230.007 249.824 228.407 215.096 233.074 238.574 188.368 
N PM3-BH10 212.459 218.068 225.055 176.050 197.607 202.538 229.459 196.834 200.032 184.880 205.318 157.480 
N PM3-BH11 189.479 199.892 191.497 157.458 185.117 162.108 183.849 171.058 167.941 161.821 183.779 155.312 
N PM3-BH12 175.339 177.297 165.995 96.542 135.014 111.375 169.728 151.255 133.986 142.395 154.121 127.382 
P PM4-AA01 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
P PM4-AA02 169.771 151.013 142.095 71.012 57.632 57.047 86.080 117.215 86.551 141.657 76.458 89.299 
P PM4-AA03 176.870 127.400 132.272 29.771 33.168 31.166 73.180 105.661 66.651 113.853 69.074 82.437 
P PM4-AA04 175.101 154.185 149.204 63.163 46.413 44.607 91.442 109.372 82.078 148.013 91.097 101.859 
P PM4-AA05 158.262 138.125 112.416 42.437 41.912 15.708 83.071 109.250 81.516 143.863 85.343 105.230 
P PM4-AA06 0.638 70.146 1.183 6.379 4.858 -2.658 -11.484 23.678 4.437 1.488 8.740 1.933 
P PM4-AA07 40.462 86.457 36.201 23.367 9.446 17.993 18.233 25.055 -22.188 17.407 14.821 0.364 
P PM4-AA08 188.903 168.974 167.263 76.759 64.079 44.000 117.312 134.178 112.571 177.226 113.259 154.004 
P PM4-AA09 193.157 167.993 171.367 144.795 133.583 152.942 130.762 140.592 128.822 162.033 122.666 147.880 
P PM4-AA10 195.662 29.278 -55.947 -23.376 136.788 164.628 140.730 136.779 -19.400 173.558 117.591 141.986 
P PM4-AA11 175.901 153.693 -60.689 129.051 128.957 131.025 140.155 132.547 111.179 158.225 102.305 130.915 
P PM4-AA12 172.274 146.246 146.992 119.078 116.240 118.988 122.474 119.912 90.091 153.130 87.872 115.950 
P PM4-AB01 141.986 128.941 118.842 43.516 37.083 51.007 77.862 95.665 82.309 134.307 69.147 102.616 
P PM4-AB02 184.989 142.654 133.267 76.991 74.055 67.804 81.586 105.225 96.943 140.713 84.343 107.279 
P PM4-AB03 188.987 166.732 173.688 138.464 131.296 128.671 126.796 124.280 129.088 167.309 109.017 127.395 
P PM4-AB04 170.038 150.083 142.899 130.403 133.130 134.828 95.325 112.021 113.489 141.854 89.724 111.642 
P PM4-AB05 167.928 159.449 153.458 73.358 71.840 61.616 85.775 116.138 100.399 146.970 98.975 121.478 
P PM4-AB06 170.325 164.107 151.928 67.507 59.868 51.362 94.905 112.997 96.466 141.162 94.592 127.075 
P PM4-AB07 162.272 145.925 151.158 65.154 48.643 50.351 86.253 113.568 95.054 137.089 88.653 127.661 
P PM4-AB08 198.228 189.118 192.080 159.629 159.962 172.578 135.628 145.157 159.768 179.276 124.240 167.051 
P PM4-AB09 196.692 166.224 170.084 128.051 123.826 127.026 138.317 124.355 115.926 163.716 106.897 137.104 
P PM4-AB10 180.408 156.299 161.774 119.849 125.109 127.612 123.328 124.166 112.800 152.247 104.388 143.429 
P PM4-AB11 161.580 135.026 143.292 108.357 109.013 105.204 108.120 103.115 96.183 131.778 78.107 124.751 
P PM4-AB12 161.814 138.074 138.863 112.299 108.580 106.041 118.305 104.037 89.239 134.297 76.142 113.987 
P PM4-AC01 160.741 142.263 141.432 58.232 33.918 49.026 82.557 102.486 75.562 134.337 81.924 94.009 
P PM4-AC02 156.783 143.017 129.967 57.558 63.716 47.128 81.637 102.265 84.804 131.351 79.984 109.904 
P PM4-AC03 198.455 174.930 184.367 147.111 145.250 156.414 133.442 136.953 133.899 178.766 112.178 153.429 
P PM4-AC04 -33.116 189.057 195.974 159.387 158.829 171.301 127.550 148.721 144.012 182.755 127.993 142.053 
P PM4-AC05 -43.782 -62.450 -56.796 -34.496 -46.871 -32.782 -84.195 -85.870 -72.649 -35.949 -103.054 -35.004 
P PM4-AC06 218.637 199.409 202.796 173.054 168.605 179.604 149.925 154.718 156.493 195.863 136.996 190.561 
P PM4-AC07 187.546 165.962 190.197 103.111 98.966 106.574 114.816 127.965 117.974 160.814 105.142 151.175 
P PM4-AC08 214.082 175.826 174.657 148.200 129.345 121.271 147.395 145.429 132.691 179.304 128.709 161.190 
P PM4-AC09 208.482 188.193 -5.517 166.092 161.887 183.034 155.633 146.313 150.155 181.101 110.670 2.980 
P PM4-AC10 -53.953 -54.075 -57.214 141.713 143.376 152.004 126.382 134.313 -65.659 163.803 91.042 156.136 
P PM4-AC11 165.318 149.397 152.339 139.524 134.409 148.308 117.845 116.595 109.275 149.249 86.668 131.592 
P PM4-AC12 178.737 156.151 164.099 150.443 131.666 146.554 130.474 129.004 93.358 155.030 92.125 121.603 
P PM4-AD01 182.311 166.707 176.084 144.950 124.405 139.428 -79.309 127.046 110.591 158.296 109.255 140.924 
P PM4-AD02 193.318 174.988 181.758 133.583 137.830 145.586 100.679 126.918 119.109 161.987 116.592 149.142 
P PM4-AD03 159.467 141.251 132.180 69.466 64.032 53.834 90.822 117.449 98.814 147.057 93.883 109.967 
P PM4-AD04 163.013 151.439 143.476 82.986 78.745 51.950 84.724 118.924 99.703 143.480 98.851 140.520 
P PM4-AD05 177.836 165.179 160.246 65.221 59.940 57.130 59.512 104.263 71.818 138.396 89.550 113.157 
P PM4-AD06 186.453 169.229 158.424 97.176 89.058 78.863 99.436 126.465 119.688 157.897 99.649 156.949 
P PM4-AD07 183.764 164.859 155.439 92.853 86.266 89.108 108.470 124.170 110.225 156.328 103.722 163.807 
P PM4-AD08 211.716 190.347 183.880 158.443 -22.224 56.339 -76.228 147.507 -49.147 179.711 118.471 109.384 
P PM4-AD09 189.434 188.307 184.501 161.854 121.743 159.838 142.974 152.863 133.287 184.996 119.042 165.596 
P PM4-AD10 -37.411 166.842 177.183 112.257 140.337 145.661 -74.699 132.857 117.509 165.820 107.418 153.436 
P PM4-AD11 181.116 155.251 168.392 136.345 134.315 135.828 133.771 122.141 101.447 160.849 92.324 136.040 
P PM4-AD12 185.525 159.697 169.699 128.207 123.812 126.901 132.422 138.618 94.808 166.251 95.586 120.030 
P PM4-AE01 180.497 160.776 155.392 67.754 48.826 35.917 94.944 118.567 90.532 -32.691 92.179 117.408 
P PM4-AE02 168.238 160.741 -19.067 -26.250 -17.109 32.379 85.883 105.346 85.963 135.932 84.947 124.679 
P PM4-AE03 171.230 140.921 139.332 48.786 57.805 57.101 91.703 116.116 101.034 143.842 84.668 126.688 
P PM4-AE04 167.168 139.897 133.380 39.575 51.088 45.583 64.055 103.515 75.759 127.967 71.693 118.020 
P PM4-AE05 173.305 162.484 156.238 68.704 65.532 60.511 91.601 120.453 101.617 145.297 94.225 136.413 
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P PM4-AE06 138.951 120.834 130.096 -4.822 -35.978 0.428 7.940 58.238 25.535 77.525 47.200 80.609 
P PM4-AE07 168.742 165.884 150.872 90.645 88.654 76.009 34.104 115.022 94.479 99.647 84.915 86.212 
P PM4-AE08 30.241 34.609 35.971 51.280 10.839 -0.745 6.144 23.840 4.236 3.661 14.820 36.014 
P PM4-AE09 177.717 166.597 146.934 118.805 120.271 106.979 110.065 126.492 105.137 157.559 93.601 141.396 
P PM4-AE10 183.034 170.041 170.250 127.850 125.738 136.170 131.757 133.518 124.004 158.386 99.096 146.483 
P PM4-AE11 116.292 78.814 57.211 22.391 14.614 11.996 16.763 44.879 19.976 41.212 21.965 40.862 
P PM4-AE12 168.721 150.424 145.276 113.659 102.649 91.151 118.732 113.813 108.214 145.083 80.379 111.383 
S PM4-AF01 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
S PM4-AF02 201.892 212.070 156.468 104.555 111.920 91.537 169.459 194.714 169.449 176.132 179.867 145.058 
S PM4-AF03 218.338 215.709 164.388 115.062 135.220 112.782 177.713 209.803 187.345 195.114 191.328 157.213 
S PM4-AF04 209.433 221.001 173.284 111.133 124.529 100.472 182.434 198.475 171.189 175.259 195.680 155.063 
S PM4-AF05 202.439 207.549 137.380 101.279 117.343 91.891 176.859 183.150 133.268 137.291 186.479 89.280 
S PM4-AF06 211.268 223.201 164.865 124.850 131.055 112.843 183.842 207.013 180.955 185.279 197.820 151.692 
S PM4-AF07 190.209 207.488 145.786 135.701 121.097 117.346 186.112 204.976 167.728 181.643 203.397 146.304 
S PM4-AF08 197.688 215.026 160.245 95.645 110.691 92.008 180.011 204.813 179.272 182.222 198.225 166.037 
S PM4-AF09 173.325 203.530 138.392 131.867 144.567 122.972 174.776 197.854 178.003 177.799 193.640 164.405 
S PM4-AF10 -5.416 -2.020 -44.941 -5.078 -0.555 1.072 1.125 4.768 2.299 -2.279 -2.358 -0.866 
S PM4-AF11 4.867 8.259 -38.721 0.526 3.571 5.322 7.733 11.811 6.853 -0.889 12.001 -1.497 
S PM4-AF12 174.599 183.018 133.028 78.801 90.520 74.347 142.538 177.578 146.255 154.154 158.408 114.725 
S PM4-AG01 -0.034 0.492 -42.401 0.017 -0.601 -0.325 -0.575 2.382 -1.709 0.400 0.436 -0.267 
S PM4-AG02 144.496 157.539 72.561 14.726 12.536 11.037 36.678 36.295 22.370 12.555 36.772 9.262 
S PM4-AG03 213.179 210.196 163.778 118.122 124.858 97.582 183.704 206.429 171.084 190.037 194.343 161.086 
S PM4-AG04 219.522 218.209 166.280 130.904 138.810 110.220 184.036 211.461 186.771 190.900 198.570 167.780 
S PM4-AG05 224.939 108.299 9.030 43.261 52.968 45.713 192.778 34.947 35.642 7.742 37.176 -1.299 
S PM4-AG06 48.518 66.325 3.809 0.704 -1.939 1.946 65.617 104.633 23.911 78.160 99.061 83.520 
S PM4-AG07 210.822 214.196 163.763 126.507 133.126 115.307 187.084 206.296 154.639 182.407 193.699 147.103 
S PM4-AG08 195.808 196.134 134.475 80.905 91.124 87.404 155.655 188.838 117.692 149.512 182.253 142.038 
S PM4-AG09 204.400 211.664 171.507 135.837 144.058 128.353 194.475 204.662 178.942 183.460 194.346 144.490 
S PM4-AG10 197.667 214.575 164.150 113.778 133.697 110.825 182.353 198.679 149.717 172.388 179.675 136.188 
S PM4-AG11 185.571 196.441 154.888 110.997 120.989 106.947 174.549 200.316 159.314 163.437 173.263 147.916 
S PM4-AG12 -7.349 -6.607 -51.654 -4.972 -4.693 -3.176 -2.874 1.001 -0.884 -1.253 -3.311 -3.582 
S PM4-AH01 179.675 193.851 133.603 65.882 68.696 63.163 141.809 183.928 99.768 163.578 190.909 119.515 
S PM4-AH02 42.480 85.532 173.187 30.596 42.113 32.645 27.528 31.136 23.400 34.925 47.359 22.454 
S PM4-AH03 41.471 3.414 -43.459 4.632 0.849 1.695 47.811 3.807 -2.747 5.138 2.845 3.904 
S PM4-AH04 19.962 27.491 -29.754 19.770 21.975 17.605 17.588 26.612 20.558 7.986 39.953 15.009 
S PM4-AH05 34.705 32.113 -19.372 10.793 25.893 11.689 24.625 22.158 15.096 13.433 22.653 12.095 
S PM4-AH06 135.885 134.778 59.678 14.305 23.572 8.033 56.043 97.163 31.521 81.101 79.876 71.770 
S PM4-AH07 103.414 116.996 48.015 20.811 31.099 23.537 58.300 89.329 40.255 79.308 60.666 69.120 
S PM4-AH08 13.593 11.553 -39.808 6.603 5.074 5.697 2.370 6.950 7.678 5.704 6.118 3.904 
S PM4-AH09 -10.230 2.228 -43.397 2.555 2.522 1.196 1.872 7.516 3.567 5.137 2.405 1.093 
S PM4-AH10 -1.095 -1.324 -43.926 -5.497 2.688 -0.959 2.433 3.025 2.030 2.649 -3.055 0.689 
S PM4-AH11 -4.654 -4.782 -47.017 -4.726 -1.034 -1.187 -2.678 -0.396 0.213 -0.016 -3.630 -3.916 
S PM4-AH12 -6.896 -5.213 -44.375 -5.551 1.204 -2.603 -0.788 -0.555 1.022 -2.078 -5.601 -4.636 
              
  
BT 3 O:5,27 BT 4 O:3 BT 5 O:2a,2b,3 
   
 
well 14902_1 14902_2 14902_3 1203_1 1203_2 1203_3 3094_1 3094_2 3094_3 
   C PM1-A01 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
   C PM1-A02 191.763 180.437 171.599 248.688 227.921 230.820 91.213 51.400 50.911 
   C PM1-A03 81.895 72.968 40.004 170.624 115.474 104.292 90.553 90.889 90.832 
   C PM1-A04 -0.063 -7.708 -2.250 -8.832 -4.942 -2.005 1.587 0.000 0.000 
   C PM1-A05 20.217 12.604 7.271 28.301 8.432 8.711 168.197 114.390 104.534 
   C PM1-A06 245.749 225.503 224.664 281.925 264.450 272.850 145.934 113.079 118.176 
   C PM1-A07 7.511 7.789 5.374 9.392 8.008 7.446 144.818 99.782 86.321 
   C PM1-A08 8.266 6.093 3.584 0.722 4.741 1.008 1.608 1.029 0.000 
   C PM1-A09 2.768 2.078 -1.257 -5.929 -4.904 -4.841 9.787 3.229 0.000 
   C PM1-A10 93.118 67.850 64.383 143.111 101.662 114.182 0.000 0.503 0.000 
   C PM1-A11 61.709 46.438 35.436 118.388 74.233 81.093 109.083 94.889 97.292 
   C PM1-A12 6.258 11.263 10.836 58.889 2.692 3.304 11.729 11.086 2.489 
   C PM1-B01 3.999 0.854 5.150 165.604 -4.074 0.993 1.133 0.755 0.000 
   C PM1-B02 123.761 104.984 87.593 160.212 118.886 118.501 4.171 3.229 1.011 
   C PM1-B03 98.879 95.393 77.364 174.705 123.021 148.220 84.584 62.903 62.876 
   C PM1-B04 2.295 -1.912 -1.045 -3.232 -4.492 -4.009 0.000 0.000 0.000 
   C PM1-B05 242.643 179.788 166.942 269.642 244.167 257.245 112.932 98.113 81.784 
   C PM1-B06 271.707 218.561 211.862 200.468 86.075 106.887 48.537 39.111 40.268 
   C PM1-B07 170.484 137.267 168.772 185.067 179.174 186.757 75.682 59.976 47.505 
   C PM1-B08 105.146 123.625 98.808 -4.704 -4.675 -5.711 94.442 57.650 56.916 
   C PM1-B09 2.995 0.984 1.384 -0.843 -3.472 -3.261 0.000 0.000 0.000 
   C PM1-B10 5.375 5.286 5.074 -2.005 4.679 2.153 0.000 0.000 0.000 
   C PM1-B11 89.390 65.630 50.475 134.130 102.093 97.986 97.645 79.311 64.687 
   
248 
C PM1-B12 9.561 13.346 14.801 131.707 115.463 136.234 20.599 27.186 19.089 
   C PM1-C01 253.249 185.212 181.246 241.478 211.797 231.790 11.459 10.528 9.221 
   C PM1-C02 3.663 -0.979 -1.137 -4.732 0.812 -3.695 0.000 0.000 0.000 
   C PM1-C03 8.724 5.075 17.366 4.263 4.267 0.446 89.150 63.755 58.103 
   C PM1-C04 79.347 84.125 75.199 195.251 180.771 159.059 60.682 44.988 44.924 
   C PM1-C05 11.851 5.917 9.478 5.526 5.616 2.543 4.066 3.818 2.542 
   C PM1-C06 1.905 -5.372 -0.743 -7.239 -4.267 -7.503 0.000 0.000 0.000 
   C PM1-C07 52.005 46.637 40.762 95.757 64.314 60.955 49.705 45.432 37.979 
   C PM1-C08 53.343 74.926 84.972 122.792 105.537 110.513 38.045 39.634 37.129 
   C PM1-C09 56.530 47.100 37.664 106.904 65.732 72.895 79.187 64.426 46.916 
   C PM1-C10 150.180 137.159 133.837 193.632 175.118 177.161 5.705 7.132 1.005 
   C PM1-C11 -0.555 -0.557 1.904 -2.095 -6.679 -7.245 0.000 0.000 0.000 
   C PM1-C12 20.587 13.414 17.336 13.913 9.059 13.264 37.383 32.325 19.753 
   C PM1-D01 7.078 0.947 1.313 7.934 4.874 0.096 44.333 27.970 20.343 
   C PM1-D02 -3.987 -4.386 -4.439 -4.745 -9.737 -14.016 0.000 0.505 0.000 
   C PM1-D03 2.045 -3.978 -0.814 83.716 -6.945 -6.757 0.000 0.000 0.000 
   C PM1-D04 1.763 -0.793 -0.658 -0.700 -0.217 -3.774 0.000 0.000 0.000 
   C PM1-D05 3.911 2.286 -1.276 -1.184 -1.512 -2.211 0.000 0.000 0.000 
   C PM1-D06 -0.224 -2.022 -5.957 -5.621 -5.817 -8.896 0.000 0.000 0.000 
   C PM1-D07 -1.567 -0.293 -6.532 -8.026 -3.874 -1.258 0.000 0.000 0.000 
   C PM1-D08 0.692 0.862 -1.080 56.884 -2.555 -5.179 0.000 0.000 0.000 
   C PM1-D09 -1.400 -0.647 5.061 -2.600 -6.170 -7.938 3.221 3.082 0.000 
   C PM1-D10 1.430 1.137 -0.413 -0.701 -0.517 -1.724 4.550 4.189 0.000 
   C PM1-D11 128.849 130.186 111.221 94.272 60.288 57.475 56.661 49.461 52.184 
   C PM1-D12 59.651 69.145 69.774 185.062 135.718 112.276 47.820 44.580 33.305 
   C PM1-E01 6.163 0.766 2.441 7.822 6.613 8.792 2.854 3.737 1.824 
   C PM1-E02 -3.547 0.383 0.564 -7.488 -0.646 -6.125 0.000 0.000 0.000 
   C PM1-E03 226.509 185.351 184.972 250.266 239.974 244.562 113.237 89.368 80.787 
   C PM1-E04 211.538 88.720 170.958 253.454 215.241 225.707 0.000 0.000 0.000 
   C PM1-E05 1.741 5.470 3.514 -0.063 3.795 -4.521 0.000 0.000 0.000 
   C PM1-E06 2.789 -2.789 0.863 -3.587 -0.291 -3.036 0.000 0.000 0.000 
   C PM1-E07 -2.405 -3.322 -3.113 -6.170 -5.805 -5.762 0.000 0.000 0.000 
   C PM1-E08 118.975 118.812 96.018 222.768 161.568 156.816 0.000 0.000 0.000 
   C PM1-E09 1.725 -6.416 0.650 -0.262 -2.886 -5.497 0.000 0.000 0.000 
   C PM1-E10 128.600 112.471 111.188 187.186 156.047 157.166 18.311 16.582 9.984 
   C PM1-E11 167.987 169.829 173.762 208.043 207.017 199.067 88.595 56.468 59.000 
   C PM1-E12 222.786 225.061 223.034 233.712 216.914 224.371 129.980 104.309 103.136 
   C PM1-F01 25.300 8.307 12.270 170.401 143.313 141.668 14.878 16.639 10.679 
   C PM1-F02 -1.395 -5.887 -3.546 -2.425 -3.374 -4.305 0.000 0.000 0.000 
   C PM1-F03 192.125 193.014 190.626 130.459 114.850 142.458 10.689 9.405 5.703 
   C PM1-F04 -1.612 -4.264 -2.216 -5.332 -5.116 -6.800 0.000 0.000 0.000 
   C PM1-F05 4.237 3.566 -0.257 -0.922 0.418 -1.621 118.750 86.074 69.061 
   C PM1-F06 0.757 -1.434 -2.724 -1.183 -1.978 -4.699 57.521 39.037 30.329 
   C PM1-F07 -2.343 -2.636 -6.655 3.929 -1.887 -6.203 0.000 0.000 0.000 
   C PM1-F08 -2.249 2.320 -2.366 -5.293 0.433 -3.234 0.000 0.000 0.000 
   C PM1-F09 -2.616 -4.170 -2.872 -12.432 -6.354 -8.075 0.000 0.000 0.000 
   C PM1-F10 -6.754 -1.841 -5.242 -6.496 -3.686 -8.358 0.000 0.000 0.000 
   C PM1-F11 132.738 128.247 116.138 143.032 129.767 123.051 103.766 85.433 65.676 
   C PM1-F12 155.280 167.291 174.488 215.782 197.564 190.429 124.090 96.182 80.770 
   C PM1-G01 80.182 68.333 73.670 110.776 99.334 102.862 14.550 8.568 6.732 
   C PM1-G02 2.880 -1.682 -0.083 173.288 -1.803 -5.489 0.000 0.000 0.000 
   C PM1-G03 226.791 212.900 210.161 240.321 239.567 244.382 128.732 113.868 109.997 
   C PM1-G04 2.516 0.714 0.609 5.700 5.158 -5.716 8.539 3.729 2.529 
   C PM1-G05 53.320 91.346 47.561 133.976 122.392 109.162 19.274 6.776 4.308 
   C PM1-G06 99.834 110.420 107.338 123.251 121.372 112.237 15.374 16.292 15.132 
   C PM1-G07 -2.426 5.191 2.013 -3.382 2.450 -1.917 6.147 0.000 0.000 
   C PM1-G08 195.690 178.717 190.683 223.388 223.957 204.190 76.547 59.058 47.976 
   C PM1-G09 7.770 8.895 3.563 2.318 7.922 2.874 46.918 42.382 34.382 
   C PM1-G10 172.963 131.386 128.232 193.228 155.701 164.082 54.642 53.453 46.845 
   C PM1-G11 2.230 4.339 4.364 -6.271 2.871 -1.318 3.539 4.063 0.886 
   C PM1-G12 11.195 34.547 28.892 67.567 24.937 35.451 138.122 114.908 102.386 
   C PM1-H01 163.753 158.768 139.293 189.801 187.383 167.980 99.171 77.916 55.614 
   C PM1-H02 7.212 4.150 3.687 3.543 3.413 0.304 2.047 2.521 -0.433 
   C PM1-H03 5.667 -0.068 2.559 0.297 -0.363 -13.236 6.368 5.867 0.725 
   C PM1-H04 5.363 3.788 2.989 86.639 4.043 4.789 1.784 2.066 0.264 
   C PM1-H05 6.525 4.117 4.553 0.849 7.128 3.076 4.033 3.643 0.550 
   C PM1-H06 -1.438 -0.059 -0.636 -3.933 -3.380 -4.476 -4.297 -2.057 -3.705 
   C PM1-H07 8.370 5.979 6.658 1.179 6.946 2.345 12.262 8.592 3.671 
   C PM1-H08 112.350 107.814 117.218 177.047 187.363 187.343 66.111 53.405 54.839 
   
249 
C PM1-H09 3.014 5.463 4.312 -0.712 5.962 0.864 4.201 4.479 0.000 
   C PM1-H10 211.090 206.628 216.346 247.755 227.932 238.630 114.328 107.280 93.709 
   C PM1-H11 -0.393 3.639 6.571 0.267 2.796 0.628 6.208 9.012 4.737 
   C PM1-H12 1.888 4.182 2.980 -11.988 1.109 -2.572 7.188 8.050 3.971 
   C PM2-AA01 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
   C PM2-AA02 -3.401 -3.495 -3.949 -2.245 -5.422 -6.005 0.000 0.505 1.587 
   C PM2-AA03 -1.651 -3.647 -0.601 -1.045 -5.276 -4.689 0.000 0.000 0.000 
   C PM2-AA04 -4.695 -3.612 -2.047 -3.034 -5.671 -5.358 0.000 0.000 1.133 
   C PM2-AA05 -6.349 -5.021 -4.132 -3.517 -7.967 -8.039 0.000 0.000 0.000 
   C PM2-AA06 21.405 10.274 10.242 41.074 2.139 6.449 9.282 9.839 9.711 
   C PM2-AA07 -5.158 -4.880 -5.987 -7.575 -6.578 -7.316 0.000 0.000 0.000 
   C PM2-AA08 -4.880 -2.962 -2.038 -1.954 -5.128 -5.529 0.000 0.000 1.016 
   C PM2-AA09 -6.929 -3.568 -3.791 -6.580 -12.062 -7.664 0.000 0.000 0.000 
   C PM2-AA10 -7.805 -10.150 -3.984 -5.250 -14.182 -7.075 0.505 0.000 3.450 
   C PM2-AA11 -4.687 -3.580 -1.605 -2.991 -5.338 -4.789 1.133 0.388 1.589 
   C PM2-AA12 132.471 87.495 86.693 155.650 159.637 120.025 49.370 40.067 45.863 
   C PM2-AB01 107.791 93.739 92.567 167.209 175.200 182.253 0.000 0.000 0.000 
   C PM2-AB02 211.784 174.055 170.901 219.074 204.268 204.975 74.774 61.150 47.189 
   C PM2-AB03 -9.742 -8.866 -9.437 -8.014 -9.705 -13.420 0.000 0.000 0.000 
   C PM2-AB04 -5.612 -4.237 -4.404 -6.283 -8.046 -8.341 0.000 0.000 0.000 
   C PM2-AB05 -9.288 -9.450 -6.341 -4.711 -10.172 -10.325 0.000 0.000 0.000 
   C PM2-AB06 -8.836 -7.530 -6.534 -8.614 -7.328 -9.464 0.000 0.000 0.000 
   C PM2-AB07 -10.742 -8.457 -8.420 -6.886 -12.647 -12.270 0.000 0.000 0.000 
   C PM2-AB08 8.389 6.632 8.354 43.276 50.824 38.955 0.000 0.000 0.000 
   C PM2-AB09 -12.309 -13.247 -8.107 -6.346 -14.607 -9.239 0.000 0.000 0.000 
   C PM2-AB10 -14.818 -8.693 -10.100 -12.292 -11.918 -13.155 0.000 0.000 0.000 
   C PM2-AB11 -8.742 -8.241 -7.670 -9.512 -9.975 -12.546 0.000 0.000 0.000 
   C PM2-AB12 3.978 7.336 6.305 4.667 3.280 -3.074 6.245 3.329 7.786 
   C PM2-AC01 157.390 126.680 112.536 187.963 168.518 186.634 0.000 0.000 0.000 
   C PM2-AC02 -8.675 -7.271 -7.211 -5.434 -9.132 -8.729 0.000 0.000 0.000 
   C PM2-AC03 -8.997 -9.333 -8.108 -9.376 -10.551 -11.291 0.000 0.000 0.000 
   C PM2-AC04 -8.254 -9.680 -7.057 -9.633 -9.984 -10.953 0.000 0.000 0.000 
   C PM2-AC05 -9.649 -6.974 -4.905 -7.907 -11.547 -10.830 0.000 0.000 0.000 
   C PM2-AC06 -11.146 -10.317 -8.943 -8.657 -11.853 -12.629 0.000 0.000 0.000 
   C PM2-AC07 -7.911 -5.579 -2.529 -2.228 -2.068 -4.336 9.282 0.000 0.000 
   C PM2-AC08 -9.586 -6.495 -6.464 -7.329 -9.759 -13.446 0.000 0.000 0.000 
   C PM2-AC09 -13.243 -9.454 -7.524 -8.386 -12.786 -13.533 0.000 0.000 0.000 
   C PM2-AC10 -13.070 -8.795 -8.122 -12.212 -12.143 -11.661 0.000 0.000 0.000 
   C PM2-AC11 -9.925 -5.689 -6.047 -8.068 -5.825 -10.774 0.000 0.000 0.000 
   C PM2-AC12 -4.484 -3.225 -2.404 -3.620 -6.696 -7.422 6.432 3.771 11.821 
   C PM2-AD01 -3.488 -5.403 -3.253 -3.064 -7.739 -8.161 1.011 2.953 1.058 
   C PM2-AD02 -6.778 -7.499 -7.034 -5.813 -8.757 -9.245 0.000 0.000 0.000 
   C PM2-AD03 -7.037 -6.776 -6.680 -5.717 -5.142 -9.399 0.000 0.000 0.000 
   C PM2-AD04 124.192 115.782 102.041 122.018 109.134 118.765 33.453 18.574 24.732 
   C PM2-AD05 -12.451 -10.746 -8.336 -9.254 -11.811 -11.913 0.000 0.000 0.000 
   C PM2-AD06 -7.716 -6.099 -5.393 -3.937 -6.995 -8.768 0.000 0.000 0.000 
   C PM2-AD07 -7.475 -10.650 -5.384 5.325 -11.333 -10.108 0.000 0.000 0.000 
   C PM2-AD08 -10.453 -9.224 -8.055 -6.726 -8.179 -10.174 0.000 0.000 0.000 
   C PM2-AD09 -11.441 -7.143 -7.139 -5.763 -10.342 -11.729 0.000 0.000 0.000 
   C PM2-AD10 -10.453 -6.396 -8.175 -7.353 -9.061 -9.688 0.000 0.000 0.000 
   C PM2-AD11 -15.142 -8.063 -8.255 -6.704 -9.095 -13.974 0.000 0.000 0.000 
   C PM2-AD12 -8.709 -2.389 -1.392 -2.476 -6.961 -8.876 1.008 1.912 5.149 
   C PM2-AE01 -18.336 -12.741 -12.047 -13.666 -19.766 -23.768 1.654 -0.066 2.626 
   C PM2-AE02 -1.395 -4.921 -1.661 -3.028 -10.761 -14.150 0.000 0.000 0.000 
   C PM2-AE03 -7.782 -4.861 -7.863 -4.353 -7.459 -7.533 0.000 0.000 0.000 
   C PM2-AE04 -12.400 -9.116 -8.593 -4.541 -8.371 -11.375 0.000 0.000 0.000 
   C PM2-AE05 72.595 57.013 48.062 190.467 186.547 196.622 62.211 68.892 61.211 
   C PM2-AE06 -13.645 -10.937 -12.384 -11.234 -14.042 -14.866 0.000 0.000 0.000 
   C PM2-AE07 -9.614 -7.001 -7.407 -3.382 -6.551 -9.357 0.000 0.000 0.000 
   C PM2-AE08 -10.997 -5.861 -7.789 -4.646 -3.839 -9.825 0.000 0.000 0.000 
   C PM2-AE09 -7.501 -5.084 -4.461 -4.384 -4.126 -8.211 0.000 0.000 0.000 
   C PM2-AE10 -10.401 -6.067 -6.611 -6.580 -9.179 -9.396 0.000 0.000 0.000 
   C PM2-AE11 -13.258 -13.859 -7.850 -10.741 -16.114 -16.692 0.000 0.000 0.000 
   C PM2-AE12 169.597 154.522 169.114 2.922 -2.008 -2.664 14.591 11.309 17.016 
   C PM2-AF01 -1.107 -1.055 1.333 1.162 -1.096 -3.501 0.000 0.000 0.000 
   C PM2-AF02 -5.537 -4.695 -3.988 -2.483 -4.321 -6.712 0.000 0.000 0.000 
   C PM2-AF03 -9.358 -3.734 -5.780 -2.403 -6.842 -7.021 0.000 0.000 0.000 
   C PM2-AF04 -8.905 -4.761 -8.253 -3.488 -5.979 -7.807 0.000 0.000 0.000 
   C PM2-AF05 -11.291 -7.301 -6.587 -4.614 -9.864 -7.511 0.000 0.000 0.000 
   
250 
C PM2-AF06 -12.445 -7.555 -8.961 -2.216 -7.014 -9.766 0.000 0.000 0.000 
   C PM2-AF07 -8.600 -7.375 -8.872 -4.588 -6.168 -8.258 0.000 0.000 0.000 
   C PM2-AF08 -9.321 -6.671 -7.776 -3.051 -8.541 -14.036 0.000 0.000 0.000 
   C PM2-AF09 -4.701 -4.532 -8.279 -0.045 -11.426 -13.988 0.000 0.000 0.000 
   C PM2-AF10 -4.986 -2.183 -2.807 0.454 -7.196 -5.830 0.000 0.000 0.000 
   C PM2-AF11 -9.464 -4.497 -4.059 -11.337 -10.657 -11.784 0.000 0.000 0.000 
   C PM2-AF12 -8.038 0.334 -3.363 1.117 -1.909 -4.018 0.000 0.000 0.000 
   C PM2-AG01 -7.250 -3.616 -1.017 -2.841 -4.300 -3.988 0.000 0.000 0.000 
   C PM2-AG02 0.154 5.016 3.546 8.959 6.718 3.436 0.000 0.000 0.000 
   C PM2-AG03 -7.746 -5.096 -6.375 -4.038 -5.068 -7.704 0.000 0.000 0.000 
   C PM2-AG04 -9.297 -6.229 -6.816 -3.295 -5.995 -8.670 0.000 0.000 0.000 
   C PM2-AG05 -9.225 -6.407 -8.457 -8.039 -8.630 -11.424 0.000 0.000 0.000 
   C PM2-AG06 -5.651 -6.463 -7.053 22.449 6.637 26.289 0.000 0.000 0.000 
   C PM2-AG07 -13.030 -8.218 -7.916 -5.839 -11.261 -11.184 0.000 0.000 0.000 
   C PM2-AG08 -7.241 -5.795 -4.946 -3.964 -9.937 -8.643 0.000 0.000 0.000 
   C PM2-AG09 -9.829 -7.805 -7.474 -8.197 -12.108 -11.658 0.000 0.000 0.000 
   C PM2-AG10 -11.628 -7.264 -8.749 -6.543 -9.071 -13.870 0.000 0.000 0.000 
   C PM2-AG11 -11.170 -3.580 -5.736 -3.251 -6.786 -12.018 0.000 0.000 0.000 
   C PM2-AG12 -2.655 0.261 0.041 4.116 -7.255 -1.754 0.503 0.000 0.000 
   C PM2-AH01 -1.488 -4.400 -1.599 0.276 -2.261 -5.932 0.000 0.000 0.000 
   C PM2-AH02 -5.697 -2.988 0.195 -2.428 -4.038 -3.717 0.000 0.000 0.000 
   C PM2-AH03 -0.549 -0.529 0.472 1.330 -0.821 -5.771 0.000 0.000 0.000 
   C PM2-AH04 -3.408 -5.280 -3.200 -4.197 -6.333 -5.346 0.000 0.000 0.000 
   C PM2-AH05 -6.542 -2.582 -3.850 -3.638 -6.675 -6.436 0.000 0.000 0.000 
   C PM2-AH06 -14.933 -10.257 -14.750 -10.664 -12.059 -15.617 0.000 0.000 0.000 
   C PM2-AH07 -5.742 -1.449 -0.253 -0.251 -3.014 -4.989 0.000 0.000 0.000 
   C PM2-AH08 -6.383 -5.489 -1.837 0.776 -0.592 -2.321 0.000 0.000 0.000 
   C PM2-AH09 -17.825 -13.089 -10.892 -13.637 -17.711 -14.899 -2.234 -7.828 -6.912 
   C PM2-AH10 -11.055 -3.274 -2.751 -5.909 -8.213 -7.055 0.000 0.000 0.000 
   C PM2-AH11 -6.712 -6.599 -0.951 -0.199 -2.264 -3.770 0.000 0.000 0.000 
   C PM2-AH12 -5.405 0.393 -1.618 -0.070 -1.004 -2.303 1.008 0.000 1.032 
   N PM3-BA01 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
   N PM3-BA02 3.214 2.604 -1.039 76.260 87.670 81.564 2.520 0.505   
   N PM3-BA03 -5.457 -8.203 -7.330 7.789 1.591 1.884 0.000 0.000 0.000 
   N PM3-BA04 2.530 3.439 -0.318 1.942 1.717 5.099 0.000 1.008 0.000 
   N PM3-BA05 -0.071 -0.225 -0.525 88.812 83.833 73.916 0.000 0.000 0.000 
   N PM3-BA06 -1.897 -4.399 -7.591 33.075 27.350 30.286 0.000 0.000 0.000 
   N PM3-BA07 15.411 37.454 21.617 74.943 77.445 69.446 0.000 0.000 0.000 
   N PM3-BA08 10.700 33.520 9.050 65.604 75.524 72.216 0.000 0.000 0.000 
   N PM3-BA09 148.580 125.410 116.953 209.146 194.426 219.753 16.308 13.895 11.200 
   N PM3-BA10 191.047 142.234 136.449 227.370 207.401 220.829 31.018 20.958 20.134 
   N PM3-BA11 83.897 271.534 265.458 15.557 123.183 130.895 1.076 0.758 0.000 
   N PM3-BA12 11.368 42.712 19.737 196.725 209.700 203.838 19.203 15.112 22.011 
   N PM3-BB01 10.925 35.750 79.674 187.287 180.404 193.786 11.239 12.171 14.524 
   N PM3-BB02 -1.095 -0.424 -1.295 148.264 136.638 135.682 0.503 0.000 0.000 
   N PM3-BB03 94.876 106.493 87.307 203.116 197.520 206.133 0.000 0.000 0.000 
   N PM3-BB04 -1.618 1.558 -3.307 34.605 25.351 30.018 0.000 0.000 0.000 
   N PM3-BB05 -4.847 -1.789 -4.838 58.867 53.204 58.507 0.000 0.000 0.000 
   N PM3-BB06 -3.016 -4.441 -7.951 22.833 8.100 23.128 0.000 0.000 0.000 
   N PM3-BB07 2.384 -3.970 7.764 25.342 27.482 46.647 0.000 0.000 0.000 
   N PM3-BB08 -4.236 -2.304 -5.475 14.843 20.714 29.301 0.000 0.000 1.005 
   N PM3-BB09 20.412 61.350 20.705 89.749 82.811 89.843 0.000 0.000 0.000 
   N PM3-BB10 77.283 98.171 117.205 163.483 152.263 161.625 0.000 0.000 0.000 
   N PM3-BB11 0.625 12.568 2.988 38.166 57.950 61.709 0.000 0.000 0.000 
   N PM3-BB12 0.068 2.339 2.800 -3.641 -3.426 -1.883 6.814 3.305 1.599 
   N PM3-BC01 -15.729 -14.439 -28.813 -15.361 -23.208 -25.857 -12.232 -13.026 -6.820 
   N PM3-BC02 -4.268 -2.864 -4.042 -3.126 2.766 1.886 0.000 0.000 0.000 
   N PM3-BC03 -3.080 -1.279 -3.187 35.074 46.653 37.657 0.000 0.000 0.000 
   N PM3-BC04 -2.708 -1.157 -3.295 -1.374 -1.817 1.480 0.000 0.000 0.000 
   N PM3-BC05 -6.593 -7.292 -7.832 -11.658 -8.863 -9.382 0.000 0.000 0.000 
   N PM3-BC06 -10.034 -11.051 -13.059 -14.216 -9.666 -10.625 0.000 0.000 0.000 
   N PM3-BC07 -7.943 -6.467 -8.421 -9.397 -7.671 -5.824 0.000 0.000 0.000 
   N PM3-BC08 -2.543 -1.795 -4.361 -12.089 -9.733 -7.034 0.000 0.000 0.000 
   N PM3-BC09 -8.339 -3.707 -6.432 -8.233 -5.587 -3.364 0.000 0.000 0.000 
   N PM3-BC10 -3.584 -2.914 -3.487 3.564 1.945 16.597 0.758 0.000 0.000 
   N PM3-BC11 -3.011 1.034 -1.730 -5.668 -1.480 0.746 0.000 0.000 0.000 
   N PM3-BC12 1.958 8.863 3.361 8.393 13.297 18.930 7.529 2.267 1.562 
   N PM3-BD01 -4.080 -2.211 -4.338 -2.545 -1.904 -1.497 0.434 1.237 2.347 
   N PM3-BD02 -6.672 -7.247 -6.875 -7.234 -6.357 -6.872 0.886 0.000 0.000 
   
251 
N PM3-BD03 -3.613 -1.547 -4.371 -9.957 -8.313 -8.633 0.000 0.000 0.000 
   N PM3-BD04 -4.568 -5.293 -7.949 -7.571 -6.009 -4.474 0.000 0.000 0.000 
   N PM3-BD05 -11.296 -11.462 -11.975 -14.658 -12.736 -12.739 0.000 0.000 0.000 
   N PM3-BD06 -9.511 -9.033 -10.709 -12.454 -9.605 -9.154 1.513 0.000 0.000 
   N PM3-BD07 -8.458 -7.054 -9.493 -10.143 -7.612 -6.447 0.000 0.000 0.000 
   N PM3-BD08 -9.853 -7.849 -6.695 -10.863 -8.987 -6.964 0.000 0.000 0.000 
   N PM3-BD09 -7.850 -3.089 -6.793 -11.132 -7.736 -5.645 0.000 0.000 0.000 
   N PM3-BD10 -9.307 -3.087 -7.976 -11.038 -7.424 -4.759 0.758 0.503 0.000 
   N PM3-BD11 -8.101 -3.403 -6.370 -13.437 -7.655 -6.349 0.000 0.000 0.000 
   N PM3-BD12 2.995 2.779 -0.982 -4.717 -4.334 -1.764 8.805 2.158 2.393 
   N PM3-BE01 -3.468 -2.420 -4.675 -4.009 -1.891 -1.562 2.829 1.024 0.633 
   N PM3-BE02 -6.299 -5.457 -7.583 -8.721 -5.293 -5.434 0.000 0.000 0.000 
   N PM3-BE03 -5.150 -2.789 -5.787 -6.986 -3.086 -4.836 0.000 0.000 0.000 
   N PM3-BE04 -4.854 -2.105 -5.942 -6.776 -3.999 -3.546 0.000 0.000 0.000 
   N PM3-BE05 -4.220 -1.414 -6.761 -6.764 -5.418 -3.521 0.000 0.000 0.000 
   N PM3-BE06 -1.534 -0.288 -2.661 -1.709 34.759 43.171 0.000 0.000 0.000 
   N PM3-BE07 -5.426 -2.189 -5.801 0.662 -4.083 7.063 0.000 0.000 0.000 
   N PM3-BE08 22.945 15.083 10.788 155.688 99.862 100.149 0.000 0.000 0.000 
   N PM3-BE09 -7.007 -3.413 -6.042 -10.258 -8.001 -5.791 0.000 0.000 0.000 
   N PM3-BE10 -9.367 -4.667 -8.862 -12.254 -11.495 -8.972 1.438 1.391 0.000 
   N PM3-BE11 13.258 22.836 9.243 9.976 31.792 13.436 2.108 0.000 0.000 
   N PM3-BE12 12.239 15.037 33.403 33.438 40.214 31.538 4.200 0.616 1.279 
   N PM3-BF01 44.629 54.203 71.850 159.137 158.530 154.349 18.609 20.430 17.250 
   N PM3-BF02 -7.253 -14.005 -9.921 -10.283 -12.161 -13.059 1.162 1.939 0.503 
   N PM3-BF03 97.724 81.629 83.532 203.700 207.282 212.499 5.797 0.000 0.000 
   N PM3-BF04 24.972 14.761 37.278 210.474 215.101 218.675 0.000 0.000 0.000 
   N PM3-BF05 -4.788 -1.004 -4.905 -6.391 -4.237 -2.533 0.000 0.000 0.000 
   N PM3-BF06 -10.803 8.553 6.995 1.028 0.116 1.882 11.197 31.908 0.378 
   N PM3-BF07 -16.862 -8.600 -10.432 -22.251 -6.025 -20.605 -0.171 0.899 0.000 
   N PM3-BF08 -6.151 0.224 -6.876 -6.730 -7.832 -1.639 1.013 0.000 0.000 
   N PM3-BF09 -8.155 -3.370 -6.763 -6.429 -5.075 -3.324 0.000 0.000 0.000 
   N PM3-BF10 -7.387 -2.097 -8.179 -9.653 -7.870 -5.207 3.595 1.047 0.000 
   N PM3-BF11 -7.457 -0.550 -5.945 -10.679 -6.996 -4.549 1.839 0.766 0.000 
   N PM3-BF12 -9.507 -1.280 -3.824 -11.228 -4.921 -5.945 4.764 1.176 1.707 
   N PM3-BG01 1.192 7.437 -2.416 21.658 39.843 31.586 -1.587 -4.286 -4.729 
   N PM3-BG02 -2.442 -0.576 -3.722 32.434 35.316 34.878 0.000 0.000 0.000 
   N PM3-BG03 -8.174 -6.747 -1.717 15.557 7.479 15.376 1.178 0.787 1.409 
   N PM3-BG04 -11.886 -1.545 -4.433 -16.462 14.554 17.436 0.195 0.255 0.000 
   N PM3-BG05 -2.821 0.911 -4.191 -0.170 4.296 14.932 0.000 0.000 0.000 
   N PM3-BG06 -2.718 6.017 -2.470 10.184 13.863 25.847 0.000 0.000 0.000 
   N PM3-BG07 -5.309 -1.114 -6.567 -4.579 1.678 0.596 0.000 0.000 0.000 
   N PM3-BG08 -3.342 5.966 -2.559 39.961 40.471 46.245 0.000 0.000 0.000 
   N PM3-BG09 -4.504 7.833 -1.789 37.272 34.617 41.559 0.380 0.000 0.000 
   N PM3-BG10 -8.921 -8.099 -13.216 -11.597 32.679 27.226 0.592 0.680 1.021 
   N PM3-BG11 -5.450 2.341 -2.439 -4.182 -3.504 0.193 5.537 3.105 1.289 
   N PM3-BG12 -3.346 4.241 -2.529 3.375 5.257 2.526 2.638 0.859 -1.709 
   N PM3-BH01 153.988 127.255 140.574 220.393 212.479 241.221 5.342 4.114 4.378 
   N PM3-BH02 157.000 169.583 155.809 230.737 222.796 219.862 0.072 -0.976 -1.099 
   N PM3-BH03 82.588 95.342 58.428 222.287 212.357 211.597 5.917 2.599 0.318 
   N PM3-BH04 13.321 7.857 5.157 154.760 151.651 151.280 1.247 1.001 1.142 
   N PM3-BH05 1.066 4.636 2.371 198.837 195.163 207.513 2.721 0.295 0.480 
   N PM3-BH06 -1.453 6.314 0.199 51.559 52.491 35.212 -0.074 0.576 0.800 
   N PM3-BH07 1.809 11.108 3.595 78.410 100.365 98.976 4.061 1.774 0.000 
   N PM3-BH08 66.543 116.976 112.787 223.613 203.236 226.164 27.674 29.111 27.413 
   N PM3-BH09 154.589 171.649 168.205 215.274 199.122 227.526 7.078 10.775 9.161 
   N PM3-BH10 3.176 67.501 84.997 192.207 178.104 191.779 13.649 15.672 14.242 
   N PM3-BH11 148.101 193.208 154.484 117.395 126.054 134.553 4.678 3.480 1.266 
   N PM3-BH12 160.236 169.295 134.714 65.328 58.795 64.205 9.454 1.563 1.325 
   P PM4-AA01 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
   P PM4-AA02 1.833 -1.451 -1.796 28.876 49.566 28.472 0.000 0.503   
   P PM4-AA03 -8.100 -3.983 -3.333 48.263 43.112 21.932 5.416 -3.028 -2.383 
   P PM4-AA04 -4.141 -6.245 -5.141 72.668 51.743 27.496 0.000 0.000 -2.092 
   P PM4-AA05 -2.966 -2.068 -6.054 50.533 47.061 28.000 0.000 0.000 -3.100 
   P PM4-AA06 -7.416 -5.483 -5.399 35.366 16.886 3.724 0.000 0.000 -3.100 
   P PM4-AA07 -5.192 -5.779 -5.528 53.737 31.143 13.263 0.000 0.000 -3.100 
   P PM4-AA08 79.878 11.118 76.608 142.714 128.746 94.054 0.000 0.000 -3.100 
   P PM4-AA09 2.961 64.064 -10.420 150.254 138.342 137.957 0.000 1.529 -3.100 
   P PM4-AA10 128.295 -13.441 9.062 171.991 138.251 -44.620 0.000 0.000 -0.508 
   P PM4-AA11 78.501 -10.454 -11.696 173.700 134.224 127.139 5.316 8.507 4.268 
   
252 
P PM4-AA12 116.257 72.225 108.387 152.426 121.161 117.635 4.745 4.475 4.814 
   P PM4-AB01 153.253 139.814 117.189 42.171 17.172 3.707 0.000 0.000 -3.100 
   P PM4-AB02 155.691 147.236 131.634 30.845 44.633 17.063 0.000 0.000 -3.100 
   P PM4-AB03 71.584 39.787 69.897 185.683 153.341 150.558 0.000 0.000 -3.100 
   P PM4-AB04 -7.550 -7.524 -7.539 145.514 128.504 112.104 0.000 0.000 -3.100 
   P PM4-AB05 -7.787 -6.634 -6.333 76.424 54.380 35.154 0.000 0.000 -3.100 
   P PM4-AB06 -7.332 -9.682 -6.376 144.939 47.901 65.557 0.000 0.000 -3.100 
   P PM4-AB07 -10.401 -8.329 -9.013 59.984 47.036 25.662 0.000 0.000 -3.100 
   P PM4-AB08 45.968 54.401 116.072 178.476 161.093 155.083 0.000 0.000 -3.100 
   P PM4-AB09 111.197 9.807 72.122 176.326 138.757 126.225 0.000 0.000 -3.100 
   P PM4-AB10 44.603 34.545 88.418 168.266 133.847 118.422 0.000 0.000 -3.100 
   P PM4-AB11 36.779 21.987 50.168 142.538 117.476 104.697 0.000 0.000 -3.100 
   P PM4-AB12 66.301 46.818 81.196 149.766 119.530 111.557 1.011 3.299 2.301 
   P PM4-AC01 0.504 -7.028 -0.293 63.353 48.209 30.768 0.000 0.000 -3.100 
   P PM4-AC02 -5.004 -7.618 -7.399 84.089 64.949 42.555 0.000 0.000 -1.022 
   P PM4-AC03 77.170 93.295 11.189 200.322 170.576 155.272 0.000 0.000 -3.100 
   P PM4-AC04 -14.457 72.184 -7.866 160.359 154.608 127.343 0.000 0.000 -3.100 
   P PM4-AC05 -16.728 -15.180 -16.109 -15.154 -40.957 -50.413 0.000 0.000 -3.100 
   P PM4-AC06 118.199 111.345 102.521 193.542 163.750 138.772 0.000 0.000 -3.100 
   P PM4-AC07 -8.305 -9.149 -7.532 87.203 56.226 33.462 0.000 0.000 -3.100 
   P PM4-AC08 37.425 31.496 56.811 182.985 144.930 133.354 0.000 0.000 -3.100 
   P PM4-AC09 56.242 15.011 -14.243 180.695 156.453 -47.107 0.000 0.000 -3.100 
   P PM4-AC10 18.399 4.338 -14.387 143.420 106.076 99.685 0.000 0.000 -3.100 
   P PM4-AC11 28.211 -5.083 26.008 142.201 122.008 113.175 0.000 0.000 -3.100 
   P PM4-AC12 23.734 4.524 41.229 149.410 116.479 119.822 0.503 5.136 4.154 
   P PM4-AD01 20.547 80.864 97.903 165.300 152.080 144.512 0.000 0.000 -3.100 
   P PM4-AD02 32.228 43.492 31.458 101.432 68.212 4.583 0.000 0.000 -3.100 
   P PM4-AD03 64.347 18.309 6.949 82.603 50.101 36.943 0.000 0.000 -3.100 
   P PM4-AD04 30.804 8.059 14.355 26.907 35.105 13.761 0.000 0.000 -3.100 
   P PM4-AD05 -9.213 -5.439 -6.112 18.674 36.553 24.184 0.000 0.000 -3.100 
   P PM4-AD06 -4.666 -6.372 -4.432 73.634 49.218 30.346 0.000 0.000 -3.100 
   P PM4-AD07 -5.658 -5.112 -5.041 90.768 54.966 30.393 0.000 0.000 -3.100 
   P PM4-AD08 -0.257 -4.158 51.413 174.974 146.055 92.897 0.000 0.000 -3.100 
   P PM4-AD09 -6.779 13.499 40.021 120.787 136.029 122.782 0.000 0.000 -3.100 
   P PM4-AD10 -12.914 14.726 -13.289 110.863 127.747 116.975 0.000 0.000 -3.100 
   P PM4-AD11 -4.024 -2.499 19.368 155.201 122.416 119.433 0.000 0.000 -3.100 
   P PM4-AD12 17.738 3.399 37.078 131.062 111.778 100.167 0.000 3.966 1.014 
   P PM4-AE01 -1.616 -1.066 -8.682 80.907 55.839 35.766 0.000 0.000 -3.100 
   P PM4-AE02 -5.011 -5.459 -9.833 80.351 49.846 -47.463 0.000 0.000 -3.100 
   P PM4-AE03 -10.816 -4.861 -4.325 82.941 47.021 25.553 0.000 0.000 -3.100 
   P PM4-AE04 -7.638 -7.134 -8.208 34.713 21.211 5.137 0.000 0.000 -3.100 
   P PM4-AE05 -6.763 -6.218 -7.332 60.664 33.322 15.992 0.000 0.000 -3.100 
   P PM4-AE06 -8.330 -6.582 -5.336 -1.916 -28.666 -40.380 0.000 0.000 -3.100 
   P PM4-AE07 -7.392 -7.391 -6.471 70.475 40.850 20.487 0.000 0.000 -3.100 
   P PM4-AE08 -5.188 -8.522 -5.733 41.046 19.512 -2.293 0.000 0.000 -3.100 
   P PM4-AE09 -4.916 -4.358 -4.967 145.704 72.922 53.525 0.000 0.000 -3.100 
   P PM4-AE10 47.220 9.176 54.762 176.179 140.717 130.710 0.000 0.000 -3.100 
   P PM4-AE11 -9.992 3.508 3.767 1.838 -13.674 -26.737 0.000 1.412 -1.558 
   P PM4-AE12 45.934 27.799 48.125 160.713 128.400 130.667 0.000 0.000 -2.597 
   S PM4-AF01 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
   S PM4-AF02 3.441 -0.101 -1.853 79.425 79.026 74.303 0.000 0.000   
   S PM4-AF03 192.607 160.508 146.010 96.636 87.126 84.274 0.000 0.000 0.000 
   S PM4-AF04 179.574 164.603 136.870 104.876 82.816 78.193 0.000 0.000 0.000 
   S PM4-AF05 166.420 124.759 98.622 79.207 75.039 74.111 0.000 0.000 0.000 
   S PM4-AF06 180.543 157.907 139.333 73.172 95.418 81.084 0.000 0.000 0.000 
   S PM4-AF07 175.554 150.195 135.151 69.974 92.067 88.722 0.000 0.000 0.000 
   S PM4-AF08 176.199 166.482 145.654 107.866 103.375 87.049 0.000 0.000 0.000 
   S PM4-AF09 163.796 163.922 147.695 19.230 76.391 62.539 0.000 0.000 0.000 
   S PM4-AF10 -3.180 -4.018 -7.874 -1.634 2.141 2.003 0.000 0.000 0.000 
   S PM4-AF11 4.030 8.634 0.575 -0.862 16.767 3.093 0.000 0.000 0.000 
   S PM4-AF12 162.564 140.708 123.125 18.422 52.647 53.226 1.203 1.225 2.588 
   S PM4-AG01 -0.668 -1.526 -1.095 105.749 1.839 0.651 1.805 1.611 0.795 
   S PM4-AG02 57.934 58.067 40.364 6.128 15.039 3.049 0.000 0.000 0.000 
   S PM4-AG03 181.575 154.942 134.641 91.770 86.261 76.926 0.000 0.000 0.000 
   S PM4-AG04 204.475 176.053 157.489 121.817 97.236 83.705 0.000 0.000 0.000 
   S PM4-AG05 165.355 25.330 13.507 61.733 3.982 -5.797 0.000 0.000 0.000 
   S PM4-AG06 25.380 34.092 1.207 12.441 38.053 13.342 0.000 0.000 0.000 
   S PM4-AG07 176.850 146.238 129.578 113.667 118.142 114.450 0.000 0.000 0.000 
   S PM4-AG08 138.288 125.513 105.285 67.259 89.895 69.974 0.000 0.000 0.000 
   
253 
S PM4-AG09 180.024 144.409 139.475 141.645 135.838 141.692 0.000 0.000 0.000 
   S PM4-AG10 172.629 142.817 119.516 86.661 113.526 112.212 0.000 0.000 0.000 
   S PM4-AG11 159.791 137.612 123.789 93.912 103.847 103.250 0.000 0.000 0.000 
   S PM4-AG12 -0.757 -1.761 -0.771 -2.941 0.717 1.164 3.995 4.063 5.359 
   S PM4-AH01 151.968 110.154 105.784 58.324 68.024 59.249 2.803 1.788 2.216 
   S PM4-AH02 27.053 32.964 24.988 20.661 32.745 12.634 0.000 0.000 1.005 
   S PM4-AH03 40.650 2.057 1.991 6.557 5.139 -4.189 0.000 0.000 0.000 
   S PM4-AH04 11.120 9.391 7.351 1.943 15.316 0.011 0.000 0.000 0.000 
   S PM4-AH05 32.188 24.051 14.475 3.807 28.011 1.645 0.000 0.000 0.000 
   S PM4-AH06 83.996 81.445 53.807 -1.164 35.829 2.042 0.000 0.000 0.000 
   S PM4-AH07 86.434 80.762 58.399 17.934 43.989 13.975 0.000 0.000 0.000 
   S PM4-AH08 2.342 2.816 2.924 5.313 2.999 3.430 0.000 0.000 0.000 
   S PM4-AH09 0.362 1.220 0.653 -1.712 4.525 2.905 0.000 0.000 0.000 
   S PM4-AH10 3.457 1.822 1.267 -6.551 -0.382 1.779 0.000 0.000 0.000 
   S PM4-AH11 -0.238 -1.630 -1.691 -5.391 -3.683 -2.222 0.000 0.000 0.503 
   S PM4-AH12 -0.028 -2.549 0.458 -5.645 -0.620 1.580 3.436 4.892 8.084 
     
254 
Table 9.10: Positive signal values and significant changes compared to BT 1B strain 8081 for 
Y. enterocolitica biotypes. p – p value; ∧/∨  - significantly higher/lower activity. 
   BT 1A BT 1B BT 2 BT 3 BT 3 BT 4 BT 5 
 
Nutrient sources 
 
5303 8081 21202 5603 14902 1203 3094 
    
p 
   
p 
  
p 
  
p 
  
p 
  
p 
 
C L-­‐Arabinose	   PM1-­‐A02	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   0.030	   ∧	 +	   0.000	   ∨	 
C 
N-­‐Acetyl-­‐D-­‐
Glucosamine	  
PM1-­‐A03	   +	   0.045	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	  
C D-­‐Galactose	   PM1-­‐A06	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   0.000	   ∨	 
C D-­‐Mannose	   PM1-­‐A11	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	  
C Glycerol	   PM1-­‐B03	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   0.050	   ∨	 +	   	  	   	  	   +	   0.004	   ∨	 
C D-­‐Glucuronic	  Acid	   PM1-­‐B05	   +	   0.009	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   0.000	   ∨	 
C D-­‐Gluconic	  Acid	   PM1-­‐B06	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   0.012	   ∨	 +	   0.000	   ∨	 
C 
D,L-­‐a-­‐Glycerol	  
Phosphate	  
PM1-­‐B07	   +	   0.001	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   0.018	   ∧	 +	   	  	   	  	  
C D-­‐Mannitol	   PM1-­‐B11	   +	   0.006	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	  
C D-­‐Ribose	   PM1-­‐C04	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   0.014	   ∨	 +	   	  	   	  	   +	   0.001	   ∨	 
C D-­‐Fructose	   PM1-­‐C07	   +	   	  	   	  	   +	   +	   0.044	   ∧	 +	   0.005	   ∧	 +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	  
C a-­‐D-­‐Glucose	   PM1-­‐C09	   +	   	  	   	  	   +	   +	   0.033	   ∧	 +	   0.010	   ∧	 +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	  
C Sucrose	   PM1-­‐D11	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	  
C D-­‐Glucose-­‐1-­‐Phosphate	   PM1-­‐E03	   +	   0.010	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   0.000	   ∨	 
C 2'-­‐Deoxyadenosine	   PM1-­‐E11	   +	   0.000	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   0.005	   ∧	 +	   0.007	   ∨	 
C Adenosine	   PM1-­‐E12	   +	   0.000	   ∧	 +	   +	   0.018	   ∧	 +	   	  	   	  	   +	   0.001	   ∧	 +	   0.012	   ∧	 +	   	  	   	  	  
C D-­‐Cellobiose	   PM1-­‐F11	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   0.018	   ∨	 
C Inosine	   PM1-­‐F12	   +	   0.000	   ∧	 +	   +	   0.006	   ∧	 +	   0.004	   ∧	 +	   0.002	   ∧	 +	   0.000	   ∧	 +	   	  	   	  	  
C L-­‐Serine	   PM1-­‐G03	   +	   0.000	   ∧	 +	   +	   0.018	   ∧	 +	   	  	   	  	   +	   	  	   	  	   +	   0.037	   ∧	 +	   0.000	   ∨	 
C 
N-­‐Acetyl-­‐D-­‐
Mannosamine	  
PM1-­‐G08	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   0.000	   ∨	 
C Methylpyruvate	   PM1-­‐G10	   +	   0.007	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   0.002	   ∨	 
C glycyl-­‐L-­‐proline	   PM1-­‐H01	   +	   	  	   	  	   +	   +	   0.008	   ∧	 +	   0.023	   ∧	 +	   	  	   	  	   +	   	  	   	  	   +	   0.000	   ∨	 
C Pyruvic	  Acid	   PM1-­‐H08	   +	   0.001	   ∧	 +	   +	   0.015	   ∧	 +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   0.000	   ∨	 
C D-­‐Galacturonic	  Acid	   PM1-­‐H10	   +	   0.000	   ∧	 +	   +	   0.007	   ∧	 +	   0.015	   ∧	 +	   	  	   	  	   +	   0.029	   ∧	 +	   0.000	   ∨	 
C Pectin	   PM2-­‐AA12	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	  
C 
N-­‐Acetyl-­‐Neuraminic	  
Acid	  
PM2-­‐AB02	   +	   0.002	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   0.000	   ∨	 
C D-­‐Glucosamine	   PM2-­‐AE05	   +	   0.003	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   0.000	   ∨	 +	   	  	   	  	   +	   0.000	   ∨	 
C D-­‐Trehalose	   PM1-­‐A10	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
C D-­‐Sorbitol	   PM1-­‐B02	   +	   0.008	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
C D-­‐Glucose-­‐6-­‐Phosphate	   PM1-­‐C01	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
C Acetic	  Acid	   PM1-­‐C08	   +	   0.005	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.001	   ∨	 
C Maltose	   PM1-­‐C10	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
C Uridine	   PM1-­‐D12	   +	   0.001	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   0.005	   ∧	 	  	   	  	   	  	  
C 
D-­‐Fructose-­‐6-­‐
Phosphate	  
PM1-­‐E04	   +	   	  	   	  	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
C b-­‐Methyl-­‐D-­‐Glucoside	   PM1-­‐E08	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
C Maltotriose	   PM1-­‐E10	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
C Glycyl-­‐L-­‐glutamic	  acid	   PM1-­‐G01	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
C L-­‐Alanine	   PM1-­‐G05	   +	   0.000	   ∧	 +	   +	   0.000	   ∧	 +	   0.002	   ∧	 +	   	  	   	  	   +	   0.041	   ∧	 	  	   0.000	   ∨	 
C L-­‐alanyl-­‐glycine	   PM1-­‐G06	   +	   0.003	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
C Gentiobiose	   PM2-­‐AC01	   +	   	  	   	  	   +	   +	   0.001	   ∧	 +	   0.003	   ∧	 +	   	  	   	  	   +	   0.004	   ∧	 	  	   0.000	   ∨	 
C L-­‐Sorbose	   PM2-­‐AD04	   +	   0.001	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
C 5-­‐Keto-­‐D-­‐Gluconic	  Acid	   PM2-­‐AE12	   +	   0.000	   ∧	 +	   +	   0.001	   ∧	 +	   0.006	   ∧	 +	   0.003	   ∧	 	  	   0.000	   ∨	 	  	   0.000	   ∨	 
255 
C 2-­‐Deoxy-­‐D-­‐Ribose	   PM2-­‐AB09	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 	  	   0.001	   ∨	 	  	   0.000	   ∨	 
C D-­‐Xylose	   PM1-­‐B08	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   0.003	   ∨	 	  	   0.000	   ∨	 +	   0.000	   ∨	 
C Succinic	  Acid	   PM1-­‐A05	   +	   	  	   	  	   +	   +	   	  	   	  	   	  	   	  	   	  	   	  	   0.005	   ∨	 	  	   0.013	   ∨	 +	   	  	   	  	  
C D,L-­‐Malic	  Acid	   PM1-­‐C03	   +	   	  	   	  	 +	   +	   	  	   	  	   	  	   	  	   	  	   	  	   0.016	   ∨	 	  	   0.027	   ∨	 +	   	  	   	  	  
C Fumaric	  Acid	   PM1-­‐F05	   +	   0.007	   ∧	 +	   +	   0.045	   ∨	 	  	   0.001	   ∨	 	  	   0.000	   ∨	 	  	   0.001	   ∨	 +	   	  	   	  	  
C L-­‐Aspartic	  Acid	   PM1-­‐A07	   +	   	  	   	  	   +	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   0.004	   ∨	 	  	   0.011	   ∨	 +	   	  	   	  	  
C L-­‐Malic	  Acid	   PM1-­‐G12	   +	   	  	   	  	   +	   +	   	  	   	  	   	  	   	  	   	  	   	  	   0.007	   ∨	 +	   0.035	   ∨	 +	   	  	   	  	  
C L-­‐Glutamic	  Acid	   PM1-­‐B12	   +	   	  	   	  	   +	   +	   	  	   	  	   	  	   	  	   	  	   	  	   0.016	   ∨	 +	   	  	   	  	   	  	   0.020	   ∨	 
C Glycyl-­‐L-­‐aspartic	  acid	   PM1-­‐F01	   +	   0.043	   ∧	 +	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   +	   	  	   	  	   	  	   	  	   	  	  
C Arbutin	   PM2-­‐AB08	   +	   0.000	   ∧	 +	   	  	   0.000	   ∨	 	  	   0.000	   ∨	 	  	   0.000	   ∨	 +	   0.000	   ∨	 	  	   0.000	   ∨	 
C 
N-­‐Acetyl-­‐D-­‐
galactosamine	  
PM2-­‐AB01	   +	   0.000	   ∧	 	  	   +	   0.000	   ∧	 +	   0.000	   ∧	 +	   0.000	   ∧	 +	   0.000	   ∧	 	  	   	  	   	  	  
C D-­‐Alanine	   PM1-­‐A09	   +	   0.000	   ∨	 +	   	  	   0.000	   ∨	 	  	   0.000	   ∨	 	  	   0.000	   ∨	 	  	   0.000	   ∨	 	  	   0.000	   ∨	 
C L-­‐Asparagine	   PM1-­‐D01	   +	   	  	   	  	   +	   	  	   	  	   	  	   	  	   0.027	   ∨	 	  	   0.003	   ∨	 	  	   0.007	   ∨	 	  	   0.009	   ∨	 
C Dextrin	   PM2-­‐AA06	   +	   	  	   	  	   +	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
C succinamic	  acid	   PM2-­‐AF10	   +	   	  	   	  	   +	   	  	   	  	   	  	   	  	   0.006	   ∨	 	  	   0.002	   ∨	 	  	   0.005	   ∨	 	  	   0.004	   ∨	 
C L-­‐Histidine	   PM2-­‐AG06	   +	   0.001	   ∧	 +	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
C D-­‐Serine	   PM1-­‐B01	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
C Formic	  acid	   PM1-­‐B10	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
C 
D-­‐galactonic	  acid-­‐g-­‐
lactone	  
PM1-­‐C02	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
C tween	  20	   PM1-­‐C05	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
C thymidine	   PM1-­‐C12	   +	   0.006	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   0.002	   ∨	 
C a-­‐D-­‐lactose	   PM1-­‐D09	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
C Lactulose	   PM1-­‐D10	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
C L-­‐glutamine	   PM1-­‐E01	   +	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
C Bromo	  succinic	  acid	   PM1-­‐F06	   +	   0.003	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
C mono	  methyl	  succinate	   PM1-­‐G09	   +	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
C D-­‐Arabitol	   PM2-­‐AB06	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   0.045	   ∧	 
C 
3-­‐0-­‐b-­‐D-­‐
Galactopyranosyl-­‐D-­‐
arabinose	  
PM2-­‐AB12	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
C b-­‐Methyl-­‐D-­‐galactoside	   PM2-­‐AC07	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
C D-­‐Raffinose	   PM2-­‐AD01	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
C Salicin	   PM2-­‐AD02	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
C Glycogen	   PM1-­‐A08	   	  	   	  	   	  	   	  	   +	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   0.040	   ∨	 
C m-­‐Inositol	   PM1-­‐F03	   	  	   0.000	   ∨	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   0.003	   ∨	 	  	   0.000	   ∨	 
N L-­‐Asparagine	   PM3-­‐BA09	   +	   0.019	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N L-­‐Aspartic	  Acid	   PM3-­‐BA10	   +	   0.023	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N L-­‐Histidine	   PM3-­‐BB03	   +	   0.027	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   0.006	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N L-­‐Serine	   PM3-­‐BB10	   +	   0.000	   ∧	 +	   +	   0.001	   ∧	 +	   0.003	   ∧	 +	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N 
N-­‐Acetyl-­‐D-­‐
Mannosamine	  
PM3-­‐BF01	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N Adenosine	   PM3-­‐BF03	   +	   0.001	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N Ala-­‐Asp	   PM3-­‐BH01	   +	   0.030	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N Ala-­‐Gln	   PM3-­‐BH02	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N Ala-­‐Glu	   PM3-­‐BH03	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N Gly-­‐Asn	   PM3-­‐BH08	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N Gly-­‐Gln	   PM3-­‐BH09	   +	   0.020	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   0.003	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N Gly-­‐Met	   PM3-­‐BH11	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   0.012	   ∨	 	  	   0.000	   ∨	 
N Met-­‐Ala	   PM3-­‐BH12	   +	   0.000	   ∧	 +	   +	   0.023	   ∧	 +	   	  	   	  	   +	   0.007	   ∧	 +	   0.004	   ∨	 	  	   0.000	   ∨	 
N Ammonia	   PM3-­‐BA02	   +	   0.000	   ∧	 +	   +	   0.000	   ∧	 +	   0.001	   ∧	 	  	   0.000	   ∨	 +	   0.033	   ∨	 	  	   0.000	   ∨	 
256 
N Urea	   PM3-­‐BA05	   +	   0.000	   ∧	 +	   +	   0.004	   ∧	 +	   0.023	   ∧	 	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N L-­‐Alanine	   PM3-­‐BA07	   +	   0.000	   ∧	 +	   +	   0.000	   ∧	 +	   0.003	   ∧	 	  	   0.000	   ∨	 +	   0.006	   ∨	 	  	   0.000	   ∨	 
N L-­‐Arginine	   PM3-­‐BA08	   +	   0.000	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   0.012	   ∨	 	  	   0.000	   ∨	 
N L-­‐Glutamic	  Acid	   PM3-­‐BA12	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   0.008	   ∨	 	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N L-­‐Glutamine	   PM3-­‐BB01	   +	   0.027	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N Glycine	   PM3-­‐BB02	   +	   0.000	   ∧	 +	   +	   0.018	   ∧	 +	   	  	   	  	   	  	   0.003	   ∨	 +	   0.006	   ∧	 	  	   0.002	   ∨	 
N L-­‐Proline	   PM3-­‐BB09	   +	   	  	   	  	 +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   0.027	   ∨	 	  	   0.000	   ∨	 
N D-­‐Alanine	   PM3-­‐BC03	   +	   0.001	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   0.001	   ∨	 	  	   0.000	   ∨	 
N D-­‐Glucosamine	   PM3-­‐BE08	   +	   0.005	   ∧	 +	   +	   0.045	   ∧	 +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N Cytidine	   PM3-­‐BF04	   +	   0.000	   ∧	 +	   +	   0.007	   ∧	 +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N Ala-­‐Gly	   PM3-­‐BH04	   +	   0.000	   ∧	 +	   +	   0.015	   ∧	 +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N Ala-­‐His	   PM3-­‐BH05	   +	   0.000	   ∧	 +	   +	   0.000	   ∧	 +	   0.000	   ∧	 	  	   0.000	   ∨	 +	   0.000	   ∧	 	  	   0.000	   ∨	 
N Ala-­‐Leu	   PM3-­‐BH06	   +	   0.000	   ∧	 +	   +	   0.003	   ∧	 +	   0.000	   ∧	 	  	   0.019	   ∨	 +	   	  	   	  	   	  	   0.010	   ∨	 
N Ala-­‐Thr	   PM3-­‐BH07	   +	   0.000	   ∧	 +	   +	   0.000	   ∧	 +	   0.000	   ∧	 	  	   0.000	   ∨	 +	   0.001	   ∨	 	  	   0.000	   ∨	 
N Gly-­‐Glu	   PM3-­‐BH10	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
N L-­‐Threonine	   PM3-­‐BB11	   +	   0.025	   ∧	 +	   +	   	  	   	  	   	  	   	  	   	  	   	  	   0.033	   ∨	 +	   	  	   	  	   	  	   0.013	   ∨	 
N L-­‐Methionine	   PM3-­‐BB07	   +	   0.009	   ∧	 +	   +	   	  	   	  	   	  	   0.035	   ∨	 	  	   0.001	   ∨	 	  	   	  	   	  	   	  	   0.001	   ∨	 
N 
N-­‐Acetyl-­‐D-­‐
Glucosamine	  
PM3-­‐BE11	   +	   	  	   	  	   +	   	  	   	  	   	  	   +	   0.020	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
N g-­‐Amino-­‐N-­‐Butyric	  Acid	   PM3-­‐BG08	   +	   	  	   	  	   +	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   0.016	   ∨	 +	   	  	   	  	   	  	   0.010	   ∨	 
N 
e-­‐Amino-­‐N-­‐Caproic	  
Acid	  
PM3-­‐BG09	   +	   	  	   	  	   +	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   0.018	   ∨	 +	   	  	   	  	   	  	   0.011	   ∨	 
N L-­‐Phenylalanine	   PM3-­‐BB08	   +	   0.000	   ∧	 +	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   0.001	   ∨	 
N D-­‐Asparagine	   PM3-­‐BC04	   +	   0.000	   ∧	 +	   	  	   0.000	   ∨	 	  	   0.000	   ∨	 	  	   0.000	   ∨	 	  	   0.000	   ∨	 	  	   0.000	   ∨	 
N L-­‐Cysteine	   PM3-­‐BA11	   +	   	  	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   	  	   	  	   	  	   	  	   0.026	   ∨	 
N D,L-­‐Lactamide	   PM3-­‐BE07	   +	   0.000	   ∧	 	  	   +	   0.003	   ∧	 +	   0.010	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
N 
D,L-­‐a-­‐Amino-­‐N-­‐Butyric	  
Acid	  
PM3-­‐BG07	   +	   	  	   	  	   	  	   +	   0.006	   ∧	 +	   0.000	   ∧	 	  	   0.012	   ∨	 	  	   0.041	   ∨	 	  	   0.015	   ∨	 
N 
N-­‐Acetyl-­‐D-­‐
Galactosamine	  
PM3-­‐BE12	   +	   	  	   	  	   	  	   +	   0.001	   ∧	 +	   0.000	   ∧	 	  	   	  	   	  	   +	   	  	   	  	   	  	   	  	   	  	  
N L-­‐Leucine	   PM3-­‐BB05	   +	   0.000	   ∧	 	  	   	  	   0.029	   ∧	 	  	   0.034	   ∧	 	  	   	  	   	  	   +	   	  	   	  	   	  	   	  	   	  	  
N Xanthosine	   PM3-­‐BG02	   +	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   0.020	   ∨	 +	   	  	   	  	   	  	   0.018	   ∨	 
N 
D,L-­‐a-­‐amino-­‐caprylic	  
acid	  
PM3-­‐BG10	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   +	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
N L-­‐Tryptophan	   PM3-­‐BB12	   	  	   	  	   	  	   +	   	  	   0.018	   ∨	 	  	   0.016	   ∨	 	  	   0.012	   ∨	 	  	   0.017	   ∨	 	  	   0.009	   ∨	 
N xanthine	   PM3-­‐BG01	   	  	   	  	   	  	   +	   	  	   0.006	   ∨	 	  	   0.001	   ∨	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   0.000	   ∨	 
N L-­‐Isoleucine	   PM3-­‐BB04	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   0.028	   ∧	 	  	   0.049	   ∨	 
N L-­‐Valine	   PM3-­‐BC02	   +	   0.001	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   0.047	   ∨	 	  	   	  	   	  	   	  	   	  	   	  	  
N D-­‐Serine	   PM3-­‐BC08	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
N L-­‐Ornithine	   PM3-­‐BC12	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
N cytosine	   PM3-­‐BF05	   +	   	  	   	  	   	  	   	  	   0.000	   ∨	 	  	   0.000	   ∨	 	  	   	  	   	  	   	  	   0.000	   ∨	 	  	   0.000	   ∨	 
N Uric	  Acid	   PM3-­‐BG03	   +	   0.001	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
N a-­‐Amino-­‐N-­‐Valeric	  Acid	   PM3-­‐BG12	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
P 
adenosine-­‐3'.5'-­‐cyclic	  
monphosphate	  (3',5'	  
cyclic	  AMP)	  
PM4-­‐AA12	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
P 
D-­‐glucosamine-­‐6-­‐
phosphate	  
PM4-­‐AC06	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   +	   0.002	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P dithiophosphate	   PM4-­‐AB02	   +	   0.000	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   0.001	   ∧	 	  	   	  	   	  	   	  	   0.000	   ∨	 
P phosphate	   PM4-­‐AA02	   +	   0.000	   ∧	 +	   +	   	  	   	  	   +	   0.041	   ∧	 	  	   0.001	   ∨	 	  	   	  	   	  	   	  	   0.001	   ∨	 
P carbamyl	  phosphate	   PM4-­‐AB05	   +	   0.000	   ∧	 +	   +	   	  	   	  	   +	   0.003	   ∧	 	  	   0.000	   ∨	 	  	   	  	   	  	   	  	   0.000	   ∨	 
P 6-­‐phospho-­‐gluconic	   PM4-­‐AC07	   +	   0.000	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 	  	   0.033	   ∨	 	  	   0.000	   ∨	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acid	  
P 
D-­‐mannose-­‐6-­‐
phosphate	  
PM4-­‐AD02	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 	  	   0.004	   ∨	 	  	   0.000	   ∨	 
P o-­‐phospho-­‐D-­‐serine	   PM4-­‐AD05	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   0.003	   ∧	 	  	   0.000	   ∨	 	  	   0.047	   ∨	 	  	   0.000	   ∨	 
P o-­‐phospho-­‐L-­‐serine	   PM4-­‐AD06	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   0.016	   ∧	 	  	   0.000	   ∨	 	  	   	  	   	  	   	  	   0.000	   ∨	 
P o-­‐phospho-­‐L-­‐threonine	   PM4-­‐AD07	   +	   0.000	   ∧	 +	   +	   	  	   	  	   +	   0.016	   ∧	 	  	   0.000	   ∨	 	  	   	  	   	  	   	  	   0.000	   ∨	 
P 
O-­‐phosphoryl-­‐
ethanolamine	  
PM4-­‐AE05	   +	   0.000	   ∧	 +	   +	   0.029	   ∧	 +	   0.002	   ∧	 	  	   0.000	   ∨	 	  	   	  	   	  	   	  	   0.000	   ∨	 
P 
thymidine-­‐3'-­‐
monophosphate	  
PM4-­‐AE09	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 	  	   	  	   	  	   	  	   0.000	   ∨	 
P 
adenosine-­‐3'-­‐
monophosphate	  (3'-­‐
AMP)	  
PM4-­‐AA09	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P 
D,L-­‐alpha-­‐glycerol	  
phosphate	  
PM4-­‐AB03	   +	   0.010	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P 
beta-­‐glycerol	  
phosphate	  
PM4-­‐AB04	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P 
guanosine-­‐2'-­‐
monophosphate	  
PM4-­‐AB08	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P 
guanosine-­‐3'-­‐
monophosphate	  
PM4-­‐AB09	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.026	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P 
guanosine-­‐5'-­‐
monophosphate	  
PM4-­‐AB10	   +	   0.030	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.002	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P 
guanosine-­‐2',3'-­‐cyclic	  
monophosphate	  
PM4-­‐AB11	   +	   0.018	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P 
guanosine-­‐3',5'-­‐cyclic	  
monophosphate	  
PM4-­‐AB12	   +	   0.036	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.017	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P D-­‐glucose-­‐1-­‐phosphate	   PM4-­‐AC03	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.001	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P 
cytidine-­‐2'-­‐
monophosphate	  
PM4-­‐AC08	   +	   0.005	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P 
cytidine-­‐2',3'-­‐cyclic	  
monophosphate	  
PM4-­‐AC11	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P 
cytidine-­‐3',5'-­‐cyclic	  
monophosphate	  
PM4-­‐AC12	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P 
uridine-­‐3'-­‐
monophosphate	  
PM4-­‐AD09	   +	   0.042	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P 
uridine-­‐2',3'-­‐cyclic	  
monophosphate	  
PM4-­‐AD11	   +	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P 
uridine-­‐3',5'-­‐cyclic	  
monophosphate	  
PM4-­‐AD12	   +	   0.026	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P 
thymidine-­‐5'-­‐
monophosphate	  
PM4-­‐AE10	   +	   0.021	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P 
thymidine-­‐3',5'-­‐cyclic	  
monophosphate	  
PM4-­‐AE12	   +	   0.003	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
P thiophosphate	   PM4-­‐AB01	   +	   0.000	   ∧	 	  	   +	   0.045	   ∧	 +	   0.006	   ∧	 +	   0.000	   ∧	 	  	   	  	   	  	   	  	   0.013	   ∨	 
P pyrophosphate	   PM4-­‐AA03	   +	   0.000	   ∧	 	  	   +	   0.015	   ∧	 +	   0.005	   ∧	 	  	   0.047	   ∨	 	  	   	  	   	  	   	  	   	  	   	  	  
P trimetaphosphate	   PM4-­‐AA04	   +	   0.000	   ∧	 	  	   +	   0.320	   ∧	 +	   0.003	   ∧	 	  	   0.003	   ∨	 	  	   	  	   	  	   	  	   0.004	   ∨	 
P tripolyphosphate	   PM4-­‐AA05	   +	   0.000	   ∧	 	  	   +	   0.007	   ∧	 +	   0.001	   ∧	 	  	   0.050	   ∨	 	  	   	  	   	  	   	  	   0.047	   ∨	 
P 
D-­‐2-­‐phospho-­‐glyceric	  
acid	  
PM4-­‐AB06	   +	   0.000	   ∧	 	  	   +	   	  	   	  	   +	   0.021	   ∧	 	  	   0.007	   ∨	 	  	   	  	   	  	   	  	   0.010	   ∨	 
P 
D-­‐3-­‐phospho-­‐glyceric	  
acid	  
PM4-­‐AB07	   +	   0.000	   ∧	 	  	   +	   0.011	   ∧	 +	   0.001	   ∧	 	  	   0.000	   ∨	 	  	   	  	   	  	   	  	   0.001	   ∨	 
P 
phosphoenoly	  
pyruvate	  
PM4-­‐AC01	   +	   0.000	   ∧	 	  	   +	   0.026	   ∧	 +	   0.003	   ∧	 	  	   0.003	   ∨	 	  	   	  	   	  	   	  	   0.003	   ∨	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P phospho-­‐glycolic	  acid	   PM4-­‐AC02	   +	   0.000	   ∧	 	  	   +	   	  	   	  	   +	   0.005	   ∧	 	  	   0.000	   ∨	 	  	   	  	   	  	   	  	   0.001	   ∨	 
P 
cysteamine-­‐S-­‐
phosphate	  
PM4-­‐AD03	   +	   0.000	   ∧	 	  	   +	   	  	   	  	   +	   0.019	   ∧	 	  	   	  	   	  	 	  	   	  	   	  	   	  	   0.003	   ∨	 
P phospho-­‐L-­‐arginine	   PM4-­‐AD04	   +	   0.000	   ∧	 	  	   +	   	  	   	  	   +	   0.004	   ∧	 	  	   0.002	   ∨	 	  	   0.015	   ∨	 	  	   0.000	   ∨	 
P phosphocreatine	   PM4-­‐AE03	   +	   0.000	   ∧	 	  	   +	   0.028	   ∧	 +	   0.004	   ∧	 	  	   0.003	   ∨	 	  	   	  	   	  	   	  	   0.005	   ∨	 
P phosphoryl	  choline	   PM4-­‐AE04	   +	   0.000	   ∧	 	  	   +	   	  	   	  	   +	   0.003	   ∧	 	  	   0.005	   ∨	 	  	   	  	   	  	   	  	   0.008	   ∨	 
P 
adenosine-­‐2'-­‐
monophosphate	  
PM4-­‐AA08	   +	   0.000	   ∧	 	  	   +	   0.032	   ∧	 +	   0.003	   ∧	 	  	   	  	   	  	   +	   0.038	   ∧	 	  	   0.010	   ∨	 
P O-­‐phospho-­‐D-­‐tyrosine	   PM4-­‐AE01	   +	   0.002	   ∧	 	  	   +	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
P 
uridine-­‐2'-­‐
monophosphate	  
PM4-­‐AD08	   +	   0.046	   ∧	 	  	   	  	   	  	   	  	   +	   	  	   	  	   	  	   	  	   	  	   +	   	  	   	  	   	  	   	  	   	  	  
P 
D-­‐mannose-­‐1-­‐
phosphate	  
PM4-­‐AD01	   +	   	  	   	  	   +	   	  	   	  	   	  	   +	   	  	   	  	   	  	   	  	   	  	   +	   	  	   	  	   	  	   0.006	   ∨	 
P 
2-­‐aminoethyl	  
phosphonic	  acid	  
PM4-­‐AE07	   +	   0.001	   ∧	 +	   	  	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 	  	   	  	   	  	   	  	   0.000	   ∨	 
P 
adenosine-­‐2',3'-­‐cyclic	  
monophosphate	  
PM4-­‐AA11	   	  	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   	  	   	  	   	  	   +	   	  	   	  	   	  	   0.027	   ∨	 
P D-­‐glucose-­‐6-­‐phosphate	   PM4-­‐AC04	   	  	   	  	   	  	   +	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.015	   ∨	 +	   	  	   	  	   	  	   0.005	   ∨	 
P 
cytidine-­‐3'-­‐
monophosphate	  
PM4-­‐AC09	   	  	   	  	   	  	   +	   +	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   0.024	   ∨	 
P 
cytidine-­‐5'-­‐
monophosphate	  
PM4-­‐AC10	   	  	   0.000	   ∨	 +	   	  	   	  	   	  	   +	   	  	   	  	   	  	   0.007	   ∨	 +	   	  	   	  	   	  	   0.004	   ∨	 
P 
uridine-­‐5'-­‐
monophosphate	  
PM4-­‐AD10	   	  	   	  	   	  	   +	   	  	   	  	   	  	   +	   	  	   	  	   	  	   	  	   	  	   +	   	  	   	  	   	  	   0.039	   ∨	 
P O-­‐phospho-­‐L-­‐tyrosine	   PM4-­‐AE02	   	  	   0.043	   ∧	 	  	   +	   	  	   	  	   +	   0.046	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
P 
adenosine-­‐5'-­‐
monophosphate	  
PM4-­‐AA10	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   +	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
P phosphono	  acetic	  acid	   PM4-­‐AE06	   +	   0.000	   ∧	 	  	   	  	   0.026	   ∧	 	  	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
P inositol	  hexaphosphate	   PM4-­‐AE11	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
S thiosulfate	   PM4-­‐AF03	   +	   0.000	   ∧	 +	   +	   0.003	   ∧	 +	   0.007	   ∧	 +	   0.026	   ∧	 +	   	  	   	  	   	  	   0.000	   ∨	 
S tetrathionate	   PM4-­‐AF04	   +	   0.000	   ∧	 +	   +	   0.002	   ∧	 +	   0.003	   ∧	 +	   0.012	   ∧	 +	   	  	   	  	   	  	   0.000	   ∨	 
S thiophosphate	   PM4-­‐AF05	   +	   0.012	   ∧	 +	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.001	   ∨	 
S dithiophosphate	   PM4-­‐AF06	   +	   0.000	   ∧	 +	   +	   0.004	   ∧	 +	   0.012	   ∧	 +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
S L-­‐cysteine	   PM4-­‐AF07	   +	   0.010	   ∧	 +	   +	   0.015	   ∧	 +	   0.029	   ∧	 +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
S D-­‐cysteine	   PM4-­‐AF08	   +	   0.000	   ∧	 +	   +	   0.000	   ∧	 +	   0.000	   ∧	 +	   0.001	   ∧	 +	   	  	   	  	   	  	   0.000	   ∨	 
S cystathionine	   PM4-­‐AG03	   +	   0.000	   ∧	 +	   +	   0.002	   ∧	 +	   0.003	   ∧	 +	   0.026	   ∧	 +	   	  	   	  	   	  	   0.000	   ∨	 
S lanthionine	   PM4-­‐AG04	   +	   0.001	   ∧	 +	   +	   0.006	   ∧	 +	   0.010	   ∧	 +	   0.013	   ∧	 +	   	  	   	  	   	  	   0.000	   ∨	 
S L-­‐methionine	   PM4-­‐AG07	   +	   0.002	   ∧	 +	   +	   0.018	   ∧	 +	   0.036	   ∧	 +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
S D-­‐methionine	   PM4-­‐AG08	   +	   0.001	   ∧	 +	   +	   0.015	   ∧	 +	   0.008	   ∧	 +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
S glycyl-­‐L-­‐methionine	   PM4-­‐AG09	   +	   0.001	   ∧	 +	   +	   0.007	   ∧	 +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
S 
N-­‐acetyl-­‐D,L-­‐
methionine	  
PM4-­‐AG10	   +	   0.002	   ∧	 +	   +	   0.021	   ∧	 +	   	  	   	  	   +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
S L-­‐methionine	  sulfoxide	   PM4-­‐AG11	   +	   0.000	   ∧	 +	   +	   0.001	   ∧	 +	   0.006	   ∧	 +	   	  	   	  	   +	   	  	   	  	   	  	   0.000	   ∨	 
S L-­‐djenkolic	  acid	   PM4-­‐AH01	   +	   0.001	   ∧	 +	   +	   0.018	   ∧	 +	   0.004	   ∧	 +	   0.049	   ∧	 +	   	  	   	  	   	  	   0.017	   ∨	 
S L-­‐cysteinyl-­‐glycine	   PM4-­‐AF09	   +	   	  	   	  	   +	   +	   0.029	   ∧	 +	   0.045	   ∧	 +	   	  	   	  	   	  	   0.002	   ∨	 	  	   0.000	   ∨	 
S L-­‐cystein	  sulfinic	  acid	   PM4-­‐AF12	   +	   0.000	   ∧	 +	   +	   0.003	   ∧	 +	   0.008	   ∧	 +	   0.005	   ∧	 	  	   	  	   	  	   	  	   0.000	   ∨	 
S sulfate	   PM4-­‐AF02	   +	   0.000	   ∧	 +	   +	   0.000	   ∧	 +	   0.001	   ∧	 	  	   0.000	   ∨	 +	   	  	   	  	   	  	   0.000	   ∨	 
S taurine	   PM4-­‐AH06	   +	   0.001	   ∧	 	  	   	  	   	  	   	  	   +	   0.024	   ∧	 	  	   0.024	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	  
S S-­‐methyl-­‐L-­‐cystein	   PM4-­‐AG02	   +	   0.000	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
S hypotaurine	   PM4-­‐AH07	   	  	   0.003	   ∧	 	  	   	  	   	  	   	  	   +	   	  	   	  	   +	   0.017	   ∧	 	  	   	  	   	  	   	  	   	  	   	  	  
S D,L-­‐ethionine	   PM4-­‐AG06	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   +	   0.002	   ∧	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